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ZUSAMMENFASSUNG	
	Homologe	 rekombination	 (HR)	 und	 Non-homologous	 end	 joining	 (NHEJ)	 sind	zwei	 Reparaturmechanismen,	 welche	 Zellen	 verwenden	 um	 DNS-Doppelstrangbrüche	(DSB)	zu	reparieren.	Der	entscheidende	Schritt	dabei	ist	die	Resektion	 der	 5'	 DNS	 Enden,	 die	mechanistisch	 den	 DNS-Reparatur	 Signalweg	bestimmt,	 indem	sie	HR	fördert	und	NHEJ	hemmt.	Aufgrund	zahlreiche	Studien	ist	bekannt,	dass	der	MRE11-RAD50-NBS1	(MRN)	Komplex	und	das	CtIP	Protein	an	 der	 Einleitung	 der	 Resektion	 beteiligt	 sind.	 Allerdings	 hat	 die	 einzige	Nuklease	 in	 dem	Komplex,	MRE11,	 entgegengestzte	 Polarität	 (3'	 zu	 5')	 zu	 der	Richtung	 der	 Resektion	 (5'	 zu	 3').	 Um	 dieses	 Rätsel	 zu	 lösen	 wurde	 ein	 so-genanntes	 bidirektionales	 Resektionsmodel	 vorgeschlagen.	 MRE11	 soll	 dabei	mithilfe	seiner	endonukleolytischer	Aktivität	Einschnitt(e)	in	der	Nähe	des	DSB	schaffen,	die	als	Einstieg	für	seine	3'	zu	5'	Exonuklease	dienen,	sodass	diese	zum	DSB	hin	arbeiten	kann.	Obwohl	dieses	Modell	das	Polaritätsparadox	 löst,	 fehlte	das	mechanistische	Verständnis	einer	solchen	endonukleolytischen	Aktivität.	Ich	zeige	 nun,	 dass	 CtIP	 die	 Endonuklease-Aktivität	 von	MRN	 an	 doppelsträngiger	DNS	 (dsDNS)	 stimuliert.	 Dabei	 ist	 die	 Phosphorylierung	 von	 CtIP	 an	 T847	absolut	notwendig	für	diesen	Effekt.	Ebenfalls	ist	das	Blockieren	der	DNS	Enden,	vor	 allem	 am	 5'	 Ende,	 erforderlich	 für	MRN-pCtIP	 Aktivität.	 Übereinstimmend	mit	 dem	 vorgeschlagenen	 Modell	 ist	 die	 Position	 des	 ersten	 Einschnittes	 von	MRN-CtIP	 ~20	 Nukleotide	 von	 dem	 5'	 DNS	 Ende	 entfernt.	 Die	endonukleolytische	 Aktivität	 ist	 spezifisch	 für	 das	 MRE11	 Protein,	 da	 die	nukleolytisch-inaktive	 (H129L	 D130V)	 Variante	 von	 MRE11	 keine	 Einschnitte	vollbringen	 kann.	 Weiterhin	 zeigen	 RAD50	 Mutanten,	 die	 entweder	 kein	 ATP	mehr	binden	(RAD50K42A),	oder	hydrolisieren	(RAD50K42R)	können,	ebenfalls	keine	 endonukleolytische	 Aktivität.	 Somit	 sind	 auch	 RAD50	 und	 seine	 ATPase	Aktivität	notwendig	 für	die	Einschnitte	von	MRN.	 Interessanterweise,	 auch	das	Enfernen	von	NBS1	aus	dem	MRN	Komplex	führt	zum	Verlust	der	Endonuklease-Aktivität,	 im	 Unterschied	 zur	 Hefe.	 Somit	 zeigt	 meine	 Arbeit,	 dass	 NBS1	 und	RAD50	 unabdingbare	 Komponenten	 des	 MRN	 Komplexes	 sind,	 um	 die	
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Endonuklease-Aktivität	von	MRE11	im	Menschen	zu	stimulieren.	Es	ist	bekannt,	dass	 CtIP	 tetramerisiert,	 indem	 es	 ein	 Dimer	 von	 Dimeren	 über	 seinen	 N-Terminus	 bildet.	 Diese	 Oligomerisation	 von	 CtIP	 ist	 wichtig	 für	 seine	 in	 vivo	Funktionen	in	HR.	Ich	habe	die	pCtIP	L27E	Mutante,	die	keine	Tetramere,	jedoch	aber	Dimere	 bilden	 kann,	 analysiert.	 Ich	 fand	heraus,	 dass	 die	Oligomerisation	von	CtIP	notwendig	für	seine	Funktion	ist,	da	die	Mutante	nur	sehr	schlecht	die	Endonuklease-Aktivität	von	MRN	stimulieren	konnte.	Ausserdem,	wenn	man	die	160	 N-terminalen	 Aminosäuren	 von	 CtIP,	 die	 für	 Dimerisation	 und	Tetramerisation	verantwortlich	sind,	entfernt	(1-160∆	pCtIP),	kann	das	Protein	ebenfalls	 die	 Endonuklease	 von	 MRN	 nur	 sehr	 schlecht	 stimulieren.	 Im	Unterschied	 zur	Hefe,	 kann	CtIP	die	 endonukleolytische	Aktivität	 von	MRN	am	ssDNS	zirkularen	Plasmid	 fördern.	Zudem	sind	Mg2+,	Mn2+	und	ATP	wichtig	 für	optimale	MRN-pCtIP	Aktivität.		In	meinem	zweiten	Projekt	habe	 ich	mich	mit	der	homologe	Rekombination	 in	der	Meisose	befasst.	Meiotische	HR	führt	zur	Bildung	von	sogenannten	„double	Holliday	 junctions“	 (dHJ)	 während	 der	 Reparatur	 von	 programmierten	 DSB.	Durch	 einen	 bisher	 unbekannten	Mechanismus	werden	 die	 dHJ	 zu	 „crossover“	(CO)	weiterverarbeitet,	 welche	 zu	 erhöhter	 genetischer	 Diversität	 führt.	 Es	 ist	sehr	 wahrscheinlich,	 dass	 in	 meiotische	 Zellen	 der	 MLH1-MLH3	 (MutLγ)	Komplex,	eine	mutmassliche	Endonuklease,	für	das	Prozessieren	von	dHJs	zu	CO	Produkten	 verantwortlich	 ist.	 Zusätzliche	 wurde	 gezeigt,	 dass	 MSH4-MSH5	(MutSγ)	 eine	 Funktion	 im	MutLγ-abhängigen	Mechanismus	 hat.	Während	 sehr	viele	 genetische	 Daten	 diese	 Mechanismen	 zum	 Schneiden	 von	 dHJs	 durch		MutLγ	 und	 zusätzlichen	 Proteine	 belegen,	 konnte	 der	 mechanistische	Hintergrund	dazu	noch	nicht	aufgezeigt	werden.	Zusammen	mit	Nicolas	Weyland	habe	ich	begonnen,	MLH1-MLH3	zusammen	mit	MSH4-MSH5	auf	biochemischer	Ebene	 zu	 charakterisieren.	 Wir	 haben	 gezeigt,	 dass	 MutLγ	 vorzugsweise	 dHJs	und	ähnliche	Strukturen	bindet.	Weitere	Experimente	zeigten,	dass	vorallem	der	Kern	von	dHJs	gebunden	werden.			Ich	 konnte	 zeigen,	 dass	 hMutLγ,	 in	 Reaktionen	 welche	 Mn2+	 beinhalten,	unspezifisch	 einen	 Strang	 von	 doppelsträngige	 DNS	 schneidet.	 Diese	 Aktivität	
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konnte	 nicht	 mit	 der	 Nuklease-inaktiven	 hMutLγ	 (MLH1-MLH3D1223N)	Mutante	 gesehen	 werden,	 was	 darauf	 hindeutet,	 dass	 die	 Aktivität	 tatsächlich	durch	hMutLγ	katalysiert	wurde.	Die	Aktivität	wurde	durch	die	Präsenz	von	ATP	in	der	Reaktion	weiter	verstärkt.			Mit	 Hilfe	 von	 aufgereinigtem	 hMutSγ	 konnte	 ich	 bestätigen,	 dass	 der	 Komplex	bevorzugterweise	 an	 HJ	 bindet	 als	 an	 doppelsträngige	 DNS	 und	 dass	 der	Komplex,	nachdem	er	ATP	gebunden	hat,	an	den	HJ-Armen	entlang	gleitet.		Wir	zeigten	auch,	dass	hMutLγ	direkt	mit	MutSγ	interagiert	in	vitro.	Des	Weitere	konnten	wir	 zeigen,	 dass	 hMutLγ	 	 zusammen	mit	 	MutSγ	 an	HJ	 bindet.	 Dieser	Effekt	scheint	spezifisch	für	HJ	zu	sein,	da	mit	doppelsträngiger	DNS	keine	solche	Beobachtungen	gemacht	wurden.	Zusammengefasst	deutet	das	darauf	hin,	dass	h	MutSγ	den	hMutLγ-DNS	Komplex	stabilisiert.			
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SUMMARY		Cells	 utilize	 two	 major	 pathways	 to	 repair	 DNA	 double	 strand	 breaks	 (DSB)	including	 homologous	 recombination	 (HR)	 and	 non-homologous	 end	 joining	(NHEJ).	DNA	end	 resection	of	 the	5'-terminated	DNA	at	DSBs	 is	 the	 key	 event,	which	mechanistically	determines	 the	 repair	pathway	 choice	by	promoting	HR	while	 inhibiting	 NHEJ.	 Numerous	 studies	 have	 established	 the	 role	 of	 the	MRE11-RAD50-NBS1	 (MRN)	 complex	 and	 CtIP	 in	 the	 initiation	 of	 resection.	However,	the	nucleolytic	polarity	of	the	only	nuclease	in	the	complex,	MRE11,	is	the	opposite	(3'	to	5')	to	the	direction	of	resection	(5'	to	3').	To	solve	this	enigma,	a	 so-called	 bidirectional	 resection	 model	 has	 been	 proposed.	 MRE11	 was	anticipated	 to	make	 incision(s)	close	 to	 the	DSB	by	 its	endonucleolytic	activity,	which	 creates	 an	 entry	 site	 for	 its	 3'	 to	 5'	 exonuclease	 that	 proceeds	 back	towards	 the	 DSB.	 Although	 this	 model	 solves	 the	 polarity	 paradox,	 the	mechanistic	 understanding	 of	 such	 nicking	 activity	 by	 MRE11	 was	 undefined.	Here	 I	 show	 that	 CtIP	 stimulates	 the	 endonuclease	 activity	 of	MRN	 on	 double	stranded	 DNA	 (dsDNA).	 Phosphorylation	 of	 CtIP	 (pCtIP)	 at	 T847	 is	 absolutely	required	for	this	stimulatory	effect.	The	blocking	of	DNA	ends,	especially	at	the	5'	end,	 is	 required	 to	 observe	 this	 MRN-pCtIP	 activity.	 In	 agreement	 with	 the	proposed	model,	the	position	of	the	first	incision	by	MRN-pCtIP	complex	maps	to	[symbol	about]	20	nucleotides	away	from	the	5'	DNA	end.	The	nicking	activity	is	intrinsic	to	MRE11,	as	nuclease-dead	(H129L	D130V)	variant	of	MRE11	does	not	show	any	clipping	activity.	Additionally,	RAD50	mutants	deficient	in	ATP	binding	(RAD50K42A)	 or	 ATP	 hydrolysis	 (RAD50K42R),	 fail	 to	 show	 any	 clipping	activity,	 indicating	 the	 essential	 role	 of	 RAD50	 and	 its	 ATPase	 activity.	Interestingly,	the	removal	of	NBS1	from	MRN	complex	results	 in	the	loss	of	the	clipping	 activity.	 Therefore,	 unlike	 in	 yeast,	 my	 work	 establishes	 NBS1	 as	 the	indispensable	component	of	the	MRN	complex	together	with	RAD50	to	stimulate		MRE11-catalyzed	 clipping	 activity	 in	 humans.	 CtIP	 tetramerizes	 by	 making	 a	dimer	 of	 dimers	 through	 its	 amino-terminus	 and	 such	 oligomerization	 is	important	 for	 its	 in	vivo	 functions	 in	HR.	The	analysis	of	pCtIP	L27E	mutant,	 in	which	 tetramerization	 is	 abolished	while	dimerization	 is	preserved,	 revealed	 a	reduced	capacity	 to	promote	MRN,	suggesting	 that	proper	oligomeric	structure	
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of	CtIP	is	likely	essential	for	its	optimal	activity.	Furthermore,	the	deletion	of	160	amino	acids	from	the	amino-terminus	of	CtIP	(1-160∆	pCtIP),	which	disrupts	the	CtIP	 dimerization	 and	 consequently	 its	 tetramerization	 as	 well,	 reduces	 the	pCtIP	 capacity	 to	 stimulate	 MRN	 drastically.	 In	 contrast	 to	 yeast,	 pCtIP	 also	stimulates	 the	 MRN	 endonuclease	 on	 ssDNA	 circular	 plasmid.	 In	 terms	 of	 co-factors,	Mg2+,	Mn2+	and	ATP	were	found	to	be	important	for	the	optimum	activity	of	of	MRN-pCtIP.		My	second	project	was	 focused	on	meiotic	homologous	 recombination.	Meiotic	HR	favours	the	formation	of	double	Holliday	junctions	(dHJ)	as	intermediates	of	programmed	 DSB	 repair.	 These	 are,	 by	 a	 yet	 unknown	mechanism,	 processed	exclusively	 to	 preferentially	 to	 crossovers	 (CO	 to	 facilitate	 the	 production	 of	genetic	diversity.	Meiotic	cells	have	a	dedicated	and	biased	mechanism	in	place	to	ensure	the	formation	of	obligate	COs.	MLH1-MLH3	(MutLγ)	has	been	strongly	implicated	in	meiosis	as	a	putative	endonuclease	responsible	for	cleaving	dHJs	in	a	 biased	manner	 to	 produces	 COs.	 Additionally,	MSH4-MSH5	 (MutSγ)	 has	 also	been	shown	to	function	in	the	MutLγ	mediated	pathway.	Despite	the	availability	of	extensive	genetic	data,	the	mechanistic	understanding	of	the	biased	cleavage	of	 dHJs	by	MutLγ	 and	 its	 partners	 remains	 elusive.	Here,	 in	 collaboration	with	Nicolas	Weyland,	 I	set	out	to	study	and	characterize	the	biochemical	behaviour	of	human	MLH1-MLH3	in	conjunction	with	human	MSH4-MSH5.	Previously,	we	showed	 that	 hMutLγ	 prefers	 binding	 to	 HJs	 and	 similar	 structures.	 Further	analysis	indicated	that	it	presumably	binds	to	the	core	of	a	HJ.	Here	I	could	show	that	hMutLγ	nicks	super-coiled	dsDNA	non-specifically	 in	the	presence	of	Mn2+.	No	 such	 activity	 with	 nuclease-dead	 hMutLγ	 (MLH1-MLH3D1223N)	 was	observed,	proving	that	the	observed	activity	is	intrinsic	to	hMutLγ.	The	presence	of	ATP	further	simulates	the	nicking	activity	of	hMutLγ.	Using	purified	hMutSγ,	I	could	confirm	that	it	prefers	binding	to	HJs	over	dsDNA	and	slides	upon	HJ	arms	upon	 ATP	 binding.	 We	 could	 also	 show	 that	 hMutLγ	 directly	 interacts	 with	hMutSγ	 in	 vitro.	 Furthermore,	 DNA	 binding	 analysis	 of	 hMutLγ	 and	 hMutSγ	revealed	 that	 hMutLγ	 binds	 cooperatively	 to	 HJ	 with	 hMutSγ.	 No	 such	observation	with	 dsDNA	 emphasizes	 the	 specific	 nature	 of	 the	 observed	 effect	
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with	HJ.	The	data	also	indicates	that	hMutSγ	further	stabilizes	the	hMutLγ-DNA	complex.			
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1.	Introduction		Cell	 theory,	 originally	 formulated	 in	 1838	 by	 Theodor	 Schwann	 and	 Matthias	Jacob	 Schlieden,	 states	 that	 all	 life	 forms	 arise	 from	 pre-existing	 life	 (Sharp,	1921).	 At	 the	 most	 basic	 level,	 the	 process	 of	 cell	 division	 ensures	 this	continuation	of	 life	on	earth.	 In	unicellular	organisms	cell	division	 is	 important	for	their	further	proliferation	whereas	in	multicellular	organisms,	 it	 is	required	for	 both	 propagation	 of	 their	 species	 as	well	 as	 for	 normal	 development	 of	 an	individual	organism.			Each	 cell	 division	 accompanies	 duplication	 of	 its	 entire	 structure	 and	constituents,	 which	 include	 DNA	 as	 well.	 DNA	 is	 one	 of	 the	 most	 important	constituents	of	the	cell	as	it	contains	overall	instruction	for	creating	an	individual	organism	(Alberts	et	al.,	2015).	The	process	of	duplication	of	DNA	known	as	DNA	replication	 must	 be	 carefully	 regulated	 to	 accurately	 copy	 the	 genetic	information	from	mother	cell	to	daughter	cell.	A	single	error	in	replication	may	lead	 to	 unfavourable	mutation,	which	may	 in	 turn	 predispose	 an	 individual	 to	various	diseases	including	cancer.	Therefore	high	fidelity	in	copying	DNA	during	replication	is	of	utmost	importance	to	the	cells.	The	cells	must	avoid	any	damage	and	 irreversible	 loss	 of	 DNA	 sequence,	 as	 once	 lost	 or	 altered	 cells	 have	 no	means	to	recover	the	original	information.			Other	 than	 the	 errors	 caused	during	 replication	 infidelity,	 both	 endogenous	 as	well	as	exogenous	sources	can	physically	damage	DNA.	While	exogenous	sources	include	UV	radiation,	X-rays,	mutagenic	chemicals	etc.,	endogenous	damage	can	occur	 by	metabolites	 such	 as	 reactive	 oxygen	 species	 (ROS),	 reactive	 nitrogen	species	 (NOS),	 lipid	 peroxidation	 products	 etc.,	 which	 are	 produced	 during	various	 cellular	 processes	 (Cadet	 and	 Wagner,	 2013)	 .	 Similarly	 obstacles	encountered	 during	 normal	 process	 of	 DNA	 replication	 may	 lead	 to	 strand	discontinuities.	 Depending	 on	 the	 kind	 of	 damage	 different	 DNA	 lesions	 may	arise,	 which	 may	 be	 toxic	 to	 the	 cells.	 Fortunately,	 with	 millions	 of	 years	 of	evolution	 cells	 have	 developed	 an	 array	 of	 different	 pathways	 to	 repair	 such	
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lesions.	These	DNA	 repair	pathways	 are	highly	 conserved	 from	prokaryotes	 to	humans.		In	 summary,	 when	 cells	 face	 any	 DNA	 damage	 their	 fate	 is	 decided	 by	 their	ability	 to	repair	 that	damage.	Depending	on	the	DNA	lesion,	cells	recognize	the	problem	and	activate	appropriate	repair	pathway(s)	to	repair	the	damage.	Once	damage	is	repaired	cells	can	continue	to	perform	their	normal	 function.	On	the	other	 hand,	 if	 cells	 fail	 to	 repair	 the	 lesions,	 cells	 can	 initiate	 the	 process	 of	programmed	cell	death	such	as	apoptosis	and	consequently	be	removed	from	the	cell	 pool.	However,	 in	 rare	 instances	when	 repair	 is	not	 entirely	 accurate	or	 is	defective	it	can	lead	to	alteration	of	DNA	sequence	of	important	genes,	which	are	required	 for	 cell	 maintenance	 and	 proliferation.	 These	 alterations	 can	 either	inactivate	the	tumour	suppressor	genes	or	activate	the	oncogenes,	which	in	turn	can	 result	 in	uncontrolled	 cellular	proliferation.	This	uncontrolled	 growth	may	eventually	give	rise	to	cancer.		
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1.1.	Nature	and	sources	of	DNA	lesions			The	 integrity	 of	 DNA	 structure	 and	 its	 sequence	 is	 important	 for	 its	 normal	function.	 DNA	 itself	 is	 a	 highly	 stable	 molecule,	 though	 spontaneous	 damage	occurs	frequently	due	to	biochemical	nature	of	DNA	(Figure	1).	For	instance,	N-glycosidic	bond	between	pentose	sugar	and	bases	 is	 labile	 in	nature	and	hence	can	spontaneously	break	even	under	normal	conditions.	Each	single	cell	 looses	approximately	 2000-10,000	 purines	 per	 day	 due	 to	 spontaneous	 breakage	(Lindahl,	1993;	Lindahl	and	Nyberg,	1972).	Similarly,	100-500	cytosine	bases	are	converted	 into	 uracil	 bases	 per	 cell	 every	 day	 by	 the	 process	 of	 deamination	(Barnes	and	Lindahl,	2004).	Additionally,	 reactive	metabolites	 like	ROS,	methyl	donor	 S-adenosylmethionine	produced	 during	 normal	 cellular	metabolism	 have	the	 potential	 to	 react	 with	 DNA	 to	 alter	 its	 structure	 (Rydberg	 and	 Lindahl,	1982).	 It	 has	 been	 estimated	 that	 oxidative	 DNA	 damage	 alone	 in	 humans	produces	10,000	DNA	lesions	per	cell	per	day	(Fraga	et	al.,	1990).	The	exogenous	sources	such	as	ultraviolet	(UV)	radiation	from	sunlight	can	form	in	between	two	adjacent	 pyrimidines	 (Grossman	 et	 al.,	 1988).	 	 On	 the	 other	 hand,	 mutagenic	chemicals	present	in	the	environment	including	acetaldehyde	can	produce	DNA	"adducts"	whereas	substances	like	cisplatin	can	crosslink	DNA	strand	in	between	the	 same	 (intra)	 or	 opposite	 (inter)	 strands	 (Wozniak	 and	 Blasiak,	 2002).	 All	such	 DNA	 lesions	 if	 not	 repaired	 in	 time	 can	 present	 an	 obstacle	 during	replication	or	 transcription	 influencing	 the	normal	division	and	 survival	 of	 the	cells.	Apart	from	DNA	base	modifications,	adducts	and	crosslinking,	DNA	strands	can	 break	 directly	 upon	 impact	 from	 high-energy	 radiations	 like	 ionizing	radiations	 (IR)	 (Liu	 et	 al.,	 2000;	 Lomax	 et	 al.,	 2013;	 Santivasi	 and	 Xia,	 2014).	Other	 than	 IR,	 certain	 chemicals	 like	 camptothecin	 (CPT)	 and	 etoposide	 can	indirectly	produce	DNA	breaks	by	 inhibiting	topoisomerases	activity	(Liu	et	al.,	2000;	Walles	et	al.,	1996).	As	mentioned	earlier,	breaks	can	occur	either	in	one	or	both	DNA	strands	known	as	SSB	and	DSB,	respectively.	In	certain	conditions,	if	SSB	 persists	 for	 a	 long	 time,	 it	 can	 be	 converted	 into	 a	 DSB.	 For	 instance,	 the	replication	of	parental	 strand	containing	a	SSB	results	 in	one	ended	DSB	when	the	 replication	 fork	 reaches	 the	 affected	 region	 (Mehta	 and	 Haber,	 2014).	Similarly,	 when	 two	 SSBs	 occur	 nearby	 to	 each	 other	 on	 opposite	 strands	 of	
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duplex	DNA,	these	SSBs	can	turn	into	a	DSB.	The	process	of	replication	itself	can	introduce	 mutations	 by	 incorporation	 of	 mispaired	 nucleotide	 in	 the	 newly	synthesized	 strand	 by	 DNA	 polymerase	 (Pray,	 2008).	 Likewise,	 insertion	 and	deletion	of	short	DNA	sequences,	often	within	repeats,	can	also	take	place	during	replication.	
																	Figure	1.	An	overview	of	various	types	of	DNA	lesions.	(Adapted	from	Helleday	et	al,	2014	Nature	
Reviews	Genetics)		Any	damage	 resulting	 in	 the	 alteration	of	 either	 structure	or	 sequence	has	 the	potential	 to	be	 lethal	 for	the	cell.	As	many	of	these	 lesions	are	endogenous	and	can	arise	spontaneously	or	due	to	reactive	metabolites,	it	is	not	possible	for	the	cells	to	completely	avoid	DNA	damage.	To	deal	with	such	high	levels	of	routine	DNA	damage,	cells	have	developed	various	DNA	repair	pathways.	Although	most	repair	 pathways	 repair	 damage	 efficiently,	 in	 some	 instances	 the	 process	 of	repair	may	 itself	modify	 DNA.	 The	main	 lesions	 relevant	 to	my	 doctoral	work	include	single	and	double	strand	DNA	breaks.	
1.1.1	Single	strand	break	(SSB)	
	The	 integrity	 and	 continuity	 of	 DNA	 strands	 is	 important	 for	 normal	 cellular	survival	 and	 proliferation.	 DNA	 strands	 can	 break	 under	 various	 conditions	leaving	 3'	 and	 5'	 termini,	 which	 can	 accompany	 the	 loss	 of	 nucleotides	(Caldecott,	2008).	SSBs	can	be	produced	directly	upon	disintegration	of	oxidized	sugar	or	indirectly	during	repair	of	modified	DNA	lesions	by	other	sources.	They	can	 also	 occur	 due	 to	 abortive	 activity	 of	 topoisomerases	 (Wang,	 2002).	 The	unwinding	 of	 DNA,	 which	 occurs	 during	 replication	 and	 transcription,	 exerts	
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topological	 constrain	 on	 the	 DNA	 helix,	 which	must	 be	 released	 for	 continued	propagation	 of	 replication/transcription	 machinery.	 DNA	 topoisomerases	continuously	cleave	and	readily	reseal	one	or	both	strands	of	helix	 to	relax	 the	strain.	 This	 action	 of	 topoisomerases	 produces	 transient	 nicked	 DNA-protein	complex,	which	is	rapidly	resealed	by	enzymes	in	the	subsequent	reaction	step.	However,	when	this	transient	complex	encounters	RNA	or	DNA	polymerase	or	is	inhibited	by	drugs,	 it	 can	be	 converted	 into	 a	 SSB.	 If	 not	 repaired	 in	due	 time,	SSBs	can	block	replication	and	may	result	in	the	formation	of	DSBs.	They	can	also	affect	 transcription,	 as	 RNA	 polymerase	 cannot	 pass	 through	 them.	 Generally,	cells	 can	 efficiently	 repair	 these	 breaks	 but	 high	 levels	 of	 SSBs	 can	 induce	prolonged	checkpoint	activation,	resulting	in	exhaustion	of	the	repair	machinery	and	apoptosis	(Wang,	2002).			
1.1.2	Double	strand	break	(DSB)		Among	all	DNA	lesions,	DSB	is	one	of	the	most	lethal	DNA	lesions.	The	failure	to	repair	even	single	DSB	can	have	deleterious	effect	on	the	cell	(Rich	et	al.,	2000).	DSBs	are	more	dangerous	to	genomic	integrity	than	SSB	or	any	other	DNA	lesion	affecting	single	strand	because	lost	information/sequence	in	the	damaged	strand	can	 be	 restored	 by	 taking	 information	 from	 the	 intact	 complementary	 strand,	which	is	not	possible	when	both	DNA	strands	are	damaged.	As	described	above,	DSBs	can	arise	through	the	failure	to	repair	SSBs	on	time	before	DNA	replication.	Certain	 chemicals	 such	 as	 camptothecin	 or	 etoposide	 can	 trap	 the	 transient	topoisomerase-DNA	 complex	 and	 lead	 to	 single	 or	 double	 strand	 DNA	 breaks,	respectively	(Liu	et	al.,	2000;	Walles	et	al.,	1996).	Other	exogenous	sources	such	as	IR	can	directly	induce	DSBs	by	breaking	the	phosphodiester	bond	of	DNA	or	indirectly	by	producing	SSBs	through	radiolysis	of	water.	At	high	doses	of	IR,	the	formation	 of	 nicks	 in	 complementary	 strand	within	 one	 helical	 turn	 also	 gives	rise	 to	DSBs.	Any	 impediment	or	pausing	of	 replication	 fork	by	 collision	either	with	 the	 transcription	 machinery	 or	 unusual	 DNA	 structures	 can	 also	 cause	DSBs.	Despite	their	lethality,	cells	themselves,	in	certain	conditions,	deliberately	introduce	DSBs	and	exploit	their	repair	mechanism	to	their	advantage.	In	meiotic	cells,	 programmed	 DSBs	 are	 introduced	 by	 topoisomerase-like	 Spo11	(SPOrulation	11)(Keeney	et	al.,	1997).	These	DSBs	facilitate	the	genetic	exchange	
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between	 homologous	 chromosome	 and	 their	 proper	 separation	 during	transitions	to	anaphase	I	 in	meiosis	(see	more	detail	 in	section	1.5)	(Borde	and	de	 Massy,	 2013).	 Similarly,	 DSBs	 are	 introduced	 during	 VJD	 and	 class-switch	recombination	(Bassing	et	al.,	2002;	Stavnezer	et	al.,	2008).	The	consequences	of	failure	to	repair	DSBs	can	be	multiple	and	may	include	genomic	 instability,	cell	death	and	neoplastic	transformation	in	multicellular	organisms	(Mladenov	et	al.,	2016).	 DSBs	 can	 be	 generally	 repaired	 by	 either	 non-homologous	 end	 joining	(NHEJ)	or	homologues	recombination	(HR)	pathways.			
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1.2	DNA	repair	pathways		
1.2.1	Base	excision	repair	(BER)		BER	 is	 responsible	 for	 correcting	 modified	 bases,	 which	 induce	 a	 minimal	structural	 distortion	 in	 DNA	 helix	 structure.	 These	 modifications	 primarily	involve	deamination,	oxidation	and	methylation.	BER	pathway	can	generally	be	divided	 into	 five	 sequential	 steps:	 lesion	 recognition	 and	 removal	 of	 damaged	base,	 incision	 of	 abasic	 site,	 processing	 of	 terminated	 end,	 gap	 filling	 by	 DNA	polymerase	and	 final	 ligation	of	 strand	 (Krokan	and	Bjoras,	2013).	BER	begins	with	 recognition	 and	 removal	 of	 damaged	 base	 by	 a	 specific	 DNA	 glycosylase	enzyme.	 Different	 types	 of	 damaged	 bases	 are	 recognized	 and	 processed	 by	distinct	DNA	glycosylases.	In	mammals,	11	glycosylases	have	been	discovered	to	date	 (Jacobs	 and	 Schar,	 2012;	 Svilar	 et	 al.,	 2011).	 Upon	 recognition,	 the	glycosylase	 flips	 the	 damaged	 base	 out	 and	 cleaves	 the	 N-glycosidic	 bond	between	the	base	and	sugar	creating	an	abasic	site	(Huffman	et	al.,	2005).	Such	sites	 are	 recognized	 by	 AP	 endonucleases,	 which	 create	 nicks	 required	 for	further	 processing	 (Mol	 et	 al.,	 2000).	 Certain	 glycosylases	 function	 as	 bi-functional	enzymes	posses	also	the	nuclease	activity	and	do	not	require	the	AP	endonuclease	 (Jacobs	 and	 Schar,	 2012).	 Nicking	 of	 abasic	 sites	 by	 AP	endonuclease	or	bi-functional	glycosylase	can	produce	non-conventional	5'	or	3'	termini,	 which	 can	 be	 refractory	 to	 DNA	 synthesis	 or	 nick	 ligation.	 Therefore,	such	 termini	must	be	processed.	Cells	posses	 specialised	proteins,	which	 carry	out	this	function.	For	instances,	polymerase	Pol	β	in	humans	additionally	posses	dRP	 lyase	 which	 functions	 to	 remove	 5'-dRP	 moiety,	 making	 nicked	 termini	suitable	 for	 ligation	 (Beard	 et	 al.,	 2006;	 Loeb	 and	 Monnat,	 2008).	 PNKP	 is	another	primary	enzyme	that	removes	blocking	3'-PO4	group	and	prepares	 the	nicked	 ends	 for	 ligation	 (Bernstein	 et	 al.,	 2005).	 In	 a	 subsequent	 step,	 DNA	polymerase	β	must	fill	the	remaining	gap.	Finally,	the	remaining	nick	is	sealed	by	a	DNA	ligase,	which	completes	the	BER.	
1.2.2	Nucleotide	excision	repair	(NER)		NER	 removes	 bulky	 DNA	 lesions,	 which	 result	 in	 a	 significant	 DNA	 helix	
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distortion.	 The	 prominent	 lesions	 repaired	 by	 NER	 include	 UV-induced	 cyclo	pyrimidine	 dimers	 (CPDs),	 6-4	 photoproducts	 (6-4	 PPs),	 adducts	 formed	 by	chemical	 mutagens	 such	 as	 benzo[a]pyrene	 or	 cisplatin,	 ROS-generated	cyclopurines	 and	 various	 other	 bulky	 lesions	 (Scharer,	 2013).	 As	with	 all	DNA	lesions,	their	detection	is	of	paramount	importance	for	their	repair.	In	NER,	the	bulkiness	 and	 thermodynamic	 destabilization	 induced	 by	 DNA	 lesions	 are	 key	factors	 for	 their	 recognition.	 NER	 pathway	 can	 be	 sub-categorized	 into	 global	genome-NER	(GG-NER)	and	transcription-coupled	NER		(TC-NER)	depending	on	occurrence	of	damage	and	its	mode	of	detection.	In	GG-NER,	various	DNA	bulky	lesions,	which	can	be	chemically	different	in	structures,	are	detected	directly	by	XPC-RAD23B	 complex.	 This	 remarkable	 ability	 of	 XPC-RAD23B	 stems	 from	 its	binding	capacity	to	ssDNA	produced	due	to	distortion	or	destabilization	of	DNA	(Gunz	et	al.,	1996;	Huang	et	al.,	1992;	Liu	et	al.,	2011;	Sugasawa	et	al.,	1998).	In	CPD	 detection,	 which	 mildly	 destabilizes	 DNA	 (Reardon	 and	 Sancar,	 2003;	Sugasawa	 et	 al.,	 2001)	 and	 hence	 is	 only	 poorly	 detected	 by	 XPC	 itself,	 the	recognition	is	aided	by	UV-DDB	complex	(Scharer	and	Campbell,	2009;	Sugasawa	et	 al.,	 2005).	 After	 lesion	 recognition,	 another	 protein	 complex	 TFIIH	(transcription	 initiation	 factor	 IIH)	 that	 is	 composed	 of	 10	 protein	 subunits	 is	recruited	to	damage	site	(Araujo	et	al.,	2001;	Compe	and	Egly,	2012;	Evans	et	al.,	1997;	 Riedl	 et	 al.,	 2003;	 Volker	 et	 al.,	 2001;	 Yokoi	 et	 al.,	 2000).	 Two	 protein	subunits	 of	 TFIIH,	 XPB	 and	 XPD	 possess	 a	 helicase	 activity	 (Coin	 et	 al.,	 2007).	Structural	studies	of	XPB	and	XPD	homologs	in	various	organisms	indicate	that	while	 XPB	 is	 required	 for	TFIIH	 anchoring	 by	DNA	melting	 upon	ATP	binding,	XPD	 subsequently	 translocate	 5'	 to	 3'	 to	 detect	 and	 verify	 the	 lesion	 (Scharer,	2013).	 XPD	 translocation	 is	 stalled	 by	 the	 presence	 of	 the	 DNA	 lesion	 hence	verifying	its	presence.	Once	verification	by	XPD	is	complete,	the	assembly	of	the	pre-incision	 complex,	 which	 includes	 XPA,	 RPA	 and	 XPG	 takes	 place.	 XPA	 is	considered	the	central	coordinator	of	the	NER	reaction	as	it	interacts	with	TFIIH,	RPA,	 XPC-RAD23B,	 DDB2,	 ERCC1-XPF	 and	 PCNA	 proteins	 (Bunick	 et	 al.,	 2006;	Gilljam	 et	 al.,	 2012;	 Li	 et	 al.,	 1994;	 Nocentini	 et	 al.,	 1997;	 Park	 et	 al.,	 1995;	Wakasugi	et	al.,	2009;	You	et	al.,	2003).	It	specifically	binds	to	kink	DNA	and	not	directly	 to	 the	DNA	 lesion,	hence	making	sure	everything	 is	 ready	and	 in	place	for	dual	incision	in	next	step	(Camenisch	et	al.,	2006;	Missura	et	al.,	2001).	The	
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structure	 specific	 nuclease	 XPG	 that	 is	 recruited	 through	 TFHII	 has	 both	structural	and	catalytic	roles.	The	second	endonuclease,	ERCC1-XPF	is	recruited	to	 DNA	 lesion	 by	 its	 interaction	 with	 XPA.	 RPA	 plays	 an	 important	 role	 in	coordinating	 excision	 and	 synthesis	 events	 by	 binding	 to	 non-damaged	 ssDNA	and	hence	helping	 to	position	both	nucleases	 correctly	on	 the	damaged	 strand	(Camenisch	et	al.,	2006).	Once	both	nucleases	are	in	place,	the	initial	5'	incision	is	made	by	ERCC1-XPF,	which	is	capable	of	 initiating	repair	synthesis.	XPG	makes	second	incision	3'	to	lesion	and	this	results	in	the	excision	and	release	of	22-30	nucleotides	containing	the	lesion	and	the	TFIIH	complex	with	it	(Fagbemi	et	al.,	2011).	 	The	gap	produced	by	 the	oligonucleotide	release	 is	 filled	by	DNA	pol	δ	and	pol	ε	with	PCNA,	RFC,	and	RPA	(Araujo	et	al.,	2000;	Ogi	and	Lehmann,	2006;	Shivji	et	al.,	1995).	Some	studies	have	also	implicated	translesion	polymerase	pol	κ	to	be	involved	in	DNA	synthesis	(Moser	et	al.,	2007;	Ogi	and	Lehmann,	2006).	The	 final	 step	 of	 sealing	 the	 nick	 is	 carried	 out	 by	 DNA	 ligase	 I	 (Moser	 et	 al.,	2007).		Transcription-coupled	 NER	 (TC-NER)	 specifically	 repairs	 DNA	 lesions,	 which	inhibit	transcription	by	blocking	the	transcript	elongation	by	RNA	polymerase	II	(Vermeulen	and	Fousteri,	 2013).	Damage	detection	 is	 therefore	 indirect	 in	TC-NER	 and	 hence	 does	 not	 require	 XPC-RAD23B.	 During	 transcription,	 UVSSA,	USP7	and	Cockayne	syndrome	protein	CSB	transiently	 interact	with	RNA	pol	 II	(Fei	and	Chen,	2012;	Yang,	2008).	The	stalling	of	RNA	pol	 II	by	 the	DNA	 lesion	stabilizes	 the	 interaction	 between	 CSB	 and	 CSA	 factors.	 The	 CSB-CSA	 complex	has	been	proposed	to	push	RNA	pol	II	backwards	exposing	the	lesion	and	making	it	 accessible	 for	 TFIIH	 to	 bind.	 From	 this	 step	 onwards,	 the	 TC-NER	 pathway	follows	 the	 same	 mechanism	 as	 described	 for	 GG-NER.	 	 As	 TC-NER	 is	 always	associated	 with	 transcription,	 the	 efficiency	 of	 NER	 is	 higher	 in	 actively	transcribed	regions	in	comparison	to	transcriptionally	silent	regions	(Vermeulen	and	Fousteri,	2013;	Yang,	2008).	
1.2.3	Post-replicative	mismatch	repair	(MMR)		DNA	replication	is	an	extremely	accurate	process	for	copying	DNA	due	to	strict	DNA	base-complementarity,	high	fidelity	and	proof	reading	exonuclease	activity	
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of	 the	 replicative	 polymerases.	 	 Despite	 such	 measures,	 errors	 such	 as	 non-canonical	 mismatched	 base	 pairing	 and	 insertion-deletion	 loops	 still	 occur	during	 replication	 at	 the	 rate	 of	 about	 1:1,000,000	 (Arana	 and	 Kunkel,	 2010).	Microsatellite	 instability	 (MSI),	 which	 is	 caused	 by	 alteration	 in	 number	 of	microsatellite	repeats	by	IDLs,	 is	one	of	the	characteristics	of	defective	MMR	in	humans	 (Boland	 and	 Goel,	 2010).	 Essentially,	 MMR	 pathway	 involves	 3	 steps:	recognition	 of	 the	 mispair	 or	 IDL,	 removal	 of	 the	 wrongly	 incorporated	nucleotide	and	resynthesis	of	DNA.	Repair	of	mispaired	nucleotides	and	IDLs	in	higher	 eukaryotes	 begins	 with	 recognition	 by	 heterodimers	 MSH2-MSH6	(MutSα)	and	MSH2-MSH3	(MutSβ)	respectively	(Jiricny,	2013).	While	MutSα	can	recognize	 single	 mismatches	 as	 well	 as	 1-2	 unpaired	 nucleotides,	 MutSβ	recognizes	 IDLs	 of	 2-10	 nucleotides	 in	 length.	 Both	 subunits	 of	 the	 MutS	complexes	contain	Walker	ATP	binding	motif	in	their	C-terminal	regions	(Jiricny,	2006).	 Although	 their	mode	 of	 substrate	 recognition	 is	 slightly	 different,	 upon	recognition,	 the	 repair	 involves	 the	 same	 set	 of	 proteins	 and	 follows	 same	pathway.		Here,	I	only	describe	the	repair	of	mismatches	or	1-2nt	long	IDLs.	Initially,	MutSα	encircles	DNA	and	slides	loosely	on	DNA	unless	it	encounters	a	mismatch.	Upon	recognition	of	the	mismatch,	MutSα	bends	DNA,	which	brings	its	conformational	change	resulting	in	ADP-ATP	exchange	and	inhibition	of	ATP	hydrolysis.	The	ATP	binding	 releases	 MutSα	 from	 the	 mismatch	 and	 it	 subsequently	 moves	 away	from	 the	mismatch	 freely	as	a	 sliding	clamp	(Jiricny,	2006).	 In	 subsequent	and	not	 very	 well	 understood	 step,	 the	 MLH1-PMS2	 (MutLα)	 heterodimer	 is	recruited	 and	 forms	 a	 ternary	 complex	 with	 MutSα	 and	 duplex	 DNA.	 MutLα	forms	a	heterodimer	through	its	C-terminal	domain	and	similarly	to	MutSα,	it	is	proposed	 to	 encircle	 DNA	 by	 further	 dimerization	 of	 its	 amino-terminal	nucleotide	 binding	 domains	 (Guarne,	 2012).	 The	 mismatch	 containing	 strand	must	be	degraded	to	remove	the	mispaired	nucleotide.	However,	as	both	strands	in	duplex	contain	undamaged	nucleotides	at	the	mismatch	site,	 it	 is	challenging	for	the	cells	to	determine	"correct"	nascent	DNA	strand	to	degrade.	To	overcome	this	problem,	cells	use	the	discontinuities	within	the	newly	synthesized	strands	as	 markers	 for	 strand	 degradation.	 The	 strand	 excision	 is	 carried	 out	 by	
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exonuclease	EXO1	that	has	a	5'	to	3'	polarity	(Tran	et	al.,	2004a).	While	5'	to	3'	degradation	 of	 the	 error	 containing	 lagging	 DNA	 strand	 by	 EXO1	 is	straightforward	 due	 to	 its	 discontinuous	 synthesis	 by	 Okazaki	 fragments,	situation	 becomes	 more	 complex	 when	 error	 occurs	 in	 the	 leading	 strand	(Claverys	and	Lacks,	1986).	As	 replication	occurs	 in	 the	5'	 to	3'	direction,	only	free	3'	end	is	available	for	EXO1	in	the	leading	strand	for	degradation.	Due	to	its	opposite	polarity,	EXO1	is	unable	to	degrade	the	error	containing	leading	strand	directly.	To	overcome	this	paradox,	MutLα	comes	into	the	action	with	its	cryptic	endonuclease	 activity.	 The	 activation	 of	 MutLα	 latent	 endonuclease	 activity	minimally	 requires	 a	 mismatch,	 MutSα,	 RFC,	 PCNA	 and	 ATP.	 Once	 MutLα	 is	enzymatically	 active,	 it	 endonucleolytically	 nicks	 the	 strand	past	 the	mismatch	and	 hence	 creates	 the	 entry	 point	 for	 EXO1	 to	 degrade	 the	 strand	 in	 5'	 to	 3'	direction	 resulting	 in	 the	 removal	 of	 the	 mismatch	 (Dzantiev	 et	 al.,	 2004;	Kadyrov	 et	 al.,	 2006).	 Strand	 excision	 is	 followed	 by	 the	 resynthesis	 of	 the	degraded	strand	by	DNA	polymerase	delta	(δ)	and	replication	resumes	normally	(Wu	et	al.,	2003).	
1.2.4	Double	strand	break	repair	(DSBR)		The	DSBs	present	serious	threat	for	the	cell	survival	and	genomic	stability.	The	failure	 to	 repair	 even	 a	 single	 DSB	 can	 lead	 to	 cell	 death	 (Rich	 et	 al.,	 2000).	Moreover,	 incorrect	 DSB	 repair	 may	 also	 lead	 to	 genomic	 instability	 by	chromosomal	 aberration	 (Jeggo	 and	 Lobrich,	 2015).	 Decades	 of	 research	 have	resulted	in	the	development	of	various	experimental	tools,	which	can	distinguish	the	use	of	particular	pathway	for	repair	of	natural	and	artificially	induced	DSBs.	By	 taking	advantage	of	 such	 tools	 in	 combination	with	other	 techniques,	 it	has	been	well	established	that	cells	can	repair	DSBs	either	by	non-homologous	end	joining	 (NHEJ)	 or	 homologous	 recombination	 (HR)	 (Figure	 2).	 Various	 factors	such	as	the	source	(exo-	vs.	endogenous)	and	nature	of	DSBs	(Double	sided	end	(DSE)	vs	single	sided	end	(SSE),	DNA	end	structure	 (ligatable	vs.	non-ligatable,	presence	of	non-canonical	chemistry),	cell	cycle	stage	(G1	vs.	S	&	G2),	repair	end	goal	(accurate	or	mutagenic)	influence	the	DSB	repair	pathway	choice	(Ceccaldi	et	 al.,	 2016).	 To	 deal	 with	 such	 different	 requirements,	 both	 NHEJ	 and	 HR	processes	use	several	related	yet	distinct	sub-pathways	of	their	own.		
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									Figure	 2.	 Double	 strand	 break	 repair	 pathways	 choice.	 The	 occurrence	 of	 DNA	 end	 resection	determines	the	repair	pathway	choice.	When	extensive	end	resection	is	suppressed	in	G1	phase,	C-NHEJ	is	favoured.	In	S	and	G2	phase,	resection	is	promoted	by	various	HR	factors	and	therefore	HR,	 SSA	 and	 Alt-EJ	 can	 repair	 DSBs.	 Alt-EJ	 can	 also	 occur	 in	 G1	 phase	 as	 well	 due	 to	 limited	resection	(adapted	from	Ceccaldi	et	al,	2016	Trends	in	Cell	Biology).	Generally,	NHEJ	is	efficient	but	error-prone,	whereas	HR	is	relatively	slower	but	more	accurate.	 In	NHEJ,	DSBs	are	 repaired	by	a	direct	 ligation	of	broken	ends,	which	is	followed	by	sealing	of	the	gap	by	a	DNA	ligase	(Davis	and	Chen,	2013).	The	propensity	of	error	occurrence	during	repair	by	NHEJ	primarily	depends	on	the	nature	of	 the	 lesion.	For	example,	DSBs	produced	by	a	nuclease	with	 intact	complementary	 overhangs,	 i.e.	 "clean"	 breaks,	 can	 be	 re-ligated	 with	 perfect	accuracy	 without	 any	 error	 (Feldmann	 et	 al.,	 2000;	 Kabotyanski	 et	 al.,	 1998;	Smith	 et	 al.,	 2001;	 Smith	 et	 al.,	 2003).	However,	 naturally	 occurring	 accidental	DSBs	produced	by	various	DNA	damaging	agents	are	almost	never	"clean".	DSBs	produced	 by	 sources	 such	 as	 IR	 leave	 ends	 unsuitable	 for	 direct	 re-ligation,	known	 as	 "dirty	 ends"	 and	 hence	 require	 additional	 processing	 of	 ends	preceding	ligation	(Chiruvella	et	al.,	2013).	As	with	other	repair	pathways,	NHEJ	utilizes	multiple	proteins	to	accomplish	the	repair,	which	may	also	involve	DNA	polymerases	 and	nucleases.	Depending	upon	 the	 structure	 of	 the	broken	 ends,	DNA	overhangs	 can	 either	 be	 cleaved	by	 a	 nuclease	 or	 receding	 strand	 can	be	extended	by	a	polymerase.	The	end	processing	 is	not	coordinated	between	 the	two	ends,	which	can	result	in	processing	of	one	end	by	polymerase	and	other	by	nuclease	(Lieber,	2008).	The	blunt	ends	created	after	these	polymerase/nuclease	activities	 are	 ligated	 DNA	 ligase	 IV.	 This	 processing	 of	 ends	 may	 thus	 be	
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accompanied	by	the	insertion	(less	likely)	or	deletion	(more	likely)	of	small	DNA	fragments.	 As	 most	 DSBs	 produced	 are	 not	 "clean"	 and	 repaired	 imprecisely,	NHEJ	is	generally	considered	error	prone	DNA	repair	pathway.		Conversely,	 HR	 is	 considered	 accurate	 as	 it	 uses	 a	 homologous	 template	 for	repair	 (Jasin	 and	 Rothstein,	 2013).	 This	 process	 of	 copying	 the	 DNA	 sequence	from	 the	 homologous	 sequence	 guarantees	 accuracy	 in	 most	 cases.	 However,	similarly	 to	 NHEJ,	 repair	 outcomes	 of	 HR	 in	 terms	 of	 accuracy	 may	 differ.	Essentially,	repair	of	DSBs	by	HR	initiates	with	limited	strand	resection	of	both	5'	ends.	It	leaves	3'	overhangs,	one	of	which	finds	and	invades	the	complementary	sequence	on	 the	donor	duplex	upon	homology	search	 (Renkawitz	et	al.,	2014).	The	donor	duplex	can	either	be	a	sister	chromatid,	homologous	chromosome	or	repeated	 regions	 on	 the	 same	 or	 a	 different	 chromosome.	 The	 choice	 of	 the	donor	duplex	 is	 critical	 for	 the	overall	accuracy	of	HR.	While	 repair	by	a	 sister	chromatid	is	extremely	accurate	due	to	the	identical	DNA	sequence,	copying	DNA	from	the	homologous	chromosomes,	which	mostly	have	different	sequences,	or	from	heterologous	regions	results	in	a	"less	accurate"	outcome.	This	may	result	in	the	loss	of	heterozygosity	(LOH)	(Moynahan	and	Jasin,	2010),	which	can	lead	to	the	loss	of	a	single	functional	allele	of	an	important	gene	by	copying	the	DNA	sequence	 from	 the	 non-functional	 allele	 and	 making	 an	 individual	 prone	 to	various	diseases	including	cancer.	The	strand	invasion	is	 followed	by	extension	of	3'	 invaded	strand	by	replicative	polymerases	Pol	δ	and	Pol	ε	(Li	et	al.,	2009;	Maloisel	et	al.,	2008).	Mutations	can	arise	during	this	step	due	to	inefficient	MMR	or	when	repair	 is	carried	out	by	error-prone	translesion	polymerases	(Hicks	et	al.,	2010;	Pomerantz	et	al.,	2013;	Sebesta	et	al.,	2013).			The	DSB	repair	pathway	choice	is	primarily	determined	by	the	phase	of	the	cell	cycle	(Ceccaldi	et	al.,	2016).	While	NHEJ	 is	 functional	 throughout	 the	cell	cycle,	HR	is	only	functional	 in	S	and	G2	phase	(Chiruvella	et	al.,	2013;	Karanam	et	al.,	2012).	 The	 differential	 use	 of	 the	 repair	 pathways	 during	 various	 cell	 cycle	phases	maximizes	 the	 efficiency	 and	accuracy	of	 repair.	 Primarily	 in	G1	phase,	DSBs	 are	 repaired	 by	 NHEJ	 as	 HR	 is	 restricted	 due	 to	 obvious	 lack	 of	 sister	chromatids.	 Once	 cell	 enters	 in	 S-phase,	 HR	machinery	 can	 be	 activated.	 NHEJ	remains	 active	 in	 S	 and	 G2	 phase	 and	 still	 repairs	 the	 majority	 of	 DSBs,	 a	
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significant	number	of	DSBs	are	now	repaired	by	HR	(Hinz	et	al.,	2005;	Mao	et	al.,	2008;	Rothkamm	et	al.,	2003;	Takata	et	al.,	1998).	As	both	repair	pathways	are	simultaneously	 active	 in	 S	 and	 G2	 phase,	 they	 both	 compete	 for	 the	 same	substrate.	How	is	it	determined,	which	pathway	is	employed	for	the	DSB	repair?	Mechanistically,	DNA	end	resection	is	the	key	event	that	determined	the	choice	of	the	repair	pathway	(Symington	and	Gautier,	2011).	Once	HR	specific-	proteins	resect	 DNA	 extensively,	 it	 becomes	 unsuitable	 for	 NHEJ.	 Therefore,	 DNA	 end	resection	represents	a	committing	step	for	HR.		
1.2.4.1	Non-homologous	end	joining	(NHEJ)			NHEJ	 primarily	 involves	 the	 ligation	 of	 the	 broken	 ends	 at	 DSB	 sites.	 As	described	earlier,	the	repair	by	NHEJ	may	be	erroneous	in	nature.	This	feature	of	NHEJ	can	be	attributed	to	its	lack	of	any	inherent	mechanisms	to	restore	the	lost	sequence	and	to	guide	the	ligation	of	correct	DNA	molecules.	In	principle,	NHEJ	can	 join	 any	 two	 ends	 irrespective	 of	 their	 origin,	 which	 can	 result	 in	chromosomal	translocation	(Frit	et	al.,	2014;	Ghezraoui	et	al.,	2014;	Lieber	et	al.,	2010).	 These	 limitations	 inherent	 to	NHEJ	make	 it	more	 error-prone	 than	HR.	However,	NHEJ	is	a	guardian	of	genome	stability	as	null	phenotype	of	core	NHEJ	proteins	 like	 Ku	 show	 gross	 abnormality	 in	 efficient	 DNA	 repair	 and	 Ku70–/–	human	cells	are	not	viable	(Bogue	et	al.,	1998;	Chistiakov	et	al.,	2009;	Fattah	et	al.,	 2008;	 Gu	 et	 al.,	 1997;	 Jung	 and	 Alt,	 2004;	 Kragelund	 et	 al.,	 2016;	 Li	 et	 al.,	2007;	 Nussenzweig	 et	 al.,	 1996).	 In	 fact,	 the	 rapid	 and	 efficient	 execution	 of	repair	 by	 NHEJ	 makes	 it	 a	 preferred	 choice	 in	 DSB	 repair.	 Thus	 sequence	alteration	 by	 NHEJ	 is	 therefore	 a	 small	 price	 to	 pay	 for	 maintaining	 overall	genomic	stability.			As	described	earlier,	DNA	end	joining	by	NHEJ	can	occur	by	several	related	yet	distinct	NHEJ	mechanisms	(Chiruvella	et	al.,	2013).	Majority	of	DSBs	are	repaired	by	canonical	or	classical	form	of	NHEJ	(C-NHEJ),	which	specifically	requires	the	DNA-PK	 holoenzyme.	 Alternative-NHEJ	 or	 as	more	 aptly	 described	 as	 Alt-EJ	 is	another	 form	 of	 NHEJ	 which	 occurs	 independently	 of	 DNA-PK	 and	 repairs	 a	subset	of	DSBs.	Alt-EJ,	 though	not	well	understood,	 is	believed	 to	encompasses	distinct	 mechanisms	 for	 DSB	 repair.	 Microhomology	 mediated	 end	 joining	
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(MMEJ)	is	a	form	of	Alt-EJ	which	utilizes	microhomology	(short	homologous	DNA	sequence)	present	at	the	DSBs	(Sinha	et	al.,	2016).	Although	the	outcome	of	DSB	repair	 by	both	C-NHEJ	 and	 alt-EJ	 can	be	 similar,	 their	 distinct	 requirements	 of	proteins	and	the	use	of	microhomology	set	them	apart.	While	DNA	end	joining	by	C-NHEJ	 can	either	be	accurate	or	 imprecise,	most	 forms	of	 alt-NHEJ,	 especially	MMEJ,	are	almost	always	mutagenic	due	to	deletion	of	several	nucleotides	to	find	microhomology	(Sfeir	and	Symington,	2015).	
1.2.4.2	Mechanism	of	DSBR	by	NHEJ		C-NHEJ	repair	mechanism	can	be	divided	 into	sequential	 steps,	which	are	DNA	end	 recognition	 and	 assembly	 of	 C-NHEJ	 proteins,	 bridging	 of	 DNA	 ends,	 DNA	end	processing	(if	required)	and	DNA	ligation	(Figure	3).	The	initiation	of	C-NHEJ	begins	 with	 extremely	 rapid	 recruitment	 of	 C-NHEJ	 specific	 DNA-end	 binding	heterodimer	Ku,	which	 is	composed	of	subunits	Ku70	and	Ku80.	Ku	binding	 to	DNA	ends	prevents	their	non-specific	processing	by	nucleases,	helps	in	bridging	the	two	ends	together	and	functions	as	a	scaffold	to	promote	the	stabilization	of	NHEJ	 protein	 complex	 on	 the	 DSB	 (Davis	 and	 Chen,	 2013).	 Ku,	 directly	 or	indirectly,	recruits	core	C-NHEJ	proteins,	which	include	DNA	dependent	protein	kinase	 catalytic	 subunit	 (DNA-PKcs)	 (Uematsu	 et	 al.,	 2007),	 X-ray	 cross	complementing	 protein	 4	 (XRCC4)	 (Mari	 et	 al.,	 2006;	 Nick	 McElhinny	 et	 al.,	2000),	DNA	Ligase	IV	(Costantini	et	al.,	2007)	and	XRCC4-like	factor	(XLF)	(Yano	et	al.,	2008)	and	Aprataxin-and-PNK-like	factor	(APLF)	(Grundy	et	al.,	2013).	Ku	directly	recruits	DNA-PKcs	(Gottlieb	and	 Jackson,	1993).	Together	with	Ku	and	DNA,	DNA-PKcs	form	the	DNA-PK	holoenzyme,	which	phosphorylates	various	C-NHEJ	 proteins.	 Structurally,	 DNA-PKcs	 also	 tethers	 DNA	 ends	 together	 by	 the	formation	 of	 a	 synaptic	 complex	 (Cary	 et	 al.,	 1997;	 Weterings	 and	 van	 Gent,	2004).	DNA	ligase	IV	is	a	specific	C-NHEJ	ligase	required	for	the	final	step	of	DNA	ligation.	DNA-ligase	IV	 forms	a	complex	with	 its	non-enzymatic	partner	XRCC4,	which	stabilizes	and	stimulates	Ligase	IV	and	also	serve	as	a	second	scaffold	to	other	C-NHEJ	proteins	(Grawunder	et	al.,	1997).	XLF	 interacts	with	 the	XRCC4-Lig	IV	complex	and	stimulates	Ligase	IV	(Ahnesorg	et	al.,	2006;	Lu	et	al.,	2007).	XRCC4-XLF	 complex	 is	 proposed	 to	 multimerize	 to	 form	 a	 long	 super-helical	structure,	which	may	further	stabilize	and	bridge	DNA	ends	(Andres	and	Junop,	
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2011;	Hammel	et	al.,	2010;	Wu	et	al.,	2011).	Ligase	IV	has	the	unique	capacity	of	ligating	 incompatible	 DNA	 ends,	 ligating	 one	 strand	 independently	 of	 another,	and	 ligating	DNA	 ends	 across	 gaps	 (Gu	 et	 al.,	 2007;	Ma	 et	 al.,	 2004).	 It	makes	Ligase	IV	an	ideal	ligating	enzyme	to	deal	with	a	wide	variety	of	DSB	structures	repaired	by	C-NHEJ.	DSBs	produced	by	various	sources	can	 lead	to	a	variety	of	complex	 DNA	 ends	 that	 may	 require	 prior	 processing	 before	 ligation.	 For	example,	DSB	ends	can	present	non-ligatable	5′	hydroxyls	or	3′	phosphates	ends.	Similarly,	DSB	formation	can	leave	3'	or	5'	overhangs	at	the	ends,	which	must	be	excised	 for	 ligation.	 Several	 end-processing	 enzymes	 with	 different	 activities	have	 been	 discovered,	which	 are	 important	 for	 C-NHEJ.	 Artemis	 is	 a	 nuclease,	which	has	been	shown	to	possess	both	ssDNA	5'	to	3'	exonuclease	as	well	as	5'	endonuclease	activity	on	5'	overhangs,	which	creates	blunt	ended	duplexes	(Ma	et	 al.,	 2002;	 Povirk	 et	 al.,	 2007).	WRN,	with	 its	 3'	 to	 5'	 exonuclease	 activity,	 is	another	nuclease	implicated	in	C-NHEJ	(Kusumoto	et	al.,	2008).	PNKP	is	another	special	enzyme	with	both	kinase	and	phosphatase	activity,	which	is	functional	in	C-NHEJ.	 It	 can	 add	 phosphate	 to	 the	 5'-OH	 group	 and	 remove	 3'	 phosphate	 at	DNA	ends	by	 its	kinase	and	phosphatase	domain,	respectively	(Bernstein	et	al.,	2005).	Apratxin	with	its	nucleotide	hydrolase	and	transferase	activity	catalyzes	the	removal	of	adenylate	groups	from	5'	termini	(Gong	et	al.,	2011;	Tumbale	et	al.,	 2011).	Additionally,	when	necessary,	 gap	 filling	at	DSB	ends	 can	be	 carried	out	 by	 template-dependent	 polymerase	 μ	 or	 by	 template-independent	 pol	 λ	(Nick	McElhinny	et	al.,	2005;	Ramadan	et	al.,	2004).		Alt-NHEJ	 is	 another	 form	 of	 NHEJ,	 which	 has	 been	 shown	 to	 have	 residual	activity	 in	 every	 studied	 system	when	C-NHEJ	 is	 inactivated	 (Frit	 et	 al.,	 2014).	Alt-NHEJ	 is	 a	 less	 defined	 pathway	 than	 C-NHEJ.	 The	 extensive	 use	 of	microhomology	 by	 Alt-NHEJ	 is	 its	 characteristics	 feature	 (MMEJ)	 but	microhomology	 independent	repair	by	Alt-NHEJ	has	been	observed	(Boboila	et	al.,	2012;	Lieber,	2010).	 It	has	been	 thus	suggested	 that	Alt-NHEJ	encompasses	distinct	 sub-pathways	 and	 Alt-EJ	 is	 more	 appropriate	 term	 to	 use	 instead.	Furthermore,	 the	 presence	 of	 terminal	 microhomology	 at	 DSB	 site	 improves	efficiency	 of	 repair	 by	 C-NHEJ	 (Lieber,	 2010).	 Therefore	 it	 is	 not	 the	 repair	outcome,	 but	 the	 lack	of	 a	 requirement	 for	 the	 core	C-NHEJ	proteins	 including	
	 26	
Ku,	DNA-PKcs	and	Ligase	IV	by	Alt-EJ,	which	distinguishes	it	from	C-NHEJ.	In	fact,	Ku	suppresses	Alt-EJ,	which	establishes	a	competition	between	these	pathways	(Audebert	et	al.,	2004;	Wang	et	al.,	2006).	Recent	evidence	suggests	Alt-EJ	being	a	 "back-up"	 mechanism	 for	 C-NHEJ	 and	 HR	 (Iliakis	 et	 al.,	 2015).	 It	 has	 been	postulated	 that	 Alt-EJ	 with	 its	 several	 sub-pathways	 can	 take	 over	 a	 partially	processed	 DNA	 intermediates	 when	 both	 C-NHEJ	 and	 HR	 were	 engaged	 but	somehow	failed	to	complete	the	repair.	The	involvement	of	MRE11-RAD50-NBS1	(MRN)	 and	 CtIP,	 the	 usage	 of	microhomology	 (possibly	 produced	 by	 a	 limited	resection)	 and	 its	marked	 enhancement	 in	 G2	 in	 comparison	 to	G1	 provides	 a	further	 evidence	 for	 Alt-EJ	 being	 a	 back-up	 mechanism	 for	 HR	 (Iliakis,	 2009;	Rositsa	Dueva,	2013).	Alt-EJ	is	also	known	to	play	a	role	in	V(D)J	recombination	and	class	switch	recombination	(Kotnis	et	al.,	2009;	Malu	et	al.,	2012).	The	Alt-EJ	repair	 mechanism,	 like	 C-NHEJ,	 also	 requires	 DSB	 recognition,	 synapsis,	 end	processing	and	ligation	.	Poly(ADP)-ribose	polymerase	1	(PARP-1)	is	a	sensor	of	SSB	and	DSB,	and	functions	in	various	DNA	repair	pathways.	Its	substitutes	the	role	of	DNA-PK	in	Alt-EJ	by	tethering	the	DNA	ends	and	also	provides	the	scaffold	activity.	DNA	Ligase	3	is	the	main	ligase	for	joining	the	ends	in	absence	of	Ligase	IV	 activity	 in	 Alt-EJ	 (Frit	 et	 al.,	 2014).	 Microhomology	 usage,	 when	 required,	needs	limited	resection	of	DNA,	which	is	followed	by	action	of	Pol	θ,	a	low	fidelity	polymerase,	 to	 synthesize	 the	 resected	 strand.	Multiple	 studies	 have	 indicated	the	role	of	MRN	with	CtIP,	which	have	been	postulated	to	be	responsible	for	the	limited	resection	required	for	MMEJ	(Badie	et	al.,	2015;	Lee-Theilen	et	al.,	2011;	Quennet	et	al.,	2011;	Rass	et	al.,	2009a).								
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Figure	3.	Mechanism	of	classical	non-homologues	end	joining	(C-NHEJ).	In	the	initial	steps	of	C-NHEJ,	Ku	heterodimer	is	recruited	to	DSBs	and	slides	over	the	ends	forming	the	tight	interaction	with	 DNA-PKcs.	 DNA	 -PKcs	 is	 activated	 by	 DNA	 end-bound	 Ku,	 which	 results	 in	 the	 further	loading	 of	 XRCC4,	 Lig4	 and	 XLF.	 The	 "core"	 NHEJ	 complex	 is	 stabilized	 by	 the	autophosphorylation	 of	 DNA-PKcs,	 which	 leads	 to	 its	 dissociation	 from	 the	 complex.	 Other	processing	 factors	 including	 nucleases	 and	 polymerase	 are	 recruited	 to	 the	 core	 complex	 via	interaction	 with	 Ku	 to	 modify	 the	 DSB	 termini	 for	 ligation.	 Finally,	 DNA	 ligase	 4	 ligates	 the	processed	 compatible	 ends,	which	 is	 facilitated	 by	 XLF	 and	 APFL	 (adapted	 from	Grundy	 at	 al,	2014	DNA	Repair).			
1.2.4.3	Homologous	recombination	(HR)		HR	is	a	template-dependent	repair	pathway.	The	lack	of	a	sister-chromatid	in	the	G1	phase	restricts	HR	to	S	and	G2	phases.	 In	principle,	 if	evoked	during	the	G1	phase,	HR	can	use	homologous	chromosomes	as	a	template	for	repair,	which	can	lead	 to	 loss	 of	 heterozygosity	 (Orthwein	 et	 al.,	 2015).	 Therefore,	 HR	 must	 be	suppressed	 during	 G1	 to	 prevent	 any	 such	 occurrence.	 The	 suppression	 and	implementation	 of	HR	 in	 the	G1	 and	 S/G2	phases,	 respectively,	 is	 regulated	 at	multiple	 levels	 by	 various	 proteins(Heyer	 et	 al.,	 2010;	 Mathiasen	 and	 Lisby,	2014).	 DSB	 resection	 is	 essential	 for	 the	 initiation	 of	 HR	 (Mimitou	 and	Symington,	 2009;	 Paques	 and	 Haber,	 1999).	 This	 is	 positively	 regulated	 by	 a	cyclin	 dependent	 kinase	 (CDK)	 activity.	While	 resection	 is	 inhibited	 in	 the	 G1	
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phase,	upon	the	entrance	into	the	S	phase	CDK	activates	the	resection	machinery	(Symington,	 2016).	 In	 case	 of	 compromised	 HR,	 the	 degree	 of	 resection	 may	determine	 the	usage	of	 alternative	pathways	 for	DSB	repair.	Depending	on	 the	length	of	resection,	DSBs	can	either	be	repaired	by	MMEJ	(5-25	nt)	or	by	single	strand	annealing	(SSA,	more	than	~	25	nt)	(Ceccaldi	et	al.,	2016;	Sharma	et	al.,	2015).	Why	 is	 a	 complex	 mechanism	 such	 as	 HR	 used	 when	 more	 efficient	 NHEJ	 is	available	at	cell's	disposal	throughout	the	cell	cycle?	It	is	generally	believed	that	one	 reason	 has	 to	 with	 the	 nature	 of	 the	 DSBs.	 During	 replication,	 the	 forks	encounter	relatively	high	level	of	SSBs	in	comparison	to	DSBs	(20:1)	(Roots	et	al.,	1985;	 Tounekti	 et	 al.,	 2001).	 When	 replication	 fork	 collides	 with	 a	 SSB,	 this	becomes	converted	to	a	DSB	due	to	free	end	of	newly	synthesized	strand	(Mehta	and	Haber,	 2014).	 These	 single-ended	DSBs	 are	 unsuitable	 for	 repair	 by	NHEJ	due	 to	 the	 absence	 of	 other	 end.	 HR	 therefore	 is	 a	 more	 suitable	 pathway	 to	repair	 such	 one-ended	 DSBs.	 The	 frequency	 of	 DSBs,	 without	 significant	exogenous	 factors,	 is	 sufficiently	 high	 enough	 that	 deficiency	 of	 single	 HR-specific	protein	 is	embryonically	 lethal(Hakem	et	al.,	1998;	Hakem	et	al.,	1996;	Lim	 and	 Hasty,	 1996;	 Suzuki	 et	 al.,	 1997;	 Tsuzuki	 et	 al.,	 1996).	 Hypomorphic	mutations	 render	 cells	more	 sensitive	 to	DSBs	 inducing	 agents	 and	predispose	affected	individuals	to	cancer	(O'Driscoll,	2012;	Prakash	et	al.,	2015).	
1.2.4.4	Mechanism	of	DSBR	by	HR			Mre11-Rad50-Xrs2/NBS1,	 is	 a	multifunctional	 protein	 that	 acts	 as	DSB	 sensor,	co-activator	of	DSB	 induced	checkpoint	signalling	and	an	effector	(Lamarche	et	al.,	2010).	It	is	recruited	quickly	to	the	break	site	upon	DSB	induction	(Nelms	et	al.,	 1998).	 Its	 disruption	 leads	 to	 defective	 ATM	 checkpoint	 signalling	 and	defective	HR	(Carson	et	al.,	2003;	Girard	et	al.,	2002;	Stewart	et	al.,	1999;	Uziel	et	al.,	2003).	MRX/N	localization	at	DSBs	is	followed	by	the	recruitment	of	various	important	proteins,	which	play	different	 roles	 at	both	early	 and	 later	 stages	of	HR.	 Among	 such	 proteins,	 CtIP,	 which	 interacts	 directly	 with	 MRN	 also	accumulate	at	DSBs	(Chen	et	al.,	2008a;	Sartori	et	al.,	2007;	Wang	et	al.,	2013a;	You	et	al.,	2009).	The	processing	of	DSBs	initiates	with	DNA	end	resection	in	a	5'	
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to	3'	direction	(Figure	4).	This	resection	leaves	3'	ssDNA	overhangs	at	both	ends	of	 the	DSB.	Mechanistically,	 resection	occurs	 in	 successive	phases	of	 short	 and	long-range	 excision,	 which	 are	 mediated	 by	 MRX/N	 with	 Sae2/CtIP	 and	Exo1/EXO1	 or	 BLM/Sgs1	 (slow	 growth	 suppressor	 1)-DNA2	 or	 WRN	respectively	(Symington,	2016).	The	3'	ssDNA	produced	due	to	 the	resection	 is	coated	by	Replication	protein-A	(RPA)	to	prevent	non-specific	degradation	from	nucleases	 (Chen	 et	 al.,	 2013;	 Lisby	 et	 al.,	 2004;	 Wang	 and	 Haber,	 2004).	Subsequently,	RPA	 is	displaced	 from	ssDNA	by	RAD51	with	 the	help	of	 several	mediators	 to	 form	 ssDNA-RAD51	 nucleoprotein	 filament	 known	 as	 "pre-synaptic"	complex	(San	Filippo	et	al.,	2008).	In	the	next	step,	known	as	synapsis,	ssDNA-RAD51	 complex	 searches	 for	 a	 homologous	 sequence	 and	 mediates	strand	 invasion	 by	 displacing	 the	 strand	 on	 the	 donor	 duplex	 forming	 the	displacement	 loop	 (D-loop)(Krejci	 et	 al.,	 2012).	 Strand	 invasion,	 mediated	 by	Rad51,	 is	a	defining	feature	of	HR.	DNA	pairing	 in	between	invaded	strand	and	the	 donor	 duplex	 with	 complementary	 sequence	 occurs	 by	 canonical	Watson-Crick	base	pairing.	Once	DNA	pairing	is	stabilized,	the	invaded	strand	is	extended	by	DNA	synthesis	with	 a	DNA	polymerase.	The	extension	 restores	 any	missing	DNA	 sequence	by	 copying	 the	 sequence	of	 donor	duplex.	The	 extended	D-loop	can	 be	 processed	 by	 distinct	 mechanisms,	 which	 may	 yield	 different	 repair	outcomes	in	terms	of	exchange	of	DNA	sequence	between	afflicted	chromosome	and	 the	 donor	 duplex	 (Ceccaldi	 et	 al.,	 2016).	 In	 first	 mechanism	 of	 synthesis	dependent	 strand	 annealing	 (SDSA),	 the	 extended	 3'	 strand	 is	 displaced	 and	anneals	back	to	its	original	complementary	strand.	Any	gap	or	flaps	created	are	processed	by	a	polymerase	or	a	flap-endonuclease.	DNA	ligase	eventually	ligates	the	 single	 nucleotide	 gap,	 hence	 completing	 the	 repair.	 SDSA	 exclusively	produces	 non-crossover	 products,	 which	 means	 non-reciprocal	 exchange	 of	information	between	donor	and	the	repaired	duplex.	Non-crossover	can	result	in	gene	 conversion,	 which	 may	 eventually	 result	 in	 LOH	 (Chen	 et	 al.,	 2007;	Thiagalingam	et	al.,	2001).	Alternatively,	the	extended	strand	in	a	D-loop	can	be	captured	by	the	original	strand	without	being	dissociated	from	complementary	donor	 strand.	 The	 second	 end	 capture	 results	 in	 the	 formation	 of	 a	 key	recombination	intermediate	termed	a	double	Holliday	junction	(dHJ)	(Bzymek	et	al.,	 2010;	 Heyer,	 2004).	 This	 can	 be	 processed	 by	 two	 distinct	 mechanisms;	
	 30	
dissolution	 and	 resolution.	 While	 dissolution	 produces	 non-crossovers	 only,	resolution	 can	 result	 in	 both	 non-crossover	 and	 crossover	 products.	 The	crossovers	 represent	 a	 final	 repair	 product	 with	 physical	 exchange	 of	 DNA	segments	between	donor	and	repaired	chromosomes.	Dissolution	is	carried	out	by	 Sgs1	 -Top3	 (Topoisomerase	 3)-Rmi1(RecQ-mediated	 genome	 instability	1)/BLM-TOPOIIIα-RMI1-RMI2	complex	where	Sgs1/BLM	converge	two	Holliday	junctions	 towards	 each	 other	 by	 branch	 migration	 together	 with	 the	topoisomerase	activity	of	Top3/	TOPOIIIα	(Swuec	and	Costa,	2014).	Convergent	branch	migration	ultimately	produces	a	hemicatenane	structure,	which	is	finally	resolved	 by	 Topoisomerase	 Top3/TOPOIIIα	 in	 conjunction	 with	 Rmi1/RMI1-RMI2.	In	somatic	cells,	dissolution	is	the	primary	mechanism	for	the	elimination	of	 dHJ	 in	 mitotic	 cells.	 Dissolution	 occurs	 primarily	 in	 S-phase	 (Sarbajna	 and	West,	2014).	Resolution,	on	the	other	hand,	involved	dHJ	processing	by	either	of	structure-selective	 endonucleases	 (SSE).	 In	 total,	 3	 SSE,	 which	 include	 Mms4-Mus81/MMS4-EME1,	Slx1-Slx4/SLX1-SLX4	and	Yen1/GEN1	have	been	identified	in	 both	 yeast	 and	 mammals	 to	 complete	 the	 resolution	 of	 dHJ	 and	 other	recombination	 intermediates	 (Matos	 and	 West,	 2014).	 Depending	 on	 the	cleavage	of	dHJ	by	these	SSE	i.e.	symmetrical	or	asymmetrical,	they	can	produce	both	 non-crossover	 and	 crossover	 products	 respectively.	 Somatic	 cells	 utilize	resolution	 to	 eliminate	 unprocessed	 recombination	 intermediate	 including	 dHJ	that	 escaped	 from	 the	dissolution	pathway	 (more	details	 in	 section	1.6.1).	The	SSE	enzymes	operate	primarily	in	the	G2	or	even	the	M	phases	of	the	cell	cycle.			Single	strand	annealing	(SSA)	is	another	distinct	mutagenic	pathway,	functional	in	both	yeast	and	humans	though	it	has	been	best	defined	in	yeast	(Stark	et	al.,	2004).	 SSA	 is	 distinct	 from	 HR	 as	 it	 lacks	 strand	 invasion	 step	 and	 is	 Rad51	independent,	it	shares	initial	DNA	end	resection	step	as	well	as	several	proteins	that	also	participate	in	HR	(Ivanov	et	al.,	1996).	SSA	primarily	occurs	when	DSBs	are	flanked	by	tandem	repeated	sequences.	Briefly,	similarly	to	HR,	the	resection	of	 DSB	 is	 followed	 by	 a	 formation	 of	 3'	 overhangs.	 The	 overhangs	 align	 and	anneal	 to	 each	 other,	 which	 is	 mediated	 by	 Rad52	 and	 Rad59	 (Davis	 and	Symington,	2001;	Pannunzio	et	al.,	2010;	Symington,	2002).	The	resulting	 flaps	are	cleaved	by	Rad1-Rad10	nuclease	with	the	help	of	Msh2-Msh3	and	the	gap	is	
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finally	 sealed	 by	 DNA	 ligase	 (Spies	 and	 Fishel,	 2015;	 Sugawara	 et	 al.,	 1997;	Tomkinson	 et	 al.,	 1993).	 The	 cleavage	 of	 flaps	 results	 in	 the	 loss	 of	 DNA	sequence.	Therefore,	SSA	is	always	mutagenic	in	nature.	As	research	on	DNA	end	resection	is	a	focus	of	my	doctoral	research,	the	topic	will	be	further	covered	in	the	next	chapter.	
	
				Figure	4.	Mechanism	of	double	strand	break	repair	by	HR	in	eukaryotes.	Repair	by	HR	initiates	with	the	short-	range	resection	of	5'	termini	 in	5'	to	3'	direction	by	MRN/X	and	CtIP/Sae2.	It	 is	followed	by	 the	 long-	range	resection,	which	 is	carried	out	by	EXO1/Exo1	or	BLM-DNA2/Sgs1-Dna2.	RPA	coats	the	3'	overhangs	(ssDNA)	to	prevent	the	formation	of	secondary	structures	and	nucleolytic	degradation.	 	RAD51/Rad51	 is	 loaded	on	RPA-coated	 ssDNA,	which	 is	mediated	by	BRCA2/Rad52	 and	 other	 RAD51	 paralogs.	 RAD51-nucleofilament	 finds	 the	 homologues	 DNA	sequence	and	invades	the	donor	duplex	by	strand	exchange.	The	invaded	strand	is	extended	by	polymerase.	Following	this	step,	repair	can	occur	by	SDSA	or	DSBR.	In	SDSA,	the	extended	strand	anneals	 back	 to	 its	 original	 duplex,	 followed	 by	 further	 DNA	 synthesis	 of	 resected	complementary	 strand	 and	 ligation.	 In	 DSBR,	 the	 extended	 strand	 is	 captured	 by	 the	 afflicted	duplex	without	dissociating	with	the	donor	duplex	giving	rise	to	double	Holliday	junctions	(HJ).	These	dHJs	are	further	processed	by	either	dissolution	or	resolution.	While	dissolution	produces	non-crossovers	only,	 resolution	 can	 result	 in	both	 crossover	and	noncrossovers	 (adapted	 from	Dueva	and	Lliaka,	2013	Translational	Cancer	Research).	
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1.3	DNA	end	resection			DSB	resection	initiates	the	HR	repair	pathway.	Resected	DSBs	inhibit	the	error-prone	 NHEJ	 and	 direct	 repair	 to	 HR	 for	 faithful	 restoration	 of	 the	 lost	 DNA	sequence.	 Here	 I	 describe	 the	 end	 resection	 mechanisms	 in	 bacteria	 and	eukaryotes.		
1.3.1	Bacteria		RecBCD	 initiates	 the	 major	 recombination	 pathway	 utilized	 by	 most	 gram-negative	 bacteria	 including	 Escherichia	 coli	 (E.	 coli)	 (Dillingham	 and	Kowalczykowski,	2008).	RecBCD	is	a	heterotrimeric	complex,	which	collectively	carries	out	the	DSB	end	resection	(Blackwood	et	al.,	2013).	In	RecBCD	complex,	the	RecB	subunit	functions	as	nuclease	and	also	possesses	a	slow	3'	to	5'	helicase	activity	(Dillingham	et	al.,	2003;	Wang	et	al.,	2000).	RecC	recognizes	a	specific	8-base	pair	non-palindromic	Chi	 sequence	 (5'	GCTGGTGG	3')	 and	 regulates	RecB	activities,	 whereas	 RecD	 possesses	 a	 fast	 5'	 to	 3'	 helicase	 activity	 (Dixon	 and	Kowalczykowski,	1993).	RecB	and	RecD	motors	 translocate	on	5'	and	3'	strand	strands	respectively,	but	in	the	same	overall	direction	(Finkelstein	et	al.,	2010).	The	simultaneous	unwinding	of	the	duplex	by	both	helicases	produces	a	long	5'	tail	 and	 a	 short	 3'	 tail	 due	 to	 the	 different	 speed	 of	 the	 respective	 helicases	(Taylor	and	Smith,	2003).	During	such	unequal	unwinding	period,	RecB	resects	3'	end	more	efficiently	than	5'	end.	Upon	encountering	the	Chi	sequence,	RecD	is	inactivated	which	makes	unwinding	slow	as	it	is	now	driven	by	RecB	only	(Spies	et	 al.,	 2003).	 Furthermore,	 RecC	 interaction	 with	 Chi	 sequence	 brings	confirmation	change	in	RecB,	which	opens	its	molecular	latch	allowing	3'	tail	to	exit	RecB	(Handa	et	al.,	2012;	Yang	et	al.,	2012).	This	modulation	of	RecB	by	RecC	and	 Chi	 sequence	 suppresses	 3'	 end	 cleavage	 and	 stimulates	 the	 5'	 end	degradation.	 Simultaneously,	 RecB	 also	 facilitates	 RecA	 (ortholog	 of	 RPA)	loading	on	the	resulting	3'	tail	(Anderson	and	Kowalczykowski,	1997).	The	RecF	pathway	 represents	 an	 additional	 repair	 mechanism,	 which	 is	 responsible	 for	residual	 recombination	 in	 the	 absence	 of	 recB	 and	 recC	 (Persky	 and	 Lovett,	2008).	 In	 this	 particular	 mechanism,	 resection	 is	 carried	 out	 by	 5'	 to	 3'	
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exonuclease	RecJ,	which	is	further	stimulated	by	the	3'	to	5'	RecQ	helicase	(Han	et	al.,	2006;	Handa	et	al.,	2009).		
1.3.2	Eukaryotes		In	eukaryotes,	DNA	end	resection	occurs	in	two	sequential	phases	of	short-range	and	long-range	resection	(Symington,	2016)	(Figure	5).	In	short-range	resection,	Mre11-Rad50-Xrs2/NBS1	complex	initiates	resection	with	Sae2/CtIP	and	excise	both	 5'	 DNA	 ends	 up	 to	 ~	 300	 nucleotides	 (in	 yeast)	 (Garcia	 et	 al.,	 2011;	Zakharyevich	 et	 al.,	 2010a).	Mre11/MRE11	 in	MRX/N	 complex	 is	 the	 nuclease	responsible	 for	 the	 initial	 limited	 resection	 (Mimitou	 and	 Symington,	 2009).	Mre11/MRE11	 is	 known	 to	 possess	 Mn2+	 –	 dependent	 3'	 to	 5'	 exo-	 and	endonuclease	activity	on	secondary	structures	of	ssDNA	and	hairpins	(Paull	and	Gellert,	1998;	Usui	et	al.,	1998).	However,	it	has	been	very	well	established	that	end	resection	occurs	in	opposite	direction	from	5'	to	3'	(Sun	et	al.,	1991;	White	and	Haber,	1990;	Zhu	et	al.,	2008).	To	solve	this	paradox,	current	model	suggests	that	 Mre11/MRE11	 with	 Sae2/CtIP	 incises	 dsDNA	 through	 its	 endonuclease	activity	in	the	close	the	vicinity	of	DSB.	This	incision	by	MRX/N	is	followed	by	the	excision	of	nicked	strand	in	3'	 to	5'	direction	by	MRE11	back	towards	the	DSB.	This	model	was	supported	by	the	seminal	studies	carried	out	in	meiotic	cells	of	S.	
cerevisiae.	 In	 yeast	 meiotic	 cells,	 the	 Spo11	 transesterase	 generates	 DSBs	intentionally	 so	 that	 recombination	 can	 occur	 between	 homologues	chromosomes	 (Bergerat	 et	 al.,	 1997;	 Keeney	 et	 al.,	 1997).	 Spo11	 remains	covalently	 attached	 to	 the	 DSB	 ends.	 Its	 ultimate	 removal	 is	 essential	 for	 HR	progression.	 Upon	 endonucleolytic	 cleavage	 of	 dsDNA	 by	 MRX,	 Spo11	 bound	oligonucleotide	 (12	 to	 40	 nt)	 is	 released	 (Garcia	 et	 al.,	 2011;	 Mimitou	 and	Symington,	 2009;	 Neale	 et	 al.,	 2005).	 On	 the	 other	 hand,	 in	 nuclease	 deficient	
mre11	mutant,	 Spo11	 remains	 attached	 to	DSB	ends,	which	 leads	 to	HR	defect	(Furuse	 et	 al.,	 1998;	 Hartsuiker	 et	 al.,	 2009a;	 Moreau	 et	 al.,	 1999;	 Nairz	 and	Klein,	1997).	Similarly,	rad50Δ	and	sae2Δ/ctp1Δ	mutants	in	budding	and	fission	yeast	 exhibit	 the	 identical	 phenotype	 as	 observed	 in	 mre11-nd	 mutant	(Hartsuiker	 et	 al.,	 2009a;	 Milman	 et	 al.,	 2009).	 Xrs2	 and	 NBS1	 are	 equally	important	 in	 MRX/N	 complex	 as	 xrs2Δ	 mutants	 are	 equally	 defective	 for	 HR	while	 NBS1	 deletion	 is	 embryonically	 lethal	 in	 mice	 (D'Amours	 and	 Jackson,	
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2001;	 Zhu	 et	 al.,	 2001).	MRX	 likely	makes	multiple	 incisions	 on	 the	 5'	 strand.	While	 the	 released	 oligonucleotide	 bound	 to	 Spo11	 is	 up	 to	~	40	 nt	 in	 length,	
exo1	deletion	still	results	in	the	resection	of	~270	nt	(Dna2-Sgs1	normally	do	not	function	in	meiosis)	(Manfrini	et	al.,	2010;	Zakharyevich	et	al.,	2010b).	In	some	cases,	MRX/Sae2	seem	to	cleave	further	away	from	the	DSB	(Neale	et	al.,	2005).	The	state/structure	of	the	DSB	ends	influences	the	DNA	end	resection	by	MRX/N.	The	formation	of	a	covalent	DNA-protein	complex	e.g.	with	Spo11	or	with	TopI	or	TopII,	can	block	the	access	of	Exo1	or	Dna2	nuclease	(Alani	et	al.,	1990;	Nairz	and	Klein,	 1997)	 (Connelly	 et	 al.,	 2003;	Hartsuiker	 et	 al.,	 2009b;	Takeda	 et	 al.,	2016).	 Hence	 as	 described	 above,	 the	 Mre11	 nuclease	 activity	 becomes	indispensable	for	elimination	of	such	blocks	and	thus	for	DNA	end	resection.	In	contrast,	endonuclease	(HO	or	 I-SceI)	generated	DSBs	with	"clean"	ends	can	be	processed	 by	 either	 overexpression	 of	 Exo1	 or	 by	 deletion	 of	 Ku	 in	mre11Δ	background	 (Mimitou	 and	 Symington,	 2010;	 Shim	 et	 al.,	 2010;	 Tomita	 et	 al.,	2003).	Furthermore,	inactivation	of	the	Mre11	nuclease	with	Exo1	deletion	still	results	in	a	substantial	resection,	most	likely	mediated	by	Sgs1-Dna2	(Moreau	et	al.,	 2001;	 Tsubouchi	 and	 Ogawa,	 2000).	 Moreover,	 mre11-nd	 cells	 are	 only	partially	sensitive	 to	 IR	and	do	not	exhibit	as	severe	phenotype	as	observed	 in	
mre11Δ	 cells,	which	points	at	a	structural	 role	of	Mre11	at	a	DSB	(Krogh	et	al.,	2005;	 Llorente	 and	 Symington,	 2004;	 Moreau	 et	 al.,	 1999)	 (Lobachev	 et	 al.,	2002).	 In	 principle,	 secondary	 structures	 at	 ends	 may	 also	 require	 the	 MRX	nuclease	 activity	 for	 their	 elimination.	 Repair	 of	 DSBs	 at	 inverted	 Alu	 repeats,	which	are	believed	to	form	hairpin	or	cruciform	structures	upon	DSB	induction,	requires	Mre11	nuclease	and	Sae2.						The	 3'	 tailed	 ssDNA,	 produced	 by	 initial	 resection,	 is	 coated	 by	 RPA,	 which	prevents	 the	 formation	 of	 secondary	 structures	 in	 ssDNA.	 The	 resected	 5'	strands	are	further	resected	extensively	in	 long-range	resection	by	two	distinct	but	 redundant	 pathways.	 These	 pathways	 involve	 either	 Exo1/EXO1	mediated	resection	or	Dna2/DNA2,	which	functions	in	conjunction	with	either	Sgs1/BLM	or	WRN	in	an	alternative	pathway	(Symington,	2016).	Exo1/EXO1	is	a	member	of	XPG/Rad2	and	FEN-1	 family	and	has	5'	 to	3'	dsDNA	exonuclease	and	5'	 flap	endonuclease	activity	and	can	carry	out	the	resection	alone	(Szankasi	and	Smith,	
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1992,	1995;	Tran	et	al.,	2004b).	Exo1	recruitment	at	DSBs	is	facilitated	by	MRX	(Shim	et	al.,	2010).	Additionally,	MRX	with	Sae2	also	stimulates	Exo1	mediated	degradation,	 likely	by	opening	or	5'	clipping	of	dsDNA	by	MRX,	which	creates	a	suitable	 substrate	 for	 Exo1	 (Cannavo	 et	 al.,	 2013;	 Nicolette	 et	 al.,	 2010a).	Additionally,	multiple	incisions	by	MRX-Sae2	may	also	serve	as	entry	points	for	Exo1	to	resect	DNA.	 In	 the	reconstituted	system,	RPA,	BLM	and	MRN	stimulate	EXO1/Exo1	activity	(Cannavo	et	al.,	2013;	Nimonkar	et	al.,	2011;	Nimonkar	et	al.,	2008).	In	the	other	redundant	pathway,	Dna2/DNA2	functions	with	Sgs1/BLM	or	WRN	 to	 process	 the	 DNA	 ends.	 Dna2/DNA2	 is	 an	 ssDNA	 endonuclease,	which	requires	helicase	activity	of	Sgs1/BLM	to	unwind	dsDNA	for	5'	to	3'	degradation	(Gravel	 et	 al.,	 2008;	 Mimitou	 and	 Symington,	 2008;	 Sturzenegger	 et	 al.,	 2014;	Thangavel	 et	 al.,	 2015;	 Zhu	 et	 al.,	 2008).	 Top3	 and	 Rmi1	 have	 a	 structural	function	in	this	step	with	Sgs1	within	the	STR	complex	and	promote	resection	by	Dna2	 (Cejka	 et	 al.,	 2010a;	 Niu	 et	 al.,	 2010).	 In	 vitro,	 Dna2/DNA2	 can	 degrade	ssDNA	in	both	3'	and	5'	directions	(Bae	et	al.,	2001;	Cejka	et	al.,	2010a;	Niu	et	al.,	2010).	 RPA	 restricts	 its	 nuclease	 activity	 to	 5'	 to	 3'	 direction	 only.	 Dna2	 also	possesses	3'	to	5'	helicase	activity	but	it	is	largely	dispensable	for	end	resection	(Cejka	et	al.,	2010a;	Nimonkar	et	al.,	2011;	Niu	et	al.,	2010;	Zhu	et	al.,	2008).		
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	Figure	5.	Mechanism	of	DNA	end	resection	in	S.	cerevisiae	and	humans.	End	resection	is	preceded	by	 sensing	 of	 the	 DSBs	 by	MRX/N	 complex.	 Upon	 recruitment	 on	 DSBs,	MRX/N	 facilitates	 the	recruitment	 of	 multiple	 HR	 associated	 proteins	 including	 CtIP/Sae2.	 	 The	 CDK/Cdc28	phosphorylates	 the	 Sae2/CtIP	 in	 cell	 cycle	 specific	 manner	 (upon	 entering	 into	 the	 S-phase),	which	leads	to	further	phosphorylation	of	Sae2/CtIP	by	ATM	and	ATR	in	response	to	DSBs	(not	shown).	According	to	proposed	bidirectional	model,	MRX/N	with	Sae2/CtIP	endonucleolytically	incises	the	strands	with	5'	termini	in	the	near	vicinity	of	DSBs.	MRX/N	enters	through	these	nicks	and	degrades	the	DNA	in	3'	to	5'	direction	in	short-range	resection	by	its	3'	to	5'	exo	nucleolytic	activity.	The	resected	ends	are	unsuitable	substrate	for	Ku	binding	and	hence	NHEJ	is	inhibited.	The	3'	ssDNA	generated	due	to	resection	is	coated	by	RPA.	Exo1/EXO1	or	Sgs1-Dna2/DNA2-BLM	further	extensively	degrades	the	DNA	in	5'	to	3'	direction	in	long-range	resection	(adapted	from	Ferretti	et	al,	2013	Frontiers	in	Genetics).			
1.3.2.1	MRN			The	MRN	complex	 is	 shown	 to	 function	 in	both	NHEJ	and	HR	(Lamarche	et	al.,	2010).	 In	 yeast,	MRX	 is	 required	 for	NHEJ;	 the	 role	 of	 human	MRN	 in	NHEJ	 is	more	 restricted	 to	 Alt-EJ	 pathway	 (Boulton	 and	 Jackson,	 1998;	 Di	 Virgilio	 and	Gautier,	2005;	Huang	and	Dynan,	2002;	Rass	et	al.,	2009b;	Xie	et	al.,	2009;	Zhang	and	Paull,	2005).	MRE11	contains	phosphoesterase	motifs	in	its	amino	terminal	region	 and	 mutation	 of	 the	 conserved	 residues	 in	 these	 motifs	 abrogates	 its	nuclease	activity	(Bressan	et	al.,	1998;	Furuse	et	al.,	1998;	Moreau	et	al.,	1999;	Trujillo	and	Sung,	2001;	Usui	et	al.,	1998).	Although	the	requirement	for	Mre11	nuclease	 activity	 in	 certain	 cases	 is	 absolute	 as	 e.g.	 in	 the	 Spo11-induced	DSB	repair,	 Mre11-nd	 (H125)	 mutants	 in	 yeast	 show	 a	 mild	 radiosensitivity	 in	comparison	to	mre11	null	mutants	(Krogh	et	al.,	2005;	Llorente	and	Symington,	2004;	 Moreau	 et	 al.,	 1999).	 This	 indicates	 a	 structural	 role	 of	 Mre11	 in	 DSB	
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repair	besides	its	contribution	through	its	enzymatic	activity.	In	agreement,	the	crystal	structure	of	Mre11	revealed	a	high	structural	conservation	of	the	amino	terminal	region	and	its	dimeric	state	in	all	3	domains	of	life	(Schiller	et	al.,	2014).	Disruption	of	Mre11	dimerization	in	yeast	confers	a	mre11Δ	phenotype	(Schiller	et	al.,	2012;	Williams	et	al.,	2008).			RAD50	is	a	member	of	the	SMC	(structural	maintenance	complex)	proteins	and	contains	Walker	A	and	B	motifs	 at	 its	 amino	and	carboxyl	 termini	 respectively	(Alani	et	al.,	1990).	The	ATPase	activity	of	Rad50	is	essential	for	MRX/N	function	in	 resection	 (Alani	 et	 al.,	 1990;	Chen	et	 al.,	 2005).	 It	 also	 contains	an	extended	coiled-coil	structure,	which	folds	back	upon	itself	by	intermolecular	association	to	 form	 an	 anti-parallel	 coiled-coil	 (~500	 Å)	 structure	 (Hopfner	 et	 al.,	 2002;	Hopfner	et	 al.,	 2000a).	At	 the	apex	of	 the	other	end	of	 coiled-coil	 region	 is	Zn-hook	domain.	MR	is	the	minimal	unit	of	MRX/N	found	in	most	organisms,	which	exists	 as	 heterotetramer	 M2R2	(Lim	 et	 al.,	 2011).	 The	 globular	 head	 region	 of	M2R2	is	 composed	of	 two	ABC-ATPase	domains	and	 two	Mre11	molecules.	ATP	binding	by	 the	ATPase	domains	of	RAD50	brings	 a	 conformational	 change	and	aids	in	dimerization	of	Rad50	at	the	nucleotide-binding	domain	(NBD)	(Hopfner	et	 al.,	 2000b).	 In	 addition,	 the	 Zn-hook	 can	 also	 mediate	 both	 intra-	 (within	M2R2)	as	well	as	intermolecular	(between	two	M2R2)	interactions	(de	Jager	et	al.,	2001;	Hopfner	 et	 al.,	 2002;	Hopfner	 et	 al.,	 2001;	Moreno-Herrero	 et	 al.,	 2005).	The	 intermolecular	 binding	 between	 two	 M2R2	 by	 Zn-hook	 provides	 the	 MR	complex	 its	 ability	 to	 bridge	 two	 DNA	 molecules	 by	 tethering	 them	 together.	Expectedly,	the	length	of	the	coiled-coil	affects	DNA	tethering	by	MR	(Deshpande	et	 al.,	 2014;	Hohl	 et	 al.,	 2011).	While	 reduction	 of	 the	 coiled-coil	 length	 in	MR	mainly	causes	NHEJ	defects,	mutation	of	Zn2+	hook	impairs	its	both	HR	and	NHEJ	functions(Hohl	et	al.,	2011).	Moreover,	the	folded	ATP-binding	domains	of	Rad50	bind	to	Mre11	dimer	near	to	DNA	binding	domain	of	Mre11	(Lafrance-Vanasse	et	al.,	2015).	This	architectural	organization	of	MR	puts	Mre11	under	the	control	of	the	Rad50	ATPase	activity.	In	Pyrococcus	furiosus,	it	was	shown	that	ATP	binding	by	 Rad50	 induces	 "closed"	 confirmation,	 which	 promotes	 DNA	 tethering	whereas	"open"	confirmation	by	ATP	hydrolysis	is	essential	for	nuclease	activity	(Deshpande	et	al.,	2014).		
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	Xrs1/Nbs1/NBS1	 is	 the	 eukaryotic-specific	 and	 non-enzymatic	 subunit	 of	 the	MRX/N	 complex,	 present	 in	 S.	 cerevisiae,	 S.	 pombe	 and	 mammals	 respectively	(Stracker	and	Petrini,	2011).	The	disruptive	mutation	of	NBS1	 gene	 in	humans	causes	Nijmegen	breakage	syndrome	(NBS)	(Carney	et	al.,	1998;	McKinnon	and	Caldecott,	 2007).	 Xrs2/NBS1	 carries	 the	 nuclear	 localization	 signal	 (NLS)	 and	facilitates	the	transportation	of	MRX/N	into	nucleus	(Carney	et	al.,	1998;	Nakada	et	al.,	2003;	Tsukamoto	et	al.,	2005).		The	phosphopeptide-binding	domain,	FHA	(Fork-head	 associated)	 and	 BRCT	 domain	 (BRCA1	 carboxy-terminal),	 are	present	 in	 both	 yeast	 and	 mammals	 (Becker	 et	 al.,	 2006;	 Lloyd	 et	 al.,	 2009;	Williams	 et	 al.,	 2009).	 Through	 these	 domains,	 NBS1	 and	 in	 effect	 the	 MRN	complex	 interacts	with	 various	mediator/effector	proteins,	which	 include	CtIP,	γ-H2AX,	 ATM	 and	MDC1	 (Chapman	 and	 Jackson,	 2008;	 Kobayashi	 et	 al.,	 2002;	Lloyd	et	al.,	2009;	Palmbos	et	al.,	2008;	Wang	et	al.,	2013b;	Williams	et	al.,	2009).		Additionally,	all	NBS1	orthologs	have	conserved	Mre11	interacting	motif	at	their	carboxy	 terminus	 (Desai-Mehta	 et	 al.,	 2001;	 Schiller	 et	 al.,	 2012;	 Tauchi	 et	 al.,	2001;	You	et	al.,	2005).	NBS1	is	phosphorylated	by	ATM	at	sites	S278	and	S343,	which	mediates	 the	 intra-S	 phase	 checkpoint	 activation	 (Buscemi	 et	 al.,	 2001;	Lim	et	al.,	2000).	The	lack	of	NBS1	in	mice	is	embryonic	 lethal	while	cells	 from	the	 NBS	 patients	 are	 highly	 sensitive	 to	 IR	 indicating	 the	 dysfunctional	 NHEJ	(Tauchi	et	al.,	2002b;	Zhu	et	al.,	2001).	Similarly	in	Nbs1	deficient	DT40	chicken	cells,	 they	 show	 great	 reduction	 in	 sister	 chromatid	 exchange	 (SCE)	 upon	mitomycin	C	exposure	and	defects	in	MMEJ	(Tauchi	et	al.,	2002a).		However,	cells	from	NBS	 patients	 show	 elevated	 level	 of	 chromosomal	 translocation	 at	 T-cell	receptors	(TCR)	(Tauchi	et	al.,	2002b).	 It	 is	consistent	with	 the	residual	role	of	MRN	in	Alt-EJ,	specifically	in	V(D)J	recombination	(Zha	et	al.,	2009).		
1.3.2.2	CtIP		CtIP	 was	 initially	 identified	 as	 co-factor	 of	 CtBP	 (C-terminal	 binding	 protein),	which	 acts	 as	 co-repressor	 of	 transcription	 (You	 and	Bailis,	 2010).	 It	 has	 been	shown	to	physically	interact	with	the	MRN	complex	and	especially	with	the	FHA	domain	of	NBS1	but	its	recruitment	to	damage	sites	by	MRN	may	be	indirect	as	CtIP	accumulates	after	5-15	minutes	of	DNA	damage	(Chen	et	al.,	2008b;	Lloyd	et	
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al.,	 2009;	 Sartori	 et	 al.,	 2007;	Williams	 et	 al.,	 2009;	 You	 et	 al.,	 2009;	 Yuan	 and	Chen,	 2009).	 Both	 amino	 and	 carboxy	 termini	 of	 CtIP	 have	 been	 shown	 to	participate	 in	 the	 interaction	 with	 MRN.	 CtIP	 (and	 Sae2)	 is	 a	 highly	phosphorylated	 protein	 in	 S	 phase	 and	 mutants	 lacking	 the	 specific	phosphorylation	sites	exhibit	DNA	end	resection	and	HR	defects	(Huertas	et	al.,	2008;	Huertas	and	Jackson,	2009;	Yu	and	Chen,	2004).	CtIP	 is	 targeted	by	both	ATM	 and	 CDK2	 (Li	 et	 al.,	 2000;	 You	 et	 al.,	 2009).	 The	 cell	 cycle	 specific	phosphorylation	 of	 CtIP	 by	 CDK2	 at	 sites	 S327	 and	 T847	 is	 essential	 for	 its	function	in	resection	and	hence	HR	(Huertas	and	Jackson,	2009;	Yu	et	al.,	2006).	The	mutation	 of	 S327A	 impairs	 the	 CtIP	 recruitment	 at	 DSB	whereas	mutants	with	T847A	are	defective	in	resection.	In	yeast,	the	mutation	of	equivalent	site	of	T847	in	Sae2	(S267A)	renders	the	cells	HR	deficient,	especially	when	DNA	ends	are	capped	by	protein	block	or	secondary	structures	like	hairpin	(Huertas	et	al.,	2008).	 BRCA1	 also	 interacts	 with	 CtIP	 upon	 S327	 phosphorylation	 and	ubiquitinates	 the	 later	 (Yu	et	 al.,	 2006).	However,	 there	 are	 conflicting	 reports	regarding	the	functional	importance	of	this	interaction	(Nakamura	et	al.,	2010).	Recently	 it	was	 shown	 that	 BRCA1	 interaction	with	 CtIP,	 though	 not	 essential,	accelerates	 the	 MRN-CtIP	 mediated	 resection	 (Cruz-Garcia	 et	 al.,	 2014).	 In	response	to	DNA	damage,	CtIP	is	also	targeted	by	ATM	and	has	been	implicated	in	 the	 facilitation	 of	 CtIP	 localization	 to	 the	 damage	 sites	 (You	 et	 al.,	 2009).	Specifically,	 three	sites	 in	CtIP	i.e.	S664,	S745	and	T859	have	been	identified	to	be	targeted	by	ATM	(Kousholt	et	al.,	2012;	Wang	et	al.,	2013b;	You	et	al.,	2009).	However,	these	sites	were	dispensable	for	the	recruitment	of	CtIP	but	combined	phospho-deficient	mutants	of	these	sites	showed	severe	HR	defects	(Wang	et	al.,	2013b).	 In	 particular,	 mutants	 of	 T859A	 exhibited	 strongly	 reduced	 HR	while	combined	mutations	of	S664A	S745A	had	only	limited	HR	defects.	Furthermore,	it	was	shown	 that	 cell	 cycle	 regulated	phosphorylation	of	CtIP	by	CDK2	 is	pre-requisite	 for	 ATM	 activity	 on	 the	 identified	 sites	 (Wang	 et	 al.,	 2013b).	 The	structural	 analysis	 of	 the	N-terminal	 domain	 of	 CtIP	 showed	 that	 it	 exists	 as	 a	homo-tetramer,	 which	 is	 arranged	 as	 dimer	 of	 dimer	 in	 a	 head	 to	 head	configuration	by	their	amino	termini	(Davies	et	al.,	2015).	The	disruption	of	CtIP	tetramerization	by	a	mutation	of	 the	conserved	residues	 implicated	 in	 the	self-
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interaction	 impairs	 its	 recruitment	 and	 consequently	 results	 in	 a	 defective	HR	(Davies	et	al.,	2015;	Wang	et	al.,	2012).		
1.4	Regulation	of	DNA	end	resection		DNA	end	resection	represents	the	crossroad	between	NHEJ	and	HR	(Symington	and	Gautier,	2011).	DSB	repair	by	HR	upon	DNA	end	resection	must	be	restricted	to	the	S/G2	phase	to	prevent	ectopic	recombination	with	a	non-sister	chromatid	sequence.	Therefore	it	 is	not	surprising	that	resection	is	primarily	regulated	by	CDK	activity	 in	a	cell	cycle-dependent	manner	(Shrivastav	et	al.,	2008).	NHEJ	is	the	predominant	pathway	to	repair	DSBs	throughout	the	cell	cycle	(Chiruvella	et	al.,	2013;	Karanam	et	al.,	2012).	Ku	binds	to	the	DNA	ends	and	facilitates	NHEJ	and	 thereby	 suppresses	 HR	 by	 preventing	 DNA	 end	 resection.	 In	 S/G2	 phase,	many	HR	proteins	are	targeted	by	CDK	(along	with	other	kinases	including	ATM	and	 ATR),	 which	 activates	 their	 HR	 function	 (Krejci	 et	 al.,	 2012).	 Hence	 low	activity	 of	 CDK/CDK2	 and	 Ku-bound	 ends	 in	 G1	 inhibits	 DSB	 end	 resection	(Aylon	et	al.,	2004;	Clerici	et	al.,	2008;	Ira	et	al.,	2004).	Ku	deletion	in	G1	arrested	yeast	 cells	 restores	 the	 Mre11-dependent	 initial	 resection,	 though	 HR	 is	 still	defective	 due	 to	 the	 absence	 of	 long-range	 DNA	 end	 resection	 (Barlow	 et	 al.,	2008;	 Clerici	 et	 al.,	 2008;	 Zierhut	 and	 Diffley,	 2008).	 In	 accordance,	 CDK	inhibition	 in	 G2/M	 phase	 arrested	 cells	 impairs	 resection	 (Aylon	 et	 al.,	 2004;	Clerici	et	al.,	2008;	Ira	et	al.,	2004).	In	S/G2	phase,	the	majority	of	DSBs	are	still	repaired	 by	 NHEJ	 by	 a	 Ku-dependent	 pathway	 (Mao	 et	 al.,	 2008).	 The	suppression	of	short-range	resection	by	CDK	inhibition	can	be	alleviated	by	the	deletion	of	Yku80	in	G1	or	G2	cells.	However,	CDK	activity	becomes	essential	for	resection	when	Ku	is	present	(Clerici	et	al.,	2008).			How	does	CDK	actually	regulate	HR	in	upon	S-phase	transition?	Sae2/CtIP	with	MRX/N	 is	 required	 for	 initial	 short-range	 resection.	 It	 is	 phosphorylated	 by	CDK/CDK2	 upon	 entering	 in	 S/G2	 phases	 (Huertas	 et	 al.,	 2008;	 Huertas	 and	Jackson,	 2009;	 Manfrini	 et	 al.,	 2010).	 Additionally,	 Sae2/CtIP	 is	 further	phosphorylated	by	ATM	upon	DSB	 induction,	which	 is	necessary	 for	 its	 role	 in	HR	 (Wang	 et	 al.,	 2013b).	 In	 particular,	 phosphorylation	 by	 CDK/CDK2	 at	 sites	S267	and	T847	in	Sae2	and	CtIP	respectively	is	critical	for	DNA	end	resection.	In	
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mammalian	 cells,	 while	 phospho-deficient	 mutant	 of	 CtIP	 at	 T847	 site	 show	impaired	 resection,	 phosphomimetic	 mutants	 can	 bypass	 the	 requirement	 of	CDK2	 activity	 (Huertas	 and	 Jackson,	 2009).	 In	 addition,	 embryonic	 lethality	 of	mice	with	homozygous	mutation	of	CtIPT847/T847A	 emphasizes	 the	 importance	of	CtIP	 phosphorylation	 by	 CDK2	 (Polato	 et	 al.,	 2014).	 Hence,	 according	 to	 the	current	model,	 resection	 is	 inhibited	 in	G1	 due	 to	 a	 low	 activity	 of	 CDK/CDK2	and	 the	 failure	 of	 removal	 of	 Ku	 from	 DNA	 ends	 by	 MRX-Sae2/MRN-CtIP	complex.	Conversely,	cells	transition	to	S-phase	by	CDK/CDK2	also	results	in	the	phosphorylation	 of	 Sae2/CtIP,	 which	 empowers	MRX-Sae2/MRN-CtIP	 complex	to	remove	DNA-end	bound	Ku	and	promoting	resection.			Resection	is	the	key	event,	which	determines	the	pathway	choice	in	DSB	repair.	However,	 to	 reach	 the	 stage	 where	 resection	 can	 occur,	 various	 proteins	promote	 their	 specific	 pathway	 while	 negatively	 regulate	 the	 alternative	pathway	(Symington,	2014a).	 In	particular,	 the	tumour	suppressors	53BP1	and	BRCA1	 have	 been	 shown	 to	 crucial	 for	 promoting	 NHEJ	 or	 HR	 in	mammalian	cells	 (Daley	and	Sung,	2014).	 In	 the	G1	phase,	53BP1	accumulates	at	DSBs	and	prevents	 end	 resection	 (Bothmer	et	 al.,	 2010)	 (Figure	6).	Upon	entering	 the	S-phase,	53BP1	 is	 replaced	by	BRCA1,	which	 facilitates	 the	 resection	 (Bunting	et	al.,	 2010).	 The	 cell	 lethality	 associated	 with	 other	 severe	 defects	 in	 BRCA1	deficient	 cells	 can	 be	 rescued	 by	 a	 53BP1	 deletion	 (Bouwman	 et	 al.,	 2010;	Bunting	et	al.,	2012;	Bunting	et	al.,	2010).	Similarly,	embryonic	 lethality	due	 to	BRCA1	deficiency	in	mice	can	be	rescued	by	elimination	of	53BP1	(Bunting	et	al.,	2010).	Interestingly,	elimination	of	53BP1	results	in	the	localization	of	BRCA1	at	DBSs	 in	 G1	 phase	 while	 BRCA1	 depletion	 results	 in	 53BPA	 accumulations	 at	break	 sites	 in	 S-phase	 (Escribano-Diaz	 et	 al.,	 2013).	 It	 indicates	 that	 the	recruitment	 mechanism	 for	 both	 proteins	 is	 intact	 throughout	 cell	 cycle	 and	additional	level	of	regulation	is	required	to	determine	the	repair	pathway	choice.			The	 RNF8-RNF168	 (E3	 ligases)	 mediated	 ubiquitination	 of	 histone	 H2A	 is	required	for	the	recruitment	of	both	53BP1	and	BRCA1	(Daley	and	Sung,	2014;	Mailand	et	al.,	2007).	 	53BP1	is	recruited	to	the	break	sites	through	association	with	 multiple	 proteins,	 which	 also	 involve	 its	 interactions	 with	 the	 BRCT	
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domains	of	MDC1,	dimethylated	H4	at	K20	(H4K20me2)	and	ubiquitinated	H2A	at	 K15	 (Botuyan	 et	 al.,	 2006;	 Eliezer	 et	 al.,	 2009).	 RIF1	 and	 PTIP	 are	 effector	proteins	 of	 53BP1,	 which	 together	 attenuate	 the	 resection	 though	 the	 exact	mechanism	is	still	not	clear	(Callen	et	al.,	2013;	Chapman	et	al.,	2013;	Di	Virgilio	et	 al.,	 2013;	 Escribano-Diaz	 et	 al.,	 2013;	 Zimmermann	 et	 al.,	 2013).	 The	interactions	 between	 these	 effectors	 and	 53BP1	 are	 ATM-phosphorylated	dependent,	indicating	them	as	specific	to	DNA	damage	response	(Bothmer	et	al.,	2011).	Similar	to	53BP1,	BRCA1	recruitment	is	dependent	on	RNF8-RNF168	but	unlike	 53BP1,	 it	 also	 requires	 RNF8-RNF168	 downstream	 RAP80	 associated	complex	 for	 its	 efficient	 recruitment	 (Kim	 et	 al.,	 2007;	 Mailand	 et	 al.,	 2007;	Sobhian	et	al.,	2007;	Wang	et	al.,	2007).	BRCA1	is	an	E3	ubiquitin	ligase	and	it	is	known	to	ubiquitinate	CtIP	though	functional	importance	of	this	modification	is	not	known.	BRCA1	also	interacts	with	MRN	through	phosphorylated	CtIP	(Chen	et	 al.,	 2008b;	Yu	et	 al.,	 2006).	How	BRCA1	 influences	 resection	 is	 still	 not	well	understood.	Intriguingly,	phosphorylation	dependent	CtIP	resection	is	proficient	in	53BP1	and	BRCA1	deficient	cells	(Bunting	et	al.,	2010).	It	indicates	that	BRCA1	may	function	upstream	of	CtIP	to	relieve	53BP1	suppressing	effect	on	resection.	Investigation	 of	 the	 interplay	 between	 53BP1	 and	 BRCA1	 by	 super	 resolution	microscopy	 hints	 that	 BRCA1	 may	 spatially	 exclude	 53BP1	 from	 DBS	 sites	(Chapman	et	al.,	2012).		
Figure	6.	Regulation	of	DNA	end	resection	by	53BP1	and	BRCA1.	In	G0/G1	phase,	BRCA1	binding	to	 DSBs	 is	 inhibited	 by	 53BP,	 which	 in	 turn	 prevents	 end	 resection	 by	 MRN	 and	 CtIP	 and	promotes	NHEJ.	In	S-phase/G2	phase,	BRCA1	is	activated	by	not	well-understood	mechanism	and	inhibits	the	53BP1	binding	to	DNA,	which	allows	MRN	and	CtIP	to	resect	the	DNA	ends	leading	to	promotion	 of	 HR.	 Removal	 of	 BRCA1	 in	 S-phase	 permits	 the	 53BP1	 binding	 to	 DSB,	 which	suppress	 resection	 and	 consequently	HR.	When	 both	 53BP1	 and	 BRCA1	 are	 lacking,	 resection	still	 occurs	 in	 S/G2	 phase	 indicating	 the	 upstream	 role	 of	 53BP1	 and	 BRCA1	 before	 resection	(adapted	from	Aly	and	Ganesan,	2011	Journal	of	Molecular	Cell	Biology).			
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1.5	Meiosis	and	homologous	recombination		With	millions	of	years	of	evolution	and	through	the	process	of	meiosis,	cells	have	developed	 an	 ingenious	 way	 to	 exploit	 and	 employ	 DSB	 repair	 process	 to	 a	specific	 purpose	 (Bernstein	 and	 Bernstein,	 2010).	 In	 eukaryotes,	 diploid	 cells	undergo	two	successive	cell	divisions	to	produce	four	haploid	gametes.	In	short,	meiosis	 is	a	specialized	cell	division,	which	exclusively	occurs	 in	 the	germ	cells	and	consists	of	one	round	of	replication	followed	by	two	rounds	of	cell	division	i.e.	 meiosis	 I	 and	 meiosis	 II	 (Alberts	 et	 al.,	 2015).	 The	 defining	 and	 distinct	feature	 of	 meiosis	 from	 mitosis	 is	 the	 alignment	 and	 separation	 of	 replicated	homologous	 chromosomes	 in	 meiosis	 I.	 In	 meiosis	 II,	 each	 chromosome	containing	 a	 pair	 of	 attached	 sister	 chromatids	 is	 further	 split	 into	 single	chromatids,	giving	rise	to	four	haploid	cells.	Although	the	origin	and	the	detailed	mechanism	of	meiosis	still	 lacks	consensus	among	biologists,	 it	has	been	firmly	established	 that	 the	 process	 of	 meiosis	 creates	 genetic	 diversity	 in	 the	population	by	exploiting	recombination	(Wilkins	and	Holliday,	2009).	Other	than	recombination,	 the	 random	distribution	 of	 parental	 homologous	 chromosomes	to	haploid	daughter	cells	during	segregation	also	contributes	to	genetic	diversity.	The	 proper	 alignment	 of	 homologous	 chromosomes	 by	 recombination	 ensures	their	 correct	 segregation	 and	 hence	 prevents	 adverse	 situation	 such	 as	 non-disjunction,	 which	 can	 lead	 to	 aneuploidy	 resulting	 in	 pathological	 conditions	including	Down's	syndrome(Antonarakis,	1991;	Antonarakis	et	al.,	1992)	.			Meiosis	 I	 and	 meiosis	 II	 are	 divided	 into	 five	 sequential	 events	 according	 to	cytologically	visible	structures.	These	sub-phases	of	meiosis	I	and	meiosis	II	are	prophase	 I	 and	 II,	metaphase	 I	 and	 II,	 anaphase	 I	 and	 II	 and	 telophase	 I	 and	 II	respectively.	 Prophase	 I	 is	 the	 longest	 phase	 of	meiosis,	 which	 is	 further	 sub-divided	 into	 four	 stages,	 namely	 leptotene,	 zygotene,	 pachytene	 and	 diplotene.	The	 process	 of	 alignment	 and	 recombination	 between	 homologous	chromosomes	 occurs	 in	 prophase	 I.	 The	 brief	 detail	 of	 summary	 of	 actions	 in	during	the	prophase	I	is	shown	in	Figure	7.			
	 44	
	
	Figure	7.	Different	stages	of	prophase	I	in	meiosis.	Prophase	I	initiates	with	the	leptotene	stage	in	which	chromatids	become	individualized	and	visible.	DSBs	occur	in	leptotene.	In	the	next	stage	of	zygotene,	homologous	chromosomes	begin	to	line	up	with	each	other,	which	is	facilitated	by	the	synaptonemal	 complex	 (SC)	 .	 The	 synapsis	 is	 fully	 competed	 in	 pachytene	 and	 crossing	 over	occurs	during	this	stage	forming	chiasmata	sites.	During	deplotene,	SC	degrades	and	connections	between	 homologous	 chromosomes	 are	 lost	 except	 at	 the	 sites	 of	 chiasmata	 until	 they	 are	resolved	at	anaphase	I.			Although	both	somatic	and	germ	cells	utilize	HR	pathway	to	repair	DSBs,	 there	are	 some	 major	 mechanistic	 variations	 between	 the	 mechanisms	 of	 the	processes	 and	 its	 final	 outcome	 (Andersen	 and	 Sekelsky,	 2010).	 The	 first	difference	 lies	 in	 the	 origin	 of	 DSBs.	 While	 DSBs	 in	 mitosis	 are	 accidental	 in	nature,	meiotic	DSBs	are	produced	in	a	programmed	manner	by	meiosis-specific	nuclease	Spo11	(Murakami	and	Keeney,	2008).	Second,	while	sister	chromatids	are	 overwhelmingly	 used	 as	 template	 in	 mitotic	 cells	 to	 avoid	 loss	 of	heterozygosity,	 homologous	 chromosomes	 are	 the	 preferred	 choice	 as	 a	template	 for	 DSBR	 in	meiotic	 cells	 (Bzymek	 et	 al.,	 2010;	 Kadyk	 and	 Hartwell,	1992;	 Lao	 and	 Hunter,	 2010;	 Schwacha	 and	 Kleckner,	 1997).	 The	 third	major	difference	 is	 in	 the	 final	 outcome	 of	 the	 DSB	 repair.	 DSBR	 in	 the	mitotic	 cells	predominantly	results	in	non-crossover	products	with	only	a	small	proportion	of	crossover	 products	 (Haber	 and	 Hearn,	 1985;	 Nickoloff	 and	 Brenneman,	 2004;	Stark	 and	 Jasin,	 2003).	 In	 contrast,	 meiotic	 cells	 have	 a	 specific	 pathway	dedicated	 to	 produce	 exclusively	 crossover	 products	 (Guillon	 et	 al.,	 2005;	Martini	 et	 al.,	 2006;	Mehrotra	 and	McKim,	 2006).	Despite	 that,	 non-crossovers	are	 still	 detected	 in	 meiotic	 HR,	 which	 arise	 due	 to	 pathways	 operational	 in	vegetative	cells	(Andersen	and	Sekelsky,	2010).		
1.5.1	Gene	conversion	(GC),	noncrossover	(NCO),	and	crossover	(CO)			The	actual	exchange	of	genetic	information	between	donor	and	acceptor	duplex	in	HR	 is	 primarily	 determined	by	 the	 choice	 of	 template	 for	 repair	 and	by	 the	
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specific	 processing	 of	 recombination	 intermediates.	 As	 explained	 above,	 both	crossover	and	noncrossover	products	form	during	meiotic	HR.	It	is	believed	that	noncrossover	 products	 can	 arise	 early	 in	 meiosis	 due	 to	 SDSA,	 or	 later	 upon	dissolution	 and	 symmetrical	 resolution	 of	 dHJs	 (Youds	 and	 Boulton,	 2011).	 In	contrast,	crossovers	can	only	be	produced	by	an	asymmetrical	cleavage	of	dHJs	(Heyer,	 2004;	 Wyatt	 and	 West,	 2014).	 Noncrossovers	 only	 involve	 non-reciprocal	 exchange	 of	 information	 by	 copying	 donor	 DNA	 sequence	 through	DNA	 synthesis.	 Typically,	 NCO	 between	 sister-chromatids	 results	 in	 no	 DNA	sequence	 alteration	 of	 the	 repaired	 duplex.	 On	 the	 other	 hand,	 the	 extent	 of	dissimilarity	 or	 heterology	 at	 repair	 site	 between	 non-sister	 chromatid	sequences	 determines	 the	 level	 of	 genetic	 alteration.	 The	 process	 of	 sequence	modification	of	the	newly	repaired	duplex	due	to	heterology	between	donor	and	acceptor	duplexes	is	known	as	gene	conversion	(Chen	et	al.,	2007).	Additionally,	when	 DNA	 synthesis	 during	 the	 3'	 strand	 extension	 is	 erroneous	 and	MMR	 is	defective	 to	 remove	 wrongly	 incorporated	 mispaired	 nucleotides,	 gene	conversion	 can	 occur	 even	 in	 between	 sister	 chromatids.	 Similarly	 to	noncrossovers,	 crossover	 events	 between	 sister	 chromatids	 do	not	 exhibit	 any	change	 of	 DNA	 sequence.	 In	 contrast,	 COs	 occurring	 between	 homologs	drastically	 alters	 the	 identity	 of	 both	 resulting	 duplexes	 through	 the	asymmetrical	cleavage	of	dHJ,	which	results	in	the	complete	exchange	of	flanking	regions	 at	 one	 side	 of	 the	 dHJ.	 Moreover,	 like	 with	 the	 case	 of	 NCOs,	 GC	 can	accompany	COs	in	addition	to	physical	swapping	of	DNA	irrespective	of	template	used	for	repair.		
1.5.2	Regulation	of	COs		Crossing	 over	 in	 meiosis	 is	 required	 to	 provide	 physical	 connection	 between	homologous	chromosomes	for	their	subsequent	segregation	(Bascom-Slack	et	al.,	1997).	Therefore,	meiotic	HR	ensures	 the	 formation	of	at	a	minimal	number	of	COs	known	as	obligate	COs	(Jones,	1984;	Martini	et	al.,	2006).	In	fact,	the	Spo11-induced	 DSBs	 are	 produced	 in	 excess	 to	 guarantee	 the	 formation	 of	 these	obligate	COs	(Keeney,	2008).	For	example,	only	1	out	of	10	DSBs	are	repaired	as	COs	in	mouse	spermatocytes	(Borner	et	al.,	2004;	Moens	et	al.,	2002).	In	both	S.	
cerevisiae	and	C.	elegans,	only	half	of	DSBs	are	finally	converted	to	COs	while	rest	
	 46	
are	repaired	as	either	 interhomolog	(IH)	NCOs	or	 intersister	(IS)	recombinants	(Chen	 et	 al.,	 2008c;	 Hillers	 and	 Villeneuve,	 2003;	 Mancera	 et	 al.,	 2008).	 Most	organisms	 have	 regulatory	 mechanisms	 known	 as	 CO	 homeostasis,	 which	ensures	 the	 formation	 of	 obligate	 COs	 upon	 diminished	 DSBs	 (Martini	 et	 al.,	2006).	 In	 S.	 cerevisiae,	 when	 DSBs	 levels	 are	 reduced	 by	 the	 usage	 of	hypomorphic	 mutant	 of	 spo11,	 obligatory	 COs	 still	 form	 at	 the	 expense	 of	decreased	NCOs.	Besides	CO	homeostasis,	another	regulatory	mechanism	known	as	CO	interference	exists	in	meiosis,	which	governs	the	spatial	distance	between	the	multiple	COs	on	the	same	chromosome	(class	I	COs)	(Hillers,	2004;	HJ,	1916).	In	essence,	 the	presence	of	CO	at	particular	site	decreases	 the	 likelihood	of	 the	formation	of	another	CO	in	the	near	vicinity.	In	budding	yeast,	multiple	COs	(~5-6)	 form	 on	 each	 chromosome,	 which	 are	 evenly	 spaced	 from	 each	 other	(Mancera	 et	 al.,	 2008).	 Such	 spatial	 distribution	 of	 COs	 would	 not	 have	 been	observed	 if	 COs	 occurred	 independently	 of	 each	 other.	 However,	 situation	 is	quite	 complicated,	 as	COs	 can	be	both	 interference	dependent	 (Class	 I	 COs)	 or	independent	 (Class	 II	 COs),	 which	 arise	 due	 to	 distinct	 pathways	 that	 will	 be	described	in	Section	(Allers	and	Lichten,	2001;	Kohl	and	Sekelsky,	2013)			
	
	 47	
1.6	Mechanism	of	meiotic	homologues	recombination			The	process	of	meiotic	HR	is	best	understood	in	S.	cerevisiae,	but	the	mechanism	is	 highly	 conserved	 in	 many-studied	 organisms	 though	 some	 substantial	differences	 exist.	 Here,	 I	 will	 describe	 the	 mechanism	 of	 meiotic	 HR	 as	discovered	in	S.	cerevisiae.		Meiotic	 homologous	 recombination	 begins	 with	 the	 introduction	 of	 DSBs	 by	Spo11	 (Keeney,	2008).	 Spo11	 is	 related	 to	archaeal	 topoIV	 topoisomerase,	 and	functions	as	a	homodimer	(Bergerat	et	al.,	1997).	It	cleaves	both	strands	of	DNA	duplex	 by	 transesterification	 reaction	 and	 covalently	 attaches	 to	 both	 5'	 ends	through	tyrosine-DNA	linkage	(Keeney	et	al.,	1997).	In	yeast,	the	reduced	level	or	failure	 in	 production	 of	 DSBs	 leads	 to	 meiotic	 arrest	 or	 formation	 of	 inviable	gametes	 with	 aneuploidy	 (Szekvolgyi	 et	 al.,	 2015).	 However,	 the	 nature	 of	Spo11-induced	 DSBs	 is	 not	 unique	 in	 the	 sense	 that	 DSBs	 produced	 by	 other	exogenous	 factors	 such	 as	 IR,	 HO	 endonuclease,	 I-SceI	 endonuclease	 etc.	 can	compensate	 for	 the	 loss	 of	 Spo11	 activity	 (Farah	 et	 al.,	 2009;	 Kolodkin	 et	 al.,	1986;	Malkova	et	al.,	2000).	Similar	to	CO	interference,	the	distribution	of	DSBs	on	 the	 chromosomes	 is	 non-random	 and	 the	 presence	 of	 one	DSB	 inhibits	 the	occurrence	of	another	DSB	in	the	near	vicinity	by	"DSB	interference"	(Szekvolgyi	et	al.,	2015).	Such	interference	exerts	this	effect	on	the	same	(i.e.	cis)	as	well	as	homologous	 chromosome	 on	 a	 cognate	 allelic	 site	 (trans)	 (Fan	 et	 al.,	 1997;	Robine	et	al.,	2007;	Rocco	et	al.,	1992;	Xu	and	Kleckner,	1995;	Zhang	et	al.,	2011).	In	addition,	DSB	levels	are	regulated	by	the	process	of	DSB	homeostasis,	in	which	suppression	 of	 a	 "hotspot"	 region	 elicits	 the	 production	 of	 DSBs	 elsewhere	 to	maintain	the	sufficient	number	of	DSBs	(Pecina	et	al.,	2002;	Robine	et	al.,	2007).	The	DSB	production	by	Spo11	is	followed	by	resection,	which	is	initiated	by	the	MRX	-Sae2	complex.	As	explained	earlier	 in	Section	X,	MRX-Sae2	complex	nicks	the	strand	endonucleolytically	to	remove	DNA	bound-Spo11	and	resects	the	DNA	back	to	towards	the	breaks.	Like	in	the	vegetative	cells,	 the	 limited	resection	is	followed	by	long-range	resection,	which	is	mediated	by	Exo1	only	as	Sgs1-Dna2	usually	 do	 not	 participate	 in	 resection	 in	 meiosis	 (Symington,	 2014b).	 The	presence	of	Spo11	at	DNA	ends	is	inhibitory	to	resection	by	Exo1,	and	the	initial	
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processing	by	MRX-Sae2	 is	 therefore	essential.	However,	extensive	resection	 in	meiosis	 is	 not	 strictly	 necessary	 as	 exo1∆	 mutant,	 while	 showing	 a	 dramatic	decrease	 in	 resection,	 still	 forms	 recombination	 intermediates	 normally	(Zakharyevich	et	al.,	2010b).			In	the	subsequent	step,	3'	overhangs	produced	by	resection	are	coated	by	RPA,	which	is	followed	by	DNA	strand	invasion.	The	invasion	of	the	3'	overhang	into	donor	 duplex	 creates	 structures	 known	as	 single	 end	 invasions	 (SEIs)	 (Hunter	and	Kleckner,	2001).	Unless	stabilized	by	additional	factors,	these	structures	can	be	disrupted	by	 the	dissociation	of	 invaded	strand	 from	the	donor	duplex.	The	"ZMM"	proteins,	including	the	Msh4-Msh5	(MutS	homolog	4	and	5)	heterodimer	have	been	proposed	to	function	as	stabilizing	factor	for	SEIs	(Bishop	and	Zickler,	2004;	 Borner	 et	 al.,	 2004;	 Hunter	 and	 Kleckner,	 2001).	 Other	 than	 stabilizing	SEIs,	Msh4-Msh5	 is	postulated	 to	 function	 the	 in	 later	 steps	of	HR	as	well	 (see	section	 1.7.2)	 (Moens	 et	 al.,	 2002;	 Snowden	 et	 al.,	 2004).	 The	 DNA	 strand	exchange	 in	meiosis	 is	 primarily	 carried	 out	 by	meiosis-specific	 protein	 Dmc1	with	 the	 help	 of	 Rad51	 (Bishop	 et	 al.,	 1992)	 (Brown	 and	 Bishop,	 2015).	 The	catalytic	 DNA	 strand	 exchange	 activity	 is	 provided	 by	meiosis-specific	 protein	Dmc1	while	Rad51,	with	 its	dispensable	enzymatic	activity,	 is	 still	 required	 for	Dmc1's	normal	function	(Cloud	et	al.,	2012).	Deletion	of	DMC1	 in	budding	yeast	results	 in	 the	accumulation	of	DSBs	and	blockage	at	 the	 strand-exchange	stage	while	 rad51∆	mutants	 show	somewhat	 lesser	 impairment	 (Bishop	et	 al.,	 1992;	Schwacha	 and	 Kleckner,	 1997;	 Shinohara	 et	 al.,	 1992;	 Shinohara	 et	 al.,	 1997).	This	 differential	 usage	 of	 strand	 exchange	 proteins	 has	 been	 attributed	 to	Dmc1's	 capacity	 to	 promote	 inter-homolog	 (IH)	 bias,	 which	 is	 necessary	 for	meiotic	recombination	(Hong	et	al.,	2013;	Lao	et	al.,	2013).	Next,	similarly	to	the	mitotic	HR,	 invaded	 strand	 is	 elongated	 by	DNA	 synthesis,	which	 results	 in	D-loop	extension.	At	 this	step,	 the	 invaded	strand	can	anneal	back	 to	 the	original	strand	by	the	SDSA	pathway	producing	NCO	products	only	(McMahill	et	al.,	2007;	Sun	et	al.,	1991).	The	balance	between	pro-	and	anti-CO	factors	is	crucial	for	the	successful	 recombination.	Many	 recombination	 intermediates	 produced	 during	HR	can	be	reverted	back	to	the	preceding	structure	by	DNA	helicases,	including	Sgs1,	Srs2	and	Mph1	(Wu	and	Hickson,	2006).	The	role	of	Sgs1	is	more	complex	
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as	 though	 it	 functions	 as	 anti-CO	 in	 mitotic	 HR;	 it	 is	 designated	 as	 central	regulator	 for	 the	 production	 of	 crossover	 in	 meiosis,	 however	 the	 underlying	mechanism	 is	 not	 clear	 (De	Muyt	 et	 al.,	 2012;	 Zakharyevich	 et	 al.,	 2012).	 Sgs1	also	 removes	 non-productive	 multi-chromatic	 structures	 arising	 due	 to	 DNA	entanglements	(Oh	et	al.,	2007).			Once	 cells	 have	 stabilized	 the	 extended	 D-loop	 and	 overcame	 the	 hurdles	imposed	 by	 various	 helicases,	 the	 second	 end	 of	 the	 broken	 chromosome	 is	captured,	 which	 ultimately	 results	 in	 dHJ	 formation	 (Kowalczykowski,	 2015).	The	elimination	of	dHJs	is	essential	for	the	proper	segregation	of	chromosomes.	Like	somatic	cells,	meiotic	cells	are	also	equipped	with	multiple	pathways,	which	include	 dissolution,	 resolution	 and	CO-biased	 resolution	 to	 remove	dHJs	 (Jasin	and	Rothstein,	2013).	The	mechanistic	details	of	these	pathways	are	described	in	the	subsequent	sections	(Figure	8).	
	Figure	 8.	 Removal	 of	 double	 Holliday	 junction.	 The	 specific	 processing	 of	 dHJ	 determines	 the	nature	of	 final	product.	The	convergent	branch	migration	of	holliday	 junctions	 in	dHJ,	 followed	by	 untangling	 of	 hemicatenane	 structure	 results	 in	 dissolution,	 which	 only	 give	 rise	 to	 non-crossover	 products.	 The	 symmetrical	 cleavage	 of	 dHJ	 produces	 non-crossovers	 products	while	asymmetrical	cleavage	results	in	crossover	products.	Gene	conversion	can	occur	in	all	described	situations	 irrespective	 of	mode	 of	 dHJ	 processing	 (modified	 from	Knoll	 et	 al,	 2014	Frontier	 in	
Plant	Science).			
1.6.1	Dissolution			Dissolution	 is	a	primary	mechanisms	used	 in	mitotic	 cells	 to	 remove	dHJs,	 and	results	 in	 NCOs	 only	 (Bizard	 and	 Hickson,	 2014).	 It	 is	 carried	 out	 by	 the	concerted	 efforts	 of	 Sgs1,	 Top3	 and	Rmi1	 that	 together	 form	a	 "dissolvasome"	
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complex	(Cejka	et	al.,	2012).	Similarly,	BLM-TOPIIIIα-RMI1	(BTR)	complex	with	the	additional	partner	protein	termed	RMI2	forms	the	dissolvasome	complex	in	humans	(Plank	et	al.,	2006;	Raynard	et	al.,	2006).	The	mechanism	of	dissolution	is	mainly	 studied	by	 reconstitution	of	 the	dissolution	 reaction	 in	vitro	with	 the	use	 of	 purified	 recombinant	 proteins	 and	 oligo-	 and	 plasmid-based	 dHJ	substrates.	Mechanistically,	 two	Holliday	 junctions	 in	dHJ	 are	 converged	 in	 the	centre	 by	 branch	 migration	 driven	 mainly	 by	 Sgs1,	 and	 supported	 by	 the	topoisomerase	activity	of	Top3.	The	convergence	of	HJs	produces	hemicatenane	structure,	which	 is	 topologically	removed	by	Top3	(Bizard	and	Hickson,	2014).	The	 third	 partner	 of	 STR	 complex,	 Rmi1	 strongly	 stimulates	 the	 dissolution	reaction	(Cejka	et	al.,	2010b).	Specifically,	analysis	of	Rmi1	with	plasmid-based	dHJ	 showed	 its	 role	 primarily	 in	 the	 final	 decatenation	 step	 rather	 than	 in	 a	branch	migration.			The	 exact	 mechanism	 of	 branch	 migration	 by	 Sgs1	 is	 not	 fully	 understood.	However	 Sgs1	 unwinding	 and	 annealing	 activities	 have	 been	 suspected	 to	function	in	a	coordinated	manner	to	carry	out	the	branch	migration.	The	ATPase	activity	 of	 Sgs1/BLM	 is	 necessary	 for	 branch	 migration	 (Cejka	 et	 al.,	 2010b;	Raynard	 et	 al.,	 2006;	Wu	 and	Hickson,	 2003).	Deletion	 of	 SGS1	 in	mitotic	 cells	results	 in	 increased	 HR,	 illegitimate	 recombination	 and	 gross	 chromosomal	rearrangements	 (Myung	 et	 al.,	 2001;	Myung	 and	Kolodner,	 2002;	Onoda	 et	 al.,	2000;	Watt	et	al.,	1996;	Yamagata	et	al.,	1998).	Humans	possess	four	more	RecQ	homologs	in	addition	to	BLM,	the	closet	counterpart	of	Sgs1.		However,	no	other	human	homolog	 can	 replace	BLM	 functionally	 in	 dissolution	 (Wu	 et	 al.,	 2005).	BLM	mutations	 in	 humans	 cause	Bloom	 syndrome,	which	predisposes	 affected	individuals	 to	cancer	development	(Ellis	and	German,	1996).	Consistently,	cells	from	 the	 Bloom	 syndrome	 patients	 show	 increased	 sister	 chromatid	 exchange	(SCE)	 level	with	other	chromosome	segregation	defects	 (Chaganti	et	al.,	1974).	Removal	 of	 TOP3	 in	 Schizosaccharomyces	 pombe,	 Drosophila	melanogaster	 and	mice	 is	 lethal,	 while	 top3∆	 mutants	 of	 S.	 cerevisiae	although	 viable	 grow	 very	slowly	(Goodwin	et	al.,	1999;	Li	and	Wang,	1998;	Maftahi	et	al.,	1999;	Plank	et	al.,	2005).	The	slow	growth	of	top3∆	mutants	can	be	suppressed	by	the	deletion	of	
sgs1(Gangloff	 et	 al.,	 1994).	 Yeast	 mutants	 lacking	 Rmi1	 phenocopy	 top3∆	
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features	 (Chang	 et	 al.,	 2005).	 Like	 Top3	 and	 Sgs1,	 deletion	 of	 Rmi1	 is	synthetically	 lethal	 with	 the	 deficiency	 in	 HJ	 resolvases	 (Mullen	 et	 al.,	 2005).	Though	dissolution	 occurs	 frequently	 in	 somatic	 cells	 to	 remove	dHJs,	most	 of	the	 NCOs	 produced	 during	 meiosis	 arise	 by	 the	 SDSA	 pathway.	 The	 relative	contribution	of	 dissolution	 in	NCOs	production	during	meiosis	 is	 currently	not	known.	The	plurality	of	 functions	of	STR/BTR	proteins	at	multiple	 steps	 in	HR	makes	it	difficult	to	determine	the	level	of	NCOs	by	dissolution.		
1.6.2	Resolution	by	structure	selective	endonuclease	(SSE)		Dissolution	 primarily	 occurs	 in	 during	 S-phase	 in	 somatic	 cells.	 Double	 HJs,	which	escape	processing	by	dissolution,	are	eliminated	later	in	the	cell	cycle	by	the	nucleolytic	activity	of	specific	SSEs	known	as	"resolvases"(Matos	and	West,	2014).	 In	 particular,	 deletion	 of	 SGS1	 in	 budding	 yeast	 results	 in	 the	accumulation	 of	 JMs,	 which	 are	 later	 processed	 by	 resolvases	 (Dayani	 et	 al.,	2011;	 Matos	 et	 al.,	 2011).	 This	 indicates	 that	 resolution	 functions	 as	 back	pathway	 for	 joint	molecule	 processing	 in	 vegetative	 cells	 (Szakal	 and	 Branzei,	2013).	 These	 resolvases	 include	Mus81-Mms4,	 Slx1-Slx4	 and	 Yen1	 in	 budding	yeast,	 while	 in	 humans	 they	 are	 MUS81-EME1/EME2,	 SLX1-SLX4	 and	 GEN1	(Blanco	and	Matos,	2015).	Although	the	action	and	regulation	of	these	nucleases	have	 been	 best	 defined	 in	 vegetative	 cells,	 they	 follow	 a	 similar	 pattern	 of	regulation	 in	 meiotic	 cells	 as	 well	 (Matos	 and	 West,	 2014).	 However,	 as	dissolution	 is	 less	 frequent	 (or	absent)	 in	meiosis,	 the	 requirement	 for	SSEs	 in	meiosis	is	higher	than	in	vegetative	cells.	In	Mus81-Mms4,	both	subunits	contain	a	 distinctive	ERCC4	 (ERCC	 excision	 repair	 4)	 nuclease	 domain	 but	 disruptive	mutation	 in	 the	nuclease	domain	of	Mms4	renders	 it	non-enzymatic	partner	of	Mus81	 (Ciccia	 et	 al.,	 2008).	 	 Therefore	 Mms4	 plays	 only	 a	 structural	 role,	enhancing	the	overall	nuclease	activity	of	the	complex.	Mus81-Mms4	is	capable	of	 cleaving	 a	 variety	 of	 structures	 including	 3'-flaps,	 D-loop	 and	 nicked-HJ,	showing	 a	 lower	 activity	 on	 intact	 HJs	 (Boddy	 et	 al.,	 2001;	 Ciccia	 et	 al.,	 2003;	Constantinou	 et	 al.,	 2002;	 Doe	 et	 al.,	 2002;	 Kaliraman	 et	 al.,	 2001).	 In	mitotic	cells,	Mus81-Mms4	activity	is	low	during	S-	and	G2	phase	(Gallo-Fernandez	et	al.,	2012;	Matos	 et	 al.,	 2011;	Matos	 et	 al.,	 2013;	 Szakal	 and	Branzei,	 2013).	 At	 the	onset	 of	 mitosis,	 the	 concerted	 action	 of	 Cdc28	 and	 Cdc5	 results	 in	 the	
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phosphorylation	of	Mms4	at	it	N-terminal	region	enhancing	the	nuclease	activity	of	Mus81-Mms4.	Similarly	 in	meiotic	cells,	phosphorylation	by	Cdc28	and	Cdc5	occurs	at	the	onset	of	first	meiotic	division	(Matos	et	al.,	2011).	MUS81-EME1	in	humans	 has	 acquired	 slightly	 different	 approach	 than	 yeast	 for	 its	 activation.	Similar	 to	 yeast	 orthologs,	 CDK1	 phosphorylates	MUS81-EME1	 at	 the	 onset	 of	mitosis,	which	increases	its	HJ	processing	capacity	(Wyatt	et	al.,	2013).	However,	this	modification	also	leads	to	MUS81-EME1	association	with	another	SSE	SLX1-SLX4	forming	SLX-MUS	complex,	which	then	functions	as	a	single	active	nuclease	complex	to	process	JMs	(Castor	et	al.,	2013;	Garner	et	al.,	2013).	It	is	noteworthy	that	 in	 budding	 yeast,	 slx1∆	 and	 slx4∆	 mutants	 do	 not	 show	 any	 significant	meiotic	 defects	 (Mullen	 et	 al.,	 2001;	 Zakharyevich	 et	 al.,	 2012).	 In	 contrast	 to	Mus81-Mms4	 activation,	 phosphorylation	 of	 Yen1	 by	 CDK	 inhibits	 its	 activity	(Blanco	 et	 al.,	 2014;	 Eissler	 et	 al.,	 2014;	 Matos	 et	 al.,	 2011).	 Specifically,	 the	phospho-deficient	 mutations	 of	 CDK-sites	 S655	 and	 S679	 could	 bypass	 the	requirement	of	Cdc-14	phosphatase,	which	targets	Yen1	and	allows	its	entry	into	nucleus.	 (Eissler	 et	 al.,	 2014;	 Kosugi	 et	 al.,	 2009).	 Additionally,	 the	 phospho-mimicking	mutations	of	S655	and	S679	impair	Yen1	nuclease	activity	(Eissler	et	al.,	 2014).	 Upon	 entering	 the	 anaphase,	 Cdc14	 phosphatase	 removes	 CDK-mediated	phosphorylation	from	Yen1,	which	enables	its	import	into	nucleus	and	transforms	 it	 into	 a	 potent	 nuclease	 (Blanco	 et	 al.,	 2014;	 Eissler	 et	 al.,	 2014).	Similarly	 to	 Yen1,	 human	 GEN1	 entry	 into	 the	 nucleus	 is	 inhibited	 by	 CDK1	mediated	phosphorylation	in	S-and	G2	phases	(Matos	et	al.,	2011).	However,	the	nuclease	activity	of	GEN1	is	not	affected	by	its	phosphorylation	to	the	degree	of	Yen1	(Chan	and	West,	2014).	Only	 in	 late	meiosis	at	 the	second	division,	CDK1	mediates	the	break	down	of	nuclease	envelope,	which	allows	GEN1	localization	into	nucleus	(Guttinger	et	al.,	2009).	This	temporal	and	sequential	application	of	distinct	 JMs	 processing	 mechanisms	 ensures	 the	 removal	 of	 all	 JMs	 with	 the	formation	of	desired	products	i.e.	CO	or	NCO	in	both	meiosis	and	mitosis.		All	 identified	 resolvases	 cleave	 a	 variety	 of	 branched	 structures.	 While	Yen1/GEN1	 and	 Slx1-Slx4/SLX1-SLX4	 can	 cleave	 intact	 HJs,	 Mus81-Mms4	requires	a	nick	in	the	HJ	structure	to	cleave	it,	at	least	in	vitro	(Blanco	and	Matos,	2015).	Additionally,	Yen1/GEN1	is	a	canonical	HJ	resolvase,	which	cleaves	HJs	by	
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making	 symmetrical	 and	 opposite	 incisions	 across	 the	 junction	 to	 produce	ligatable	 products.	 In	 contrast,	 other	 resolvases	 asymmetrically	 nicks	 HJs,	generating	 products,	 which	 cannot	 be	 ligated	 in	 vitro.	 The	 in	 vivo	 analysis	 has	showed	 that	 in	 spite	of	 having	different	modes	of	 cleavage,	 all	 these	nucleases	produce	 equal	 amount	 of	 CO	 and	 NCO	 products	 (Schwartz	 and	 Heyer,	 2011).	Importantly,	 COs	 produced	 by	 resolvases	 are	 interference	 independent	 (de	 los	Santos	et	al.,	2003;	de	los	Santos	et	al.,	2001;	Interthal	and	Heyer,	2000;	Oh	et	al.,	2008).	In	fission	yeast,	Mus81-Eme1	(ortholog	of	Mms4)	is	the	primary	nuclease	responsible	 for	 COs	 production	 and	 hence	 COs	 in	 S.	 pombe	 do	 not	 exhibit	interference	 (Boddy	 et	 al.,	 2001).	 The	 symmetrical	 cleavage	 by	 resolvases	indicates	that	the	nicking	of	two	HJs	in	the	dHJ	structure	is	not	coordinated	and	hence	 independent	 of	 each	 other.	 Therefore	 this	 random	 processing	 by	 these	resolvases	equally	generates	both	CO	and	NCO	products.	Such	mode	of	cleavage	is	not	 ideal	when	a	particular	 final	product,	 i.e.	CO,	 is	desired.	Therefore	as	CO	formation	 is	 necessary	 in	 meiosis	 for	 genetic	 recombination	 and	 proper	chromosome	segregation,	meiotic	 cells	 cannot	 rely	 solely	on	 the	activity	of	 the	above	 described	 nucleases,	 and	 therefore	 require	 a	 dedicated	 mechanism	 to	ensure	formation	of	obligate	COs	(see	section	1.8).		
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1.7	Mlh1-Mlh3	(MutLγ)	mediated	biased	resolution		The	 identification	 of	 the	 above	 described	 resolvases	 solved	 how	 COs	 form	 in	somatic	 cells.	 However	 various	 studies	 carried	 out	 in	 budding	 yeast,	mice	 and	humans	 indicated	 the	 existence	 of	 an	 additional	 pathway	 responsible	 for	 the	formation	of	majority	of	COs	 in	meiosis	(Zakharyevich	et	al.,	2012).	Analysis	of	recombination	 products	 by	 DNA	 physical	 assay	 in	 budding	 yeast	 provided	 a	deeper	 insight	 into	 the	 nature	 and	 logistic	 of	 JMs	 processing	 and	 thereby	 CO	formation.	More	 than	decade	earlier,	 it	was	shown	 that	 the	 removal	of	Mus81-Mms4	pathway	in	yeast	resulted	only	in	a	20%	decrease	in	COs	(Argueso	et	al.,	2004).	 By	 extending	 the	 scope	 of	 the	 investigation,	 another	 seminal	 study	showed	that	deletion	of	all	three	identified	resolvases	similarly	resulted	in	only	~	 20%	 reduction	 of	 CO	 numbers,	 which	 corroborated	 the	 previous	 findings	(Zakharyevich	et	al.,	2012).	Multiple	studies	in	different	organisms	revealed	the	existence	of	a	pathway	dependent	on	Mlh1-Mlh3	 in	meiosis	 responsible	 for	CO	formation	 (Baker	 et	 al.,	 1996;	 Hunter	 and	 Borts,	 1997).	 Specifically,	 a	 single	deletion	of	MLH3	in	budding	yeast	exhibited	70%	reduction	in	CO	levels,	while	a	disruption	of	MLH3	 in	mice	rendered	them	sterile	(Lipkin	et	al.,	2002;	Wang	et	al.,	 1999).	 Consistent	 with	 earlier	 findings,	 disruption	 of	mlh3	 in	 addition	 to	triple	 deletion	 of	 mms4	 slx4	 yen1	 resulted	 in	 a	 complete	 elimination	 of	 COs	(Zakharyevich	et	 al.,	 2012).	 Surprisingly,	 the	COs	 formation	by	Mlh1-Mlh3	was	dependent	on	the	presence	of	Sgs1,	which	had	been	previously	described	as	anti-CO	 factor.	How	does	 Sgs1	 act	 as	 pro-crossover	 factor	 in	meiosis	 besides	 being	responsible	for	majority	of	NCOs	in	vegetative	cells?	Whether	it	cooperates	with	Mlh1-Mlh3	at	later	stage	or	helps	earlier	in	preparing	the	appropriate	substrate	for	Mlh1-Mlh3	processing	 is	still	a	matter	of	on-going	 investigation.	 In	addition	to	Sgs1,	Exo1	was	also	shown	to	play	an	essential	structural	role	in	CO	formation	together	 with	 Mlh1-Mlh3,	 which	 was	 independent	 of	 its	 nucleolytic	 activity	(Zakharyevich	 et	 al.,	 2010a).	 Mlh1-Mlh3	 processes	 JMs	 to	 produce	 exclusively	COs,	while	Mus81-Mms4	processes	a	subset	of	JMs	generating	COs	and	NCOs	in	an	equal	ratio.	However,	when	Sgs1	is	missing,	NCOs	are	reduced	and	JMs	level	rises,	 which	 are	 primarily	 resolved	 by	 Mus81-Mms4.	 Additionally,	 while	 Slx1-Slx4	becomes	indispensable	in	the	sgs1∆	mms4∆	mutants,	Yen1	can	only	partially	
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compensate	 the	 for	 loss	 of	mms4	 in	 these	mutants	 (Zakharyevich	 et	 al.,	 2012).	The	 normal	 formation	 of	 JMs	 in	 the	 absence	 of	mlh1	 or	mlh3	 further	 suggests	their	later	role	in	CO	formation.	Many	studies	have	indicated	that	Mlh1-Mlh3	and	Msh4-Msh5	 function	 in	 the	 same	pathway	and	give	 rise	 to	obligate	COs,	which	are	class	I-interference	dependent.	
1.7.1	Role	of	Mlh1-Mlh3	in	meiosis	and	CO	formation		MutLγ	was	initially	suspected	to	play	role	in	the	MMR	pathway	as	it	belongs	to	the	MutL	 family	 of	 proteins.	 Although	 several	 reports	 suggest	 its	minimal	 but	consistent	 role	 in	MMR,	 its	major	 function	 has	 been	 discovered	 in	meiotic	 CO	formation.	 Unlike	 in	 case	 of	 the	 NCOs	 products,	 COs	 can	 only	 arise	 upon	nucleolytic	cleavage	of	dHJs.	Another	member	of	the	MutL	family,	MutLα	(Mlh1-Pms1	 in	 yeast;	 MLH1-PMS2	 in	 mammals)	 with	 a	 nuclease	 domain	 in	Pms1/PMS2,	has	been	 firmly	established	as	 cryptic	 endonuclease	 in	MMR	 (see	section	 1.2.3)	 (Kadyrov	 et	 al.,	 2006).	 Sequence	 alignment	 of	Mlh3/MLH3	with	Pms1	 and	 PMS2	 subunits	 identified	 the	 presence	 of	 conserved	 nuclease	motif DQHAX2EX4E	 in	 the	C-termini	 of	 the	polypeptides.	Remarkably,	 a	disruption	of	this	motif	in	budding	yeast	MLH3	phenocopies	mlh3∆	mutant	defects,	indicating	the	functional	importance	of	this	nuclease	motif	(Nishant	et	al.,	2008).	Similarly,	triple	deletion	mutant	of	mms4∆	slx1∆	yen1∆	with	nuclease	dead	mlh3	exhibited	severe	 reduction	 in	 CO	 as	 was	 observed	 for	 the	 mms4∆	 slx1∆	 yen1∆	 mlh3∆	quadruple	 mutant	 (Zakharyevich	 et	 al.,	 2012).	 Besides	 genetic	 evidence,	biochemical	 characterization	 of	 yeast	 MutLγ	 revealed	 its	 nicking	 activity	 on	super-coiled	dsDNA	 in	 the	presence	of	Mn2+	(Ranjha	 et	 al.,	 2014).	Additionally,	both	 yeast	 and	 human	 MutLγ	 exhibited	 DNA	 binding	 preference	 to	 HJ-like	structures.	In	mice,	deletion	of	MLH1	leads	to	10-fold	reduction	in	COs,	increased	frequency	of	aneuploidy	and	apoptosis	(Baker	et	al.,	1996).	Similarly,	the	lack	of	MLH3	also	results	in	aneuploidy	and	apoptosis.	Both	MLH1–/–	and	MLH3–/–	mice	are	infertile	(Lipkin	et	al.,	2002).				
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1.7.2	Role	of	Msh4-Msh5	(MutSγ)	in	meiosis	and	CO	formation		Like	 MutLγ,	 Msh4	 and	 Msh5	 were	 initially	 suspected	 to	 function	 in	 MMR	pathways	as	 they	structurally	belong	 to	MutS	 family	of	MMR	proteins	 (Lynn	et	al.,	 2007).	 However,	 it	 was	 shown	 later	 that	 they	 function	 in	 meiosis	 as	 a	heterodimer	and	have	no	role	in	MMR	(Hollingsworth	et	al.,	1995).	Functionally,	they	 have	 been	 categorized	 as	 part	 of	 the	 ZMM	 group	 (acronym	 for	 yeast	proteins	 Zip1/	 Zip2/	 Zip3/	 Zip4,	 Msh4/Msh5,	 Mer3).	 Mutation	 of	 any	 ZMM	group	member	 results	 in	 the	 reduction	or	absence	of	COs	 (Borner	et	 al.,	 2004;	Sym	 et	 al.,	 1993).	 The	 orthologs	 of	Msh4-Msh5	 have	 been	 discovered	 in	many	organisms.	 Intriguingly,	 while	 the	 loss	 of	 Msh4	 or	 Msh5	 results	 in	 a	 50-70%	reduction	of	COs	 in	S.	cerevisiae,	 the	absence	of	MutSγ	 in	C.	elegans	 and	mouse	eliminates	 COs	 completely	 (de	 Vries	 et	 al.,	 1999;	 Edelmann	 et	 al.,	 1999;	Hollingsworth	et	al.,	1995;	Kelly	et	al.,	2000;	Kneitz	et	al.,	2000;	Ross-Macdonald	and	 Roeder,	 1994;	 Zalevsky	 et	 al.,	 1999).	 Similarly	 in	 Arabidopsis	 thaliana	 (A.	
thaliana),	 COs	 are	 reduced	 but	 not	 completely	 abolished	 in	 the	 absence	 of	
atmsh4	or	atmsh5	(ortholog	of	MSH4	and	MSH5	respectively)	(Berchowitz	et	al.,	2007).	It	indicates	that	although	the	majority	of	COs	are	produced	by	the	MutSγ	pathway	in	S.	cervisiae	and	A.	thaliana,	residual	COs	still	occur	in	their	absence.	In	both	organisms,	further	investigations	of	the	nature	of	MutSγ	dependent	and	independent	 COs	 revealed	 that	 while	 former	 showed	 interference,	 latter	 COs	were	 interference	 independent	(Kohl	and	Sekelsky,	2013).	Consistently,	all	COs	in	S.	pombe,	which	lacks	MutSγ	orthologs,	are	non-interfering	whereas	all	COs	in	
C.	elegans,	which	absolutely	depend	on	MutSγ,	display	 interference	(Meneely	et	al.,	2002;	Munz,	1994).	These	observations	clearly	establish	the	role	of	MutSγ	in	COs	formation	in	the	MutLγ-dependent	pathway.		Evidences	from	various	studies	indicate	the	role	of	MutSγ	in	both	early	and	late	stages	of	recombination.	Null	mutant	of	msh5	exhibits	a	marked	reduction	in	SEI	formation	 (Borner	 et	 al.,	 2004).	 In	 agreement,	 human	 MutSγ	 binds	 to	 pro-HJ	structures,	 which	 resemble	 SEIs	 (Snowden	 et	 al.,	 2004).	 MutSγ	 is	 believed	 to	function	after	strand	invasion,	most	likely	in	the	stabilization	of	SEI	structures.	In	
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additions	to	its	early	role,	MutSγ	has	been	proposed	to	have	a	late	role	in	meiotic	HR	to	facilitate	biased	CO	formation	mediated	by	MutLγ.	S.	cerevisiae	msh4	and	
msh4	mlh1	 mutants	 have	 similar	 reduction	 in	 the	 recombination	 rate	 (Hunter	and	 Borts,	 1997;	 Stahl	 et	 al.,	 2004).	 In	 mouse	 meiotic	 cells,	 Msh4	 co-immunoprecipitates	with	Mlh3	and	recombinant	Msh4	directly	interacts	with	in	
vitro	 translated	Mlh3	 (Santucci-Darmanin	 et	 al.,	 2002).	Biochemical	 analysis	 of	human	MutSγ	revealed	that	it	binds	to	the	core	of	oligo-based	HJ	and	slides	along	the	 HJ	 arms	 upon	 ATP	 binding	 (Snowden	 et	 al.,	 2004).	 The	 sliding	 effect	 was	independent	 of	 MutSγ	 ATP	 hydrolysis	 activity.	 However,	 whether	 and	 how	MutSγ	promotes	CO-specific	HJ	 resolution	 together	with	MutLγ	 in	meiotic	 cells	remains	to	be	established.	
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2.	Results	
	
2.1	Phosphorylated	CtIP	functions	as	a	co-factor	of	the	MRE11-RAD50-NBS1	
endonuclease	in	DNA	end	resection		
Roopesh	Anand,	Lepakshi	Ranjha,	Elda	Cannavo	and	Petr	Cejka1		Manuscript	accepted	in	Molecular	Cell			I	 designed	 the	 research	 together	 with	 P.C.	 and	 performed	 all	 the	 experiments	except	electrophoretic	mobility	shift	assays	(EMSA).	The	EMSAs	were	carried	out	by	L.R	and	yeast	proteins	used	in	this	study	were	purified	and	provided	by	E.C.	All	authors	analysed	the	data	and	I	wrote	the	manuscript	with	P.C.				
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SUMMARY	
To	repair	a	DNA	double-strand	break	(DSB)	by	homologous	recombination	
(HR),	 the	 5'-terminated	 strand	 of	 the	 DSB	must	 be	 resected.	 The	 human	
MRE11-RAD50-NBS1	 (MRN)	 and	 CtIP	 proteins	 were	 implicated	 in	 the	
initiation	of	DNA	end	 resection,	 but	 the	underlying	mechanism	 remained	
undefined.	 Here	 we	 show	 that	 CtIP	 is	 a	 co-factor	 of	 the	 MRE11	
endonuclease	activity	within	the	MRN	complex.	This	function	is	absolutely	
dependent	on	CtIP	phosphorylation	that	includes	the	key	cyclin-dependent	
kinase	 target	 motif	 at	 Thr-847.	 	 Unlike	 in	 yeast	 where	 the	 Xrs2/NBS1	
subunit	 is	dispensable	 in	vitro,	NBS1	 is	absolutely	 required	 in	 the	human	
system.	 The	 MRE11	 endonuclease	 in	 conjunction	 with	 RAD50,	 NBS1	 and	
phosphorylated	CtIP	preferentially	cleaves	5'-terminated	DNA	strands	near	
DSBs.	Our	results	define	the	initial	step	of	HR	that	is	particularly	relevant	
for	 the	 processing	 of	 DSBs	 bearing	 protein	 blocks	 or	 secondary	 DNA	
structures.				
	
INTRODUCTION	To	 repair	 a	 DSB,	 cells	 employ	 either	 homologous	 recombination	 (HR)	 or	 non-homologous	end-joining	(NHEJ)	pathway.	Whereas	HR	is	template-directed	and	largely	accurate,	NHEJ	occurs	through	a	 ligation	of	 the	broken	DNA	ends	 in	the	absence	of	homology	and	may	therefore	lead	to	mutations	in	the	vicinity	of	the	break	site	(Chiruvella	et	al.,	2013;	Kowalczykowski,	2015).	HR	commences	by	a	nucleolytic	 processing	 of	 the	DSB	 (Cejka,	 2015).	 Specifically,	 the	 5'-terminated	strand	of	the	DSB	must	be	resected	to	reveal	a	3'-terminated	ssDNA	tail,	which	becomes	 a	 substrate	 for	 the	 strand	 exchange	 protein	 RAD51.	 RAD51	 then	catalyzes	 the	 invasion	 of	 the	 nucleoprotein	 filament	 into	 homologous	 DNA,	where	 the	 newly	 paired	 3'-terminated	 DNA	 may	 prime	 DNA	 synthesis	(Kowalczykowski,	 2015).	 The	 choice	 whether	 or	 not	 to	 resect	 broken	 DNA	 is	thus	 a	 critical	 regulatory	 step	 that	 affects	 the	 DSB	 repair	 pathway	 choice.	Misregulation	 of	 the	 balance	 between	 two	 key	 DSB	 repair	 pathways	 leads	 to	
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genome	 instability	 that	 is	 typical	 in	 many	 cancer	 types	 (Jackson	 and	 Bartek,	2009;	O'Driscoll,	2012).	The	mechanism	of	DNA	end	resection	has	been	extensively	studied	in	recent	years.	Research	 from	multiple	 laboratories	established	that	DNA	resection	 is	 in	most	cases	a	two-stage	process	(Mimitou	and	Symington,	2008;	Zhu	et	al.,	2008).	The	first	step	is	slow	and	involves	5'	end	resection	that	is	limited	up	to	~200-300	nucleotides	 away	 from	 the	 DSB.	 In	 contrast	 the	 second	 resection	 step	 is	relatively	fast	and	capable	to	resect	DNA	thousands	of	nucleotides	in	length.	The	first	 phase	 is	 catalyzed	 by	 the	Mre11-Rad50-Xrs2	 (MRX)	 complex	 and	 Sae2	 in	
Saccharomyces	 cerevisiae	 (S.	 cerevisiae)	 and	 the	 MRE11-RAD50-NBS1	 (MRN)	complex	 and	CtIP	 in	human	 cells	 (Gravel	 et	 al.,	 2008;	Mimitou	 and	 Symington,	2008;	 Zhu	 et	 al.,	 2008).	 The	 initial	 5'	 DNA	 end	 resection	 by	 these	 proteins	 is	especially	 important	 for	 the	 processing	 of	 DNA	 ends	 with	 non-canonical	structures,	 such	 as	 protein	 blocks	 or	 DNA	 secondary	 structures	 (Mimitou	 and	Symington,	 2010).	 This	 has	 been	 revealed	 particularly	 in	 yeast	 meiotic	recombination,	 where	 Sae2	 and	 the	 nuclease	 activity	 of	 Mre11	 are	 absolutely	required	for	the	resection	of	DSBs	covalently	bound	by	the	Spo11	transesterase	(Bergerat	et	al.,	1997;	Keeney	et	al.,	1997;	Moreau	et	al.,	1999;	Neale	et	al.,	2005).	Topoisomerase	poisoning	may	also	result	in	covalent	TopoII-DNA	or	TopoI-DNA	adducts	 at	 the	 ends	 of	 broken	 DNA.	 Here,	 the	 requirement	 for	 MRX/N	 and	Sae2/CtIP	 is	 less	 pronounced,	 possibly	 due	 to	 the	 presence	 of	 Tdp1	 and	Tdp2	enzymes	that	can	compete	for	the	same	substrate	(Cortes	Ledesma	et	al.,	2009;	Deng	 et	 al.,	 2005;	 Hartsuiker	 et	 al.,	 2009b;	 Liu	 et	 al.,	 2002;	 Neale	 et	 al.,	 2005;	Pouliot	et	al.,	1999).	Moreover,	poisoning	of	TopoI	does	not	necessarily	 lead	to	DSBs	(Ray	Chaudhuri	et	al.,	2012).		Nevertheless,	Mre11	nuclease	and	Sae2/CtIP-deficient	 cells	 are	 sensitive	 to	 topoisomerase	 inhibitors	 in	 various	 organisms	(Deng	 et	 al.,	 2005;	 Hartsuiker	 et	 al.,	 2009b;	 Huertas	 and	 Jackson,	 2009;	Nakamura	et	al.,	2010;	Sartori	et	al.,	2007).	In	budding	yeast,	the	requirement	for	MRX	 in	DNA	end	resection	can	sometimes	be	bypassed	to	process	"clean"	DNA	ends,	 in	 particular	 in	 the	 absence	 of	 the	 Ku	 heterodimer	 (Bonetti	 et	 al.,	 2010;	Clerici	et	al.,	2008;	Foster	et	al.,	2011;	Mimitou	and	Symington,	2010;	Moreau	et	al.,	 1999).	 In	 contrast	 fission	 yeast	 and	 higher	 eukaryotes	 rely	 on	 MRN	 and	Ctp1/CtIP	for	resection	in	most	cases,	and	the	nuclease	of	MRE11	is	essential	for	
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viability	 in	mouse	 cells	 (Buis	 et	 al.,	 2008;	 Langerak	 et	 al.,	 2011;	 Sartori	 et	 al.,	2007).	In	addition	to	a	catalytical	role,	the	MRN/X	complex	also	has	a	structural	role	 to	 promote	 recruitment	 of	 factors	 belonging	 to	 the	 second	 resection	 step	(Cejka	 et	 al.,	 2010a;	 Nicolette	 et	 al.,	 2010b;	 Nimonkar	 et	 al.,	 2011;	 Niu	 et	 al.,	2010).	 In	 yeast,	 this	 includes	 either	 the	 exonuclease	 Exo1	 or	 the	 helicase-nuclease	 Sgs1-Dna2	 pair	 (Mimitou	 and	 Symington,	 2008;	 Zhu	 et	 al.,	 2008).	 In	human	 cells,	 processive	 long-range	 DNA	 end	 resection	 may	 be	 similarly	catalyzed	 by	 the	 nuclease	 of	 EXO1	 or	 DNA2,	 the	 latter	 of	 which	 functions	 in	conjunction	with	either	BLM	or	WRN	helicase	(Gravel	et	al.,	2008;	Nimonkar	et	al.,	2011;	Sturzenegger	et	al.,	2014).	The	long-range	DNA	end	resection	catalyzed	by	these	enzymes	is	relatively	well	understood	and	has	also	been	reconstituted	
in	 vitro	 (Cannavo	 et	 al.,	 2013;	 Cejka	 et	 al.,	 2010a;	 Nicolette	 et	 al.,	 2010b;	Nimonkar	et	al.,	2011;	Niu	et	al.,	2010).	In	contrast,	the	nuclease	function	during	the	 initial	 resection	 step	 is	 less	 defined.	 In	 particular,	 the	 involvement	 of	Mre11/MRE11	in	the	first	resection	step	has	been	perplexing	as	Mre11/MRE11	is	a	3'-5'	exonuclease	(Furuse	et	al.,	1998;	Paull	and	Gellert,	1998;	Trujillo	et	al.,	1998;	Usui	et	al.,	1998).	This	nuclease	polarity	would	lead	to	5'-terminated	DNA,	which	is	 in	disagreement	with	the	DSB	repair	model	and	direct	observations	in	multiple	 organisms,	 which	 demonstrate	 that	 5'-terminated	 DNA	 is	 being	degraded	 (Sun	 et	 al.,	 1991;	White	 and	 Haber,	 1990;	 Zhu	 et	 al.,	 2008).	 To	 this	point	 a	 bidirectional	DSB	 repair	model	 has	 been	 proposed,	where	DNA	 is	 first	incised	 endonucleolytically	 away	 from	 the	 DNA	 break,	 and	 the	 Mre11	exonuclease	proceeds	back	towards	the	DNA	end	in	a	3'-5'	direction	(Keeney	et	al.,	 1997;	 Neale	 et	 al.,	 2005;	 Shibata	 et	 al.,	 2014;	 Zakharyevich	 et	 al.,	 2010b),	possibly	in	conjunction	with	EXD2	(Broderick	et	al.,	2016).	The	endonucleolytic	cleavage	creates	an	entry	 site	 for	 the	 long-range	 resection	machinery	 to	 resect	DNA	 in	 a	 5'-3'	 direction	 away	 from	 the	DSB	 (Cejka	 et	 al.,	 2010a;	 Gravel	 et	 al.,	2008;	 Mimitou	 and	 Symington,	 2008;	 Nimonkar	 et	 al.,	 2011;	 Niu	 et	 al.,	 2010;	Sturzenegger	 et	 al.,	 2014;	 Zhu	 et	 al.,	 2008).	 Recently,	 using	 recombinant	 S.	
cerevisiae	 proteins	 in	vitro,	we	 could	demonstrate	 that	 Sae2	 activates	 a	 cryptic	endonuclease	activity	within	the	Mre11	subunit	of	the	MRX	complex	that	cleaves	preferentially	5'-terminated	DNA	in	the	vicinity	of	protein	blocks	(Cannavo	and	Cejka,	2014).	This	provided	a	direct	 support	 for	 the	bidirectional	 repair	model	
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and	provided	strong	evidence	that	DSB	resection	is	initiated	by	the	endonuclease	activity	 of	 Mre11,	 which	 cleaves	 DNA	 in	 a	 way	 that	 initiates	 5'	 DNA	 end	resection.	 Interestingly,	 the	Escherichia	coli	 (E.	coli)	 SbcCD	 can	 similarly	 cleave	dsDNA	past	protein	blocks,	indicating	that	this	might	be	a	conserved	mechanism	(Connelly	et	al.,	2003).	At	 the	same	time,	 it	has	been	shown	that	also	Sae2	and	CtIP	 possess	 an	 intrinsic	 endonuclease	 activity,	 and	 in	 particular	 the	 5'	 flap	endonuclease	 of	 CtIP	 has	 been	 proposed	 to	 process	 DNA	 adducts	 at	 DSBs	(Lengsfeld	et	al.,	2007;	Makharashvili	et	al.,	2014;	Wang	et	al.,	2014).	Contrary	to	these	observations,	other	groups	purified	nuclease-free	Sae2/CtIP	(Andres	et	al.,	2015;	Cannavo	and	Cejka,	2014;	Niu	et	al.,	2010).	Therefore,	the	mechanism	by	which	MRN	and	CtIP	proteins	process	5'-terminated	DNA	at	DSBs,	particularly	in	human	cells,	remains	unresolved.	Resected	 DSBs	 are	 in	 general	 non-ligatable	 and	 DNA	 end	 resection	 thus	commits	 the	DSB	 repair	 to	 the	HR	 pathway	 (Dupre	 et	 al.,	 2008;	 Shibata	 et	 al.,	2014).	 Human	 cells	 employ	 a	 number	 of	 factors	 that	 regulate	 the	 balance	between	 HR	 and	 NHEJ.	 In	 particular	 the	 53BP1	 protein	 through	 its	 multiple	effectors	including	PTIP,	REV7	and	RIF1	functions	as	a	general	inhibitor	of	DNA	end	 resection	 (Bunting	 et	 al.,	 2010;	Zimmermann	and	de	Lange,	2014).	On	 the	other	hand	BRCA1,	possibly	in	complex	with	BARD1,	may	function	to	counteract	53BP1	(Bouwman	et	al.,	2010;	Bunting	et	al.,	2010;	Chen	et	al.,	2008b),	or	even	directly	promote	resection	through	a	physical	interaction	with	CtIP	(Chen	et	al.,	2008b;	Yu	and	Chen,	2004).	Vegetative	cells	typically	use	a	sister	chromatid	as	a	template	 for	 DSB	 repair	 during	 HR.	 Therefore,	 DNA	 end	 resection	 is	 typically	only	 activated	 during	 the	 S	 and	 G2	 phases	 of	 the	 cell	 cycle	 when	 such	homologous	 template	 is	 available.	 This	 is	 achieved	by	 a	 regulatory	mechanism	dependent	on	the	phosphorylation	of	Sae2/CtIP	by	the	cyclin-dependent	kinase	(CDK).	Phosphorylation	of	Sae2	at	S267	and	CtIP	at	T847	by	CDK	is	essential	for	resection	 in	 vivo	 (Huertas	 et	 al.,	 2008;	 Huertas	 and	 Jackson,	 2009).	 The	requirement	for	CDK	can	be	partially	bypassed	in	cells	expressing	the	phospho-mimicking	 Sae2	 S267E	 or	 CtIP	 T847E	 variants,	 implicating	 Sae2/CtIP	 as	exclusive	CDK	 targets	 in	HR	 (Huertas	 et	 al.,	 2008;	Huertas	 and	 Jackson,	2009).	Using	purified	recombinant	proteins	in	vitro,	we	show	here	that	CtIP	functions	as	co-factor	of	MRE11	endonuclease	activity	within	the	human	MRN	complex.	This	
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function	of	CtIP	is	absolutely	dependent	on	its	phosphorylation	that	includes	the	CDK	site	T847.	Unlike	in	yeast	where	the	Mre11-Rad50	complex	is	sufficient	for	resection	 in	vitro,	we	show	that	NBS1	is	an	essential	reaction	component	in	the	reconstituted	 human	 system.	 These	 results	 imply	 MRE11	 as	 the	 primary	nuclease	 in	 the	 initiation	step	of	DSB	end	resection.	The	reconstituted	reaction	will	 be	 invaluable	 to	 define	mechanisms	 that	 regulate	 this	 critical	 step	 in	 DSB	repair.	
	
RESULTS		
Phosphorylated	CtIP	promotes	the	MRE11	endonuclease	within	the	human	
MRE11-RAD50-NBS1	complex		Sae2	from	S.	cerevisiae	promotes	the	endonuclease	activity	of	Mre11	within	the	Mre11-Rad50-Xrs2	 (MRX)	 complex	 to	 initiate	 resection	 of	 protein-blocked	dsDNA	 ends	 (Cannavo	 and	 Cejka,	 2014).	 To	 investigate	 whether	 human	 CtIP	similarly	promotes	the	endonuclease	of	the	human	MRE11-RAD50-NBS1	(MRN)	complex,	 we	 initially	 expressed	 and	 purified	 MRN	 and	 CtIP	 from	 baculovirus	infected	 Spodoptera	 frugiperda	 9	 (Sf9)	 cells	 using	 a	 procedure	 similar	 to	 that	used	previously	for	yeast	MRX	and	Sae2	(Cannavo	and	Cejka,	2014)(Figure	S1A	and	 S1B).	 Recombinant	 MRN	 showed	 a	 manganese-dependent	 3'	 to	 5'	exonuclease	activity	as	reported	previously	(Paull	and	Gellert,	1998)	(Figure	S1C	and	 S1D).	 CtIP	 failed	 to	 stimulate	 either	 the	 endonuclease	 or	 the	 3'-5'	exonuclease	of	MRN	(Figures	1A	and	S1E).	The	 function	of	CtIP	 in	homologous	recombination	 is	 strongly	 dependent	 on	 its	 phosphorylation,	 especially	 by	 a	cyclin-dependent	 kinase	 (CDK)	 (Huertas	 and	 Jackson,	 2009).	 To	 enrich	 for	phosphorylated	 variants	 of	 recombinant	 CtIP,	 we	 modified	 its	 preparation	procedure	 by	 supplementing	 the	 Sf9	 culture	 and	 extracts	 with	 phosphatase	inhibitors.	This	procedure	yielded	CtIP	that	exhibited	an	electrophoretic	mobility	shift	(Figures	S1F	and	1B)	that	disappeared	upon	treatment	with	λ-phosphatase	(Figure	 1C).	 The	 phosphorylated	 CtIP,	 hereafter	 referred	 to	 as	 pCtIP,	 lacked	 a	detectable	 intrinsic	 nuclease	 activity	 in	 our	 assays	 (Figure	 S1G).	 Strikingly	however,	the	combination	of	both	pCtIP	and	MRN	resulted	in	an	endonucleolytic	cleavage	of	a	synthetic	70	bp-long	dsDNA	substrate	blocked	on	both	ends	with	
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biotin-streptavidin	 (Figure	 1D).	 Treatment	 of	 pCtIP	 with	 λ-phosphatase	eliminated	this	activity	(Figure	1E),	showing	that	CtIP	phosphorylation	is	indeed	required	 for	 the	observed	endonucleolytic	 cleavage.	A	 failure	 to	phosphorylate	CtIP	by	CDK	at	T847	was	shown	to	impair	resection	and	cause	cellular	sensitivity	to	 DNA-damaging	 drugs	 in	 vivo	 (Huertas	 and	 Jackson,	 2009).	 Accordingly,	 the	non-phosphorylatable	CtIP	T847A	mutant	(Figure	S1H)	was	severely	impaired	in	the	 dsDNA-clipping	 assay	 (Figure	 1F),	 despite	 being	 phosphorylated	 at	 other	residues	resulting	in	a	phosphorylation-dependent	electrophoretic	mobility	shift	(Figure	S1H).	The	previously	 established	 control	 of	DNA	end	 resection	by	CDK	can	therefore	be	reconstituted	in	the	minimal	in	vitro	resection	system	as	well.		To	determine	whether	the	nuclease	of	MRE11	is	responsible	for	the	observed	endonucleolytic	 cleavage,	 we	 mutated	 the	 conserved	 nuclease	 motif	 within	MRE11	 to	 prepare	 the	 M(H129L	 D130V)RN	 complex	 	 (Figure	 S1G).	 The	M(H129L	D130V)RN	variant	behaved	similarly	as	the	wild	type	complex	during	purification,	 and	 lacked	 magnesium-dependent	 3'-5'	 exonuclease	 activity,	 as	expected	(Figure	S1K	and	S1L)	(Arthur	et	al.,	2004).	Similarly	as	in	S.	cerevisiae,	the	 nuclease-deficient	 variant	 was	 completely	 deficient	 in	 the	 clipping	 assay	(Figure	1G)	(Cannavo	and	Cejka,	2014),	showing	that	the	nuclease	of	MRE11	is	entirely	responsible	for	the	observed	endonucleolytic	cleavage	activity.	The	endonucleolytic	cleavage	was	dependent	on	concentrations	of	both	MRN	and	 CtIP	 (Figure	 2A-D).	 Unlike	 the	 MRE11	 exonuclease,	 the	 endonuclease	 of	MRN-pCtIP	 required	 both	 manganese	 and	 magnesium	 metal	 cofactors	 for	optimal	 activity	 (Figure	 S2A).	 While	 low	 manganese	 concentrations	 were	sufficient,	 at	 least	 5	mM	magnesium	was	 required	 for	 optimal	 activity	 (Figure	S2B	 and	 S2C),	 in	 agreement	 with	 a	 significantly	 higher	 cellular	 magnesium	concentration	 than	 that	 of	manganese	 (Tholey	 et	 al.,	 1988).	 Increasing	 the	 salt	concentration	 in	 the	 reaction	 resulted	 in	 the	 reduction	of	 the	pCtIP-stimulated	endonuclease	 activity	 of	 MRN	 indicating	 its	 dependence	 on	 ionic	 interactions	between	MRN	and	pCtIP	and/or	with	DNA	(Figure	S2D).	Next,	we	tested	whether	phosphorylation	 affects	 the	 DNA	 binding	 capacity	 of	 CtIP.	 We	 observed	 that	phosphorylation	 of	 CtIP	 reduced	 its	 affinity	 to	 DNA	 (Figure	 2E).	 CtIP	 could	stabilize	MRN	on	DNA,	however	 its	 capacity	 to	do	so	was	 severely	 impaired	 in	case	 of	 the	 hyperphosphorylated	 CtIP	 variant	 (Figure	 2E).	 Our	 results	 thus	
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suggest	that	the	stabilization	of	MRN	and	CtIP	on	DNA,	as	well	as	the	proposed	DNA	end	bridging	function	that	was	described	for	Ctp1	of	S.	pombe	(Andres	et	al.,	2015),	 might	 be	 dispensable	 for	 the	 dsDNA	 clipping	 reaction,	 at	 least	 in	 the	reconstituted	 system.	 Finally,	 we	 tested	 the	 requirement	 for	 species-specific	interactions.	Yeast	 Sae2	did	not	promote	 the	nuclease	of	human	MRN	and	vice	
versa,	pCtIP	did	not	promote	the	nuclease	of	yeast	MRX,	both	at	37°C	and	30°C	(Figure	 2F	 and	 S2E).	 Species-specific	 interactions	 between	 the	 two	 cognate	complexes	are	 therefore	 likely	required	 for	 the	observed	DNA	clipping	activity.	In	summary,	we	demonstrate	 that	phosphorylated	CtIP	 functions	as	a	co-factor	of	 the	MRN	 endonuclease	 in	 a	 species-specific	 reaction	 that	 is	 able	 to	 process	protein-blocked	DNA	ends.			
ATP	hydrolysis	by	RAD50	and	a	 structural	 function	of	NBS1	are	 required	
for	the	CtIP-MRN	endonuclease	The	MRN-pCtIP	clipping	activity	 required	ATP,	which	could	not	be	 replaced	by	ADP	or	the	non-hydrolysable	ATP	analogue	ATPγS	(Figure	3A).	We	next	mutated	the	 conserved	 lysine	 residue	 within	 the	Walker	 A	 motif	 of	 RAD50	 into	 either	arginine,	resulting	in	the	MR(K42R)N	complex	(Figure	S3A),	which	is	expected	to	be	deficient	in	ATP	hydrolysis,	or	into	alanine,	resulting	in	MR(K42A)N		(Figure	S3B)	 deficient	 in	 ATP	 binding	 (Paull	 and	 Gellert,	 1999).	 	 Both	 mutations	eliminated	the	endonuclease	activity	in	conjunction	with	CtIP,	proving	that	ATP	hydrolysis	 by	 the	 RAD50	 subunit	 is	 required	 for	 the	 DNA	 clipping	 activity		(Figure	3B	and	3C).	In	contrast,	the	RAD50	mutations	had	no	significant	effect	on	the	 manganese-dependent	 exonuclease	 of	 MRE11	 within	 the	 MRN	 complex	variants	(Figure	S3C-F).	ATP	hydrolysis	by	RAD50	is	therefore	either	specifically	required	 for	 the	 MRN	 complex	 to	 melt	 into	 dsDNA	 and/or	 mediates	 a	conformational	 change	 that	 is	 essential	 to	 trigger	 the	 MRE11	 endonuclease	within	 the	MRN-pCtIP	 complex	 (Deshpande	et	 al.,	 2014;	Lammens	et	 al.,	 2011;	Paull	and	Gellert,	1999).		Interestingly,	 yeast	 Xrs2	 is	 essential	 for	 the	 nuclear	 import	 of	 the	 MRX	complex,	 but	 is	 not	 required	 for	 most	 MRX	 functions	 in	 homologous	recombination	 per	 se;	 in	 accord,	 Xrs2	 is	 not	 required	 for	 the	 Sae2-stimulated	dsDNA	 clipping	 reaction	 by	MRX	 (Oh	 et	 al.,	 Symington	 laboratory,	manuscript	
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under	revision).	Here	we	purified	the	human	MRE11-RAD50	(MR)	complex	using	the	 same	 procedure	 as	MRN	 (Figure	 S4A).	 In	 contrast	 to	 the	MR	 complex	 and	Sae2	from	S.	cerevisiae,	human	MR	complex	failed	to	cleave	dsDNA	in	conjunction	with	pCtIP	(Figure	4A),	while	the	MR	was	exonuclease-proficient	in	the	absence	of	NBS1	(Figure	4B	and	S4B).	These	results	show	a	differential	requirement	for	the	Xrs2/NBS1	 factor	 in	homologous	recombination	between	 lower	and	higher	eukaryotes	 and	 are	 in	 agreement	 with	 previous	 observations	 that	 NBS1	 is	required	 for	 ATP-dependent	 functions	 of	 the	 human	MRN	 complex	 (Paull	 and	Gellert,	 1999).	 In	 summary,	 our	 results	 demonstrate	 that	 phosphorylated	 CtIP	functions	as	a	co-factor	of	the	MRE11	endonuclease	within	the	MRN	complex	in	a	process	 that	 also	 requires	 ATP	 hydrolysis	 by	 RAD50	 and	 a	 structural	 role	 of	NBS1.		
CtIP-MRN	endonuclease	preferentially	 clips	5'	 terminated	DNA	 strands	of	
protein-blocked	DNA	ends	In	 the	 absence	 of	 streptavidin,	 the	 free	 DNA	 ends	 were	 resected	 by	 MRN	exonucleolytically	 in	 the	3'-5'	direction.	This	can	be	seen	 in	Figure	5A	(lane	3),	where	 the	 unblocked	 3'	 end-labeled	 DNA	 substrate	 was	 cleaved	 to	 produce	 a	species	 that	 is	 likely	 the	 terminally	 labeled	 mononucleotide	 migrating	 at	 the	bottom	of	 the	 gel.	 The	 exonuclease	 of	MRE11	was	unaffected	by	pCtIP	 (Figure	5A,	lane	5),	as	also	observed	on	a	5'-labeled	DNA	substrate	(Figure	S5A).	This	3'-5'	 directionality	of	 resection	 is	paradoxically	 the	opposite	 than	 that	postulated	by	the	DSB	repair	model	and	observed	by	various	methods	in	diverse	organisms	including	human	cells	 in	vivo	(Sun	et	al.,	1991;	White	and	Haber,	1990;	Zhou	et	al.,	2014;	Zhu	et	al.,	2008).	We	next	analyzed	the	positions	of	the	endonucleolytic	cleavage	 to	 determine	 whether	 it	 may	 explain	 the	 MRE11	 nuclease	 polarity	paradox.	 On	 3'-end	 labeled	 substrates	 of	 70	 bp	 in	 length	 blocked	 with	streptavidin	 on	 both	 DNA	 ends,	 the	 clipping	 reactions	 with	 MRN	 and	 pCtIP	consistently	produced	DNA	fragments	of	~50	and	~30	nt	in	length	indicative	of	an	 endonuclease	 activity	 (Figure	 1D,	 lane	 5;	 Figure	 5A,	 lane	 10).	 This	corresponds	 to	 cleavage	 sites	 located	 ~20	 and	 ~40	 nt	 away	 from	 the	 protein	blocked	5'-terminated	DNA	end.	Kinetic	analysis	suggested	that	the	site	closer	to	the	5'	end	is	cleaved	slightly	faster,	however	we	could	not	determine	whether	a	
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small	 number	 of	 sites	 is	 initially	 cleaved	 at	 the	 40	 nt	 position	 or	whether	 the	cleavage	 occurs	 simultaneously	 in	 some	 cases	 (Figure	 5B).	 To	 distinguish	between	these	scenarios,	we	prepared	the	streptavidin-blocked	dsDNA	substrate	with	a	32P-label	on	the	5'	end.	In	this	case,	we	could	exclusively	detect	a	fragment	of	~20	nt	in	length	upon	the	reaction	with	the	MRN-pCtIP	complex	(Figure	5C).	This	demonstrated	 that	 the	 first	 cleavage	event	occurs	near	 the	5'	end	and	 the	second	 site	 is	 cut	 subsequently,	which	 can	 only	 be	 detected	 using	 a	 3'-labeled	DNA.	 We	 speculate	 that	 MRN-pCtIP	 bound	 near	 the	 DNA	 end	 may	 create	 a	secondary	protein	block	that	is	subsequently	recognized	by	another	MRN-pCtIP	complex	to	cleave	at	the	second	site,	which	might	lead	to	the	resection	of	longer	stretches	of	DNA	in	a	stepwise	manner.		We	next	prepared	a	5'-labeled	DNA	blocked	on	a	single	DNA	end.	Using	 this	substrate,	MRN	 and	 pCtIP	 also	 yielded	 a	 fragment	 of	~20	 nt	 in	 length	 (Figure	5D),	indicating	that	the	cleavage	site	is	determined	by	a	protein	block	located	at	the	5'	DNA	end	respective	to	the	cut	site.	In	this	case	however,	as	the	substrate	was	free	on	the	other	end,	we	also	observed	an	electrophoretic	mobility	shift	of	the	 substrate	 DNA	 indicative	 of	 a	 3'-5'	 exonuclease	 activity	 in	 reactions	containing	 MRN.	 This	 likely	 lowered	 the	 effective	 MRN	 concentration	 in	 the	reactions	that	was	available	for	the	endonucleolytic	cleavage,	which	may	explain	the	lower	efficiency	of	the	DNA	clipping	(Figure	5D).	Importantly,	the	position	of	the	DNA	cleavage	did	not	change	when	we	extended	the	length	of	DNA	in	the	3'	direction	 from	 the	 cut	 site	 (Figure	 S5B).	 These	 experiments	 collectively	demonstrated	that	the	cleavage	occurs	preferentially	on	the	5'	-terminated	DNA	strand	~20	nt	away	from	a	protein-blocked	DNA	end.			
Phosphorylated	 CtIP	 promotes	 MRN	 cleavage	 near	 DNA	 secondary	
structures	Several	 lines	of	 evidence	 suggest	 that	 the	MRX/MRN	complex	may	 cleave	near	DNA	secondary	structures	such	as	hairpins	or	cruciform	structures,	which	may	arise	at	inverted	DNA	repeats.	This	is	best	evidenced	in	yeast,	where	both	Sae2	and	 the	 nuclease	 of	 Mre11	 are	 required	 for	 recombination	 induced	 by	 a	 DNA	fragment	bearing	 inverted	 repeats	 at	DSB	 ends	 in	vivo	 (Lobachev	 et	 al.,	 2002).	Consistently,	recombinant	yeast	Mre11	and	human	MRE11	exhibit	endonuclease	
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activities	on	ssDNA	near	hairpin	DNA	structures	(Paull	and	Gellert,	1998;	Trujillo	and	 Sung,	 2001).	 	 Surprisingly,	 we	 observed	 previously	 that	 Sae2	 did	 not	promote	 the	 capacity	of	MRX	 to	 cleave	near	DNA	secondary	 structures	 in	vitro	(Cannavo	 and	 Cejka,	 2014),	 and	 L.	 Symington	 and	 colleagues	 established	 that	hairpin	cleavage	can	be	catalyzed	by	Mre11	in	the	absence	of	Sae2	in	some	cases	
in	 vivo	 (manuscript	 under	 review).	 In	 contrast,	 we	 observed	 here	 that	 pCtIP	stimulated	the	capacity	of	human	MRN	to	cleave	M13	ssDNA	containing	a	variety	of	DNA	 secondary	 structures	~1.5-2-fold	 (Figure	5E	 and	5F).	 Similarly	 as	with	protein	blocked	DNA	substrates,	 this	stimulatory	effect	was	entirely	dependent	on	 phosphorylated	 CtIP,	 and	 pCtIP	 possessed	 no	 capacity	 to	 cleave	 these	structures	 on	 its	 own.	 Similarly	 to	 the	 MRN-pCtIP	 endonuclease	 activity	 on	protein-blocked	 dsDNA,	 the	 enhancement	 of	 MRN	 endonuclease	 by	 pCtIP	 on	DNA	secondary	 structures	was	 completely	dependent	on	ATP	 (compare	Figure	5E	 and	 Figure	 S5C)	 and	 was	 most	 vigorous	 when	 both	 magnesium	 and	manganese	 were	 present	 (Figure	 S5D).	 With	 magnesium	 alone,	 the	 MRN	endonuclease	was	very	weak	and	entirely	dependent	on	pCtIP;	with	manganese	alone,	 the	MRN	endonuclease	was	strong	but	completely	 independent	of	pCtIP.	Taken	together,	we	demonstrate	that	the	dsDNA	clipping	by	MRN	and	pCtIP	can	initiate	 not	 only	 the	 resection	 of	 protein-blocked	 DNA	 ends,	 but	 also	 DNA	molecules	bearing	secondary	structures.			
Oligomerization	 of	 CtIP	 promotes	 its	 capacity	 to	 resect	 DNA	 ends	 in	
conjunction	with	MRN	The	 N-terminal	 domain	 of	 CtIP	 contains	 a	 coiled-coiled	 region	 that	 adopts	 a	tetrameric	structure	in	solution.	 	More	specifically,	the	tetramers	consist	of	two	coiled-coil	 dimers	 assembled	 in	 an	 anti-parallel	 dimer-of-dimers	 configuration	(Davies	 et	 al.,	 2015),	which	 is	 conserved	 in	 evolution	 (Andres	 et	 al.,	 2015).	 To	investigate	 whether	 CtIP	 oligomerization	 regulates	 its	 capacity	 to	 activate	 the	endonuclease	 of	 MRN,	 we	 prepared	 CtIP	 variants	 that	 affect	 the	 oligomer	assembly.	The	elimination	of	the	first	160	amino	acids	of	CtIP,	which	completely	abolishes	CtIP	oligomerization	 (Davies	 et	 al.,	 2015),	dramatically	 increased	 the	solubility	 and	 thus	 the	 yield	 of	 the	 recombinant	 CtIP	 variant	 (Figure	 S6A);	 the	polypeptide	was	similarly	hyperphosphorylated	upon	treatment	of	Sf9	cells	with	
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phosphatase	 inhibitors	 (Figure	 S6B).	 In	 contrast	 to	 the	 full-length	polypeptide,	the	truncated	variant	was	however	largely	inactive	in	the	clipping	assay	(Figure	6A	and	6D).	We	next	prepared	the	pCtIP	L27E	mutant	(Figure	S6C),	which	does	not	 affect	 the	 coiled-coil	 structures	 required	 for	 CtIP	 dimerization	 but	specifically	eliminates	 tetramerization	and	 largely	abolishes	DNA	end	resection	
in	 vivo	 (Davies	 et	 al.,	 2015).	 Similarly	 to	 the	 wild	 type	 polypeptide,	 the	 L27E	variant	 exhibited	 electrophoretic	 mobility	 shift	 that	 could	 be	 eliminated	 upon	treatment	with	 λ-phosphatase.	 This	 indicates	 that	 the	 L27E	mutation	does	 not	apparently	 interfere	 with	 the	 capacity	 of	 the	 CtIP	 variant	 to	 undergo	phosphorylation	 (Figure	 S6D).	Also,	 the	pCtIP	 L27E	 variant	was	highly	 soluble	and	could	be	purified	with	high	yields.	Figure	6B	shows	 that	pCtIP	L27E	could	clearly	 stimulate	 the	MRN	 endonuclease	 yet	 quantitative	 comparison	 revealed	that	 it	was	 less	efficient	 in	doing	so	 than	wild	 type	pCtIP	 (Figure	6B-D),	which	could	 partially	 explain	 defects	 in	 DNA	 end	 resection	 caused	 by	 the	 CtIP	 L27E	mutation	in	vivo.	It	is	not	possible	to	distinguish	whether	the	reduced	capacity	to	promote	 MRN	 observed	 with	 the	 pCtIP	 Δ1-160	 variant	 was	 due	 to	 its	presumably	monomeric	form	or	other	defects	caused	by	the	elimination	of	the	N-terminal	 domain.	 However,	 the	 fact	 that	 a	 single	 L27E	 mutation	 reduced	 the	capacity	of	the	MRN-pCtIP	complex	to	clip	protein-blocked	DNA	strongly	suggest	that	a	proper	oligomeric	structure	of	CtIP	is	required	for	its	optimal	capacity	to	promote	the	endonuclease	of	MRN	and	therefore	for	its	function	in	the	initiation	of	DNA	end	resection.				
DISCUSSION	Our	data	demonstrate	that	phosphorylated	CtIP	specifically	promotes	the	MRE11	endonuclease	 activity.	 We	 show	 that	 MRN	 and	 pCtIP	 form	 a	 very	 integrated	functional	unit.	The	dsDNA	clipping	activity	described	here	is	dependent	on	the	integrity	of	the	MRE11	nuclease	active	site,	requires	ATP	hydrolysis	by	RAD50,	as	well	as	the	structural	role	of	the	NBS1	subunit.	The	reaction	is	optimal	when	both	 magnesium	 and	 manganese	 cofactors	 are	 present.	 We	 believe	 that	 the	requirement	 for	manganese	 reflects	 the	 preference	 of	 the	MRE11	 nuclease	 for	this	metal	 cofactor,	whereas	magnesium	 is	 essential	 for	 the	ATPase	 of	 RAD50.	We	 show	 that	 low	 manganese	 concentration	 is	 sufficient	 for	 optimal	 DNA	
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cleavage	 efficiency,	 whereas	 this	 activity	 increased	 with	 magnesium	concentration.	This	corresponds	well	to	the	physiological	concentrations	of	these	two	 metal	 co-factors	 in	 vivo,	 where	 magnesium	 largely	 extends	 that	 of	manganese	(Tholey	et	al.,	1988).	Whereas	the	MRE11	exonuclease	degrades	DNA	with	 a	 3'-5'	 polarity,	 the	 endonuclease	 of	 MRN-pCtIP	 reported	 here	 targets	preferentially	the	5'-terminated	strand	in	the	vicinity	of	protein	blocks.	The	DSB	repair	model	 posits	 that	 specifically	 the	 5'-terminated	DNA	must	 be	 degraded.	This	leads	to	the	formation	of	3'-tailed	DNA	that	serves	as	a	template	for	the	DNA	strand	exchange	proteins	RAD51	and/or	DMC1	 (Kowalczykowski,	2015).	Upon	DNA	strand	exchange	and	invasion	into	homologous	DNA,	the	3'-	tailed	DNA	can	prime	 DNA	 synthesis.	 This	 is	 in	 agreement	 with	 physical	 assays	 in	 several	organisms	 including	 human	 cells	 that	 conclusively	 demonstrate	 that	 5'-terminated	DNA	is	preferentially	(Sun	et	al.,	1991;	White	and	Haber,	1990;	Zhou	et	 al.,	 2014;	 Zhu	 et	 al.,	 2008),	 although	 not	 solely	 (Hartsuiker	 et	 al.,	 2009b),	resected.	Therefore,	unlike	the	exonuclease	of	MRE11	that	resects	DNA	with	the	'wrong'	 polarity,	 the	 endonuclease	 reported	 here	 preferentially	 cleaves	 5'-terminated	 DNA	 (Figure	 5).	 This	 might	 explain	 the	 MRE11	 nuclease	 polarity	paradox,	as	proposed	previously	by	 the	bidirectional	DNA	end	resection	model	by	multiple	groups	(Keeney	et	al.,	1997;	Neale	et	al.,	2005;	Shibata	et	al.,	2014;	Zakharyevich	 et	 al.,	 2010b).	Our	 results	 thus	 provide	 a	 direct	 evidence	 for	 the	bidirectional	model	in	human	cells.	The	general	 reaction	mechanism	described	here	appears	 to	be	 conserved	 in	evolution	 from	prokaryotes	 to	eukaryotes,	although	 it	 shows	different	 levels	of	complexity.	 In	E.	 coli,	 the	 SbcCD	 complex	 (a	 functional	 counterpart	 of	MRE11-RAD50)	cleaves	DNA	in	the	vicinity	of	protein	blocks,	DNA	secondary	structures	or	even	free	DNA	ends	(Connelly	et	al.,	2003;	Lim	et	al.,	2015).	DNA	cleavage	past	protein	blocks	did	not	require	ATP	hydrolysis	in	E.	coli	(Connelly	et	al.,	2003).	In	contrast	 ATP	 hydrolysis	 by	 Rad50	 is	 essential	 in	 the	 yeast	 system,	 where	additionally	Sae2,	which	is	absent	in	prokaryotes,	provides	a	critical	stimulatory	function	 (Cannavo	 and	 Cejka,	 2014).	 The	 Xrs2	 subunit	 of	 the	 MRX	 complex	carries	a	nuclear	localization	signal.	Placing	a	nuclear	localization	signal	on	the	C-terminus	of	Mre11	could	generally	overcome	homologous-recombination	defects	of	 yeast	 xrs2Δ	 cells	 (Oh	 et	 al.,	 manuscript	 under	 revision).	 Symington	 and	
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colleagues	demonstrated	that	Xrs2	per	se	is	required	for	the	checkpoint	and	non-homologous	 end-joining	 function	 of	 the	 MRX	 complex	 in	 yeast,	 but	 largely	dispensable	 for	 DNA	 end	 resection.	 Consequently,	 the	 yeast	 MR	 complex	 was	fully	 proficient	 in	 the	 dsDNA	 clipping	 reaction	 in	 conjunction	with	 Sae2	 in	 the	absence	of	Xrs2	 (Oh	 et	 al.,	manuscript	under	 revision).	We	 show	here	 that	 the	NBS1	subunit	becomes	an	essential	component	of	the	dsDNA	clipping	machinery	and	NBS1	is	thus	an	integral	component	of	the	human	pCtIP-MRN	endonuclease	(Figure	4).	This	points	at	a	differential	requirement	for	the	Xrs2/NBS1	subunit	in	evolution,	 which	 could	 enable	 additional	 regulatory	 control	 that	 might	 only	apply	to	higher	eukaryotes.	Our	 data	 demonstrate	 a	 clear	 requirement	 for	 CtIP	 phosphorylation	 in	 the	reconstituted	reaction.	When	we	initially	purified	the	CtIP	protein	according	to	a	similar	procedure	as	used	for	yeast	Sae2	(Cannavo	and	Cejka,	2014),	we	did	not	detect	any	effect	on	the	endonuclease	of	MRN.	We	had	to	modify	the	preparation	procedure	 by	 treating	 the	 Sf9	 cells	 with	 camptothecin	 (CPT)	 to	 induce	 DNA	damage	 response	 phosphorylation	 cascade	 and	 additionally	 to	 actively	 inhibit	protein	dephosphorylation	by	treating	the	Sf9	cells	with	phosphatase	inhibitors.	These	 modifications	 resulted	 in	 a	 phosphorylation-dependent	 electrophoretic	mobility	 shift	 of	 purified	 recombinant	 pCtIP.	 We	 show	 than	 only	 this	hyperphosphorylated	variant	became	capable	to	promote	the	MRN	endonuclease	(Figure	 1).	 In	 contrast	 yeast	 Sae2	 expressed	 and	 purified	 from	 Sf9	 cells	 was	capable	to	promote	MRX	even	without	these	modifications	(Cannavo	and	Cejka,	2014).	However,	dephosphorylation	of	 the	Sae2	preparation	similarly	 impaired	the	 dsDNA	 clipping	 reaction	 (Cannavo	 and	 Cejka,	 2014),	 showing	 that	phosphorylation	 of	 Sae2/CtIP	 is	 important	 in	 both	 experimental	 systems.	Jackson	and	colleagues	previously	demonstrated	that	phosphorylation	of	CtIP	at	the	CDK	site	T847	is	essential	for	the	DNA	end	resection	activity	in	vivo;	this	CDK	site	is	conserved	in	all	CtIP/Sae2	homologues	(Huertas	et	al.,	2008;	Huertas	and	Jackson,	 2009).	 The	non-phosphorylatable	CtIP	T847A	variant	was	deficient	 in	DNA	 end	 resection	 in	 vivo,	 pointing	 towards	 an	 essential	 regulatory	 control	mechanism	 by	 CDK	 (Huertas	 and	 Jackson,	 2009).	 This	 likely	 ensures	 that	resection	only	takes	place	in	S/G2	phases	of	the	cell	cycle,	when	sister	chromatid	is	 available	 as	 a	 homologous	 template	 for	 repair.	 The	phospho-mimicking	CtIP	
	 73	
T847E	mutation	represents	one	of	the	two	key	requirements	that	was	necessary	to	activate	homologous	recombination	in	G1	cells	(Orthwein	et	al.,	2015),	further	underlining	the	critical	importance	of	this	posttranslational	modification	in	DSB	repair	pathway	choice.	We	demonstrated	here	that	the	CtIP	T847A	mutant	non-phosphorylatable	 at	 the	 key	 CDK	 site	 was	 severely	 impaired	 in	 the	 dsDNA	clipping	in	conjunction	with	MRN	even	in	the	minimal	reconstituted	system.	This	indicates	 that	 CtIP	 phosphorylation	 likely	 regulates	 MRN	 and	 CtIP	 interaction	with	each	other	or	with	DNA.	To	this	point,	we	found	that	phosphorylated	pCtIP	showed	a	much	lower	affinity	to	DNA	(Figure	2).	Furthermore,	pCtIP	was	much	less	 capable	 to	 stabilize	 MRN	 bound	 to	 DNA	 compared	 to	 the	 non-phosphorylated	CtIP	variant.	These	results	infer	that	the	DNA-binding	capacity	of	CtIP	and	the	stabilization	of	MRN-DNA	interaction	is	 likely	not	rate-limiting	for	dsDNA	 clipping.	 Rather,	 these	 results	 suggest	 that	 CtIP	 phosphorylation	 may	regulate	 the	 interaction	 with	 the	 MRN	 complex,	 which	 is	 supported	 by	 our	observation	 that	 only	 the	 cognate	 MRX-Sae2	 and	 MRN-pCtIP	 polypeptides	promoted	 the	dsDNA	 clipping	 reaction	 (Figure	2).	 CtIP	however	 interacts	with	MRN	 through	 multiple	 interaction	 sites,	 and	 thus	 the	 critical	 interaction	interphase	 between	 MRN	 and	 CtIP	 that	 may	 be	 regulated	 by	 CtIP	phosphorylation	 remains	 to	 be	 identified	 (Sartori	 et	 al.,	 2007;	 Yuan	 and	 Chen,	2009).				Our	 data	 suggest	 that	 pCtIP	 functions	 as	 a	 co-factor	 of	 the	 MRE11	endonuclease,	as	the	endonuclease	activity	in	our	assays	was	dependent	on	the	integrity	of	the	MRE11	endonuclease	active	site	(Figure	1).	This	is	intriguing,	as	CtIP	was	previously	reported	to	possess	an	inherent	5'	flap	endonuclease	activity	capable	 to	 cleave	 branched	 DNA	 structures,	 which	 was	 suggested	 to	 be	specifically	 required	 for	 the	 processing	 of	 protein-blocked	 DNA	 ends	(Makharashvili	et	al.,	2014;	Wang	et	al.,	2014).	Our	preparation	of	pCtIP	did	not	possess	this	activity,	yet	it	was	capable	to	promote	the	endonuclease	of	MRE11.	The	 reason	 for	 this	 difference	 is	 not	 clear,	 and	 may	 result	 from	 diverse	purification	 procedures.	 The	 intrinsic	 CtIP	 endonuclease	 activity	 described	previously	 is	 clearly	 distinct	 from	 the	 pCtIP-stimulated	 MRE11	 nuclease	reported	here,	as	the	CtIP	endonuclease	did	not	require	phosphorylation	of	the	
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CtIP-T847	CDK	site	that	is	essential	for	resection	in	vivo	and	in	the	reconstituted	system	presented	here.	What	may	be	the	nature	of	blocks	that	direct	the	MRN-pCtIP	endonuclease	in	
vivo?	Meiotic	Spo11	is	a	good	candidate,	in	fact	processing	of	meiotic	DNA	breaks	requires	both	the	nuclease	of	Mre11	as	well	as	Sae2	in	yeast,	and	this	process	is	likely	 highly	 conserved	 in	 evolution	 (Keeney	 et	 al.,	 1997;	 Mahadevaiah	 et	 al.,	2001;	Neale	et	al.,	2005;	Robert	et	al.,	2016).	Likewise,	the	processing	of	stalled	DNA-topoisomerase	adducts	requires	the	MRE11	nuclease	and	Sae2/CtIP	(Paull,	2010),	and	may	be	explained	by	the	mechanism	reported	here.	Interestingly,	the	MRE11-dependent	DNA	end	resection	is	capable	to	resect	up	to	~200-300	nts	in	
vivo.	 This	may	 be	 either	 due	 to	 a	 stepwise	 resection	mechanism	 as	 suggested	here	(Figure	5),	or	a	mutually	non-exclusive	cleavage	further	away	from	the	DNA	end	 (Garcia	 et	 al.,	 2011).	 Interestingly,	 in	 yeast	 meiotic	 cells	 the	 Mre11-dependent	resection	endpoints	correlated	with	nucleosome	positions,	suggesting	that	chromatin	may	play	a	critical	role	in	regulating	resection	(E.	Mimitou	and	S.	Keeney,	personal	communication).	Clearly,	the	identification	of	the	physiological	protein	 blocks	 that	 promote	 the	 MRN-pCtIP	 endonuclease	 represents	 an	important	future	challenge.	We	also	show	here	that	not	only	protein	blocks,	but	also	 DNA	 secondary	 structures	 can	 direct	 the	 MRN-pCtIP	 endonuclease,	 and	therefore	 the	 mechanism	 reported	 here	 might	 likely	 be	 generally	 applicable.	Collectively,	we	 believe	 that	 the	 reaction	 described	here	 reconstitutes	 the	 first	steps	 in	DSB	 repair	 that	 requires	 the	 human	MRE11	 endonuclease.	 This	 assay	will	be	essential	to	define	the	function	of	factors	that	may	regulate	this	process,	including	EXD2,	 RECQ4,	 SOSS1	 and	MCM8-9	 (Broderick	 et	 al.,	 2016;	 Lee	 et	 al.,	2015;	Lu	et	al.,	2016a;	Richard	et	al.,	2011).	The	mechanism	described	here	may	explain	the	processing	of	DNA	ends	with	non-canonical	structures,	such	as	those	containing	 protein	 adducts	 that	 arise	 during	 anti-cancer	 therapy	 with	topoisomerase	inhibitors.		
EXPERIMENTAL	PROCEDURES	
Cloning,	expression	and	purification	of	recombinant	proteins	The	sequences	of	all	oligonucleotides	used	for	cloning	in	this	study	are	listed	in	Table	S1.	Recombinant	MRN	was	expressed	and	purified	as	a	complex	in	Sf9	cells	
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by	co-infection	with	baculoviruses	prepared	from	individual	pFastBac1	plasmids	pTP17,	pFB-RAD50-FLAG	and	pTP36	coding	for	MRE11-6xhis,	RAD50-FLAG	and	NBS1.	To	prepare	pFB-RAD50-FLAG,	the	FLAG-tag	sequence	was	fused	with	the	C-terminus	 of	RAD50	by	 amplifying	RAD50	 from	pTP11	by	PCR	using	primers	RAD50_F	 and	 RAD50_FLAG_R.	 The	 amplified	 PCR	 product	 was	 digested	 with	BamHI	 and	 XhoI	 (New	 England	 Biolabs)	 and	 inserted	 in	 pFB-MBP-MLH3-his	(Ranjha	et	al.,	2014),	which	generated	pFB-RAD50-FLAG.	The	pTP17,	pTP11	and	pTP36	vectors	were	a	kind	gift	from	T.	Paull	(University	of	Texas	at	Austin).	The	MRN	variants	were	prepared	by	mutating	the	respective	pFastBac1	plasmids	by	QuikChange	site-directed	mutagenesis	kit	following	manufacturer's	instructions	(Agilent	 Technology).	 To	 prepare	 the	 MRE11	 (H129L	 D130V)	 nuclease-dead	variant,	we	used	oligonucleotides	hMRE11_ND_F	and	hMRE11_ND_R.	To	prepare	the	 ATP	 hydrolysis	 and	 binding	 deficient	 variants	 of	 RAD50,	 we	 used	 primer	pairs	 hRAD50_ATP_B_F	 and	 hRAD50_ATP_B_R	 to	 generate	 the	 RAD50	 K42A	mutation	and	primers	hRAD50_ATP_H_F	and	hRAD50_ATP_H_R	to	generate	 the	RAD50	 K42R	 mutant.	 Bacmids,	 primary	 and	 secondary	 baculoviruses	 for	 all	constructs	 were	 prepared	 using	 standard	 procedures	 according	 to	manufacturer's	 instructions	(Bac-to-Bac,	Life	Technologies).	The	transfection	of	
Sf9	 cells	 was	 carried	 out	 using	 a	 Trans-IT	 insect	 reagent	 (Mirus	 Bio).	 The	sequence	of	 all	 constructs	 amplified	by	PCR	was	 verified	by	 sequencing	 and	 is	available	on	request.	For	the	large-scale	expression	and	purification	of	the	MRN	complex,	Sf9	cells	were	 seeded	 at	 0.5x106	 per	 ml	 and	 co-infected	 16	 h	 later	 with	 recombinant	baculoviruses	 expressing	 MRE11-6xhis,	 RAD50-FLAG	 and	 NBS1.	 The	 optimal	ratio	of	the	recombinant	baculoviruses	had	been	determined	in	previous	small-scale	experiments.	The	infected	cells	were	incubated	in	suspension	at	27°C	for	52	h	with	 constant	 agitation.	 The	 cells	 were	 then	 harvested	 (500	 g,	 10	min)	 and	washed	once	with	phosphate	 buffered	 saline	 (PBS).	 The	 cell	 pellets	were	 snap	frozen	 in	 liquid	nitrogen	and	 stored	at	 -80°C.	All	 subsequent	purification	 steps	were	 carried	 out	 at	 4°C	 or	 on	 ice.	 The	 Sf9	 cell	 pellets	 were	 resuspended	 in	 3	volumes	 of	 lysis	 buffer	 (Tris-HCl,	 pH	 7.5,	 50	 mM;	 β-mercaptoethanol,	 2	 mM;	ethylenediaminetetraacetic	 acid	 (EDTA),	 1	 mM;	 Protease	 inhibitory	 cocktail,	Sigma	P8340,	1:400;	phenylmethylsulfonyl	fluoride	(PMSF),	1	mM;	leupeptin,	30	
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µg/ml;	 imidazole,	 20	 mM)	 for	 20	 min	 with	 continuous	 stirring.	 Glycerol	 was	added	to	16%	(v/v)	concentration.	Next,	5	M	NaCl	was	added	slowly	to	reach	a	final	concentration	of	305	mM.	The	cell	suspension	was	further	incubated	for	30	min	 with	 continuous	 stirring,	 centrifuged	 at	 57'800	 g	 for	 30	 min	 to	 obtain	soluble	 extract.	 Pre-equilibrated	 nickel-nitrilotriacetic	 acid	 (Ni-NTA)	 agarose	resin	 (Qiagen)	 was	 added	 to	 the	 cleared	 extract	 and	 incubated	 for	 1	 h	 with	continuous	mixing.	The	Ni-NTA	resin	was	separated	from	the	soluble	extract	by	centrifugation	at	2'000	g	for	2	min	and	the	supernatant	was	discarded.	The	Ni-NTA	resin	was	washed	extensively	batch	wise	as	well	as	on	disposable	columns	(Thermo	 Scientific)	 with	 wash	 buffer	 (Tris-HCl,	 pH	 7.5,	 50	 mM;	 β-mercaptoethanol,	2	mM;	NaCl,	300	mM;	glycerol,	10%;	PMSF,	1	mM;	 imidazole,	20	 mM),	 transferred	 and	 further	 washed	 on	 a	 disposable	 column	 (Thermo	Scientific).	The	bound	proteins	were	eluted	with	elution	buffer	(Tris-HCl,	pH	7.5,	50	mM;	β-mercaptoethanol,	1	mM;	NaCl,	300	mM;	glycerol,	10%;	 leupeptin,	10	
µg/ml;	PMSF,	1	mM;	imidazole,	250	mM).	The	eluate	was	diluted	3x	with	dilution	buffer	 (Tris-HCl,	 pH	 7.5,	 50	 mM;	 NaCl,	 300	 mM;	 glycerol,	 10%;	 leupeptin,	 10	
µg/ml;	 PMSF,	 1	mM)	 to	 decrease	 the	 concentration	 of	β-mercaptoethanol	 and	imidazole.	The	diluted	Ni-NTA	eluate	was	then	 incubated	with	pre-equilibrated	anti-FLAG	M2	Affinity	Gel	 (A2220,	 Sigma)	 for	1	h	with	 continuous	mixing.	The	FLAG	resin	was	washed	extensively	on	a	disposable	column	(Thermo	Scientific)	with	FLAG	wash	buffer	(Tris-HCl,	pH	7.5,	50	mM;	NaCl,	150	mM;	glycerol,	10%;	PMSF,	1	mM;	β-mercaptoethanol,	1	mM).	Finally,	 recombinant	MRN	was	eluted	from	 the	FLAG	 resin	by	FLAG	wash	buffer	 supplemented	with	3xFLAG	peptide	(200	µg/ml,	Sigma,	F4799).	Fractions	containing	protein	were	pooled,	aliquoted,	snap	frozen	and	stored	at	–80°C.	All	MRN	variants	were	expressed	and	purified	using	 the	 identical	 procedure.	 To	 prepare	 the	MRE11-RAD50	heterodimer,	 the	NBS1	 virus	was	 excluded	 during	 the	 infection	 of	 Sf9	 cells	 and	 the	 purification	was	carried	out	exactly	as	described	above	for	the	MRN	complex.		The	 gene	 coding	 for	 CtIP	was	 amplified	 by	 PCR	 from	 vector	 pEGFP-C1-CtIP	(kindly	 provided	 by	 A.	Sartori,	 University	 of	 Zurich)	 using	 oligonucleotides	CtIP_F	 and	 CtIP_R.	 The	 amplified	 product	 was	 digested	 with	 NheI	 and	 XmaI	restriction	endonucleases	(New	England	Biolabs)	and	inserted	into	plasmid	pFB-MBP-MLH3-his	 to	 prepare	 the	 pFB-MBP-CtIP-his	 construct.	 The	 non-
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phosphorylatable	 mutant	 of	 CtIP	 at	 site	 T847	 was	 prepared	 by	 site-directed	mutagenesis	 with	 oligonucleotides	 CtIP_T847A_F	 and	 CtIP_T847A_R	 as	described	above.	The	tetramerization	deficient	CtIP	L27E	variant	was	prepared	with	 oligonucleotides	 CtIP_L27E_F	 and	 CtIP_L27E_R.	 To	 remove	 the	 first	 160	amino	 acids	 from	 the	 N-terminus	 of	 CtIP,	 the	 CtIP	 gene	 was	 amplified	 with	oligonucleotides	 MBP-161CtIP	 and	 CtIP_R	 by	 PCR.	 The	 amplified	 product	 was	digested	with	NheI	 and	XmaI	 and	 inserted	 into	pFB-MBP-MLH3-his	 to	prepare	pFB-MBP-CtIPΔ1-160-his.		CtIP	 was	 expressed	 in	 Sf9	 cells	 similarly	 as	 described	 above	 for	 MRN.	 To	obtain	 hyperphosphorylated	 variant	 of	 CtIP	 (pCtIP),	 the	 Sf9	 cell	 culture	 was	supplemented	 with	 25	 nM	 okadaic	 acid	 (Calbiochem)	 for	 the	 last	 4	 h	 before	harvesting	 (i.e.	 48	 h	 upon	 infection	 with	 recombinant	 baculovirus)	 to	 inhibit	protein	dephosphorylation.	Furthermore,	1	μM	camptothecin	(Sigma)	was	added	to	the	cell	culture	1	h	before	collection	(i.e.	after	51	h	after	infection)	to	activate	DNA	damage	checkpoint	signaling.	The	CtIP	variants	including	CtIP	T847A,	CtIP	L27E	 and	 CtIP	 Δ1-160	 were	 also	 expressed	 similarly	 as	 described	 above	 to	obtain	the	hyper-phosphorylated	species.	Cells	were	pelleted,	washed	with	PBS,	frozen	in	liquid	nitrogen	and	stored	at	-80°C.	All	subsequent	steps	were	carried	out	at	4°C	or	on	 ice.	Cell	pellets	were	resuspended	 in	3	volumes	of	 lysis	buffer	[Tris-HCl,	pH	7.5,	50	mM;	dithiothreitol,	1	mM;	EDTA,	1	mM;	Protease	inhibitory	cocktail,	Sigma	P8340,	1:400;	PMSF,	1	mM;	leupeptin,	30	µg/ml;	NaCl,	300	mM;	glycerol,	 10%	and	phosphatase	 inhibitors	 including	okadaic	 acid	 (Calbiochem),	25	nM;	Na3VO4	(Sigma),	1	mM;	NaF	(Applichem),	20	mM;	Na4O7P2	(Applichem),	15	mM;	 Nonidet	 P-40	 substitute	 (Sigma),	 0.5%	 (v/v)].	 The	 re-suspended	 cells	were	sonicated	6	times	for	45	s	with	70%	cycle	and	max	power	(Sonopuls	GM70,	Bandelin)	 and	 the	 cell	 lysate	 was	 centrifuged	 at	 74'000	 g	 for	 45	 min.	 Pre-equilibrated	 amylose	 resin	 (New	 England	 Biolabs)	 was	 added	 to	 the	 cleared	soluble	extract	and	incubated	for	1	h	with	continuous	mixing.	The	resin	was	then	collected	 by	 centrifugation	 at	 2'000	 g	 for	 2	min	 and	washed	 extensively	 batch	wise	 as	 well	 as	 on	 disposable	 columns	 (Thermo	 Scientific)	 with	 wash	 buffer	(Tris-HCl,	 pH	 7.5,	 50	 mM;	 β-mercaptoethanol,	 2	 mM;	 NaCl,	 300	mM;	 glycerol,	10%;	PMSF,	1	mM;	leupeptin,	10	µg/ml;	Nonidet	P-40	substitute	(Sigma),	0.5%	(v/v)).	Protein	was	eluted	with	wash	buffer	containing	10	mM	maltose	(Sigma).	
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The	eluates	were	further	treated	with	PreScission	protease	for	90	min	to	cleave	of	 the	 maltose	 binding	 protein	 affinity	 tag	 (MBP).	 The	 sample	 was	 then	supplemented	 with	 20	 mM	 imidazole	 and	 further	 incubated	 with	 pre-equilibrated	 Ni-NTA	 agarose	 resin	 (Qiagen)	 for	 1	 h.	 The	 Ni-NTA	 resin	 was	transferred	on	a	disposable	column	and	washed	extensively	with	Ni-NTA	wash	buffer	 (Tris-HCl,	 pH	 7.5,	 50	 mM;	 β-mercaptoethanol,	 2	 mM;	 NaCl,	 150	 mM;	glycerol,	 10%;	 PMSF,	 1	mM;	 imidazole,	 20	mM).	 CtIP	was	 eluted	with	 Ni-NTA	wash	 buffer	 containing	 300	 mM	 imidazole.	 The	 amount	 of	 protein	 in	 the	individual	fractions	was	estimated	by	Bradford	assay	(Biorad).	Pooled	fractions	were	 further	 dialyzed	 in	 dialysis	 buffer	 (Tris-HCl,	 pH	 7.5,	 50	 mM;	 β-mercaptoethanol,	2	mM;	NaCl,	150	mM;	glycerol,	10%;	PMSF,	1	mM)	 for	2	h	 to	remove	imidazole.	Finally,	the	sample	was	aliquoted,	snap	frozen	and	stored	at	-80°C.	 To	 prepare	 non-phosphorylated	 CtIP,	 the	 phosphatase	 inhibitors	 were	excluded	 from	 the	 above	 procedure.	 All	 CtIP	 variants	 were	 expressed	 and	purified	using	an	 identical	procedure	with	 the	exception	of	CtIP	Δ1-160,	which	was	 highly	 soluble	 and	 did	 not	 require	 a	 detergent	 in	 the	 lysis	 buffer	 and	subsequent	 sonication.	 Specifically,	 the	 Sf9	 cell	 pellet	 with	 CtIP	 Δ1-160	 was	resuspended	in	3	volumes	of	lysis	buffer	(Tris-HCl,	pH	7.5,	50	mM;	dithiothreitol,	1	mM;	EDTA,	1	mM;	Protease	 inhibitory	cocktail,	Sigma	P8340,	1:400;	PMSF,	1	mM;	 leupeptin,	 30	 µg/ml;	 NaCl,	 300	 mM;	 glycerol,	 10%	 and	 phosphatase	inhibitors	 including	okadaic	 acid	 (Calbiochem),	25	nM;	Na3VO4	 (Sigma),	1	mM;	NaF	 (Applichem),	 20	 mM;	 Na4O7P2	 (Applichem),	 15	 mM)	 for	 20	 min	 with	continuous	stirring.	Glycerol	was	added	to	16	%	(v/v)	concentration.	5	M	NaCl	was	added	slowly	to	reach	a	final	concentration	of	305	mM.	The	cell	suspension	was	further	incubated	for	30	min	with	continuous	stirring,	centrifuged	at	74'000	g	for	45	min	to	obtain	soluble	extract.	From	this	step	onwards,	the	CtIP	Δ1-160	variant	was	purified	as	described	above	for	other	CtIP	constructs.		Where	indicated,	the	protein	was	dephosphorylated	with	λ-phosphatase	(New	England	Biolabs).	To	this	point,	the	CtIP	variant	(1-1.5	µg)	was	incubated	in	a	20	
µl	 volume	 with	 200	 U	 λ-phosphatase	 for	 15	 min	 at	 30°C	 in	 PMP	 buffer	supplemented	 with	 magnesium	 chloride	 according	 to	 manufacturer’s	recommendation	 (New	 England	 Biolabs).	 For	 'mock'	 controls,	 λ-phosphatase	
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was	 excluded	 from	 the	 reactions.	 The	 samples	 from	mock-	 and	 λ-phosphatase	treated	reactions	were	subsequently	immediately	used	in	nuclease	assays.			
Nuclease	assays	Nuclease	 assays	 were	 carried	 out	 in	 a	 15	 µl	 volume	 in	 a	 reaction	 buffer	containing	 Tris-acetate	 pH	 7.5,	 25	mM;	manganese	 acetate,	 1	mM;	magnesium	acetate,	 5	mM;	 dithiothreitol,	 1	mM;	ATP,	 1	mM;	 bovine	 serum	albumin,	 (New	England	 Biolabs),	 0.25	 mg/ml;	 phosphoenolpyruvate,	 1	 mM;	 pyruvate	 kinase,	(Sigma),	80	U/ml	and	oligonucleotide-based	DNA	substrate,	1	nM	(in	molecules,	endonuclease	 assays	 with	 70	 bp-long	 structures)	 or	 0.5	 nM	 (in	 molecules,	exonuclease	assays	with	50	bp-long	structures).	Where	indicated,	reactions	were	supplemented	with	streptavidin	(15	nM,	Sigma)	and	incubated	for	5	min	at	room	temperature	 to	 block	 the	 end(s)	 of	 biotinylated	 substrates.	 Recombinant	proteins	 were	 then	 added	 to	 the	 reactions	 on	 ice	 and	 the	 samples	 were	incubated	for	30	min	at	37°C.	Reactions	were	stopped	with	0.5	µl	Proteinase	K	(20.6	mg/mL,	Roche);	and	1	µL	solution	containing	5%	SDS	and	0.25	M	EDTA	for	30	 minutes	 at	 37°C.	 Finally,	 16.5	 µL	 loading	 buffer	 (95%	 formamide,	 20	 mM	EDTA	 and	 bromophenol	 blue)	was	 added	 to	 all	 the	 samples	 and	 the	 products	were	separated	on	15%	polyacrylamide	denaturing	urea	gels	(19:1	acrylamide-bisacrylamide,	 BioRad).	 The	 gels	 were	 fixed	 in	 a	 solution	 containing	 40%	methanol,	10%	acetic	acid	and	5%	glycerol	for	30	min	at	room	temperature	and	dried	on	a	3	mm	CHR	paper	(Whatman).	The	dried	gels	were	exposed	to	storage	phosphor	screens	(GE	Healthcare)	and	scanned	by	a	Typhoon	Phosphor	imager	(FLA	9500,	GE	Healthcare).	Nuclease	assays	with	circular	ssDNA	substrate	(M13,	250	ng	per	reaction,	New	England	Biolabs)	were	carried	out	similarly	except	for	the	 incubation	 time	was	 1	 h	 and	 the	 reaction	products	were	 separated	 on	1%	agarose	 gels	 post-stained	 with	 GelRed	 (1:20'000,	 Biotium)	 for	 45	 min.	 The	stained	gels	were	imaged	on	a	gel	imager	(Alpha	Innotech).			
Electrophoretic	mobility	shift	assays		The	 reactions	 (15	 µl)	 were	 carried	 out	 in	 the	 same	 buffer	 as	 nuclease	 assays	without	 streptavidin.	 Proteins	were	 added	 on	 ice	 and	 incubated	 for	 30	min	 at	4°C.	5	µl	loading	dye	(50%	glycerol,	bromophenol	blue)	was	added	to	reactions	
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and	 products	 were	 separated	 by	 electrophoresis	 on	 0.6%	 agarose	 at	 4°C.	 The	gels	 were	 dried	 on	 DE81	 ion-exchange	 paper	 (Whatman),	 exposed	 to	 storage	phosphor	screens	and	analyzed	as	described	above.		
Oligonucleotide-based	DNA	substrates		DNA	 substrates	 were	 prepared	 with	 oligonucleotides	 purchased	 from	Microsynth	 (Switzerland)	 that	 had	 been	 purified	 by	 polyacrylamide	 gel	electrophoresis.	The	oligonucleotides	were	radioactively	labeled	at	either	the	5'	end	with	T4	polynucleotide	kinase	(New	England	Biolabs)	and	[γ-32P]	ATP	or	at	the	 3'	 end	 with	 terminal	 deoxynucleotidyl	 transferase	 (New	 England	 Biolabs)	and	 [α-32P]	 cordycepin	 5'	 triphosphate	 according	 to	 manufacturer's	recommendations.	 The	 5'	 and	 3'	 radiolabelled	 oligonucleotides	were	 annealed	with	 a	 2-fold	 excess	 of	 the	 complementary	 'cold'	 oligonucleotides	 in	 PNK	 and	TdT	 buffer	 respectively	 (New	 England	 Biolabs).	 To	 prepare	 the	 70	 bp-long	dsDNA	substrate	with	biotin	at	both	ends	the	oligonucleotides	PC210	and	PC211	were	 used	 as	 described	 previously	 (Cannavo	 and	 Cejka,	 2014).	 The	oligonucleotides	used	to	prepare	the	70	bp-long	dsDNA	substrate	with	a	block	at	only	 one	 end	 were	 PC206	(GTAAGTGCCGCGGTGCGGGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCGCGTACTCCACCTCATGCATC)	 and	 PC209	(GATGCATGAGGTGGAGTACGCGCCCGGGGAGCCCAAGGGCACGCCCTGGCACCCGCACCGCGGCACTTAC),	the	bold	T	represents	the	site	of	the	biotin	modification.	The	oligonucleotides	used	to	prepare	the	100	bp-long	dsDNA	substrate	were	Bio100	(GTAAGTGCCGCGGTGCGGGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCGCGTACTCCACCTCATAATCTTCTGCCATGGTCGTAGCAGCCTCCTGCATC)	 and	 Bio100C	(GATGCAGGAGGCTGCTACGACCATGGCAGAAGATTATGAGGTGGAGTACGCGCCCGGGGAGCCCAAGGGCACGCCCTGGCACCCGCACCGCGGCACTTAC).	 The	 50	 bp-long	dsDNA	substrate	was	prepared	by	annealing	oligonucleotides	X12-3	and	X12-4C	and	 the	 50	 bp-long	 Y-structured	 DNA	 was	 prepared	 with	 oligonucleotides	PC1253	and	PC1254	as	described	previously	(Cejka	and	Kowalczykowski,	2010;	Ranjha	et	al.,	2014).		
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FIGURE	LEGENDS	
Figure	1.	Phosphorylated	pCtIP	stimulates	the	MRE11	endonuclease	within	
the	MRN	complex.	(A)	Nuclease	assay	with	MRN	and	non-phosphorylated	CtIP	on	a	3'	end-labeled	70	bp-long	dsDNA	blocked	at	both	ends	with	streptavidin.	(B)	Electrophoretic	mobility	of	CtIP	prepared	without	phosphatase	 inhibitors	(lane	2)	and	pCtIP	(lane	3)	prepared	with	phosphatase	inhibitors.	(C)	Electrophoretic	mobility	 of	 pCtIP	 either	 not-treated	 (lane	 2)	 or	 treated	 (lane	 3)	 with	 λ	phosphatase.	 (D)	Nuclease	assay	with	MRN	and	pCtIP.	 (E)	Nuclease	assay	with	MRN	and	either	mock-	or	λ-phosphatase	treated	pCtIP.	 (F)	Nuclease	assay	with	MRN	and	either	wild	type	pCtIP	or	pCtIP	T847A	variant.	(G)	Nuclease	assay	with	either	wild	type	MRN	or	the	nuclease-deficient	M(H129L	D130V)RN	variant	and	pCtIP.	
	
Figure	2.	Species-specific	interactions	between	cognate	MRN	and	pCtIP,	but	
not	 the	DNA-binding	capacity	of	pCtIP	 regulate	 the	endonuclease	activity.	(A)	Nuclease	assay	with	pCtIP	 (60	nM)	and	various	concentrations	of	MRN	(B)	Quantitation	of	experiments	such	as	shown	in	panel	A;	n=2,	error	bars,	SEM.	(C)	Nuclease	 assay	 with	 MRN	 (25	 nM)	 and	 various	 concentrations	 of	 pCtIP.	 (D)	
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Quantitation	of	experiments	such	as	shown	in	panel	C;	n=2,	error	bars,	SEM.	(E)	Binding	of	MRN	and	phosphorylated	CtIP	or	non-phosphorylated	CtIP	to	dsDNA.	(F)	Nuclease	assay	with	yeast	MRX,	human	MRN,	yeast	Sae2	and	human	pCtIP,	as	indicated,	 carried	 out	 at	 37°C.	 Only	 combination	 of	 the	 cognate	 polypeptides	results	 in	 the	 stimulation	 of	 the	 endonuclease	 activity.	 Note	 that	 yeast	 MRX	shows	Sae2-independent	DNA	cleavage	activity	at	37°C.	
	
Figure	3.	ATP	binding	and	hydrolysis	by	RAD50	is	essential	 for	the	pCtIP-
stimulated	endonuclease	of	MRN.	(A)	Nuclease	assay	with	MRN	and	pCtIP	and	its	dependence	on	ATP	and	its	analogues.	(B)	Nuclease	assay	with	wild	type	MRN	and	 the	 ATP	 hydrolysis-deficient	 MR(K42R)N	 variant	 and	 pCtIP.	 (C)	 Nuclease	assay	 with	 wild	 type	 MRN	 and	 the	 ATP	 binding-deficient	 MR(K42A)N	 variant	and	pCtIP.		
Figure	 4.	 NBS1	 is	 required	 for	 the	 endonuclease	 of	 MRN-pCtIP.	 Nuclease	assay	with	MRE11-RAD50-NBS1	 (MRN)	or	MRE11-RAD50	 (MR)	 and	pCtIP.	 (B)	Nuclease	 assay	with	MR	 complex	 on	 5'	 end-labeled	 dsDNA,	 either	 with	 5	mM	magnesium	(left	part)	or	5	mM	manganese	(right	part).		
Figure	 5.	MRN-pCtIP	 preferentially	 cleave	near	 5'	 ends	 of	 blocked	dsDNA	
ends.	(A)	Nuclease	assay	with	MRN	and	pCtIP	on	DNA	substrates	not	blocked	(–Strep)	or	blocked	(+Strep)	with	streptavidin.	3'	end-labeled	dsDNA	was	used.	(B)	Kinetic	 analysis	 of	 the	 nuclease	 activity	 of	 MRN	 and	 pCtIP	 on	 blocked	 dsDNA	labeled	at	the	3'	end.	(C)	Nuclease	assay	with	MRN	and	pCtIP	on	blocked	dsDNA	labeled	at	the	5'	end.	(D)	Nuclease	assay	with	MRN	and	pCtIP	on	dsDNA	blocked	at	only	one	end	and	labeled	at	the	5'	end.	(E)	Nuclease	assay	with	MRN	and	pCtIP	or	 CtIP	 on	 circular	 ssDNA.	 (F)	 Quantitation	 of	 experiments	 such	 as	 shown	 in	panel	E;	n=2,	error	bars,	SEM.		
Figure	 6.	 Oligomerization	 of	 pCtIP	 regulates	 its	 capacity	 to	 stimulate	 the	
MRN	endonuclease.	(A)	Nuclease	assay	with	MRN	and	pCtIP	Δ1-160	truncation	mutant.	(B)	Nuclease	assay	with	MRN	and	tetramerization-deficient	pCtIP	L27E.	(C)	Nuclease	assay	with	MRN	and	wild	type	pCtIP,	pCtIP	L27E	or	pCtIP	Δ1-160.	
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(D)	Quantitation	of	 the	experiments	such	as	shown	 in	panel	C;	n=2,	error	bars,	SEM.				
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	SUPPLEMENTARY	FIGURE	LEGENDS		
Figure	S1	(related	to	Figure	1).	(A)	Samples	from	a	representative	purification	of	the	MRN	complex	analyzed	by	polyacrylamide	gel	electrophoresis.	The	gel	was	stained	 with	 Coomassie	 brilliant	 blue.	 Ni-NTA	 flowthrough	 and	 eluate,	flowthrough	 and	 eluate	 from	 nickel-nitrilotriacetic	 acid	 (Ni-NTA)	 resin;	 Flag	flowthrough	and	eluate,	flowthrough	and	eluate	from	anti-Flag	affinity	resin.	(B)	Samples	from	a	representative	purification	of	non-phosphorylated	CtIP	analyzed	by	 polyacrylamide	 gel	 electrophoresis.	 The	 gel	 was	 stained	 with	 Coomassie	brilliant	 blue.	 MBP,	 maltose-binding	 protein;	 PP,	 PreScission	 protease.	 (C)	Nuclease	assay	with	wild	type	MRN	on	5'	end-labeled	dsDNA	with	either	5	mM	magnesium	 (left	 part)	 or	 5	 mM	 manganese	 (right	 part).	 MRN	 exhibits	manganese-dependent	 3'-5'	 exonuclease	 activity.	 (D)	Nuclease	 assay	with	wild	type	 MRN	 on	 3'	 end-labeled	 dsDNA	 with	 either	 magnesium	 (left	 part)	 or	manganese	 (right	 part).	MRN	 exhibits	manganese-dependent	 3'-5'	 exonuclease	activity.	 (E)	 Nuclease	 assay	 with	 MRN	 and	 various	 concentrations	 of	 non-phosphorylated	CtIP	on	5'	end-labeled	dsDNA.	(F)	Samples	from	a	representative	purification	 of	 phosphorylated	 CtIP	 (treated	 with	 phosphatase	 inhibitors)	analyzed	 by	 polyacrylamide	 gel	 electrophoresis.	 The	 gel	 was	 stained	 with	Coomassie	brilliant	blue.	MBP,	maltose	binding	protein;	PP,	PreScission	protease.	(G)	Nuclease	assay	with	pCtIP	on	a	5'	 end-labeled	Y-structured	DNA	substrate.	(H)	Samples	from	a	purification	of	pCtIP	T847A	analyzed	by	polyacrylamide	gel	electrophoresis.	The	sample	was	treated	with	phosphatase	 inhibitors.	This	CtIP	variant	cannot	be	phosphorylated	on	a	key	CDK	site	(T847).	(I)	Polyacrylamide	gel	 electrophoresis	 of	 purified	 recombinant	 wild	 type	 pCtIP	 (lane	 2),	 and	 the	pCtIP	 T847A	 variant	 either	 not	 treated	 (lane	 3)	 or	 treated	 (lane	 4)	 with	 λ	phosphatase.	The	pCtIP	T847A	mutant	is	phosphorylated	on	other	residues	than	T847,	 which	 results	 in	 a	 phosphorylation-dependent	 electrophoretic	 mobility	shift.	 (J)	 Samples	 from	 a	 representative	 purification	 of	 the	 nuclease-deficient	M(H129L	 D130V)RN	 complex	 analyzed	 by	 polyacrylamide	 gel	 electrophoresis.	(K)	 Nuclease	 assay	 with	 wild	 type	 or	 nuclease-deficient	 M(H129L	 D130V)RN	variant	on	5'-end	 labeled	dsDNA,	either	with	5	mM	magnesium	(left	part)	or	5	mM	 manganese	 (right	 part).	 (L)	 Nuclease	 assay	 with	 wild	 type	 or	 nuclease-
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deficient	 M(H129L	 D130V)RN	 variant	 on	 3'	 end-labeled	 dsDNA,	 either	 with	 5	mM	magnesium	(left	part)	or	5	mM	manganese	(right	part).		
Figure	S2	(related	to	Figure	2).	(A)	Nuclease	assay	with	MRN	and	pCtIP	in	the	presence	of	magnesium	and/or	manganese,	as	indicated.	(B)	Nuclease	assay	with	MRN,	 pCtIP,	 1	 mM	 manganese	 and	 various	 concentrations	 of	 magnesium.	 (C)	Nuclease	assay	with	MRN,	pCtIP,	5	mM	magnesium	and	various	concentrations	of	manganese.	 (D)	Nuclease	 assay	with	MRN	and	pCtIP	 and	 its	 dependence	on	NaCl	concentration.	(E)	Nuclease	assay	with	yeast	MRX,	human	MRN,	yeast	Sae2	and	 human	 pCtIP,	 as	 indicated,	 carried	 out	 at	 30°C.	 Only	 combination	 of	 the	cognate	polypeptides	results	in	the	stimulation	of	the	endonuclease	activity.		
Figure	S3	(related	to	Figure	3).	(A)	Samples	from	a	representative	purification	of	the	MR(K42R)N	complex	deficient	in	ATP	hydrolysis.	The	gel	was	stained	with	Coomassie	brilliant	 blue.	 (B)	 Samples	 from	a	 representative	purification	of	 the	MR(K42A)N	 complex	 deficient	 in	 ATP	 binding.	 The	 gel	 was	 stained	 with	Coomassie	brilliant	blue.	(C)	Nuclease	assay	with	MR(K42R)N	variant	on	5'	end-labeled	 dsDNA,	 either	 with	 5mM	 magnesium	 (left	 part)	 or	 5	 mM	 manganese	(right	 part).	 (D)	 Nuclease	 assay	 with	 MR(K42R)N	 variant	 on	 3'	 end-labeled	dsDNA,	either	with	5	mM	magnesium	(left	part)	or	5	mM	manganese	(right	part).	(E)	 Nuclease	 assay	 with	 MR(K42A)N	 variant	 on	 5'	 end-labeled	 dsDNA,	 either	with	5mM	magnesium	(left	part)	or	5	mM	manganese	(right	part).	(F)	Nuclease	assay	 with	 MR(K42A)N	 variant	 on	 3'	 end-labeled	 dsDNA,	 either	 with	 5	 mM	magnesium	(left	part)	or	5	mM	manganese	(right	part).			
Figure	S4	(related	to	Figure	4).	(A)	Samples	from	a	representative	purification	of	the	MR	complex	analyzed	by	polyacrylamide	gel	electrophoresis.	The	gel	was	stained	with	Coomassie	brilliant	blue.	(B)	Nuclease	assay	with	MR	complex	on	3'	end-labeled	dsDNA,	either	with	5	mM	magnesium	(left	part)	or	5	mM	manganese	(right	part).		
Figure	 S5	 (related	 to	 Figure	 5).	 (A)	 Nuclease	 assay	 with	 MRN	 and	 various	concentration	of	pCtIP	on	unblocked	5'	end-labeled	dsDNA.	 (B)	Nuclease	assay	
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with	MRN	and	pCtIP	on	100	bp-long	dsDNA	with	a	single	streptavidin	block	and	labeled	at	 the	5'	end,	see	cartoon	for	details.	 (C)	Nuclease	assay	with	MRN	and	pCtIP	on	circular	ssDNA	in	the	absence	of	ATP.	(D)	Nuclease	assay	with	MRN	and	pCtIP	 on	 circular	 ssDNA	 in	 the	 presence	 of	magnesium	 and/or	manganese,	 as	indicated.			
Figure	S6	(related	to	Figure	6).	(A)	Samples	from	a	representative	purification	of	 pCtIP	 Δ1-160	 truncation	 mutant	 analyzed	 by	 polyacrylamide	 gel	electrophoresis.	The	gel	was	stained	with	Coomassie	brilliant	blue.	(B)	The	pCtIP	
Δ1-160	was	either	not-treated	(lane	2)	or	 treated	with	λ	phosphatase	 (lane	3).	The	 pCtIP	 Δ1-160	 variant	 shows	 a	 phosphorylation-dependent	 shift	 in	electrophoretic	mobility.	(C)	Samples	from	a	representative	purification	of	pCtIP	L27E	 deficient	 in	 oligomerization	 analyzed	 by	 polyacrylamide	 gel	electrophoresis.	The	gel	was	stained	with	Coomassie	brilliant	blue.	(D)	The	pCtIP	L27E	was	either	not-treated	(lane	2)	or	treated	with	λ	phosphatase	(lane	3).	The	pCtIP	L27E	variant	shows	a	phosphorylation-dependent	shift	 in	electrophoretic	mobility.			
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Supplementary Figure 2 (related to Figure 2) 
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The Saccharomyces cerevisiaeMlh1-Mlh3Heterodimer Is an
Endonuclease That Preferentially Binds toHolliday Junctions*□S
Received for publication,November 13, 2013, and in revised form, January 16, 2014 Published, JBC Papers in Press, January 17, 2014, DOI 10.1074/jbc.M113.533810
Lepakshi Ranjha, Roopesh Anand, and Petr Cejka1
From the Institute of Molecular Cancer Research, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland
Background:Mlh1-Mlh3 is required for meiotic interference-dependent crossovers.
Results:We produced recombinant Mlh1-Mlh3 and show that it is an endonuclease that binds specifically Holliday junctions.
Conclusion:Mlh1-Mlh3 prefers to bind the open conformation of Holliday junctions, which infers that it acts as part of a larger
complex to process Holliday junctions in meiosis.
Significance: Recombinant Mlh1-Mlh3 complexes will be invaluable for further studies.
MutL!, a heterodimer of the MutL homologues Mlh1 and
Mlh3, plays a critical role during meiotic homologous recombi-
nation. The meiotic function of Mlh3 is fully dependent on the
integrity of a putative nuclease motif DQHAX2EX4E, inferring
that the anticipated nuclease activity of Mlh1-Mlh3 is involved
in the processing of joint molecules to generate crossover
recombination products. Although a vast body of genetic and
cell biological data regardingMlh1-Mlh3 is available,mechanis-
tic insights into its function have been lacking due to the
unavailability of the recombinant protein complex. Here we
expressed the yeastMlh1-Mlh3 heterodimer and purified it into
near homogeneity. We show that recombinant MutL! is a
nuclease that nicks double-stranded DNA. We demonstrate
that MutL! binds DNAwith a high affinity and shows a marked
preference forHolliday junctions.We also expressed the human
MLH1-MLH3 complex and show that preferential binding to
Holliday junctions is a conserved capacity of eukaryotic MutL!
complexes. Specific DNA recognition has never been observed
with any other eukaryotic MutL homologue. MutL! thus repre-
sents a new paradigm for the function of the eukaryotic MutL
protein family. We provide insights into the mode of Holliday
junction recognition and show that Mlh1-Mlh3 prefers to bind
the open unstacked Holliday junction form. This further sup-
ports the model where MutL! is part of a complex acting on
joint molecules to generate crossovers in meiosis.
DNA repair mechanisms safeguard genome stability and
ensure correct passage of genetic information duringDNA rep-
lication. By preventingmutagenesis, DNA repair pathways rep-
resent a barrier to cellular transformation to prevent carcino-
genesis and delay aging (1). These pathways repair accidental
DNAdamage caused by a variety of exogenous and endogenous
agents or replication errors. Double-strand DNA (dsDNA)
breaks represent one of the most cytotoxic and dangerous
lesions and are repaired by either non-homologous end-joining
or homologous recombination pathways. During meiosis, pro-
grammed chromosomebreakage and subsequent dsDNAbreak
repair by homologous recombination help to ensure correct
chromosome segregation and promote genetic diversity of the
progeny (2, 3).
The post-replicativemismatch repair (MMR)2 correctsDNA
polymerases errors that escape their proofreading activity.
In Escherichia coli, mismatches are detected by the MutS
homodimer. Upon mismatch recognition, the ADP-bound
MutS is converted into an ATP-bound sliding clamp, which
recruits the MutL homodimer, and both MutS and MutL pro-
teins complexed with ATP then activate the MutH endonu-
clease.MutH incises the newly synthesizedDNA strand at non-
methylated d(GATC) sites, and this provides entry points for a
DNAhelicase and one of several exonucleases that degrades the
error-containing strand (4). In eukaryotes the MutS and MutL
homologues are represented by heterodimers (5, 6). TheMsh2-
Msh6 (MutS!) andMsh2-Msh3 (MutS") complexes recognize
base-basemismatches or insertion-deletion loops, respectively.
The main MutL complex involved in Saccharomyces cerevisiae
MMR is theMlh1-Pms1 heterodimer (MutL!, MLH1-PMS2 in
humans). The other major MutL homologue complex, MutL#
(Mlh1-Mlh3), has a key function during meiotic homologous
recombination (see below) but also a minor MMR role in the
repair of insertion-deletion loops alongside Msh2-Msh3
(7–11). Unlike in E. coli, there are no MutH homologues in
eukaryotes.However,MutL!has been shown to possess a cryp-
tic endonuclease activity, which is dependent on the integrity of
the DQHAX2EX4E motif within human PMS2 or yeast Pms1
(12–15). In contrast toMutS! andMutS", MutL! has very low
affinity for DNA and shows no preference for mismatches (16,
17). In the reconstituted system, it was shown that the latent
MutL! endonuclease is activated in a concerted reaction
dependent on a preexisting nick, mismatch,MutS!, replication
factor C (RFC), and proliferating cell nuclear antigen (PCNA).
Likely, these factors help to trigger a conformational change in
MutL! that licenses the endonuclease (18). MutL! incises the
discontinuous strand and generates new entry points for the
* This work was supported by Swiss National Science Foundation Grants
PP00P3 133636 (to P. C.) and PDFMP3 141759 (to J. Jiricny (University of
Zurich) and P. C.).
□S This article contains supplemental Table 1.
1 To whom correspondence should be addressed. Tel.: 41-44-635-4786;
E-mail: cejka@imcr.uzh.ch.
2 The abbreviations used are: MMR, mismatch repair; HJ, Holliday junction;
PCNA, proliferating cell nuclear antigen; RFC, replication factor C; MBP,
maltose-binding protein; scDNA, supercoiled DNA; Exo1, Exonuclease 1.
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5!-3! dsDNA-specific Exonuclease 1 (Exo1) to degrade the
strand containing the misincorporated nucleotide. Thus, the
endonucleolytic activity of MutL! is critically important for
MMR, which is in agreement with high mutation rates caused
by pointmutations (e.g. pms1E707K) within the PMS1 nuclease
motif (13).
Meiosis is a specialized cell division that results in the pro-
duction of spores or gametes. Programmed Spo11-dependent
double-strand breaks activate homologous recombination,
which facilitates proper pairing of homologous chromosomes
and their subsequent segregation (19). Furthermore, by cross-
ing over, or exchanging of DNA sequences between the broken
chromosome and a homologous template, homologous recom-
bination contributes to the generation of genetic diversity dur-
ing sexual reproduction (2). Meiotic crossovers are dependent
on the functionally diverse group of proteins belonging to the
ZMM family. These factors help to form and stabilize interme-
diates termed single end invasions and facilitate their conver-
sion into double Holliday junctions (HJs) that are prerequisite
for crossover formation (20–24). Both MutS and MutL family
proteins have critical functions in meiotic recombination. The
Msh4-Msh5 complex is amember of the ZMMgroup and likely
has both early and late roles in meiotic recombination. Msh4-
Msh5 localizes as early as leptotene to the chromosome axis,
and mutant mice are defective in synapsis (25). Later in
pachytene, Msh4-Msh5 might recruit Mlh1-Mlh3 (MutL") via
its HJ binding and protein-protein interaction (26, 27). MutL"
is, together with the ZMMproteins, essential for meiotic inter-
ference-dependent crossovers (28). Joint molecule formation
occurs normally in yeastmlh1 mlh3mutants, but crossing over
is impaired, which suggests that MutL" functions only in a late
step ofmeiotic recombination to promote a crossover outcome
(29–32). Similarly in mice, Mlh1 or Mlh3 foci on pachytene
chromosomes mark future crossover sites (33–36). Mlh3 also
contains the DQHAX2EX4E metal binding motif that is critical
for theMMR function of yeast Pms1 or human PMS2 (12). The
pro-crossover function of MutL" is absolutely dependent on
the integrity of this motif, and mlh3D523N mutation that dis-
rupts the motif confers joint molecule resolution defect that is
identical tomlh3 null mutants (29, 31). This infers that MutL"
and its nuclease activity is an integral part of a meiotic resolu-
tion pathway. The absence of other resolution activities includ-
ing Mus81-Mms4 (MUS81-EME1 in humans), Yen1 (GEN1 in
humans), and Slx1-Slx4 had only amodest impact on jointmol-
ecule resolution, which together with other data shows that
Mlh1-Mlh3 is responsible for the majority of interference-de-
pendent meiotic crossovers (29, 31). Furthermore, the disrup-
tion of the metal binding motif in Mlh3 resulted in a modest
mutator phenotype in mitotic cells, suggesting that the antici-
pated endonuclease activity of Mlh3 is required for both its
meiotic and MMR functions (31).
In contrast to MutL!, the analysis of the Mlh1-Mlh3 behav-
ior was hindered by the fact that previous attempts to prepare
recombinant MutL" have been unsuccessful. Here we demon-
strate the expression and purification of both yeast and human
Mlh1-Mlh3/MLH1-MLH3 heterodimers from Sf9 cells. We
show that yeastMutL" is indeed a DNA endonuclease as antic-
ipated by genetic studies. We demonstrate that MutL" has a
strong DNA binding activity with amarked preference for Hol-
liday junctions. These recombinant complexes will be invalu-
able for further studies of MutL" biochemistry.
EXPERIMENTAL PROCEDURES
Preparation of Expression Plasmids and Purification of
Recombinant Proteins—The sequence of all primers is listed in
supplemental Table 1. The yeastMLH3 sequencewas amplified
from pEAE220 (E. Alani, Cornell University) using primers 245
and 246 (31). The PCR product was digested with ApaI and
XhoI restriction endonucleases and cloned into ApaI and XhoI
sites of pFB-MBP-SGS1-His (37), creating pFB-MBP-MLH3-
his. Similarly, the sequence of yeastMLH1 was amplified from
pEAA109 (E. Alani, Cornell University) using primers 251 and
252. The PCR product was digested by NheI and XhoI restric-
tion endonucleases and cloned intoNheI andXhoI sites of pFB-
GST-TOP3 (38), creating pFB-GST-MLH1. The cloned genes
were verified by sequencing. The viruses were produced using a
Bac-to-Bac system (Invitrogen) according to manufacturers’
recommendations. Spodoptera frugiperda Sf9 cells were then
co-infected with optimal ratios of both viruses, and the cells
were harvested 52 h after infection, washed with phosphate-
buffered saline, frozen in liquid nitrogen, and kept at "80 °C
until use.
Typical purification was performed with cell pellets from 3.6
liters of culture. All subsequent steps were carried out at
0–4 °C. Cells were resuspended in 3 volumes of lysis buffer (50
mM Tris-HCl, pH 7.5, 1 mM DTT, 1 mM EDTA, 1:500 (v/v)
Sigma protease inhibitory mixture (P8340), 1 mM phenylmeth-
ylsulfonyl fluoride, 30 #g/ml leupeptin). Sample was stirred
slowly for 15 min. Then, glycerol was added (16% final concen-
tration). Finally, 5 M NaCl was added to 325 mM (final concen-
tration), and the sample was stirred for 30min. Cell suspension
was centrifuged at 50,000 # g for 30 min to obtain soluble
extract. The cleared extract was bound to pre-equilibrated
amylose resin (8 ml, New England Biolabs) for 1 h batch-wise.
The resin was washed extensively with wash buffer (50 mM
Tris-HCl, pH 7.5, 2mM$-mercaptoethanol, 250mMNaCl, 10%
glycerol, 1 mM phenylmethylsulfonyl fluoride, 10 #g/ml leu-
peptin). MBP-Mlh3 and glutathione S-transferase (GST)-Mlh1
complex was eluted in wash buffer containing 10 mM maltose.
Next, the maltose-binding protein (MBP) and GST tags were
cleaved by PreScission protease (1 h) (the GST tag onMlh1 did
not improve our purification; therefore, we did not utilize it in
our final protocol). The sample was applied on pre-equilibrated
nickel nitriloacetic acid resin (0.7 ml, Qiagen) during 45 min of
incubation in the wash buffer supplemented with 20 mM imid-
azole. The resinwaswashedwithwash buffer containing 40mM
imidazole and eluted in the same buffer but with 400 mM imid-
azole. Pooled fractions were dialyzed against dialysis buffer (50
mM Tris-HCl, pH 7.5, 5 mM $-mercaptoethanol, 300 mMNaCl,
10% glycerol, 0.5 mM phenylmethylsulfonyl fluoride). The sam-
ple was aliquoted, frozen in liquid nitrogen, and stored at
"80 °C. The sequence coding for the nuclease-deficient Mlh1-
Mlh3 (D523N) mutant was amplified from plasmid pEAE282
(E. Alani, Cornell University) (31) and prepared in the sameway
as the wild type complex. To verify that the C-terminal His tag
onMlh3 does not affect its biochemical function reported here,
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a recombinant wild typeMutL!with aHis tag on theN terminus
of Mlh1 rather than the C terminus of Mlh3 was also prepared.
Bothconstructs behavedvery similarly inour assays.Only thedata
obtained using the former construct are shown in this work. The
construct for the expression of Mlh1 (N35A) was prepared using
oligonucleotides 325 and326, and the construct for the expression
ofMlh3 (N35A)was prepared using oligonucleotides 327 and 328
byQuikChange site-directedmutagenesis (Agilent Technologies)
followingmanufacturers’ instructions.
ThesequenceofhumanMLH3wasamplifiedusingprimers288
and 289 from pFB-MLH3 (11), digested with NheI and XmaI
restriction endonucleases, and cloned intoNheI andXmaI sites of
pFB-MBP-SGS1-his, creating pFB-MBP-hMLH3-His. The pFB-
MLH1 was described previously (39). The human MLH1-MLH3
complex was expressed and purified using the same procedure as
the yeast homologue.
Recombinant Exo1 (D173A) was prepared as described pre-
viously (40). PCNA and RFC were expressed and purified from
E. coli by minor modifications of previously established proce-
dures (41, 42). We thank Robert Bambara (University of Roch-
ester) and Manju Hingorani (Wesleyan University) for the
expression plasmids.
DNA Substrates for Nuclease and Binding Assays—The oli-
gonucleotide-based substrates were prepared as described pre-
viously (37). The sequences of all oligonucleotides used here are
listed in supplemental Table 1. The oligonucleotides used for
the respective substrate were: HJ (1253, 1254, 1255, 1256);
dsDNA (1253, 1253C); Y-structure (1253, 1254); Nicked HJ
(1253, 1254, 1255, 312, 314); Open HJ (1253, 1254, 316, 317),
3-Way junction (1253, 1254, 1255), ssDNA (1253). For endonu-
clease assays, negatively supercoiled pUC19 dsDNA (scDNA)
was used.
ElectrophoreticMobility Shift Assays—The binding reactions
(15"l volume) were carried out in 25mMTris acetate, pH 7.5, 1
mM DTT, 100 "g/ml BSA (New England Biolabs), DNA sub-
strate (1 nM, molecules), and either 3 mM EDTA or 2 mM mag-
nesium acetate as indicated (!Mg2" or"Mg2", respectively).
Where indicated, the reactions were supplemented with com-
petitors, either dsDNA (pUC19), 3.3 ng/"l, or poly(dI-dC), 1.3
ng/"l. This corresponded to 50-fold molar excess (in nucleo-
tides) over HJ for dsDNA competitor and a 20-fold molar
excess (in nucleotides) for poly(dI-dC) competitor. Finally, the
recombinant proteins were added. All reactions were assem-
bled on ice. The reactions were then incubated for 30 min at
30 °C (yeast heterodimer) or 37 °C (human heterodimer). Upon
adding 5 "l of 50% glycerol with bromphenol blue (0.25%) into
each reaction, the products were separated by electrophoresis
in 6% polyacrylamide gel (ratio acrylamide:bisacrylamide 19:1,
Bio-Rad) at 4 °C. Gels were dried on DE81 chromatography
paper (Whatman), exposed to storage phosphor screens (GE
Healthcare), and analyzed by Typhoon FLA 9500 (GE Health-
care). The reactions were quantified using Image Quant soft-
ware. The Kd corresponds to MutL! concentration when 50%
of the respective DNA substrate was protein-bound. The Kd is
only reported when at least 90% substrate saturation was
reached.
Nuclease Assays—The nuclease assays (15 "l volume) were
carried out unless indicated otherwise in 25 mM Tris acetate,
pH 7.5, 5 mM manganese acetate, 0.1 mM EDTA, 1 mM DTT,
100"g/ml BSA (NewEngland Biolabs), DNA substrate (200 ng,
pUC19), and recombinant proteins as indicated. The reactions
were incubated for 1 h at 30 °C and stopped with 5 "l of stop
solution (150 mM EDTA, 2% SDS, 30% glycerol, 0.25% bro-
mphenol blue) and 1 "l of Proteinase K (14–22 mg/ml, Roche
Applied Science) for 15 min at 30 °C. The products were sepa-
rated by 1% agarose gel electrophoresis, and DNA was visual-
ized by staining with ethidium bromide (0.1 "g/ml) using the
Alpha InnoTec imaging station.
RESULTS
Expression andPurification of S. cerevisiae andHomo sapiens
MutL!—The sequences coding for yeast Mlh3 and Mlh1 pro-
teins were cloned into pFastBac1 vectors behind MBP or GST
affinity tags, respectively (Fig. 1A). The heterodimer was
expressed in S. frugiperda Sf9 cells and purified to near homo-
geneity (Fig. 1B). During purification, the MBP and GST tags
were cleaved off by the PreScission protease (see “Experimental
Procedures” for details). Using an identical procedure, we also
prepared the Mlh1-Mlh3 (D523N) mutant with a disrupted
putative endonuclease active site (Fig. 1C). The typical yield of
the recombinant yeast Mlh1-Mlh3 heterodimers was # 0.5–1
mg from 3.6 liters of Sf9 culture, and the protein concentration
was#5 "M.
MutL! Is an Endonuclease—We first set out to test whether
MutL! has an intrinsic endonuclease activity, as anticipated
based on the presence of the metal binding DQHAX2EX4E
motif within MLH3 and on the phenotype of the putative
nuclease sitemutants (12, 13, 29, 31). BecauseMutL# exhibited
a Mn2"-ATP-dependent endonuclease activity on supercoiled
dsDNA (13), we set out to test for a similar activity of MutL!
(Fig. 2A). We show here thatMlh1-Mlh3 does nick supercoiled
dsDNA, whereas mutant Mlh1-Mlh3 (D523N) is devoid of this
activity (Fig. 2B). The mutant MutL! was prepared in exactly
the same way as the wild type complex, and as we show below,
both wild type and mutant complexes behave similarly with
regard to DNA binding. We thus conclude that the endonu-
clease activity is inherent to MutL!. As with MutL#, the endo-
nuclease activity was dependent onmanganese, as we observed
almost no activity when manganese was substituted with mag-
nesium (Fig. 2B). The optimal activity required at least 3–5 mM
manganese (Fig. 2C), and magnesium added in addition to
manganese had neither stimulatory nor inhibitory effect on the
endonuclease activity of MutL! (Fig. 2D). The endonuclease
activity was inhibited by elevated levels of sodium or potassium
chloride, as expected (Fig. 2E). We also found that MutL!
exhibits optimal endonuclease activity at pH 7.5–8.5 (Fig. 2F).
ATP binding and hydrolysis by MutL# are required for mis-
match repair, and the endonuclease activity is strongly stimu-
lated by ATP (13). As ATP binding and hydrolysis are equally
important for the meiotic and mismatch repair functions of
MutL! in genetic assays (44), we set out to test the effect of ATP
on its endonuclease activity. Initially, we observed that ATP
inhibited the cleavage of scDNA byMutL! (Fig. 2G). However,
ATP is known to chelate divalent cations such as Mn2" or
Mg2". To distinguish whether ATP has a direct effect on the
MutL! endonuclease or affects it indirectly via reducing the
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free manganese concentration, we supplemented the reactions
with ATP as well as an equimolar concentration of manganese
acetate (Fig. 2G). The simultaneous addition of Mn2! largely,
but not completely, negated the inhibitory effect of ATP. Thus,
in contrast toMutL!, ATP does not promote the endonuclease
activity of MutL", indicating thatMutL! andMutL" nucleases
are regulated differently. Furthermore, we found out that ATP
binding is important for the stability of theMutL"heterodimer.
Mutations that disrupt ATP binding inMlh1 (Mlh1 (N35A)) or
are predicted to confer the same defect onMlh3 (Mlh3 (N35A))
(44) resulted in nearly complete protein degradation in Sf9 cells
(Fig. 2H). ATP binding was previously found to be important
for the stability of humanMutL! (45), and we show here that it
is similar for MutL".
Yeast Exo1 was found in genetic assays to be required for all
Mlh1-Mlh3-dependent meiotic crossovers. Surprisingly, the
direct protein-protein interaction between Exo1 andMlh1, but
not the nuclease activity of Exo1, was essential for this effect
(30). We set out to test whether the nuclease-deficient Exo1
(D173A)mutant stimulated the endonuclease activity ofMlh1-
Mlh3 on dsDNA (46). We show in Fig. 3A that this was not the
case; Exo1 (D173A) did not stimulate the Mlh1-Mlh3 endonu-
clease. Rather, we observed a decrease of the MutL" endonu-
clease activity. The reason for this effect is not known; never-
theless, we point out thatMn2!-dependent nicking of scDNA is
unlikely the physiological condition for the MutL" endonu-
clease. Therefore, we cannot exclude that Exo1 (D173A) might
have a very different role on other substrates and/or under dif-
ferent experimental conditions.
Furthermore, the nuclease activity of MutL! was strongly
promoted by RFC and PCNA in both yeast and human systems
(12, 13). The effect of these proteins on the meiotic function of
Mlh1-Mlh3 is unknown due to the inviability of the respective
mutants.We show here that in contrast toMutL!, the endonu-
clease of MutL" was not promoted by the recombinant yeast
RFC and PCNA proteins (Fig. 3, B and C), not even in combi-
nation with Exo1 (D173A) (Fig. 3D). We also show that our
preparations of RFC and PCNA were active, as demonstrated
by their capacity to stimulate the endonuclease of hMutL! (Fig.
3E). Furthermore, we observed no magnesium-dependent
endonuclease activity on either scDNA or a plasmid-based
DNA substrate containing a cruciform structure resembling a
Holliday junction (data not shown (43)). In summary, we dem-
onstrate here that Mlh1-Mlh3 is indeed an endonuclease as
anticipated from biochemical studies. Its activation in the con-
text of meiotic recombination is likely to be regulated in a dif-
ferent manner than the nuclease of MutL! in MMR.
Mlh1-Mlh3 Preferentially Binds Holliday Junctions—Having
shown that our preparation of yeast MutL" is active as a
nuclease, we next set out to analyze its DNA binding activity.
To this end, we used a variety of oligonucleotide-based DNA
structures and monitored DNA binding by electrophoretic
mobility shift assays. In contrast to what was observed for
MutL!, we show in Fig. 4A that MutL" binds DNA with a very
high affinity (Kd for dsDNA, Y-structure, and HJ"1–2 nM and
for ssDNA"3 nM). Yeast MutL!was initially described to lack
DNA binding activity (17). Later, DNA binding of MutL! was
observed, but the apparent affinity was very low, withKd values
for oligonucleotide-based DNA in the high nanomolar or
micromolar range (47–49). Initially, we did not observe signif-
icant differences between the various structures tested, and the
DNA-bound Mlh1-Mlh3 complex was mostly trapped in the
FIGURE 1. Purification of recombinant yeast MutL!. A, a diagram of
S. cerevisiaeMlh1 andMlh3 constructs. PP, PreScission protease cleavage site.
B, a representative Mlh1-Mlh3 purification showing fractions analyzed by
SDS-PAGE. Themass ofmolecular weightmarkers is indicated on the left, and
the positions of the respective recombinant constructs are indicated on the
right. The gelwas photographedupon stainingwith Coomassie Brilliant Blue.
C, a representative purification as in panel B but with the nuclease-deficient
Mlh1-Mlh3 (D523N) mutant.
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wells of the polyacrylamide gels, which was suggestive of a
cooperative binding or aggregation (data not shown). Thus,
similarly to MutL!, the DNA binding appeared to be rather
unspecific (47). The only exception was theHJ substrate, where
we observed a minor protein-bound DNA species that entered
the gel (data not shown).
We next supplemented the reactions with competitor DNA
(pUC19 dsDNA, 3.3 ng/"l) and repeated the binding analyses.
The presence of the DNA competitor lowered the apparent
DNA binding affinity (Fig. 4B). Importantly, we could now
observe a clear preference for the HJ substrate (Fig. 4, B andC).
The apparent Kd for HJ was !16 nM, which was about 5-fold
lower than that for dsDNA (Kd! 82 nM) and 11-fold lower than
for ssDNA (Kd ! 180 nM). Furthermore, the protein-bound
DNA species that entered the polyacrylamide gel was very
prominent andwas observed only in the case of theHJ substrate
(Fig. 4C, indicated by a red arrow). We believe that this species
represents the Mlh1-Mlh3 heterodimer bound specifically to
the HJ structure. At higher concentrations and in the case of
other DNA substrates such as dsDNA and ssDNA, the DNA
was bound rather unspecifically, likely by multiple MutL# het-
erodimers, and the complexes then became too large to enter
the polyacrylamide gels (Fig. 4C and data not shown).
DNA binding by MutL# decreased as a function of NaCl
concentration, indicating that DNA binding was mediated pri-
marily via ionic interactions (data not shown). Next we supple-
mented the reactions with Tween 20, which is a non-ionic
detergent that reduces hydrophobic interactions that may be
responsible for protein-protein aggregation. The inclusion of
Tween 20 (0.5%) in the binding buffer increased the selectivity
FIGURE2.YeastMlh1-Mlh3 is anendonuclease that cleavesdsDNA.A, a schemeof the endonuclease assay.B, endonuclease assaywas carriedoutwithwild
type or mutant Mlh1-Mlh3 (D523N), in a reaction buffer containing either 5 mM manganese acetate (left side) or 5 mM magnesium acetate (right side) as
indicated.Cleavage (%), the average value from two independent experiments.C, endonuclease assaywithMlh1-Mlh3 (300nM)was carriedout in thepresence
of various concentrations of manganese acetate as indicated. The results are based on two independent experiments; error bars, S.E. D, endonuclease assay
with Mlh1-Mlh3 (300 nM) was carried out in the presence of 5 mM manganese acetate and various concentrations of magnesium acetate as indicated. The
results are based on two independent experiments; error bars, S.E. E, the effect of sodium and potassium chloride on the endonuclease activity of Mlh1-Mlh3
(300 nM). The results are based on two independent experiments; error bars, S.E. F, the effect of pH on the endonuclease activity of Mlh1-Mlh3 (300 nM) in Tris
acetate-based reaction buffers. The results are based on three independent experiments; error bars, S.E. G, the effect of ATP on the endonuclease activity of
Mlh1-Mlh3 (300 nM). Cleavage (%), the average value from two independent experiments. H, ATP binding is required for the stability of MutL# in Sf9 cells.
Amylose pulldown assays were carried out using extracts from Sf9 cells infected with a combination of baculoviruses coding for wild type or mutant Mlh1 or
Mlh3 proteins.
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ofMutL! binding toHJ (Fig. 4E). Tween 20 reduced the binding
affinity to dsDNA about 2-fold (Kd! 160 nM), whereas it had a
minimal effect on the apparentKd for HJ (Kd! 20 nM). Thus, in
the presence of Tween 20, MutL! preferred HJ over dsDNA
"8-fold. Based on these results, we conclude that DNAbinding
by MutL! is mainly ionic in nature and that unspecific DNA
binding is promoted by protein aggregationmediated largely by
hydrophobic interactions. Next we analyzed the DNA binding
in the presence of the synthetic polymer poly(dI-dC) (1.3
ng/"l). When using both poly(dI-dC) competitor and 0.5%
Tween 20, MutL! preferred binding to HJ "10-fold over
dsDNA (Fig. 4, D and F). We also show that the fraction of the
specifically bound HJs was very prominent (up to about 70% of
the DNA substrate) and was apparent over a wide range of
Mlh1-Mlh3 concentrations (Fig. 4F). In contrast, no specific
binding to dsDNA was observed. Such binding selectivity is in
agreement with the anticipated role ofMutL! in the processing
of meiotic double Holliday junctions. It, however, stands in
contrast with the behavior of MutL#, which shows no specific
binding tomismatchedDNA (17). Such behavior is rather rem-
iniscent ofMutS# orMutS$ factors, which show a similar bind-
ing preference formismatched over homoduplexDNA (50, 51).
We also analyzed DNA binding of the Mlh1-Mlh3 (D523N)
mutant. As shown in Fig. 4, G and H, the mutant preferred to
bind HJs similarly to the wild type protein. Although the bind-
ing affinity was lower than that of the wild type protein, the
experiment shows that the integrity of the putative endonu-
clease active site does not affect the DNA binding selectivity. In
summary, MutL! has a strong affinity for DNA and exhibits a
striking preference for binding to Holliday junctions.
Mlh1-Mlh3 Prefers to Bind the Unstacked Form of a Holliday
Junction—We next analyzed the DNA binding by Mlh1-Mlh3
in a reaction buffer supplemented with magnesium. The inclu-
sion ofmagnesiumhad a relativelymodest effect on the binding
affinity to dsDNA (Kd !155 nM versus !82 nM, decrease of
binding affinity less than 2-fold). In contrast, magnesium low-
ered the binding affinity to HJ !8-fold (Kd !130 versus !16
nM). Thus, in the presence of magnesium, the binding prefer-
ence ofMutL! to HJ-like structures was strongly reduced (data
not shown). The loss of binding preference to HJ in the pres-
ence of magnesium was, however, not complete, as revealed by
a competition experiment. We prebound MutL! to a 32P-la-
beled HJ and then challenged the complex with an excess of
either unlabeled HJ or dsDNA. As shown in Fig. 5A, the HJ
competitor was more effective in disrupting the MutL!-HJ
complex than the dsDNA competitor. Preference for binding
HJs in reactions with magnesium was further revealed in the
presence of poly(dI-dC) competitor andTween 20.Under these
conditions, MutL! preferred binding to HJs over dsDNA
!3-fold (Fig. 5, B and C). We could also clearly detect the spe-
cific MutL!-HJ complex (Fig. 5, B and C). Nevertheless, the
!3-fold preference for HJs over dsDNA was still significantly
smaller than that observed in the absence ofmagnesium (Fig. 4,
D and F, !10-fold). Supplementing the reaction with ATP
affected neither the affinity for DNA nor the preference for
binding HJs by Mlh1-Mlh3 (Fig. 5, E and F).
We believe that the lower preference for binding HJs in the
presence of magnesium reflects an altered HJ structure. Hol-
liday junctions are known to exist in two major conforma-
tions. In the absence of metal ions such as Mg2#, HJ adopts
an open planar structure with a 4-fold symmetry. In the pres-
ence of Mg2#, HJ stacks into a closed antiparallel structure
with a 2-fold symmetry (52, 53). Under our experimental
conditions, HJ adopts the open or closed conformation
depending on the presence of magnesium (data not shown)
as expected. Our observation thatMlh1-Mlh3 shows a stron-
ger preference for HJs in the absence of magnesium suggests
that MutL! prefers to bind the open unfolded HJ or a similar
structure.
To characterize the binding selectivity of MutL! in greater
detail, we constructed additional oligonucleotide-based DNA
substrates, including a three-way junction, a nicked HJ, and a
four-way junction with a non-complementary core (open HJ).
We next performed electrophoretic mobility shift assays in the
presence or absence of magnesium. The most notable results
FIGURE 3. The endonuclease activity of yeastMlh1-Mlh3 is not promoted
by either Exo1 or RFC/PCNA. A, the effect of nuclease-dead yeast Exo1
(D173A, 100 nM) on the endonuclease activity of yeast Mlh1-Mlh3 (100 nM).
ATP was present in the reaction buffer where indicated (1 mM). Cleavage (%),
the average value from two independent experiments. B, purified recombi-
nant yeast PCNA and yeast RFC proteins used in this study. The gel was pho-
tographed upon staining with Coomassie Brilliant Blue. C, the effect of yeast
PCNA (100 nM) and yeast RFC (100 nM) on the endonuclease activity of yeast
Mlh1-Mlh3 (100 nM). ATP was present in the reaction buffer where indicated
(1 mM). Cleavage (%), the average value from two independent experiments.
D, the effect of yeast PCNA, yeast RFC, and yeast Exo1 (D173A) on the endo-
nuclease activity of yeast Mlh1-Mlh3 (all proteins 100 nM). ATPwas present in
the reaction buffer where indicated (1 mM). Cleavage (%), the average value
from two independent experiments. E, the effect of yeast PCNA (90 nM) and
yeast RFC (27nM) on theendonuclease activity of humanMLH1-PMS2 (60nM).
ATP was present in the reaction buffer where indicated (1 mM). Cleavage (%),
the average value from two independent experiments.
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were obtained with the non-complementary core junction
(open HJ). As shown in Fig. 6, A and B, in the absence of mag-
nesium, the open junctionwas as good a substrate forMutL! as
the HJ substrate (Kd ! 10 nM). Upon the inclusion of magne-
sium (Fig. 6, C and D), the open junction, which cannot stack
due to a lack of complementarity, became the preferred sub-
strate for MutL! binding (Kd ! 35 nM). In summary, we dem-
onstrate here that the binding preference of MutL! to HJs is
reduced in the presence of magnesium that stacks HJs into a
closed conformation. Our results indicate that MutL! prefers
to bind the unstacked form of HJs. By inference, we believe that
MutL! in vivo acts in a complexwith other factors that facilitate
its access to the junction under physiological conditions when
magnesium is present (see “Discussion”).
FIGURE 4. YeastMlh1-Mlh3 has a high affinity for DNA and prefers to bind Holliday junctions. Electrophoretic mobility shift assays were carried out with
oligonucleotide-basedDNA substrates, as indicated. All oligonucleotideswere 50-nucleotides long. A, quantitation of assays carried out in a buffer containing
3mMEDTAandnoDNAcompetitor. The curves show thedisappearanceof the substratebandandarebasedon three independent experiments; error bars, S.E.
B, electrophoretic mobility shift assays were carried out in a buffer containing 3mM EDTA and a dsDNA competitor. The curves show the disappearance of the
substrate band and are based on two independent experiments; error bars, S.E. C, representative experiments from the condition described in panel B.
The species representingMlh1-Mlh3bound specifically to theHolliday junction is indicatedby anarrow anddenoted as Specific complex. Ablue arrow indicates
the position of wells. D, non-ionic detergent increases the fraction of specifically bound HJ by Mlh1-Mlh3. An electrophoretic mobility shift assay was carried
out as in panel C but in a buffer supplementedwith 0.5% Tween 20 and poly(dI-dC) competitor instead of dsDNA. Shown are representative experiments. The
species representingMlh1-Mlh3bound specifically to theHolliday junction is indicatedby an arrow anddenoted as Specific complex. Ablue arrow indicates the
position of wells. E, quantitation of the fraction of specifically bound DNA from experiments carried out in a buffer containing 3mM EDTA, dsDNA competitor,
and 0.5% Tween 20. Results are based on two independent experiments, and error bars show S.E. F, quantitation of the specific complex from panel D. Results
are based on two independent experiments, and error bars show S.E. G, representative experiments such as in panel C but with the nuclease-deficient
Mlh1-Mlh3 (D523N)mutant (0.8–100nM). The species representingMlh1-Mlh3 (D523N) bound specifically to theHolliday junction is indicatedby anarrow and
is denoted as Specific complex. Ablue arrow indicates thepositionofwells.H, quantitationof total DNAbinding fromassays such as inpanel G. Results are based
on two independent experiments, and error bars show S.E.
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Specific Holliday Junction Binding Is a Conserved Property of
Eukaryotic MutL! Proteins—To test whether the preference
for HJ binding is conserved in evolution, we expressed the
human MutL! heterodimer. The sequence coding for hMLH3
was cloned behind a MBP affinity tag (Fig. 7A) and co-ex-
pressed with untagged hMLH1 in Sf9 cells. The typical yield of
the human recombinant heterodimer was !0.1 mg from 3.6 L
Sf9 cells, and the protein concentration was!645 nM (Fig. 7B).
Next, we analyzed its DNA binding activity. In the absence of
magnesium, the human complex also clearly preferred binding
to HJs and related structures (Fig. 7, C and D). Upon supple-
menting the reaction buffer with magnesium, the apparent
affinity to DNA was decreased, and the complex clearly pre-
ferred binding to the open junction structure with the non-
complementary core, similarly to the yeast homologue (Fig. 7,C
and E). In contrast to the yeast protein, however, the human
MutL!-bound DNA species remained trapped in the wells of
the acrylamide gel, which likely reflects a greater propensity of
hMutL! to multimerize upon DNA binding (Fig. 7C). The
lower protein concentration of our humanMLH1-MLH3 prep-
aration did not allow us to reliably establish the apparent Kd
values for all substrates tested; however, the data presented
here strongly suggest that the human and yeast MutL! com-
plexes behave similarly with regard to preferred HJ binding.
DISCUSSION
Here we present the first biochemical characterization of
Mlh1-Mlh3.We show that the heterodimer can be expressed in
Sf9 cells and purified to near homogeneity. Our analysis reveals
thatMutL! has an unexpectedly strong affinity for DNAwith a
marked preference forHolliday junctions. This behavior stands
in sharp contrast to the MMR-specific MutL" (Mlh1-Pms1 in
yeast orMLH1-PMS2 in humans) and defines a novel paradigm
for a function of a MutL homologue in eukaryotes. We also
demonstrate that yeastMlh1-Mlh3 endonucleolytically cleaves
dsDNA and that the regulation of this endonuclease activity is
distinct from that of MutL".
A vast body of in vivo data from a number of organisms
including yeast, mice, and humans identified MutL! as a cen-
tral player in meiotic homologous recombination (26, 29,
FIGURE 5.Magnesium lowers the specificity of yeast Mlh1-Mlh3 binding to Holliday junctions. A, HJ is effective as a DNA competitor in the presence of
magnesium. The Mlh1-Mlh3 heterodimer (100 nM) was prebound for 15 min to 32P-labeled HJ in a buffer containing 2 mM Mg2". The complex was then
challenged with an excess of unlabeled dsDNA or HJ as indicated and incubated for an additional 15 min. The reaction products were then analyzed by
electrophoresis. Results are basedon two independent experiments, and error bars showS.E.B, electrophoreticmobility shift assayswere carriedout in abuffer
with 2mMMg2", 0.5% Tween 20, and poly(dI-dC) competitor. Shown are representative experiments. The species representingMlh1-Mlh3 bound specifically
to Holliday junction is indicated by an arrow and denoted as Specific complex. A blue arrow indicates the position of wells. C, quantitation of the experiments
such as shown in panel B, based on the disappearance of the substrate band. Three independent experiments were done, and error bars show S.E. D,
quantitation of the fraction of specifically bound DNA from experiments such as shown in panel B. Results are based on three independent experiments, and
error bars show S.E. E, assays were as in B but additionally supplemented with ATP (1 mM). Representative experiments are shown. The species representing
Mlh1-Mlh3 bound specifically to the Holliday junction is indicated by an arrow and denoted as Specific complex. A blue arrow indicates the position of wells. F,
quantitation of the experiments such as shown in panel E, based on the disappearance of the substrate band. Three independent experimentswere done, and
error bars show S.E.
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31–34, 54, 55). Available evidence infers a late function, likely in
the processing of joint molecules such as double Holliday junc-
tions into crossover recombination products. It was shown that
MutL! is responsible for the majority of meiotic crossovers
(29). In addition, MutL! likely has a minor role in post-replica-
tive MMR (7–11). Understanding the molecular mechanism of
MutL! function is a major challenge, as this complex has been
very difficult to obtain. The analysis of the full-length recombi-
nant MutL! heterodimer presented here thus represents a
major step toward that goal.
As first shown by Kunkel and co-workers (16, 47), theMMR-
specific yeast MutL" is a DNA-binding protein. However, the
affinity of Mlh1-Pms1 for DNA is very low. In the absence of a
DNA competitor, the apparent Kd is in the high nanomolar or
micromolar range, which represents 2–3 orders of magnitude
lower affinity than what we demonstrate here for MutL!.
Although the MutL" heterodimer shows a modest preference
for binding to ssDNA, the binding is lost upon supplementing
the reaction with a competitor (47). The complex shows no
preference for binding either mismatched DNA or a Holliday
junction (17, 47). Thus, the DNA binding byMutL" is believed
to be unspecific, and it has no direct role in mismatch recogni-
tion. This function is carried out by either the MutS" or the
MutS# heterodimers. AlthoughMutL"may increase the affin-
ity ofMutS" orMutS# formismatchedDNA (17, 56),MutL" is
not believed to come into contact with the heteroduplex. Yet
FIGURE 6. Yeast Mlh1-Mlh3 prefers to bind the open conformation of a Holliday junction. A, an electrophoretic mobility shift assay was carried out in a
buffer containing 3 mM EDTA (!Mg2"), dsDNA competitor, the respective DNA substrate as indicated on the left, and a range of Mlh1-Mlh3 concentrations.
Shownare representative experiments. The image showingMlh1-Mlh3binding toHJ is the sameas in Fig. 4C and is shownhere again for reference. The species
representing Mlh1-Mlh3 bound specifically to DNA is indicated by an arrow and denoted as Specific complex. A blue arrow indicates the position of wells. B,
quantitation of the experiments such as shown in panel A. The curves show the disappearance of the substrate band and are based on two independent
experiments; error bars, S.E. C, an electrophoreticmobility shift assay was carried out as in panel A but with 2mMmagnesium acetate ("Mg2") instead of 3mM
EDTA. The species representing Mlh1-Mlh3 bound specifically to DNA is indicated by an arrow and denoted as Specific complex. A blue arrow indicates the
position of wells.D, quantitation of the experiments such as shown in panel C. The curves show the disappearance of the substrate band and are based on two
independent experiments; error bars, S.E.
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themodest DNAbinding activity ofMutL! is important in vivo
as revealed by mutator phenotypes ofmlh1 and pms1mutants
lacking the DNA binding capacity (16, 49). It may be important
downstream of mismatch recognition for the movement of
MutL! along the DNA contour before engagement of its endo-
nuclease activity (57, 58).
The strong and specific binding of HJ substrates by MutL"
reported here contrasts with the behavior of MutL!. We dem-
onstrate thatMutL" shows up to a 10-fold preference for bind-
ing HJs over dsDNA. This value is very similar to the reported
preference of either MutS! (Msh2-Msh6) or MutS# (Msh2-
Msh3) toward binding heteroduplex over homoduplex dsDNA
in the presence of the same competitor (50, 51). Analysis of the
human MLH1-MLH3 complex further reveals that specific HJ
binding by MutL" is conserved in evolution. This infers that,
duringmeiosis,MutL"may directly contactHJs. Together with
previously published compelling genetic data, our results fur-
ther support the hypothesis that MutL" is part of a meiosis-
specific HJ resolvase (29, 31, 32).
The conformation of HJs is strongly dependent on the pres-
ence of divalent metal ions such as magnesium. In the absence
of magnesium, HJs assume an open, 4-fold symmetrical struc-
ture. In the presence ofmagnesium, the core of theHJ folds into
a stacked, X-like structure (52). We observed that the prefer-
FIGURE 7.HumanMLH1-MLH3 prefers to bindHolliday junctions. A, a diagram ofH. sapiensMLH1 andMLH3 constructs. PP, PreScission protease cleavage
site. B, a representative MLH1-MLH3 purification showing fractions analyzed by SDS-PAGE. Themass of molecular weight markers is indicated on the left, and
the positions of the respective recombinant constructs on the right. The gel was photographed upon staining with Coomassie Brilliant Blue. PP, PreScission
protease. C, an electrophoretic mobility shift assay was carried out in a buffer containing 3 mM EDTA (!Mg2") or 2 mM Mg2" ("Mg2") as indicated, pUC19
dsDNA competitor, the respective DNA substrate as depicted on the left, and a range of MLH1-MLH3 concentrations. Shown are representative experiments.
D, quantitation of the experimentswith 3mMEDTA such as shown in panel C. The curves show the disappearance of the substrate band and are based on three
independent experiments; error bars, S.E. E, quantitation of the experiments with 2mMMg2" such as shown in panel C. The curves show disappearance of the
substrate band and are based on three independent experiments; error bars, S.E.
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ence of Mlh1-Mlh3 binding to HJ over dsDNA was greater in
the absence (up to !10-fold; Fig. 4) than in the presence of
magnesium (up to !3-fold; Fig. 5). This revealed that Mlh1-
Mlh3 prefers to bind the unstacked, open form of a Holliday
junction. This was further supported by the analysis of Mlh1-
Mlh3 binding to a HJ structure with a non-complementary
core. We show that Mlh1-Mlh3 bound this structure with a
high affinity even in the presence of magnesium, showing that
the conformation of the HJ, and not the absence ofmagnesium,
results in the high binding affinity. The affinity of MutL! to
ssDNA is very low (Fig. 4); thus the preferred binding to the
unstacked formof aHJ cannot be explained by binding to exposed
ssDNA. Furthermore, no specific bindingwas observed to a 3-way
junction, showing that a junction with all four arms is the favored
substrate ofMutL! (Fig. 6).
Preferred binding to the open conformation is rather unusual
for HJ resolvases. Typically, as it has been observed with e.g. the
canonical E. coli resolvase RuvC or the mitochondrial S. cerevi-
siae resolvase Cce1, these enzymes bind equally well the
stacked and the unstacked forms of HJs (59, 60). Upon binding,
however, these proteins open the core of the HJ so that the
resolvase-bound HJ in the presence of magnesium resembles
more the conformation of the protein-free structure observed
without magnesium rather than the stacked structure (59, 60).
We believe that the simplest explanation of our results is that
Mlh1-Mlh3 does not bindHJs alone but rather in complex with
other factors, such as Exo1, Msh4-Msh5, or Sgs1, which may
facilitate its access to HJs. Msh4-Msh5 is an obvious candidate
for this role. The human heterodimer was shown to form a
complexwithHJs thatwas stable in the presence ofmagnesium.
UponHJ binding andADP3ATPexchange, theMSH4-MSH5
complex turns into a sliding clamp that slides away from the HJ
(27, 61). It remains to be established whether MSH4-MSH5
makes the HJ more accessible for MLH1-MLH3 binding and
whether yeast Msh4-Msh5 behaves similarly. Furthermore,
Sgs1 and its helicase activity is part of the crossover-specific
pathway together with Mlh1-Mlh33 (29, 32). As Sgs1 shows a
preference for unwindingHJs and it interacts withMlh3 during
meiosis (37, 62), it is possible also that the Sgs1 helicasemay act
in complex with Mlh1-Mlh3 to melt the HJ structure. Finally,
Exo1 has a non-catalytic role in promoting joint molecule res-
olution by Mlh1-Mlh3. However, the molecular mechanism of
this function remains unknown (30). We anticipate that some
of these proteins, possibly in combinationwith yet-unidentified
factors, may help to recruit MutL! to the joint molecules.
During MMR, human and yeast MutL" exhibit a Mg2"-de-
pendent endonuclease activity that nicks dsDNA and that is
activated in a concerted reaction requiring a pre-existing strand
discontinuity (i.e. a nick), amismatch, and theMutS", RFC, and
PCNAproteins. In addition,MutL" exhibits a rather unspecific
Mn2"-dependent endonuclease activity that nicks supercoiled
dsDNA. The presence of manganese bypasses the requirement
for the presence of the above reaction components (12, 13).
Thus, the analysis of theMn2"-dependent nuclease reveals ele-
ments of the specific reaction. To this point, it was demon-
strated that the MutL" endonuclease is strongly stimulated by
ATP as well as by RFC and PCNA. We show here that MutL!
exhibits a similar, Mn2"-dependent endonuclease activity. We
show that, similarly to MutL", ATP binding by either Mlh1 or
Mlh3 is required for the stability of the MutL! heterodimer. In
contrast toMutL", however, ATP does not stimulate the endo-
nuclease of MutL!. We also show that RFC and PCNA also do
not promote the MutL! endonuclease. Thus, the endonu-
cleases of MutL" andMutL! differ dramatically with regard to
how their activity is regulated in a physiological context.
It is anticipated that the physiological substrate for the
MutL! endonuclease are double HJs. As MutL! and its part-
ners process these structures into specifically crossovers, the
key question is what determines the crossover-specific resolu-
tion. Double HJs may not be fully matured (i.e. ligated), and the
position of nicks may indicate the directionality of cleavage.
Furthermore, asymmetric protein binding (such as Msh4-
Msh5 or other ZMM family members, Exo1, Sgs1) may direct
MutL! cleavage. Finally, it is possible that the structure of the
double HJ itself, in particular when both HJs are in close prox-
imity, may activate MutL! in a structure-specific manner. The
availability of recombinant MutL! will prove instrumental
toward further understanding of this important and evolution-
arily conserved pathway.
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Oligonucleotide, Sequence,503',
1253, TGGGTCAACGTGGGCAAAGATGTCCTAGCAATGTAATCGTCTATGACGTT%
1254, TGCCGAATTCTACCAGTGCCAGTGATGGACATCTTTGCCCACGTTGACCC%
1255, GTCGGATCCTCTAGACAGCTCCATGATCACTGGCACTGGTAGAATTCGGC%
1256, CAACGTCATAGACGATTACATTGCTACATGGAGCTGTCTAGAGGATCCGA%
1253C, AACGTCATAGACGATTACATTGCTAGGACATCTTTGCCCACGTTGACCCA%
312, AACGTCATAGACGATTACATTGCTA%
314, CATGGAGCTGTCTAGAGGATCCGAC%
316, TGCCGAATTCTACCAGTGCCGGCAGCAAGTCGCTTTGCCCACGTTGACCC%
317, CAACGTCATAGACGATTACAGTTAGGTCGAAGGCTGTCTAGAGGATCCGA%
288, GGCTAGCTGCTAGCGGATCCATGATCAAGTGCTTGTCAGTTG%
289, CGCAAATCCTCGAGCCCGGGTGGTGGCTCACAGGGAGGCATG%
245, GGCTAGCT%GGGCCC%GCTAGC%GGATCC%ATGAGCCAGCATATTAGGAAATTAG%
246, CGCAAATC%CTCGAG%CCCGGG%CTTCAATTCTGCAATGGGTACC%
251, GGCTAGCT%GCTAGC%GGATCC%ATGTCTCTCAGAATAAAAGCAC%
252, CGCAAATC%CTCGAG%CCCGGG%TTAACACCTCTCAAAAACTTTGTATAG%
325, CTCTCAAA%GAAATGATGG%AGGCCTCCAT%CGATGCGAAT%GCTAC%
326, GTAGC%ATTCGCATCG%ATGGAGGCCT%CCATCATTTC%TTTGAGAG%
327, CGGTTAGA%GAAATAGTTC%AAGCCTCTGT%AGATGCACAC%GCTAC%
328, GTAGC%GTGTGCATCT%ACAGAGGCTT%GAACTATTTC%TCTAACCG%%
Table 1. Oligonucleotide sequences. Sequences of all deoxyribonucleotides used in this study are listed in a 5' to 3' 
orientation. 
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SUMMARY
The RecQ helicase RECQL4, mutated in Rothmund-
Thomson syndrome, regulates genome stability,
aging, and cancer. Here, we identify a crucial role
for RECQL4 in DNA end resection, which is the
initial and an essential step of homologous recom-
bination (HR)-dependent DNA double-strand break
repair (DSBR). Depletion of RECQL4 severely re-
duces HR-mediated repair and 50 end resection
in vivo. RECQL4 physically interacts with MRE11-
RAD50-NBS1 (MRN), which senses DSBs and initi-
ates DNA end resection with CtIP. The MRE11
exonuclease regulates the retention of RECQL4 at
laser-induced DSBs. RECQL4 also directly interacts
with CtIP via its N-terminal domain and promotes
CtIP recruitment to the MRN complex at DSBs.
Moreover, inactivation of RECQL4’s helicase activ-
ity impairs DNA end processing and HR-depen-
dent DSBR without affecting its interaction with
MRE11 and CtIP, suggesting an important role for
RECQL4’s unwinding activity in the process. Thus,
we report that RECQL4 is an important participant
in HR-dependent DSBR.
INTRODUCTION
DNA double-strand breaks (DSBs) are generated by exoge-
nous stress, endogenous replication, and programmed
recombination events. Improperly repaired DSBs can lead
to genome instability, chromosomal rearrangements, and/or
cell death (Symington, 2014). DSBs are usually repaired by
one of two major pathways: homologous recombination
(HR) and non-homologous end joining (NHEJ) (Aparicio
et al., 2014). HR-dependent DSBR is mostly error free, but
it requires a sister or non-sister chromatid as template and
is only active during the S and G2 phases of the cell cycle.
In contrast, NHEJ-dependent DSBR is error prone, DNA
template-independent, and active during all phases of the
cell cycle.
HR-dependent DSBR is initiated by 50 end resection of
the DSBs, which generates 30 protruding single-strand DNA
(ssDNA) tails (Chen et al., 2013; Zhu et al., 2008). RPA coats
the ssDNA, and then RAD51 replaces RPA to promote strand in-
vasion. This is followed by repair synthesis, dissolution, and
resolution of Holliday junctions and ligation of the ends (Prakash
et al., 2015). It is generally considered that DNA end resection
occurs in two steps (Cejka et al., 2010; Gravel et al., 2008; Mim-
itou and Symington, 2008; Nimonkar et al., 2011; Niu et al.,
2010; Zhu et al., 2008). The first step is the initial resection by
Mre11-Rad50-Xrs2 (MRX) and Sae2 at the DSB in yeast (Can-
navo and Cejka, 2014; Mimitou and Symington, 2008) or by
MRE11-RAD50-NBS1 (MRN) and CtIP (CtBP-interacting pro-
tein) in human cells (Sartori et al., 2007; You et al., 2009). This
is followed by extensive resection by either exonuclease1
(EXO1) or DNA2/BLM/TOP3/RMI1/2 (Dna2/Sgs1/Top3/Rmi1
in yeast) (Cejka et al., 2010; Gravel et al., 2008; Mimitou and Sy-
mington, 2008; Nimonkar et al., 2008, 2011; Niu et al., 2010; Zhu
et al., 2008).
RECQL4 is one of five RecQ helicase proteins in mamma-
lian cells. Defects in human RECQL4 are associated with
three genetic diseases: Rothmund-Thomson syndrome (RTS),
RAPADILINO, and Baller-Gerold syndrome (Siitonen et al.,
2009) as well as several cancers (Fang et al., 2013; Lu et al.,
2014b; Su et al., 2010). It is well established that RECQL4 is
required for the assembly of the DNA replication initiation ma-
chinery (Im et al., 2009; Sangrithi et al., 2005; Xu et al., 2009).
However, the role of RECQL4 in DNA repair is less clear (Croteau
et al., 2014). Lack of RECQL4 increases persistent DNA damage
and triggers cellular senescence in human andmouse primary fi-
broblasts (Lu et al., 2014a). RECQL4 is recruited to laser-induced
DSBs and RTS fibroblasts are sensitive to ionizing radiation (IR),
suggesting that RECQL4 plays a role in DSBR (Singh et al.,
2010). Recently, we showed that depletion of RECQL4 inhibits
NHEJ in U2OS cells (Shamanna et al., 2014). Nevertheless,
RECQL4 is highly expressed during S phase (Singh et al.,
2012; Xu et al., 2009), when HR-dependent DSBR dominates.
Thus, we explore the possibility that RECQL4 also plays a role
in HR-dependent DSBR. We find that RECQL4 promotes DNA
end resection and HR-dependent DSBR by stimulating the asso-
ciation of CtIP with MRN at DSBs and that the helicase activity of
RECQL4 is necessary for DNA end resection. Together, these
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findings suggest that RECQL4 plays an important role in the DNA
end resection step of HR-mediated DSBR in human cells.
RESULTS
RECQL4 Promotes DNA End Resection during
HR-Dependent DSBR
Endogenous RECQL4 co-localized with gH2AX at laser-induced
DSBs in U2OS cells (Figure 1A) and depletion of RECQL4 caused
U2OS and HeLa cells to be significantly more sensitive to IR (Fig-
ures 1B and S1A). Since DSB repair pathway choice is cell-cycle
regulated (Aparicio et al., 2014), we first examined the effect of
RECQL4 depletion on cell-cycle progression. Knockdown of
RECQL4 did not perturb cell-cycle progression significantly in
U2OS or HEK293T cells and did not alter expression of cell-cycle
marker proteins Cyclin A and Cyclin D1 (Figure S2), which is
consistent with a previous finding in HEK293 cells (Park et al.,
2006).
Figure 1. RECQL4 Is Required for HR-Mediated Repair and DNA End Resection
(A) Co-localization of endogenous RECQL4 and gH2AX at laser-induced DSB tracks. Scale bar represents 10 mm.
(B) Clonogenic survival of siRQ4-transfected U2OS cells treated with g radiation.
(C) Representative dot-plot images of DR-GFP U2OS cells showing in vivo HR.
(D) Quantification of HR repair.
(E) RPA foci in U2OS cells treated with control or RECQL4 siRNA 1 hr after 10 Gy IR. Scale bar represents 10 mm.
(F) IR-induced RPA32 phosphorylation on serine 4 and 8. U2OS cells expressing control or RECQL4 shRNA were exposed to 10 Gy of IR then allowed to recover
for the indicated time. UT, untreated.
(G) Quantification of ssDNA generated by 50 end resection at two AsiSI-induced DSBs in AID-DIvA U2OS cells.
All graphs show mean ± SEM from at least three biological repeats. p values (*p < 0.05; **p < 0.01) was determined by Student’s t test. See also Figures S1
and S2.
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The role of RECQL4 in HR-dependent DSBR was then inves-
tigated in DR-GFP U2OS cells, which can be scored for effi-
ciency of HR-mediated repair of an I-SceI endonuclease-
induced DSB by measuring the fraction of GFP-positive cells
(Pierce et al., 1999; Wang et al., 2014). DR-GFP U2OS cells
were transfected with one of three RECQL4-targeted small inter-
fering RNAs (siRNAs). The efficiency of RECQL4 knockdown
was about 90%, 60%, and 50% for siRQ4, siRQ4-2, and
siRQ4-3, respectively (Figure 1D). Given that siRQ4 produced
the greatest knockdown it was used in all subsequent experi-
ments. Depletion of RECQL4 by siRQ4 significantly reduced
the proportion of GFP-positive cells by 73%, from 5.5% in con-
trol cells to 1.47% in knockdown cells (Figures 1C and 1D), sug-
gesting that RECQL4 plays a crucial role in HR-dependent
DSBR. The other two siRNAs, siRQ4-2 and siRQ4-3, also signif-
icantly reduced the proportions of GFP-positive cells to 3.71%
and 4.0%, respectively (Figures 1C and 1D). These data show
that knockdown efficiency of RECQL4 correlates with a
decrease of HR-mediated DSBR.
RECQL4 is rapidly recruited to laser-induced DSBs where it is
retained for a short time (Singh et al., 2010). Thus, we speculated
that it plays a role in the early stages of HR repair. As mentioned
above, the first step of HR-mediated DSBR is 50-30 end resection
of the DSBs to generate 30 protruding ssDNA tails, which are
rapidly coated by RPA to form a nuclease-resistant protective
protein-DNA filament (Chen et al., 2013). We then examined
RPA foci formation in RECQL4-depleted cells. After exposure
to 10 Gy of IR, the fraction of cells with >20 RPA foci was
!33.6% in the siRQ4-treated U2OS cells, significantly less
than 75.8% in the control cells (Figure 1E). Depletion of RECQL4
also repressed RPA foci formation after IR in HeLa cells (Fig-
ure S1B). Consistent with these results, the abundance of
phosphorylated RPA32 on serine 4 and serine 8, a maker of
ssDNA-bound RPA (Shao et al., 1999), was increased in IR-
treated control U2OS and HEK293T cells, but not in RECQL4
knockdown cells (Figures 1F and S1C).
AID-DIvA U2OS cells have been used to directly quantify
ssDNA generated by 50 end resection at two AsiSI-induced
DSBs (Aymard et al., 2014). With addition of 4-hydroxytamox-
ifen (4-OHT), the AsiSI endonuclease fused to an estrogen re-
ceptor ligand binding domain translocates from the cytoplasm
to the nucleus to induce DSBs (Aymard et al., 2014). Genomic
DNA from these cells was prepared and analyzed for ssDNA at
two DSBs by TaqMan qPCR, as previously described (Aymard
et al., 2014; Zhou et al., 2014). Consistent with a previous
report (Zhou et al., 2014), we observed notably lower ssDNA
in cells treated with CtIP siRNA because CtIP stimulates
DNA end resection (Sartori et al., 2007). On the contrary,
depletion of 53BP1 increased the amount of ssDNA (Fig-
ure 1G), since 53BP1 inhibits resection (Bunting et al., 2010).
To investigate the role of RECQL4 in 50 end resection, ssDNA
content was measured in siRQ4-transfected AID-DIvA U2OS
cells. Interestingly, the amount of ssDNA generated at position
335 nt from DSB1 was 40.2% lower than that in siCtrl-treated
cells, and similar to the reduction caused by CtIP depletion. At
DSB2, depletion of RECQL4 reduced ssDNA content by
57.2%, 70.1%, and 75.2% at positions 364, 1,754, and
3,574 nt, respectively. Together, these results demonstrate
that RECQL4 is important for HR by promoting 50 end resec-
tion of DSBs.
Retention of RECQL4 at DSBs Depends on MRE11
To explore the function of RECQL4 in 50 end resection, we
used mass spectroscopy to analyze proteins captured by co-
immunoprecipitation (IP) with RECQL4-3xFLAG from irradiated
HEK293T cells in the presence of benzonase. MRN components
MRE11 and RAD50 and other DNA resection proteins BLM,
EXO1, and DNA2 were identified (Figure S3A; Table S1), and
their interactions with RECQL4 were independently confirmed
by IP with GFP-RECQL4 in the presence of benzonase (Fig-
ure S3B) or ethidium bromide (Figure S3C). We found that
RECQL4 co-localized with MRE11 at DSBs and that the
RECQL4-MRN interaction is stimulated by IR (Figures 2A and
2B). Purified recombinant RECQL4 also immunoprecipitated re-
combinant MRE11, RAD50, and NBS1 (Figure 2C), indicating
complex formation between RECQL4 and MRN. To map the
interaction region of RECQL4 with MRE11, purified RECQL4-
3xFLAG and truncation fragments were incubated with purified
YFP-MRE11 bound to GFP agarose beads. YFP-MRE11 pulled
down full-length and the N-terminal domain of RECQL4 (Fig-
ure 2D), indicating that the N-terminal fragment of RECQL4 is
responsible for the interaction with MRE11. To determine
whether the interaction between RECQL4 andMRN is functional,
we measured the nuclease activity of MRN on closed-circular
single-strand PhiX174 DNA in the presence of RECQL4 in vitro
as previously reported (Sartori et al., 2007). Wild-type MRN
and nuclease-dead MRN-ND (H129L/D130V) (Stracker et al.,
2002) as well as RECQL4 and its helicase-dead mutant
RQ4KM were used (Figure S4A). We found that RECQL4 slightly
stimulated the nuclease activity of MRN on closed-circular sin-
gle-strand PhiX174 DNA (Figure 2E).
Both RECQL4 and MRE11 are rapidly recruited to DSB
(Haince et al., 2008; Singh et al., 2010), and thus we evaluated
whether RECQL4 and MRE11 affected each other’s recruitment
to DNA damage. GFP-RECQL4 was recruited significantly less
to laser-induced DSBs in siMRE11-treated U2OS cells than in
control cells (Figure 2F), and there is less chromatin-bound
RECQL4 in siMRE11-treated U2OS cells than in control cells
after IR (Figure S4B). However, depletion of RECQL4 did not
affect the recruitment of YFP-MRE11 to laser-induced DSB
(Figure S4C), suggesting that recruitment of RECQL4 to DSBs
requires MRE11, but not vice versa.
Given that MRE11 nuclease regulates the pathway choice be-
tween NHEJ and HR (Shibata et al., 2014), the dynamics of GFP-
RECQL4 recruitment was also evaluated in cells exposed to
mirin, which specifically inhibits the MRE11 exonuclease but
does not inhibit MRN complex formation (Dupre´ et al., 2008).
RECQL4 was still rapidly recruited to laser-induced DSBs in
mirin-treated cells (Figure 2G), indicating that the recruitment
of RECQL4 does not depend on the exonuclease activity of
MRE11. However, GFP-RECQL4 was retained at DSBs for a
significantly shorter time after mirin treatment (Figure 2G). This
suggests that retention of RECQL4 at DSBs is regulated by
MRE11 nuclease activity.
When ssDNA was measured at AsiSI-induced DSB in AID-
DIvA U2OS cells pre-treated with mirin, siRQ4 or siMRE11, a
Cell Reports 16, 161–173, June 28, 2016 163
	 127	
(legend on next page)
164 Cell Reports 16, 161–173, June 28, 2016
	 128	
lower amount of ssDNA was detected (Figure 2H). However, the
effect was not additive (Figure 2H). Using the DR-GFP reporter
system, it was observed that pre-treatment with siRQ4 or
siMRE11 significantly reduced HR-mediated DSBR, but the ef-
fect was also not additive (Figure 2I). These results suggest
that RECQL4 functions downstream of MRN to promote DNA
50 end resection and HR-dependent DSBR.
RECQL4 Promotes Recruitment of CtIP to DSBs
CtIP is required for initiation of MRN-catalyzed 50 end resection
at DSBs (Chen et al., 2008; Sartori et al., 2007; Yuan and
Chen, 2009). Here, we found that RECQL4 co-localized with
CtIP at laser-induced DSBs (Figure 3A) and interacted with
CtIP in irradiated HEK293T cells (Figures 3B, S3B, and S3C).
The interaction between CtIP and RECQL4 appeared to be
stronger in IR-treated cells (Figure 3B). CoIP of recombinant
RECQL4 and CtIP suggests that RECQL4 interacts directly
with CtIP (Figure 3C), and the N terminus of RECQL4 was map-
ped as the interacting region with CtIP (Figure 3D).
Recruitment of RECQL4 reaches its peak about 1 min after
laser damage (Figure 2G), while CtIP needs much longer
(Wang et al., 2013). Considering the direct interaction between
RECQL4 and CtIP, it is possible that RECQL4 promotes CtIP
recruitment to DSBs. To test this hypothesis, we first measured
the abundance of chromatin-bound CtIP in control and RECQL4
knockdown U2OS cells after IR and found that IR increased
chromatin-bound CtIP in the control cells but not in RECQL4-
depleted cells (Figure 3E). Interestingly, more mobility shift of
chromatin-bound CtIP was detected in control cells that in
RECQL4-depleted cells after IR (Figure 3E), indicating that
RECQL4 promotes IR-induced posttranslational modification
of CtIP. Also, IR-treated control U2OS cells had an average of
22.6 GFP-CtIP foci per cell, significantly higher than that in
siRQ4-treated cells (Figure 3F). Furthermore, in the RECQL4
knockdown U2OS cells, recruitment of GFP-CtIP was signifi-
cantly slower and less efficient than that in control cells (Fig-
ure 3G). Together these data suggest that RECQL4 promotes
stable CtIP recruitment to DSBs.
Given that RECQL4 promotes recruitment of CtIP to DSBs, we
asked whether RECQL4 is required for MRN-CtIP complex for-
mation after IR. Pull-down assays were conducted in control
and RECQL4 knockdown HEK293T cells expressing YFP-
MRE11 or GFP-CtIP. Expression levels of MRE11, RAD50,
NBS1, and CtIP proteins were similar in control and RECQL4
knockdown cells (input of Figure 3H). Cell-cycle status was not
significantly different between RECQL4-depleted and control
HEK293T cells (Figures S2D and S2E). IP of YFP-MRE11 effi-
ciently pulled down similar amounts of RAD50 and NBS1 from
control and RECQL4 knockdown cells. In contrast, the interac-
tion between MRE11 and CtIP was inhibited by knockdown of
RECQL4 (Figure 3H). In the reverse experiments with GFP-
CtIP-expressing cells, GFP-CtIP efficiently co-immunoprecipi-
tated MRE11, RAD50, and NBS1 from control cells but much
less from RECQL4 knockdown cells (Figure 3H). These data
are consistent with the idea that RECQL4 promotes the interac-
tion between MRN and CtIP in human cells.
Depletion of RECQL4 or CtIP significantly reduced ssDNA
generation at DSB1 in AID-DIvA cells (Figure 3I). However, there
were no differences among RECQL4 or CtIP-depleted cells and
RECQL4/CtIP double-knockdown cells. A similar result was ob-
tained from the experiments measuring the HR efficiency (Fig-
ure 3J). These results imply that RECQL4 and CtIP both play a
role in HR-dependent DSBR and that RECQL4 promotes recruit-
ment of CtIP to DSBs.
BLM and EXO1 Act Downstream of RECQL4 during HR-
Mediated DSBR
50 resection, initiated by the MRN-CtIP complex, is extended by
BLM/DNA2 and EXO1 via two alternative pathways (Cejka, 2015;
Symington, 2014). Recruitment of both BLM and EXO1 to DSBs
requires CtIP (Wang et al., 2013). Since RECQL4 promotes CtIP
recruitment to DSBs, we tested whether removal of RECQL4
could result in failure of the two extensive resection pathways.
We found that BLM, DNA2, and EXO1 interact with RECQL4 in
irradiated HEK293T cells (Figure S3). In addition, the retention
of GFP-BLM at DSBs was reduced in U2OS cells after RECQL4
knockdown (Figure 4A), suggesting that RECQL4 stimulates
retention of BLM at IR-induced DSBs. In addition, knockdown
of BLM, RECQL4, or both inhibited 50 resection to a similar extent
at DSB1 in AID-DIvA U2OS cells (Figure 4B). In the HR assay,
knockdown of BLM, RECQL4, or both significantly reduced HR
by 40%, 60%, or 60%, respectively (Figure 4C). These findings
Figure 2. MRE11 Mediates Recruitment of RECQL4 to DSBs to Promote HR Repair
(A) Co-localization of endogenous RECQL4 and MRE11 at laser-induced DSB tracks in U2OS cells. Scale bar represents 10 mm.
(B) RECQL4 interacts with MRN complex in vivo. FLAG-IP was carried out using extracts prepared from vector and RQ4-3xFLAG expressing HEK293T cells
treated with a 10-Gy IR and recovered for 10 min.
(C) CoIP of recombinant MRE11, RAD50, and NBS1 with RECQL4.
(D) N-terminal domain of RECQL4 interacts with MRE11.
(E) Nuclease of MRN is stimulated by RECQL4 on closed circular single-strand PhiX174 DNA. MRN (20 nM) or the nuclease-dead mutant, MRN-ND, was
incubated with 20 nM RECQL4, boiled RECQL4, or BSA. Buffer, nuclease reaction buffer.
(F) MRE11 promotes RECQL4 recruitment to DSBs in U2OS cells. The recruitment of GFP-RECQL4 to DSB tracks, generated with a 435-nm laser, wasmonitored
in the control and MRE11-depleted U2OS cells, and the fluorescence intensity was quantified. n = 27. Scale bar represents 10 mm.
(G) Retention of RECQL4 at DSBs depends on the exonuclease activity of MRE11. U2OS cells were treated with 100 mM mirin. Graphic quantification below
images, n = 21. Scale bar represents 10 mm.
(H) RECQL4 andMRE11 regulate resection at DSBs. Bar graph showing percent of ssDNA content generated at DSB1 in siRNA- or mirin-treated cells. Error bars
represent SEM from four biological repeats.
(I) HR repair assay and western blots from RECQL4 and MRE11 knockdown DR-GFP cells.
All data are presented as mean ± SEM from at least three independent experiments with p value calculated with Student’s t test. *p < 0.05. See also Figures S3
and S4 and Table S1.
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Figure 3. RECQL4 Promotes CtIP Recruitment to DSBs for DNA End Resection and HR Repair
(A) Co-localization of endogenous RECQL4 and CtIP at laser-induced DSB tracks. Scale bar represents 5 mm
(B) CoIP of CtIP with RECQL4 in response to IR.
(C) In vitro coIP analysis of recombinant RECQL4 and CtIP.
(D) The N terminus of RECQL4 interacts with CtIP.
(E) Subcellular distribution of CtIP in control and RECQL4-depleted U2OS cells 10 min after IR.
(F) GFP-CtIP foci in the control and RECQL4-depeted U2OS cells 30 min after IR. Scale bar represents 10 mm.
(G) Recruitment of GFP-CtIP to DSB tracks in control and RECQL4-depeted U2OS cells. n = 29. Scale bar represents 10 mm.
(H) RECQL4 supports the interaction betweenMRN and CtIP. Western analysis of indicated proteins pulled down with YFP-MRE11 or GFP-CtIP from control and
RECQL4 knockdown HEK293T cells 10 min after IR.
(I) Quantification of ssDNA generated at DSB1 in AID-DIvA U2OS cells after knockdown of RECQL4 and CtIP.
(J) HR repair assay after knockdown of RECQL4 and CtIP in DR-GFP U2OS cells.
Error bars for (I) and (J) represent SEM from three independent experiments. The IR dose is 10 Gy. See also Figures S2 and S3 and Table S1.
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suggest that RECQL4 promotes retention of BLM at DSBs to
stimulate HR.
We also evaluated the impact of RECQL4 loss on EXO1-medi-
ated resection. RECQL4 co-localized with EXO1 at laser-in-
duced DSBs in U2OS cells (Figure S3E) and co-immunoprecipi-
tated endogenous EXO1 in irradiated U2OS cells but not in
untreated cells (Figure S3F). GFP-EXO1 was rapidly recruited
to DSBs in U2OS cells, but significantly more slowly in siRQ4-
treated U2OS cells (Figure 4D), indicating that RECQL4 also pro-
motes EXO1 function at DSBs. Knockdown of EXO1 reduced the
amount of 50-end-resected DSBs in AID-DIvA U2OS cells (Fig-
ure 4E), which is consistent with previous findings (Zhou et al.,
2014). However, EXO1 and RECQL4 double knockdown was
not additive in resection of DSBs (Figure 4E). EXO1 knockdown
reduced HR by about 31.4% but did not significantly exacerbate
the reduction of HR in combination with RECQL4 depletion (Fig-
ure 4F). These data support a model in which RECQL4 acts up-
stream of DNA2/BLM and EXO1 in HR-dependent DSBR.
Figure 4. RECQL4 Promotes Recruitment of BLM and EXO1 to Laser-Induced DSBs
(A) Recruitment of GFP-BLM in control and RECQL4-depeted U2OS cells. n = 22. Scale bar represents 10 mm.
(B) Quantification of ssDNA content generated at DSB1 in AID-DIvA U2OS cells depleted for RECQL4 and BLM.
(C) Quantification of GFP-positive cells from the HR repair in control, RECQL4, and BLM knockdown cells.
(D) Recruitment of GFP-EXO1 in control and RECQL4 knockdown U2OS cells. n = 27. Scale bar represents 10 mm.
(E) Quantification of the ssDNA generated from resection at DSB1 in cells with knockdown for RECQL4 and EXO1.
(F) HR assay from EXO1 and RECQL4 knockdown DR-GFP cells. Data are presented as mean ± SEM from three biological repeats. See also Figure S3 and
Table S1.
Cell Reports 16, 161–173, June 28, 2016 167
	 131	
RECQL4 Helicase Activity Is Required for DNA End
Resection during HR-Mediated Repair
The RecQ proteins share a conserved RecQ helicase domain
and possess 30-50 DNA unwinding activity (Croteau et al.,
2014). The helicase activity of human RECQL4 is weak
compared to the others in vitro (Rossi et al., 2010; Xu and Liu,
2009). However, mutations in the helicase domain have been
identified in many reported RECQL4-asscociated syndrome
patients (Siitonen et al., 2009), indicating the importance of the
helicase domain in vivo. To explore whether RECQL4 helicase
activity is involved in DNA end resection and HR repair, we trans-
fected siRQ4-resistant plasmids to ectopically express 3xFLAG-
tagged wild-type (WT) RECQL4 or the helicase-dead mutant
RECQL4-KM in siRQ4-treated AID-DIvA U2OS or DR-GFP
U2OS cells. Western blots showed that endogenous RECQL4
was depleted by siRQ4 and that 3xFLAG-tagged RECQL4 and
RECQL4-KM were expressed in AID-DIvA U2OS cells (Fig-
ure 5A). Depletion of RECQL4 resulted in a reduction of ssDNA
generated by DNA resection at the DSB1 site, and overexpres-
sion of RECQL4-3xFLAG completely restored the loss of 50
end resection in siRQ4-transfected cells, whereas overexpres-
sion of RECQL4-KM-3xFLAG did not (Figure 5A). These results
indicate that the RECQL4 helicase activity is required for DNA
end resection.
In the HR repair assay, DSBs were generated by transfection
of I-SceI-expressing plasmid into DR-GFP U2OS cells (Pierce
et al., 1999). To reduce competition with I-SceI-expressing
plasmid, the amount of pCMVtag4A-RQ4-siR, pCMVtag4A-
RQ4KM-siR or vector was reduced to 0.5 mg for 2 3 106 cells,
which resulted in a low expression level of 3xFLAG-tagged
RECQL4 and the mutant. However, this level of RECQL4-
3xFLAG still significantly increased the percentage of GFP-pos-
itive cells, depleted for endogenous RECQL4 (Figure 5B). This is
consistent with our observation that RECQL4 levels correlate
with HR repair (Figures 1C and 1D). The RECQL4-KM-3xFLAG
expression was higher than that of WT RECQL4 but did not
significantly rescue the loss of HR repair after RECQL4 deple-
tion. These data suggest that the RECQL4’s helicase activity is
important for DNA end resection and HR-dependent DSBR.
Given that RECQL4 promotes complex formation between
CtIP and MRN by interacting with these proteins, we then
measured whether inactivation of the helicase impairs
RECQL4’s ability to interact with CtIP and MRE11. RECQL4-
KM-3xFLAG was pulled down with YFP-MRE11 to the same
extent as RECQL4-3xFLAG (Figure 5C). Similarly, helicase-
dead RECQL4 also interacted with CtIP as well as WT RECQL4
did (Figure 5D). These findings suggests that inactivation of the
helicase domain of RECQL4 does not affect the interaction be-
tween RECQL4 and MRE11 or CtIP. Additionally, we found
that both helicase-dead and WT RECQL4 proteins were able
to stimulate the nuclease activity of MRN on closed circle sin-
gle-strand PhiX174 DNA (Figure 5E). Taken together, the DNA
unwinding activity of RECQL4 is required to promote DNA end
resection and HR repair.
RPA-Mediated Displacement of RECQL4 from ssDNA
Unlike BLM and WRN, RECQL4 remains at DSB sites for only a
short time (Singh et al., 2010), suggesting that it falls off or is dis-
placed. After DNA end resection, RPA coats the ssDNA tails for
protection, which supported by the observation that RPA recruit-
ment to DSBs increases continuously in 1 hr (Figure S5A), as pre-
viously reported (Costelloe et al., 2012). Thus, we used an in vitro
RECQL4 displacement assay to determine whether RPA could
remove RECQL4 from ssDNA. Biotin-labeled ssDNA, dsDNA,
or 30 tailed dsDNA substrates were first incubated with RECQL4
and then with either RPA or BSA. RPA-mediated RECQL4
displacement was detected by visualization of RECQL4 in the
supernatant (Figure 5F). Consistent with previous findings (Jen-
sen et al., 2012; Keller et al., 2014), RECQL4 binds to ssDNA,
dsDNA, and 30 tailed dsDNA substrates (Figure 5F). RPA prefers
to bind DNA substrates with longer ssDNA (Figures S5C and
S5D). When RPA was added to the RECQL4 coated 80-nt-long
ssDNA G80, RECQL4 was displaced as RPA bound to this sub-
strate (Figure 5F). A similar phenomenon was observed using
GC40 and GC60 DNA substrates, which contain 40 or 20 nucle-
otide 30 tails, respectively (Figure 5F). However, very little
RECQL4 was replaced by RPA from the blunt-ended dsDNA
GC80 or from the 6-nt-tailed dsDNA G80/C74 (Figure 5F).
BSA, our negative control, did not displace RECQL4 from the
tested DNA substrates (Figure 5F). Together, these data imply
that RPA can displace RECQL4 from ssDNA or 30 tailed dsDNA
in vitro but not duplex DNA.
DISCUSSION
DNA end resection generates 30 tailed ssDNA, which is critical for
launching HR repair. The MRN complex initiates 50 end resection
with CtIP, and then extensive resection is carried out by the nu-
cleases EXO1 or DNA2 in two alternative pathways (Cejka, 2015;
Symington, 2014). In the present work, we establish that
RECQL4 is required for robust DNA end resection by regulating
the interaction between MRN and CtIP and further that the heli-
case activity of RECQL4 is required for the process. We show
that depletion of RECQL4 results in loss of HR repair as a result
of diminished 50 resection. IR enhances the physical interaction
of RECQL4 with MRN and CtIP. The nuclease activity of
MRE11 regulates the retention of RECQL4 at DSBs, and
RECQL4 promotes recruitment of CtIP, as well as downstream
players like BLM, DNA2, and EXO1, which participate in the
extensive resection step of HR. Thus, this work ascribes a hith-
erto unrecognized role for RECQL4 as an important regulator
of DNA end resection in HR repair.
The data presented here indicate that rapid recruitment of
RECQL4 to laser-induced DSBs depends on prior recruitment
of MRN while RECQL4 is not required for recruitment of MRN
to IR-induced DSBs. Additionally, RECQL4 interacts physically
with the MRN complex in living cells and under cell-free condi-
tions in vitro (Figures 2A–2D). RECQL4 and MRN function in
the same pathway during 50 end resection in HR repair (Figures
2H and 2I). These findings suggest that RECQL4 functions
downstream of MRN in HR DSBR. Combining these findings
with the previous reports that both MRE11 and RECQL4 imme-
diately gather at laser-induced DSB (Haince et al., 2008; Singh
et al., 2010), it is likely that MRN and RECQL4 act sequentially
and cooperatively at DSBs to promote 50 end resection at DNA
DSBs.
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Retention of RECQL4 at DSBs is dramatically reduced in the
presence of mirin (Figure 2G). Mirin inhibits MRE11 exonuclease
and also represses MRN-dependent ATM activation (Dupre´
et al., 2008). After recruitment byMRN, RECQL4 is likely retained
at DSBs by the resected DNA, which depends on the exonu-
clease activity of MRE11. Meanwhile, RECQL4 stimulates the
nuclease activity of MRN in vitro and promotes MRN-CtIP com-
plex formation after IR, which is required for initiation of DNA
resection (Sartori et al., 2007; You et al., 2009). Therefore, it is
possible that RECQL4 promotes MRE11-mediated resection at
a limited level, which further stimulates retention of RECQL4 at
DSBs. Meanwhile, initially resected DNA also leads to limited
Figure 5. Helicase Activity of RECQL4 Is Required for RECQL4 to Function in DNA Resection and HR Repair
(A) Quantification of the ssDNA generated from resection at DSB1 after endogenous RECQL4 depletion of AID-DIvA U2OS cells but complementation with
RECQL4-WT-3xFLAG or RECQL4-KM-3xFLAG. Data presented are mean ± SEM from three biological repeats.
(B) HR repair assay after endogenous RECLQ4 depletion in DR-GFP U2OS cells expressing wild-type or helicase dead mutant RECQL4. Error bars represent
SEM from four independent experiments. N.S., no significance.
(C and D) Pull-down assay using YFP-MRE11 (C) or GFP-CtIP (D) with RQ4Wt-3xFLAG and RQ4KM-3xFLAG in vitro.
(E) Both WT and helicase-dead mutant RECQL4 significantly stimulate nuclease of MRN on closed circular single-strand PhiX174 DNA. The concentration of
MRN, RECQL4 and RQ4KM were 20 nM. Error bars represent SEM from three repeats with p value by Student’s t test.
(F) RPA displaces RECQL4 from ssDNA. Various substrates as shown were pre-incubated with RECQL4 then RPA or BSA were added to compete off RECQL4.
Detection of displaced RECQL4 and DNA-bound RPA were visualized by western blotting.
(G) Model showing RECQL4’s role in DNA end resection of HR-mediated repair. MRN complex recognizes and binds to DSBs and recruits RECQL4 to the sites of
damage. In turn, RECQL4 promotes the stable recruitment of CtIP to DSBs and performs unwinding at the DNA ends thereby promoting resection.
See also Figure S5.
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ATR activation and ATR-dependent phosphorylation of CtIP,
and in turn promotes stable chromatin association of CtIP for
robust resection (Peterson et al., 2013). With 50 resection
ongoing, RPA binds to long ssDNA and disassociates RECQL4.
Therefore, MRN, RECQL4, CtIP, and checkpoint kinases can
function in a feedback loop during DNA end processing at DSBs.
Recruitment of CtIP to DSBs depends on MRN and ATM (You
et al., 2009). MRN is recruited earlier than CtIP to DSBs; there-
fore, MRN may not directly recruit CtIP (You et al., 2009). This
study reports that RECQL4 physically interacts with CtIP and
promotes stable recruitment of CtIP to DSBs. However, the ki-
netics of the accumulation of CtIP differs from that of RECQL4.
CtIP reaches its peak of abundance at laser-induced DSBs
around 15min aftermicroirradiation (Figure 3G), as previously re-
ported (Wang et al., 2013; You et al., 2009). However, RECQL4
only needs about 1 min to reach its recruitment peak (Figure 2G).
Therefore, it is possible that RECQL4 recruits CtIP directly to
initiate DNA resection, which further promotes more recruitment
of CtIP due to checkpoint activation. RECQL4 also facilitates for-
mation of an MRN-CtIP complex in vivo after IR (Figure 3H). In
summary, the data are consistent with the model that RECQL4
promotes CtIP recruitment to DSBs and thereby directly pro-
motes end processing and HR-dependent DSBR.
BLM/DNA2 and EXO1 are required for extensive 50-end-resec-
tion step during HR-dependent DSBR (Symington, 2014). In
contrast to RECQL4, BLM appears to play a somewhat more
complex role during HR in human cells, possibly at two steps,
once during end processing and a second time during dissolu-
tion of Holliday junctions together with TopoIIIa/RMI1/2 (Croteau
et al., 2014). Here, we show that RECQL4 plays a role in recruit-
ing and retaining BLM and EXO1 at DSBs and that RECQL4 acts
in the same pathway as BLM and EXO1 (Figure 4). Since MRE11
and CtIP are required to recruit/retain BLM/EXO1 at DSBs (Eid
et al., 2010; Truong et al., 2013; Wang et al., 2013), this lack of
retention of BLM/EXO1 on DSBs in RECQL4-depleted cells is
probably a consequence of the inhibition of CtIP recruitment
caused by loss of RECQL4. Another possibility is that RECQL4
directly recruits BLM and EXO1 in order to switch from initial
resection to extensive resection.
RECQL4 is unlikely to be directly involved in the extensive
resection step with DNA2/BLM or EXO1, although it interacts
with the all of them. Short retention of RECQL4 at DSBs reduces
the possibility that RECQL4 works together with DNA2/BLM or
EXO1 in extensive resection. Second, BLM, but not RECQL4,
specifically stimulates the nuclease activities of both DNA2
and EXO1 in vitro (Nimonkar et al., 2008, 2011). Moreover,
RPA displaces RECQL4 from ssDNA (Figure 5F). However, it is
possible that RECQL4 after interacting with MRN and CtIP re-
mains bound to the ssDNA long enough to interact with DNA2/
BLM and EXO1 and promotes their recruitment and chromatin
association, which may activate the switch from initial resection
to extensive resection.
Here, we found that depletion of either BLM or EXO1 reduces
DNA resection and HR (Figure 4). In yeast, absence of Exo1
reduced resection 1–5 kb from the DSB (Llorente and Syming-
ton, 2004; Mimitou and Symington, 2008). Dysfunction of sgs1
also markedly reduced the DNA resection rate and efficiency
(Zhu et al., 2008). However, co-depletion of sgs1 and exo1
caused more dramatic loss of DNA resection (Mimitou and Sy-
mington, 2008; Zhu et al., 2008). In human cells, depletion of
EXO1, DNA2, or BLM reduced 50 DNA resection in U2OS cells
(Grabarz et al., 2013; Gravel et al., 2008; Myler et al., 2016; Tomi-
matsu et al., 2012; Zhou et al., 2014). DNA2/BLM (Dna2/sgs1)
and EXO1 can compensate for each other in extensive resection
(Symington, 2014). However, dysfunction of either pathway
could affect efficiency of DNA resection in vivo.
The helicase-dead mutant RECQL4-KM did not rescue the
loss of either DNA end resection or HR repair (Figure 5), demon-
strating that the helicase activity of RECQL4 is required for DNA
end resection and HR repair. RECQL4-KMwas generated by re-
placing lysine 508 in the Walker A motif of the SFII helicase
domain with methionine, and the mutation eliminates 30-50 DNA
unwinding activity and ATPase of RECQL4 but not its annealing
activity (Rossi et al., 2010). The expression of RECQL4-KM only
partially restored the ability of RECQL4 to prevent cellular senes-
cence in primary human fibroblasts with depletion of the endog-
enous RECQL4, indicating the importance of helicase activity
in vivo (Lu et al., 2014a). However, the helicase activity is neither
involved in the physical interaction between RECQL4 and MRN
and CtIP, nor in the stimulation of the nuclease activity of
MRN. In vivo DSBs are complex due to chromatin organization
and DSB binding proteins competing at the site. RECQL4 has
several activities. The failure of RECQL4-KM to rescue the resec-
tion and HR in endogenous RECQL4-depleted cells may reflect
that it acts as a dominant-negative. RECQL4 can unwind dsDNA,
dsDNA with 30 overhang (not 50 overhang), bubble-structured
dsDNA, Y-structured duplex, and D-loop (Ghosh et al., 2012;
Rossi et al., 2010; Xu and Liu, 2009). Thus, these activities might
also help resolve secondary structures near the DNA ends to
facilitate the initiation or extensive steps of DNA end resection.
A model for 50 DNA resection is presented in Figure 5G, which
highlights the role of RECQL4 in initiating 50 end resection at a
nascent DSB. DSB arise due to endo- or exogenous insults,
which are first sensed by theMRNcomplex. RECQL4 is recruited
by MRN, and RECQL4 possibly promotes a limited resection
with MRN, which also promotes retention of RECQL4 at DSB.
The MRN-RECQL4 complex then promotes recruitment of CtIP
to DSBs. After CtIP enters the complex, the nuclease activity
of MRN is greatly stimulated (Sartori et al., 2007). The resultant
short ssDNA strands then may also promote greater retention
of RECQL4 and CtIP. This feedback loop would then facilitate
recruitment of proteins involved in the extensive end resection
step like BLM/DNA2 and EXO1.We are proposing that an activity
of RECQL4 may remove DNA secondary structure barriers near
the ends of the DNA to promote MRN-mediated DNA resection.
After some length of resection, RPA binds the ssDNA and pro-
motes displacement of RECQL4 allowing it to be recycled for
use at other dsDNA break sites.
EXPERIMENTAL PROCEDURES
Cell Culture, Knockdown, DNA Transfection, g Radiation, and
Survival Assay
U2OS, HEK293T, and HeLa cell lines were cultured in DMEM medium with
10% fetal bovine serum (Sigma-Aldrich), 1 3 penicillin/streptomycin (Gibco).
All cells were cultured in an atmosphere of 5% CO2 at 37!C. Lentivirus-medi-
ated small hairpin RNA (shRNA) knockdown and siRNA knockdown were
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performed as reported (Lu et al., 2014a). The sequences of siRNA and shRNA
are listed in Table S2. Polyplus JetPrime was used for DNA transfection. g rays
were generated using a cesium-137 source (Gammacell Exactor 40, Best
Theratronics). Radiation dose is 10 Gy, and post-irradiation recovery time is
indicated in the figure legends. For the colony formation assay, cells were irra-
diated and then stained with 2% methylene blue in 5% ethanol 10 days after
IR. The colonies with over 50 cells were counted. The results are presented
asmean ±SEM from three independent experiments with p value by Student’s
t test.
Laser-Induced DNA Damage and Real-Time Recruitment of
Fluorescence Proteins
Laser-induced DSB and the recruitment of GFP-RECQL4, GFP-CtIP, GFP-
BLM, GFP-EXO1, and GFP-RPA were performed as described (Singh et al.,
2010). For mirin treatment, U2OS cells expressing GFP-RECQL4 were pre-
incubated with 100 mM mirin for 4 hr before laser microirradiation. The results
are presented as mean ± SEM with p value by Student’s t test.
HR Assay
RECQL4 and other target proteins were knocked down by siRNA in the DR-
GFP U2OS cells (a gift from Prof. Xiaofan Wang), and, 72 hr after siRNA trans-
fection, the HR assay was performed as reported (Pierce et al., 1999; Wang
et al., 2014). The siRQ4-resistant plasmids, pCMVTag4A-RQ4-siR and
pCMVTag4A-RQ4KM-siR, expressing 3xFLAG-tagged wild-type RECQL4
and helicase-dead mutant RECQL4KM, respectively, were generated
by PCR with primers RQ4-siR-PF and RQ4-siR-PR (Table S2). 0.5 mg
vector, pCMVTag4A-RQ4-siR, or pCMVTag4A-RQ4KM-siR were transfected
into 5 3 105 siRQ4-treated DR-GFP U2OS cells. 24 hr later, cells were then
processed for HR assay. The results are presented as mean ± SEM from three
independent experiments with p value by Student’s t test.
50 Resection Assay
In vivo 50 end resection was measured in AID-DIvA U2OS cells (a gift from
Dr. Gae¨lle Legube), as previously described (Zhou et al., 2014). For the rescue
assay, 5 mg pCMVTag4A-RQ4-siR, pCMVTag4A-RQ4KM-siR, or control
vector was transfected into 2 3 106 RECQL4 siRQ4-treated cells. 45 hr later,
cells were treated with 4-OHT and then processed for the resection assay. At
least three biological repeats were performed, and data are presented as the
mean ± SEM.
Subcellular Fractionation, Western Blotting, and
Immunofluorescence Microscopy
Subcellular fractions were isolated using a subcellular protein fractionation kit
(Thermo Fisher Scientific) according to the manufacturer’s instructions, and
the resultant fractions were analyzed with western blotting. Western blot and
immunofluorescence microscopy were performed as previously described
(Lu et al., 2014a). Antibodies used in this study are listed in the Supplemental
Experimental Procedures.
Protein Purification
The MRE11-RAD50-NBS1 complex was purified from insect cells as previ-
ously described (Cheng et al., 2004). Purification of recombinant RECQL4
and helicase-dead mutant RECQL4-KM were performed as described (Rossi
et al., 2010). RPA purification was performed as described (Henricksen et al.,
1994). The details of CtIP purification and 3xFLAG-tagged RECQL4 and its
truncation fragments are provided in the Supplemental Experimental
Procedures.
IP, Pull-Down Assay, Silver Staining, and Protein Identification
Control and g-irradiated cells were incubated for 10min and then sonicated on
ice in IP Lysis Buffer 2 containing 40mMTris-HCl (pH 7.4), 150mMNaCl, 2mM
MgCl2, 0.2% NP-40, 0.4% Triton 100, 1 3 protease inhibitor cocktail (Thermo
Fisher Scientific), 13 phosphatase inhibitor cocktail 2 and 3 (Sigma-Aldrich),
and 20 U/ml benzonase (Novagen). 50 mg/ml ethidium bromide was added
in lysate where it was indicated. For coIP with RECQL4 antibody, 2 mg protein
was incubated with 2 mg of RECQL4 antibody (Lu et al., 2014a) or normal rabbit
immunoglobulin G (IgG) (Thermo Fisher Scientific). For FLAG IP, the cell lysate
was incubated with M2 FLAG-magnetic beads (Sigma-Aldrich). For GFP IP,
GFP-TRAP beads (ChromoTek) were used to capture GFP-RECQL4 or YFP-
MRE11. The beads were washed with cold washing buffer 4 (20 mM Tris-
HCl [pH 7.4], 150 mM NaCl, 0.2% Triton X-100) five times and then subjected
to western blotting, silver staining, or mass spectrometry analysis by Harvard
Taplin Mass Spectrometry Facility. The details of mass spectrometry are listed
in Table S1.
For in vitro IP, purified RECQL4 was incubated with recombinant MRN com-
plex or CtIP in Binding Buffer 1 (20 mM Tris-HCl [pH 7.4], 100 mM NaCl, 0.2%
Triton X-100) for 2 hr at 4!C and then incubated with anti-RECQL4 antibody or
normal rabbit IgG. After washing with Binding Buffer, the proteins remained on
the beads were analyzed by western blotting.
Nuclease Assay
Nuclease assays were carried out with 20 nM MRN or nuclease-dead MRN-
ND in the presence of 20 nM wild-type RECQL4 or helicase-dead RECQL4
RQ4KMon 50 ng closed circular single-stranded PhiX174 DNA in the resection
buffer containing 20 mM MOPS (pH 7.2), 1 mM DTT, 5 mM MgCl2, 5 mM
MnCl2, 1 mM ATP, as previously described (Sartori et al., 2007). After 3 hr in-
cubation at 37!C, DNAwas separated in 0.8%agarose gel, further stainedwith
SYBR Gold, visualized with Chemidoc XRS+ system (Bio-Rad) and quantified
with Bio-Rad Image Lab (v.3.0). Data were presented as mean ± SEM from
three repeats.
Displacement Assay
A biotin-labeled oligonucleotide (G80) was annealed with C80, C74, C60, and
C40 and resulted in dsDNA GC80 and 30 tailed dsDNA GC74, GC60, and
GC40, respectively (see the sequences in Table S2). RECQL4 (200 nM) was
incubated with 20 nM DNA substrates bound to M280-streptavidin beads
(Life Technologies) in the binding buffer (20 mM HEPES [pH 7.4], 100 mM
NaCl, 1 mM MgCl2, 0.1% Triton X-100, and 200 ng/ml BSA) at room temper-
ature (RT) for 15 min. After washing with the binding buffer, the beads were
incubated with 200 nM RPA or 200 ng/ml BSA at RT for 15 min. The superna-
tants and beads were then collected for detecting displaced RECQL4 and
DNA-bound RPA by western blotting.
SUPPLEMENTAL INFORMATION
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2.4	Additional	results		
2.4.1	Biochemical	characterisation	of	human	MLH1-MLH3	and	its	interplay	
with	human	MSH4-MSH5		
Human	MLH1-MLH3	is	an	endonuclease	
	
Introduction:	 Human	MLH1-MLH3	 (MutLγ)	 has	 been	 strongly	 implicated	 as	 a	putative	 endonuclease	 in	 meiosis,	 which	 is	 responsible	 for	 the	 formation	 of	majority	of	meiotic	COs	(Zakharyevich	et	al.,	2012).	Many	genetic	studies	carried	out	 in	various	organisms	 found	 that	 an	 inactivation	of	hMLH1-hMLH3	 leads	 to	drastic	 reduction	 in	 COs	 (Wang	 et	 al.,	 1999).	 However,	 all	 such	 studies	 have	mostly	 used	 genetic	 and	 cytological	 approach	 to	 investigate	 the	 function	 of	hMutLγ.	Until	recently,	no	biochemical	characterization	was	available	for	MutLγ	from	 any	 species	 due	 to	 the	 technical	 challenges	 encountered	 in	 purifying	 the	recombinant	protein.	Previously,	we	succeeded	 in	purifying	 the	recombinant	S.	
cerevisiae	MutLγ	and	could	show	that	it	is	an	endonuclease(Ranjha	et	al.,	2014).	Simultaneously,	another	group	(E.	Alani,	Cornell	University)	could	also	confirm	the	same	findings	(Rogacheva	et	al.,	2014).	In	my	PhD	project,	I	was	interested	in	studying	 the	 biochemical	 behaviour	 of	 hMutLγ.	 Therefore,	 I	 purified	recombinant	hMLH1-hMLH3	from	Sf9	cells,	which	was	equally	challenging	as	 it	was	for	the	yeast	protein.			MutLγ	is	a	member	of	the	MutL	family	of	MMR	proteins.	MutLα,	another	member	of	 the	MutL	 family,	 has	 already	 been	well	 established	 as	 endonuclease,	 which	shares	 the	 same	nuclease	motif	 as	MutLγ.	For	MutLα,	 it	was	 shown	 that	 it	 is	 a	cryptic	endonuclease,	which	requires	mismatch,	MutSα,	proliferating	cell	nuclear	antigen	(PCNA),	replication	factor	C	(RFC)	and	ATP	for	its	latent	nuclease	activity	in	reconstituted	system	(Kadyrov	et	al.,	2006).	Interestingly,	MutLα	showed	Mn2+	dependent	 nicking	 activity	 on	 super-coiled	 dsDNA	 in	 the	 absence	 of	 minimal	required	 components	 of	 reconstituted	 system,	 hence	 bypassing	 their	requirements.	 I	 therefore	 I	 took	 a	 cue	 from	 the	 already	 defined	 MutLα	biochemistry	and	performed	nicking	assay	under	similar	conditions.	
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Results	 and	 conclusion:	 The	 constructs	 used	 for	 purifying	 human	MutLγ	was	slightly	modified	 from	 the	 ones	 reported	 previously.	 For	 yeast	MutLα	 (yMlh1-yPms1),	 it	 was	 shown	 that	 mutation	 of	 the	 last	 residue	 of	 yMlh1	 (Cys769)	abolishes	 the	 yMutLα	 activity	without	 affecting	 the	 dimerization	 of	 yMlh1	 and	yPms1.	Therefore,	 in	the	newly	prepared	constructs	of	hMLH3,	 the	His	tag	was	removed	from	the	C-terminus	of	MLH3,	while	the	MBP	tag	at	the	N-terminus	of	MLH3	 was	 preserved.	 A	 Flag	 tag	 was	 inserted	 at	 the	 N-terminus	 of	 MLH1.	hMLH1-hMLH3	 purified	 from	 the	 new	 construct	 (Figure	 1A	 and	 B)	 behaved	similarly	in	DNA	binding	as	the	previous	construct	as	reported	previously	(data	not	 shown).	 A	 nuclease	 assay	 was	 performed	 with	 this	 "new"	 hMLH1-hMLH3	preparation	 and	 super-coiled	 dsDNA	 as	 a	 substrate	 in	 the	 presence	 of	 either	Mn2+	 or	 Mg2+.	 hMLH1-hMLH3	 nicked	 the	 substrate	 and	 produced	 the	 linear	species	 of	 DNA	 in	 the	 presence	 of	 Mn2+	 (Figure	 1C)	 while	 no	 activity	 was	observed	with	Mg2+	(Figure	1D).	To	exclude	the	possibility	that	observed	nicking	activity	was	due	to	a	nuclease	contamination	in	our	protein	preparation,	we	next	purified	 nuclease	 inactive	 variant	 of	 hMLH1-hMLH3	 by	 introducing	 the	 point	mutation	 (D1223N)	 in	 the	nuclease	motif	 of	 the	MLH3	 subunit	 (Figure	1E).	As	anticipated,	 this	 point	 mutation	 in	 MLH3	 abolished	 the	 nuclease	 activity	 of	hMLH1-hMLH3,	 showing	 clearly	 that	 the	 observed	 nicking	 observed	 was	intrinsic	 to	 hMLH1-hMLH3	 (Figure	 1F).	 	 Further	 analysis	 revealed	 that	 ATP	slightly	 stimulates	 the	 hMLH1-hMLH3	 nicking	 activity,	 whereas	 no	 such	stimulation	was	observed	upon	supplementing	the	reaction	with	hMSH4-hMSH5	(Figure	 1G	 and	 H).	 Additionally,	 hMLH1-hMLH3	 did	 not	 show	 any	 cleavage	activity	with	or	without	hMSH4-hMSH5	on	oligonucleotide-based	HJ	(Figure	1I).	In	 summary,	 I	 could	 show	 that	 hMLH1-hMLH3	 possesses	 an	 endonuclease	activity,	which	 is	slightly	stimulated	by	ATP.	No	HJ	cleavage	by	hMLH1-hMLH3	with	our	without	hMSH4-hMSH5was	observed,	indicating	the	likely	requirement	for	additional	factors,	which	were	missing	in	our	reactions.			
Human	 MSH4-MSH5	 prefers	 binding	 to	 HJs	 that	 is	 decreased	 in	 the	
presence	of	ATP	
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Introduction:	 MutSγ	 plays	 a	 significant	 role	 in	 the	 production	 of	 interference	dependent	 COs.	 Deletion	 of	 either	 MSH4	 or	 MSH5	 subunit	 leads	 to	 a	 severe	reduction	 in	 CO	 levels	 (Lynn	 et	 al.,	 2007;	 Ross-Macdonald	 and	 Roeder,	 1994).	Moreover	 in	S.	cerevisiae,	MutSγ	and	MutLγ	have	been	shown	to	function	in	the	same	pathway.	In	addition	to	its	early	role,	MutSγ	may	function	with	MutLγ	at	a	late	 stage	 of	 meiotic	 HR.	 More	 than	 a	 decade	 earlier,	 a	 biochemical	characterization	 of	 human	MSH4-MSH5	 showed	 that	 it	 preferably	 binds	 to	HJs	and	similar	structures	and	slides	on	the	HJ	arms	upon	ATP	binding	(Snowden	et	al.,	 2004).	 The	 sliding	 was	 independent	 of	 ATP	 hydrolysis.	 These	 findings	compelled	us	 to	study	the	 interplay	of	hMSH4-hMSH5with	hMutLγ.	Therefore	 I	purified	recombinant	hMSH4-hMSH5and	tested	its	DNA	binding	capacity	and	its	dependence	 on	 ATP	 to	 make	 sure	 that	 our	 purified	 protein	 is	 active	 and	conforms	to	previously	reported	characteristics.			
Results	and	conclusion:	I	expressed	and	purified	the	recombinant	human	MutSγ	(MSH4-Strep-MSH5-His)	 in	 Sf9	 cells	 using	 the	 baculovirus	 system.	 The	 single	baculovirus	 of	 hMSH4-hMSH5	was	prepared	 from	 the	plasmid	 containing	 both	MSH4	and	MSH5	genes.	It	was	kindly	provided	by	Eva	R	Hoffmann	(University	of	Copenhagen).	Both	his	and	strep	tags	were	utilized	sequentially	for	purification	(Figure	2A	and	B).	To	test	the	DNA	binding	capacity	and	preference	of	hMutSγ,	in	collaboration	 with	 Nicolas	 Weyland,	 a	 master	 student	 in	 our	 laboratory,	 we	performed	 electrophoretic	 mobility	 shift	 assays	 (EMSA)	 using	 first	polyacrylamide	gels.	hMSH4-hMSH5	did	 indeed	prefer	binding	HJs	over	dsDNA	(Figure	 2C).	 Without	 Mg2+,	 hMSH4-hMSH5	 binding	 to	 HJ	 was	 stronger,	 which	could	be	attributed	to	the	un-stacked	form	of	HJ	 in	 the	absence	of	Mg2+	(Figure	2D).	 We	 further	 investigated	 the	 influence	 of	 ATP	 on	 hMSH4-hMSH5	 DNA	binding.	The	addition	of	ATP	in	the	EMSA	reaction	decreased	hMutSγ's	binding	to	 HJ	 though	 not	 to	 a	 very	 large	 extent	 (Figure	 2E-G).	 It	 indicated	 a	 negative	influence	of	ATP	on	DNA	binding	by	hMSH4-hMSH5,	in	agreement	with	previous	reports.	However,	 it	was	not	clear	 that	whether	hMSH4-hMSH5	simply	 falls	off	the	 HJ	 arms	 upon	 ATP	 binding	 or	 whether	 it	 slides	 along	 the	 HJ	 arms	 to	ultimately	 fall	 off	 at	 the	 ends	 of	 the	 arms.	 To	 distinguish	 between	 these	 two	
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scenarios,	I	prepared	an	oligonucleotide-based	HJ	with	biotin	labels	at	each	end	of	the	fours	arms.	Streptavidin	was	used	to	block	all	DNA	ends	of	the	HJ	substrate	(Figure	2H).	With	 this	quadruple	blocked	HJ,	hMSH4-hMSH5	did	not	 show	any	decrease	in	DNA	binding	upon	ATP	addition,	indicating	that	it	slides	along	the	HJ	arms	 when	 ATP	 is	 present	 (Figure	 2I-K).	 The	 binding	 was	 specific	 to	 the	 HJ	structure,	 as	 I	 also	 prepared	 blocked	 dsDNA,	 and	 did	 not	 observe	 any	 specific	DNA	binding	(Figure	2L).	To	summarise,	I	could	purify	an	active	preparation	of	recombinant	hMSH4-hMSH5,	which	showed	DNA	binding	preference	to	HJs	and	exhibited	sliding	on	HJ	arms	upon	ATP	binding.					
Human	MLH1-MLH3	physically	interacts	with	human	MSH4-MSH5		
Introduction:	 MutSγ	 has	 been	 shown	 to	 be	 necessary	 for	 the	 formation	 of	interference	dependent	COs	in	meiosis	(Lynn	et	al.,	2007).	It	has	been	postulated	to	function	at	an	early	stage	of	HR	by	antagonizing	the	Sgs1	anti-CO	activity	and	thus	 stabilizing	 the	 single	 end	 invasion	 (SEI)	 structures	 (Borner	 et	 al.,	 2004).	Other	than	its	early	role,	MutSγ	is	also	believed	to	function	at	later	stages	of	HR	due	 to	 the	 co-localization	 of	 MSH4	 in	 human	 with	 Mlh1	 and	 Mlh3	 in	 mid	pachynema	 (Oliver-Bonet	 et	 al.,	 2005).	 In	 other	 observations,	 MSH4	 co-immunoprecipitates	 with	 MLH3	 in	 mouse	 meiotic	 cell	 extract	 and	 hMSH4-hMSH5	binds	HJ	in	vitro	(Santucci-Darmanin	et	al.,	2002;	Snowden	et	al.,	2004).	This	evidence	indicates	that	MutSγ	functions	together	with	MutLγ,	which	may	be	facilitated	by	direct	protein-protein	interactions.	Previously,	recombinant	human	MSH4	has	been	shown	to	interact	with	human	MLH3	(Santucci-Darmanin	et	al.,	2002).	 However,	 MLH3	 used	 for	 the	 testing	 was	 in	 vitro	 translated	 and	 only	single	 subunits	 of	 both	heterodimers	were	used.	Here,	we	 set	 out	 to	 study	 the	physical	 interaction	between	both	heterodimers	by	using	recombinant	hMSH4-hMSH5	and	hMLH1-hMLH3.				
Results	and	 conclusion:	 To	 study	 the	 interaction	between	hMSH4-hMSH5	and	hMLH1-hMLH3,	I	designed	the	interaction	assays,	which	were	performed	in	the	collaboration	 with	 Nicolas	Weyland.	 In	 brief,	 either	 anti-His	 (for	 MSH4-Strep-MSH5-His)	 or	 anti-Flag	 (for	 Flag-MLH1-MLH3)	 antibodies	 were	 captured	 on	
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protein	G.	 Subsequently,	 recombinant	 proteins	with	 the	 appropriate	 tags	were	further	 immobilized	 on	 protein-G-antibodies	 complex.	 Finally,	 second	recombinant	 protein	 was	 added	 and	 incubated,	 followed	 by	 an	 extensive	washing	and	elution.	The	eluted	products	were	analysed	by	silver	staining.	With	these	assay,	we	could	show	that	hMSH4-hMSH5	interacts	directly	with	hMLH1-hMLH3	 in	vitro	(Figure	 3A).	 To	 confirm	 this	 interaction	 further,	we	performed	the	 reverse	 of	 the	 previous	 assay	 where	 we	 captured	 hMLH1-hMLH3	 with	immobilized	hMSH4-hMSH5	 (Figure	3B).	These	 results	 further	prove	 that	both	complexes	directly	interact	with	each	other.					
Human	MLH1-MLH3	binds	cooperatively	to	HJs	with	hMSH4-hMSH5.		
Introduction:	MutSγ	has	been	proposed	to	function	with	MutLγ	in	CO	formation.	In	 fact,	 hMSH4-hMSH5	 itself	 binds	 to	 the	 core	 of	 oligonucleotide-based	 HJs.	Recently,	we	showed	that	hMLH1-hMLH3	prefers	binding	to	the	HJs	and	similar		structures.	We	specifically	showed	a	binding	preference	to	the	un-stacked	form	of	HJs.	As	 both	MutSγ	 and	MutLγ	 complexes	binds	 to	HJs,	we	were	wondering	about	the	possibility	that	hMSH4-hMSH5	could	stimulate	the	binding	of	hMLH1-hMLH3	 to	 HJs.	 Such	 speculation	 was	 based	 on	 the	 proposed	 model	 where	hMSH4-hMSH5,	upon	ATP	binding,	may	form	sliding	clamp	and	vacate	the	sites	for	 hMLH1-hMLH3	binding.	 In	 such	 a	 scenario,	 it	 is	 also	 possible	 that	 hMLH1-hMLH3	may	inhibit	hMSH4-hMSH5	binding	to	the	DNA	structure	preventing	its	further	loading.			
Result	 and	 conclusion:	 EMSAs	 were	 used	 to	 test	 for	 cooperativity	 between	hMSH4-hMSH5	and	hMLH1-hMLH3	in	HJ	binding.	These	assays	were	also	carried	out	 in	 collaboration	with	Nicolas	Weyland.	 Instead	of	 standard	polyacrylamide	gels,	 we	 used	 0.6%	 agarose	 gels	 as	 both	 hMLH1-hMLH3	 and	 hMSH4-hMSH5	remain	stuck	in	the	wells	of	polyacrylamide	gels,	which	hindered	us	to	detect	any	super-shift	 produced	 by	 their	 (potential)	 cooperativity.	 We	 also	 modified	 our	reaction	conditions	from	our	previous	DNA	binding	analysis	to	include	salt	and	ATP	 to	 further	 optimize	 the	 reactions	 so	 that	 complex	 can	 enter	 the	 gel.	 We	performed	 these	 EMSAs	 in	 both	 presence	 and	 absence	 of	 Mg2+.	 Under	 these	
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modified	 conditions,	 while	 hMSH4-hMSH5	 alone	 did	 not	 bind	 at	 all	 to	 either	dsDNA	or	HJ,	 hMLH1-hMLH3	only	bound	 to	HJs	 and	migrated	 as	distinct	 band	with	 additional	 smearing	 below,	 indicating	 that	 the	 DNA-protein	 complex	 is	rather	unstable	(Figure	4A).	When	both	proteins	were	added	together	with	the	HJ	 substrate,	 we	 observed	 a	 slight	 but	 consistent	 shift	 (super-shift)	 protein-bound	DNA	band.	The	limited	extent	of	observed	super-shift	with	these	proteins	can	 likely	 be	 attributed	 to	 the	 limited	 resolution	 capacity	 of	 the	 agarose	 gel.	Interestingly,	both	proteins	together	also	showed	a	slight	reduction	in	the	band	smearing,	 indicating	 the	 stabilization	 of	 the	 MutLγ-HJ	 complex	 by	 hMSH4-hMSH5.	In	the	absence	of	Mg2+,	the	super-shift	was	still	observed	and	effect	was	more	 prominent	 than	 with	 Mg2+	 (Figure	 4B),	 most	 likely	 due	 to	 enhanced	protein-DNA	binding.	This	effect	was	specific	 for	HJs,	as	no	dsDNA	binding	was	observed	under	 any	 condition	 (Figure	 4C	 and	D).	Hence,	 taken	 together,	 these	data	indicate	further	that	hMLH1-hMLH3	functions	together	with	hMSH4-hMSH5	
in	vivo	as	it	shows	a	cooperative	binding	to	HJs	with	hMSH4-hMSH5.				
Human	 MLH1-MLH3	 does	 not	 show	 cooperative	 binding	 to	 HJ	 with	 non-
cognate	yeast	Msh4-Msh5	(yMutSγ)		
Introduction:	 The	 cooperative	 binding	 to	HJs	 by	 hMLH1-hMLH3	with	 hMSH4-hMSH5	encouraged	us	 to	 further	 investigation	 the	nature	of	 this	 cooperativity.	As	shown	previously,	both	complexes	bind	to	HJ.	Therefore,	it	was	possible	that	both	proteins	are	binding	to	the	HJ	separately	and	hence	produce	the	super-shift.	To	 determine	 the	 mechanism,	 we	 used	 yeast	 Msh4-Msh5	 (L.	 Ranjha,	unpublished),	which	 also	 binds	 to	HJs	 but	 is	 not	 a	 cognate	 partner	 of	 hMLH1-hMLH3.			
	
Results	and	conclusion:	I	collaborated	with	Lepakshi	Ranjha	to	provide	yMutSγ	and	to	perform	this	assay.	Importantly,	yMutSγ	with	hMLH1-hMLH3,		did	not	show	any	cooperativity	 in	HJ	binding	(Figure	5A	and	B).	Unlike	human	MutSγ,	 yMutSγ	 alone	 bound	 to	 HJs,	 which	 indicates	 that	 observed	 lack	 of	cooperativity	 in	 between	 yMutSγ	 and	 human	 MLH1-MLH3	 was	 not	 due	 to	
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inactive	 yMutSγ.	 	 Therefore,	 we	 conclude	 that	 the	 super-shift	 observed	 with	human	MLH1-MLH3	and	hMSH4-hMSH5	 is	based	on	a	cognate,	 species-specific	interactions	between	both	heterodimers.											
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Figure	legends	
	
Figure	1.	Human	MLH1-MLH3	is	an	endonuclease.		
A.	 Schematic	 representation	 of	 human	 MLH1-MLH3	 constructs	 used	 in	experiments	 shown	 as	 additional	 results.	 B.	 Samples	 from	 a	 representative	purification	of	hMLH1-hMLH3	analysed	by	10%	polyacrylamide	gel.	The	gel	was	stained	 with	 Coomassie	 brilliant	 blue.	 MBP,	 maltose-binding	 protein;	 PP,	PreScission	protease;	Flag	flowthrough	and	eluate,	flowthrough	and	eluate	from	anti-Flag	 affinity	 resin.	 C.	 Agarose	 gel	 (1%)	 showing	 the	 nuclease	 assay	 with	hMLH1-hMLH3	on	super-coiled	dsDNA	(sc-dsDNA)	plasmid	with	Mn2+(5	mM).	D.	Nuclease	assay	with	hMLH1-hMLH3	on	sc-dsDNA	with	Mg2+(5	mM).		
E.	 Samples	 from	 a	 representative	 purification	 of	 nuclease	 deficient	 variant	 of	hMLH1-hMLH3	 (D1223N)	 analysed	 by	 10%	 polyacrylamide	 gel.	 The	 gel	 was	stained	 with	 Coomassie	 brilliant	 blue.	 MBP,	 maltose-binding	 protein;	 PP,	PreScission	protease;	Flag	flowthrough	and	eluate,	flowthrough	and	eluate	from	anti-Flag	affinity	resin.	F.	Nuclease	assay	with	nuclease	deficient	hMLH1-hMLH3	(D1223N)	 on	 sc-dsDNA	 with	 Mn2+(5	 mM).	 G.	 Nuclease	 assay	 with	 hMLH1-hMLH3	on	sc-dsDNA	and	with	various	concentration	of	ATP.	H.	Nuclease	assay	with	 hMLH1-hMLH3	 and	 hMSH4-hMSH5	 on	 sc-dsDNA.	 I.	 Denaturing	polyacrylamide	gel	showing	the	nuclease	assay	with	hMLH1-hMLH3	and	hMSH4-hMSH5	on	a	5'-end	 labeled	HJ	(50-mer).	 (*)	denotes	the	position	of	radioactive	32P	on	DNA	substrate.		
	
Figure	 2.	 Human	 MSH4-MSH5	 prefers	 binding	 to	 Holliday	 junction	 and	
slides	on	its	arms	upon	ATP	binding.	
A.	Schematic	representation	of	human	MSH4-MSH5	constructs	used	in	this	study.	
B.	 Samples	 from	 a	 representative	 purification	 of	 hMSH4-hMSH5	 analysed	 by	10%	polyacrylamide	gel.	The	gel	was	stained	with	Coomassie	brilliant	blue.	Ni-NTA	flowthrough	and	eluate,	flowthrough	and	eluate	from	nickel-nitrilotriacetic	acid	(Ni-NTA)	resin;	Strep	flowthrough	and	eluate,	flowthrough	and	eluate	from	StrepTactin	 sepharose	 resin.	 C.	 Representative	 6%	 native	 polyacrylamide	 gel	
	 145	
showing	the	DNA	binding	affinity	of	various	concentrations	of	hMSH4-hMSH5	to	radioactive	labeled	HJ	and	dsDNA	by	electrophoretic	mobility	shift	assay	(EMSA)	in	the	presence	of	Mg2+.	Below,	quantitation	of	experiments	shown	in	this	panel;	n=2,	error	bars,	SEM.	D.	Representative	EMSA	showing	DNA	binding	of	various	concentrations	of	hMSH4-hMSH5	to	HJ	and	dsDNA	in	the	absence	of	Mg2+.	Below,	quantitation	 of	 experiments	 shown	 in	 this	 panel;	 n=2,	 error	 bars,	 SEM.	 E.	Representative	EMSA	showing	DNA	binding	of	various	concentrations	of	hMSH4-hMSH5	 to	 HJ	 in	 the	 presence	 of	 ATP.	 F.	 Representative	 EMSA	 showing	 DNA	binding	of	various	concentrations	of	hMSH4-hMSH5	to	HJ	in	the	absence	of	ATP.	
G.	Quantitation	showing	the	hMSH4-hMSH5	binding	to	HJ	such	as	shown	in	panel	D	 and	 E;	 n=2,	 error	 bars,	 SEM.	 H.	 Schematic	 representation	 of	 quadruple	streptavidin-blocked	HJ.	Representative	EMSA	showing	DNA	binding	of	various	concentrations	of	hMSH4-hMSH5	with	quadruple-blocked	HJ	 in	the	presence	of	ATP.	I.	Representative	EMSA	showing	DNA	binding	of	various	concentrations	of	hMSH4-hMSH5	with	quadruple-blocked	HJ	in	the	absence	of	ATP.	J.	Quantitation	showing	the	hMSH4-hMSH5	binding	 to	quadruple-blocked	HJ	such	as	shown	 in	panel	G	and	H;	n=2,	error	bars,	SEM.	K.	Quantitation	showing	the	hMSH4-hMSH5	binding	 to	 quadruple-blocked	HJ	 and	double-blocked	dsDNA	 (gels	 not	 shown);	n=2,	error	bars,	SEM.			
	
Figure	3.	Human	MLH1-MLH3	physically	interacts	with	hMSH4-hMSH5.	
A.	 Silver	 stained	 10%	 polyacrylamide	 gel	 showing	 the	 pull	 down	 of	 hMSH4-hMSH5	 by	 hMLH1-hMLH3,	 immobilized	 on	 Protein-G	 beads	 with	 anti-MLH1	antibody,	 indicating	 the	 interaction	 between	 both	 complexes.	B.	 Pull	 down	 of	hMLH1-hMLH3	by	hMSH4-hMSH5,	immobilized	on	protein-G	beads	with	anti-His	antibody,	further	confirming	the	interaction	between	both	heterodimers.			
Figure	 4.	 Human	 MLH1-MLH3	 cooperatively	 binds	 to	 HJ	 with	 hMSH4-
hMSH5.		
A.	 EMSA	 with	 0.6%	 agarose	 gel	 showing	 the	 DNA	 binding	 of	 multiple	concentrations	 of	 hMLH1-hMLH3	 and	 hMSH4-hMSH5	 to	 HJ	 in	 the	 presence	 of	Mg2+.	B.	EMSA	showing	 the	DNA	binding	of	multiple	concentrations	of	hMLH1-
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hMLH3	and	hMSH4-hMSH5	 to	HJ	 in	 the	absence	of	Mg2+.	 C.	EMSA	showing	 the	DNA	binding	of	multiple	concentrations	of	hMLH1-hMLH3	and	hMSH4-hMSH5	to	dsDNA	 in	 the	presence	of	Mg2+.	D.	EMSA	showing	 the	DNA	binding	of	multiple	concentrations	of	hMLH1-hMLH3	and	hMSH4-hMSH5	to	dsDNA	in	the	absence	of	Mg2+.		
Figure	 5.	 Human	 MLH1-MLH3	 does	 not	 show	 cooperative	 binding	 to	
Holliday	junction	with	non-cognate	yeast	Mlh1-Mlh3	
A.	 EMSA	 showing	 the	 DNA	 binding	 of	 hMLH1-hMLH3,	 hMSH4-hMSH5	 and	yMsh4-yMsh5	to	HJ	in	the	presence	of	Mg2+.	B.	EMSA	showing	the	DNA	binding	of	 hMLH1-hMLH3,	 hMSH4-hMSH5	 and	 yMsh4-yMsh5	 to	 HJ	 in	 the	 absence	 of	Mg2+.																						
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Experimental	procedures		
Cloning,	expression	and	purification	of	recombinant	proteins	Recombinant	hMutLγ	was	prepared	from	the	codon-optimized	(for	 insect	cells)	constructs	of	hMLH1	and	hMLH3	 for	expression	 in	Spodoptera	frugiperda	 (Sf9)	cells.	 The	 single	 plasmid	 pFL-MLH1co/His-MLH3co	 (co;	 codon	 optimized)	containing	 both	 genes	 was	 kindly	 provided	 by	 Jean-Baptiste	 Charbonnier	(Institut	de	Biologie	et	Technologies	de	Saclay,	France).	I	modified	the	previously	reported	 constructs	 of	 hMutLγ	 from	 MBP-hMLH3-his	 to	 MBP-hMLH3co	 and	hMLH1	 to	 Flag-hMLH1co	 (Ranjha	 et	 al.,	 2014).	 To	 prepare	 the	 pFB-MBP-MLH3co,	hMLH3	gene	was	amplified	by	PCR	using	pFL-MLH1co/His-MLH3co	as	template	 with	 forward	 primer	 MLH3co_F	 and	 reverse	 primer	 MLH3co_R.	 The	amplified	product	was	digested	with	NheI	and	XmaI	and	cloned	 into	pFB-MBP-MLH3-his.	The	reverse	primer	MLH3co_R	contained	stop	codon,	which	resulted	in	its	insertion	between	MLH3	gene	and	his	tag	and	hence	forming	plasmid	pFB-MBP-hMLH3co.	Similarly,	Flag	tag	was	inserted	at	N-terminus	of	pFB-hMLH1	by	amplification	 of	 hMLH1	 from	 pFL-MLH1co/His-MLH3co	 by	 PCR	 using	 forward	primer	 reverse	 primer	 Flag_MLH1co_F	 and	 MLH1co_R.	 The	 amplified	 product	was	digested	with	BamHI	and	XbaI	and	cloned	into	pFB-MBP-MLH3co	giving	rise	to	pFB-Flag-MLH1co.	To	prepare	the	nuclease	deficient	variant	of	MLH3,	aspartic	acid	 (D)	 at	 position	 1223	 in	 MLH3	 was	 mutated	 to	 asparagine	 (N)	 by	QuikChangeII	 site-directed	 mutagenesis	 kit	 (Agilent	 Techonologies)	 using	primers	 MLH3co_ND_F	 and	 MLH3co_ND_R	 by	 following	 the	 manufacturer's	instructions.		All	cloned	genes	were	verified	by	sequencing.	Bacmids,	primary	and	secondary	baculoviruses	 were	 prepared	 by	 Bac-to-Bac	 system	 (Invitrogen)	 according	 to	manufacturer’s	 recommendations.	The	 transfection	of	Sf9	cells	was	 carried	out	using	Trans-IT	insect	reagent	(Mirus	Bio).			For	 the	 large-scale	expression	and	purification	of	hMLH1-hMLH3,	3.2	 litres	Sf9	cells	were	 seeded	 at	 0.5x106	 per	ml	 and	 co-infected	16	hours	 later	with	 equal	amount	 of	 secondary	 baculoviruses	 of	 MLH3	 and	 MLH1.	 Cells	 were	 further	incubated	for	52	hours	at	27°	C	with	constant	agitation.	The	cells	were	harvested	
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by	centrifuging	them	for	10	minutes	at	500	X	g	and	washed	once	with	phosphate	buffered	saline	(PBS).	The	collected	pellets	were	snap	frozen	and	stored	at	–80°	C.	All	subsequent	steps	during	purification	were	carried	out	at	4°	C	or	on	ice.	Cell	pellets	were	re-suspended	in	3	volumes	of	lysis	buffer	(Tris-HCl,	pH	7.5,	50	mM;	dithiothreitol,	 1	 mM;	 EDTA,	 1	mM;	 Protease	 inhibitory	 cocktail,	 Sigma	 P8340,	1:400;	phenylmethylsulfonyl	fluoride	(PMSF),	1	mM;	leupeptin,	30	µg/ml;	NaCl,	300	mM;	glycerol,	10%)	and	 incubated	for	20	minutes	with	continuous	mixing.	Glycerol	was	added	 to	16%	(v/v)	concentration	 followed	by	 (slow)	addition	of	NaCl	to	reach	the	final	concentration	of	305	mM.	The	cell	suspension	was	further	incubated	 for	 30	 minutes	 with	 continuous	 stirring.	 Total	 cell	 suspension	 was	centrifuged	at	57'800	X	g	 for	30	min	to	obtain	soluble	extract.	Pre-equilibrated	amylose	resin	(Qiagen)	was	added	to	cleared	soluble	extract	and	incubated	for	1	hour	 with	 continuous	 mixing.	 The	 soluble	 extract	 with	 amylose	 resin	 was	centrifuged	for	2	minutes	at	2000	X	g	to	separate	the	resin	with	the	supernatant.	The	resin	was	washed	extensively	with	wash	buffer	(Tris-HCl,	pH	7.5,	50	mM;	β-mercaptoethanol,	2	mM;	NaCl,	300	mM;	glycerol,	10%;	PMSF,	1	mM)	batch	wise	as	 well	 as	 on	 disposable	 columns	 (ThermoFisher	 Scientific).	 The	 protein	 was	eluted	from	the	resin	with	wash	buffer	containing	10	mM	maltose	(Sigma).	The	eluates	were	 further	treated	with	PreScission	protease	 for	1	hour	 to	cleave	the	maltose	 binding	 protein	 affinity	 tag	 (MBP).	 The	 eluate	 was	 further	 incubated	with	anti-FLAG	M2	Affinity	Gel	(A2220,	Sigma)	 for	1	h	with	continuous	mixing.	The	FLAG-resin	was	 then	washed	extensively	on	disposable	column	with	FLAG	wash	 buffer	 (Tris-HCl,	 pH	 7.5,	 50	mM;	 NaCl,	 150	mM;	 glycerol,	 10%;	 PMSF,	 1	mM;	β-mercaptoethanol,	1	mM).	Finally,	recombinant	hMLH1-hMLH3	was	eluted	with	FLAG	wash	buffer	containing	3xFLAG	peptide	(200	µg/ml,	Sigma,	F4799)	in	multiple	 fractions.	 Fractions	with	proteins	were	pooled,	 aliquoted,	 snap	 frozen	and	 stored	 at	 –80°	 C.	 The	 purification	 of	 nuclease	 deficient	 variant	 of	 hMLH1-hMLH3	(D1223N)	was	carried	out	with	the	identical	expression	and	purification	procedure	as	wild	type	hMLH1-hMLH3.			To	express	 and	purify	hMSH4-hMSH5	at	 large-scale,	 primary	virus	 for	hMSH4-hMSH5,	received	from	Eva	R	Hoffman	(University	of	Copenhagen),	was	amplified	to	prepare	secondary	virus.	The	Sf9	cells	were	seeded	at	0.5x106	per	ml	and	16	
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hours	 later	 infected	 with	 single	 secondary	 virus	 of	 hMSH4-hMSH5.	 The	 cells	were	incubated	for	52	hours	at	27°	C	with	constant	agitation.		The	infected	cells	were	 harvested	 by	 centrifugation	 (10	 minutes,	 500	 g)	 and	 washed	 once	 with	PBS.	The	collected	pellets	were	snap	frozen	and	stored	at	–80°	C.	All	subsequent	steps	of	purification	were	carried	out	either	at	4°	C	or	on	ice.	The	pellets	were	re-suspended	 with	 3	 volumes	 of	 lysis	 buffer	 (Tris-HCl,	 pH	 7.5,	 50	 mM;	 β-mercaptoethanol,	 2	 mM;	 ethylenediaminetetraacetic	 acid	 (EDTA),	 1	 mM;	Protease	inhibitory	cocktail,	Sigma	P8340,	1:400;	phenylmethylsulfonyl	fluoride	(PMSF),	 1	mM;	 leupeptin,	 30	µg/ml;	 imidazole,	 20	mM)	 and	 incubated	 for	 20	minutes	with	 continuous	mixing.	 After	 incubation,	 glycerol	was	 added	 to	 16%	(v/v)	 concentration,	 followed	 by	 slow	 addition	 of	 NaCl	 to	 reach	 the	 final	concentration	of	305	mM.	The	cell	suspension	was	further	incubated	for	30	min	with	continuous	stirring.	The	suspension	was	centrifuged	at	57'800	g	for	30	min	to	 obtain	 the	 soluble	 extract.	 Pre-equilibrated	 nickel-nitrilotriacetic	 acid	 (Ni-NTA)	agarose	resin	(Qiagen)	was	added	to	the	soluble	extract	and	incubated	for	1	hour	with	continuous	mixing.	The	Ni-NTA	resin	was	separated	from	the	soluble	extract	by	centrifugation	at	2'000	g	 for	2	min	and	washed	extensively	with	Ni-NTA	wash	buffer	(Tris-HCl,	pH	7.5,	50	mM;	β-mercaptoethanol,	2	mM;	NaCl,	300	mM;	 glycerol,	 10%;	 PMSF,	 1	mM;	 imidazole,	 20	mM)	 batch	wise	 as	well	 as	 on	disposable	 columns	 (Thermo	 Scientific).	 The	 protein	 was	 eluted	 with	 Ni-NTA	wash	 buffer	 containing	 250	mM	 Imidazole.	 The	 eluted	 protein	was	mixed	 and	incubated	with	Strep-Tactin	Superflow	resin	(Qiagen)	for	1	hour	with	continues	mixing.	 The	Strep-Tactin	 resin	was	washed	 extensively	with	 Strep	wash	buffer	(Tris-HCl,	 pH	 7.5,	 50	 mM;	 β-mercaptoethanol,	 2	 mM;	 NaCl,	 300	mM;	 glycerol,	10%;	PMSF,	 1	mM)	on	disposable	 column	 (Thermo	Scientific).	 In	 the	 last	 step,	recombinant	 hMSH4-hMSH5	 was	 eluted	 in	 fractions	 with	 strep	 wash	 buffer	containing	150	mM	NaCl	(instead	of	300	mM)	and	2.5	mM	desthiobiotin	(Sigma).	The	fractions	containing	proteins	were	pooled,	aliquoted,	snap	frozen	and	stored	at	–80°	C.		
Nuclease	assay	Nuclease	assays	were	carried	out	 in	15	μL	volume	with	buffer	containing	Tris-acetate	 pH	 7.5,	 25	mM;	manganese	 or	magnesium	 acetate	 (or	 as	 indicated),	 5	
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mM;	dithiothreitol,	1	mM;	EDTA,	100	μM;	bovine	serum	albumin,	(New	England	Biolabs),	 0.1	mg/ml;	 DNA	 substrate,	 100	 μg	 (pUC19)	 on	 ice.	 Additionally,	 ATP	(100	μM)	was	added	to	the	reactions	wherever	indicated.	Recombinant	proteins	were	then	added	to	the	reactions	on	ice	and	samples	were	incubated	for	1	hour	at	37°	C.	Reactions	were	stopped	with	5	μL	of	stop	solution	(EDTA,	150	mM;	SDS	(Sodium	dodecyl	sulfate),	2%;	glycerol,	30%;	bromophenol	blue,	0.25%)	and	1μL	Proteinase	K	 (14-22	mg/mL,	Roche)	 for	30	minutes	 at	 37°	C.	 Finally,	 products	were	separated	by	electrophoresis	on	1%	agarose	gel	electrophoresis	and	DNA	was	visualized	by	 staining	with	ethidium	bromide	 (0.1	μg/ml)	using	 the	Alpha	InnoTec	imaging	station.	Nuclease	 assays	with	 radioactive	 labeled	 32P	 substrates	were	 carried	 in	 15	 μL	volume	with	buffer	containing	Tris-acetate	pH	7.5,	25	mM;	manganese	acetate,	1	mM;	magnesium	acetate,	5	mM;	dithiothreitol,	1	mM;	ATP,	1	mM;	bovine	serum	albumin,	 (New	 England	 Biolabs),	 0.25	 mg/ml;	 phosphoenolpyruvate,	 1	 mM;	pyruvate	kinase,	(Sigma),	80	U/ml	and	oligonucleotide-based	DNA	substrate	(50-mer),	 1	 nM	 (in	 molecules)	 on	 ice.	 Recombinant	 proteins	 were	 added	 to	 the	reactions	and	 incubated	 for	30	minutes	 at	37°	C.	Reactions	were	 stopped	with	0.5	µl	Proteinase	K	(20.6	mg/mL,	Roche);	and	1	µL	solution	containing	5%	SDS	and	0.25	M	EDTA	 for	30	minutes	at	37°C.	Finally,	16.5	µL	 loading	buffer	 (95%	formamide,	20	mM	EDTA	and	bromophenol	blue)	was	added	to	all	the	samples	and	 the	products	were	separated	on	15%	polyacrylamide	denaturing	urea	gels	(19:1	 acrylamide-bisacrylamide,	 BioRad).	 The	 gels	 were	 fixed	 in	 a	 solution	containing	 40%	methanol,	 10%	 acetic	 acid	 and	 5%	 glycerol	 for	 30	minutes	 at	room	temperature	and	dried	on	a	3	mm	CHR	paper	(Whatman).	The	dried	gels	were	 exposed	 to	 storage	 phosphor	 screens	 (GE	 Healthcare)	 and	 scanned	 by	Typhoon	Phosphor	imager	(FLA	9500,	GE	Healthcare)		
DNA	substrates	The	 radioactive	 labeled	 (32P)	 oligonucleotide-based	 Holliday	 junction	 (HJ)	 or	double	stranded	DNA	(dsDNA)	substrates	were	prepared	and	used	as	described	previously.	 To	 prepare	 the	 blocked	 substrates,	 oligonucleotides	 with	 the	attached	 biotin	 at	 both	 ends	 were	 purchased	 from	 the	 Microsynth	 AG.	 The	
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sequences	of	biotinylated	oligonucleotides	were	identical	to	the	non-biotinylated	oligonucleotides	used	for	preparing	non-blocked	dsDNA	and	HJ.			
Electrophoretic	mobility	shift	assay	(EMSA)	The	DNA	binding	assays	were	carried	out	in	15	μL	volume	with	buffer	containing	HEPES	 pH	 7.8,	 25	mM;	magnesium	 chloride,	 2	mM	or	 EDTA,	 3	mM	 (in	 –	Mg2+	assays);	glycerol,	5%;	dithiothreitol,	1	mM;	bovine	serum	albumin,	(New	England	Biolabs),	 0.05	 mg/ml;	 DNA	 substrate	 (non-	 or	 biotinylated),	 0.5	 nM	 (in	molecules);	dsDNA	(50-mer,	"cold"	oligonucleotide	used	as	competitor	DNA),	3.3	ng/uL	 (corresponded	 to	 ~	 200	 molar	 fold	 excess);	 ATP,	 1	 mM	 (wherever	indicated)	on	ice.	In	super-shift	assays	(as	shown	in	Figure	4	and	5),	ATP	(10	μM)	and	 NaCl	 (75	 mM)	 were	 also	 included	 in	 the	 reactions.	 Wherever	 blocked	substrates	are	indicated,	reactions	were	supplemented	with	streptavidin	(15	nM,	Sigma)	 and	 pre-incubated	 at	 room	 temperature	 for	 5	 minutes.	 Recombinant	proteins	were	 added	 and	 incubated	 for	 15	minutes	 on	 ice.	 Next,	 5	 μL	 loading	buffer	[50%	glycerol	with	bromophenol	blue	(0.25%)]	was	added	to	each	sample	and	products	were	separated	by	electrophoresis	in	6%	polyacrylamide	gel	(ratio	acrylamide:bisacrylamide	 19:1,	 Bio-Rad)	 at	 4	 °C.	 Wherever	 indicated,	 0.6%	agarose	gels	were	used	for	separating	the	larger	complexes.	Gels	were	dried	on	DE-81	 chromatography	 paper	 (Whatman)	 and	 were	 exposed	 to	 storage	phosphor	screens	(GE	Healthcare)	and	scanned	by	a	Typhoon	Phosphor	imager	(FLA	9500,	GE	Healthcare).			
Pull	down	interaction	assays	Interaction	 assays	 were	 carried	 out	 in	 collaboration	 with	 Nicolas	 Weyland,	master	 student	 in	 our	 lab.	 The	 anti-MLH1	 or	 anti-His	 (GenScript)	 antibodies	were	re-suspended	in	50	μL	PBS-T	(PBS-Tween	0.2%)	and	incubated	with	60	μL	magnetic	Dynabead	Protein-G	 (ThermoFisher	 Scientific)	 for	 60	minutes	 at	 4	C.	The	 supernatant	 was	 discarded	 and	 beads	 were	 washed	 3	 times	 with	 150	 μL	PBS-T	 on	 magnetic	 rack	 and	 again	 re-suspended	 in	 60	 μL	 PBS-T.	 Beads	 with	immobilized	 antibodies	 were	 transferred	 to	 microtubes	 equally	 (15	 μL).	Recombinant	 proteins	 hMLH1-hMLH3	 (220	 nM)	 and	 hMSH4-hMSH5	 (220	 nM)	either	alone	or	 together	were	re-suspended	 in	50	uL	binding	buffer	containing	
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HEPES	pH	7.8,	25	mM;	EDTA,	3	mM;	DTT,	1	mM;	BSA,	0.05	μg/mL;	NaCl,	80	mM;	transferred	and	incubated	with	15	μL	washed	beads	for	45	minutes	at	4°	C	with	regular	 gentle	 tapping.	 Beads	 were	 washed	 3X	 with	 150	 μL	 binding	 buffer	additionally	 containing	0.1%	Triton-X100.	 Proteins	were	 eluted	by	 adding	 SDS	buffer	 (0.25	%	 bromophenol	 blue,	 0.5	M	DTT,	 50%	 glycerol	 and	 10%	 SDS)	 to	each	 tube	 and	 boiling	 them	 for	 3	 minutes	 at	 95	 C.	 The	 boiled	 samples	 were	analysed	by	polyacrylamide	gel	electrophoresis	 (PAGE)	and	stained	with	 silver	staining.		
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3.	Discussion		DSB	repair	by	HR	is	an	essential	process	to	repair	accidental	DNA	breaks	where	its	task	is	to	maintain	genomic	integrity	(Aparicio	et	al.,	2014).	Cells	also	utilize	HR	 to	 produce	 genetic	 diversity	 during	 meiosis	 (Hunter,	 2015).	 DNA	 end	resection	represents	a	critical	key	step	in	the	repair	of	DSB	by	suppressing	NHEJ	while	 facilitating	 HR.	 In	 my	 PhD,	 I	 investigated	 the	 key	 steps	 of	 HR,	 which	included	DNA	 end	 resection	 and	 the	 resolution	 of	 recombination	 intermediate	produced	during	meiosis.			In	 recent	 past,	 various	 studies	 have	 firmly	 established	 that	DNA	 end	 resection	occurs	 in	 5'	 to	 3'	 direction	 (Symington,	 2014a).	 It	 is	 initiated	 by	 the	 MRE11	nuclease	with	RAD50	and	NBS1	along	with	CtIP.	However,	MRE11	exhibits	 the	opposite	 exonuclease	 polarity	 	 (3'	 to	 5')	 and	 shows	 nicking	 activity	 only	 on	ssDNA	 (Paull	 and	Gellert,	1998).	The	 first	project	of	my	PhD	 thesis	 specifically	focused	on	the	elucidation	of	mechanism	of	DNA	end	resection	by	MRN	and	CtIP.	Here,	 I	 could	 show	 that	 phosphorylated	 CtIP	 (pCtIP)	 promotes	 MRN	endonuclease	activity	on	dsDNA.	This	stimulation	of	MRN	is	strongly	dependent	on	 phosphorylation	 of	 CtIP	 as	 in	 vitro	 phosphatase	 treatment	 of	 CtIP	incapacitates	it	to	stimulate	MRN	activity.	The	phosphorylation	of	certain	sites	in	CtIP	 is	 cell	 cycle	 regulated,	 which	 is	 mediated	 by	 CDK	 (Huertas	 and	 Jackson,	2009).	 In	 particular,	 highly	 conserved	 CDK	 site	 T847	 is	 important	 for	 the	 HR	function	 of	 CtIP.	 The	 nonphosphorylatable	 mutation	 CtIP	 T847A	 abolishes	 its	capacity	 to	 promote	 the	 clipping	 activity	 of	 MRN.	 The	 failure	 of	 CtIP	 T847A	mutant	 to	 promote	MRN	 activity	 explains	 the	DNA	 end	 resection	 deficiency	 of	CtIP	T847A	 in	vivo	(Huertas	 and	 Jackson,	 2009).	 I	 could	 also	demonstrate	 that	the	 nuclease	 activity	 responsible	 for	 observed	 MRN-pCtIP	 clipping	 activity	 is	integral	 to	 MRE11,	 as	 nuclease-deficient	 variant	 of	 MRE11	 (MRE11	 H129L	D130V)	does	not	show	any	clipping	activity.	The	ability	of	phosphorylated	CtIP	to	stimulate	MRN	is	independent	of	its	DNA	binding	capacity,	as	pCtIP	binds	less	to	 dsDNA	 substrate	 than	 CtIP,	 which	 was	 expressed	 and	 purified	 without	phosphatase	 inhibitors	and	is	unable	to	stimulate	MRN.	Recently,	 it	was	shown	
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that	yeast	Sae2	promotes	MRX	endonuclease	activity	(Cannavo	and	Cejka,	2014).	The	 cross-species	 analysis	 of	MRN	 and	 CtIP	with	MRX	 and	 Sae2	 demonstrates	that	the	stimulation	of	MRN	or	MRX	is	specific	to	their	cognate	protein	partners,	and	infers	the	requirement	for	direct	protein-protein	interactions.			The	RAD50	ATPase	activity	is	essential	for	MRN	function	(Luo	et	al.,	1999)	(Paull	and	Deshpande,	2014).	The	mutation	of	the	Rad50	ATPase	motif	in	yeast	exhibits	the	same	HR	defects	as	rad50	null	mutants	(Alani	et	al.,	1990).	To	investigate	the	contribution	of	RAD50	ATPase	activity,	I	prepared	RAD50	variants,	which	were	deficient	 in	 either	 ATP	 binding	 (K42A)	 or	 ATP	 hydrolysis	 (K42R)	 but	 still	showed	 the	 efficient	 exonucleolytic	 ssDNA	 degradation.	 I	 could	 clearly	demonstrate	 that	 not	 only	 ATP	 binding	 but	 also	 ATP	 hydrolysis	 by	 RAD50	 is	essential	 for	 MRN-pCtIP	 clipping	 activity.	 In	 accordance,	 the	 exclusion	 of	 ATP	from	 the	 reactions	 containing	wild	 type	 proteins	 results	 in	 the	 failure	 of	MRN	stimulation	 by	 pCtIP.	 In	 addition,	 ATP	 cannot	 be	 replaced	 by	 either	 ADP	 or	ATPγS,	 which	 further	 states	 the	 importance	 of	 ATP	 hydrolysis	 for	 MRN-pCtIP	activity.	 This	 data	 explains	 the	 functional	 importance	 of	 ATP	 motif	 of	 RAD50	during	 HR.	 Furthermore;	 I	 also	 found	 that	 while	 MRE11	 is	 Mn2+	 -dependent	exonuclease,	 both	 Mg2+	 and	 Mn2+	 are	 essential	 for	 MRN-pCtIP	 activity.	Specifically,	 we	 observed	 that	 more	 Mg2+	 is	 required	 than	 Mn2+	 for	 optimal	clipping	 activity,	which	 roughly	 represents	 the	 cellular	 physiological	 condition	where	Mg2+	is	more	abundant	in	comparison	to	Mn2+.			The	NBS1	 is	not	highly	 conserved	 in	 evolution	and	 it	 is	 present	only	 in	higher	eukaryotes	(Saito	and	Komatsu,	2015).	In	yeast	and	humans,	both	Xrs2	and	NBS1	contain	 nuclear	 localization	 signal	 (NLS),	 which	 is	 required	 for	 MR	 function.	Besides	 nuclear	 localization	 of	 MR,	 Xrs2/NBS1	 also	 play	 an	 important	 role	 in	checkpoint	 signalling	 and	 coordinating	 the	 interactions	 with	 various	mediator	proteins(Thompson,	2012).	In	yeast,	Xrs2	has	been	shown	to	be	dispensable	for	MR	 stimulation	 by	 Sae2	 (Oh	 et	 al.,	 2016).	 Surprisingly,	 NBS1	 in	 humans	 is	required	 for	 MRN	 stimulation	 by	 pCtIP,	 as	 MR	 with	 pCtIP	 fails	 to	 show	 any	clipping	 activity.	 The	 exonuclease	 activity	 of	 MR	 is	 proficient	 and	 hence	 not	negatively	influenced	by	the	absence	of	NBS1.	It	indicates	the	direct	participation	
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of	NBS1	in	resection	other	than	its	mediator	functions.	I	also	discovered	that	the	blocking	of	DNA	ends	is	important	to	observe	the	clipping	activity	as	exclusion	of	streptavidin	 in	 the	 reactions	 inhibited	 DNA	 cleavage.	 It	 is	 not	 clear	 which	physiological	 protein	 blocks	 stimulate	 MRN-pCtIP	 activity	 in	 vivo,	 although	Spo11	 in	 meiosis	 is	 an	 excellent	 candidate	 as	 MRN-pCtIP	 nicking	 activity	 is	required	 to	 remove	 Sae2	 proteins	 prior	 to	 resection.	 In	 yeast,	 HO-	 or	 I-SceI	mediated	 "clean"	 DSBs	 can	 be	 resected	 even	 in	 the	 absence	 of	 the	 Mre11	nuclease	or	Sae2,	which	support	my	 finding	 (Symington,	2016).	By	varying	 the	position	of	P32	label	on	dsDNA,	I	could	demonstrate	that	MRN-pCtIP	nicks	at	~	20	nt	away	from	the	5'	end,	which	corroborates	well	with	the	5'	end	resection	in	HR.	Additionally,	 the	 length	 of	 total	 DNA	 substrate,	 at	 least	 in	 our	 reconstituted	system,	does	not	 influence	the	position	of	cleavage.	While	pCtIP	does	not	affect	MRN	exonuclease	activity	on	dsDNA,	 it	 surprisingly	enhances	 the	MRN	nicking	activity	of	circular	ssDNA,	in	contrast	to	yeast	system	(Cannavo	and	Cejka,	2014).	Although	 circular	 ssDNA	 is	 a	 poorly	 defined	 substrate,	 it	 provides	 hints	 that	pCtIP	 is	 likely	 to	 be	 capable	 to	 stimulate	 MRN	 cleavage	 of	 yet	 unknown	secondary	structures.	In	yeast,	it	was	shown	that	inverted	Alu-repeats,	which	can	create	hairpins	or	other	secondary	structures,	require	MRX	and	Sae2	for	mitotic	recombination	(Lobachev	et	al.,	2002).			CtIP	exists	as	 tetramer	 in	vivo	 and	 this	oligomeric	 state	 is	 important	 for	 its	HR	functions	 (Davies	 et	 al.,	 2015).	 Recent	 analysis	 from	 Davies	 and	 colleagues	showed	 that	CtIP	 acquires	 tetrameric	 state	 in	 a	dimer	of	dimers	 configuration,	which	 associate	 with	 each	 other	 in	 head	 to	 head	 association	 through	 their	 N-termini.	 To	 examine	 the	 effect	 of	 the	 CtIP	 oligomeric	 state	 on	 MRN	 clipping	activity,	 I	 initially	constructed	and	purified	N-terminal	 truncated	pCtIP	∆1-160,	which	 is	 unable	 to	 form	 dimers	 and	 hence	 consequently,	 no	 tetramers.	 The	stimulation	capacity	of	pCtIP	∆1-160	is	strongly	impaired	in	comparison	to	wild	type	 pCtIP.	 Additionally,	 we	 also	 prepared	 the	 pCtIP	 L27E	 mutant,	 which	abolishes	the	tetrameric	form	while	retaining	the	dimeric	state	of	CtIP	(Davies	et	al.,	2015;	Kowalczykowski,	2015).	My	investigation	with	pCtIP	L27E	showed	that	while	 it	 does	 promote	 MRN	 activity,	 the	 comparative	 analysis	 with	 wild	 type	revealed	 that	pCtIP	L27E	 is	 less	proficient	 than	pCtIP	 in	MRN	stimulation.	This	
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observation	 partially	 explains	 the	 impaired	 resection	 phenotype	 of	 CtIP	 L27E	cells.	 It	 is	 important	 to	 note	 here	 that	 pCtIP	 L27E	 fails	 to	 form	 foci	 at	 DSBs	indicating	its	impaired	localization	at	break	sites.	Collectively,	our	data	show	that	the	disruption	of	CtIP	oligomeric	state	negatively	affects	MRN	stimulation.			Meiosis	 is	 a	 key	 process	 required	 for	 the	 generation	 of	 genetic	 diversity	demanded	by	evolution.	In	meiosis,	diploid	germ	cells	recombine	DNA	sequences	between	 homologous	 chromosomes,	 which	 gives	 rise	 to	 the	 new	 set	 of	chromosomes	 with	 a	 sequence	 that	 differs	 from	 the	 original	 parental	chromosomes.	 During	 genetic	 recombination,	 various	 recombination	intermediates	are	produced	including	the	dHJ.	The	specific	processing	of	dHJs	by	various	 enzymes	 give	 rise	 to	 either	 COs	 or	 NCOs	 or	 both	 products.	 MutLγ,	 an	endonuclease,	which	exclusively	produces	COs,	has	been	strongly	 implicated	 in	the	 production	 of	 obligate	 COs	 in	 meiosis.	 Disruption	 or	 deletion	 of	 MutLγ	 in	many	organisms	 reduces	CO	 levels	 significantly	 (Lipkin	et	 al.,	 2002;	Nishant	et	al.,	 2008;	Wang	 et	 al.,	 1999;	 Zakharyevich	 et	 al.,	 2012).	 In	 addition	 to	 MutLγ,	MutSγ	has	also	been	shown	to	function	as	a	pro-CO	factor	within	same	pathway	as	MutLγ.	Most	of	the	evidence	for	MutLγ	being	the	main	putative	endonuclease	for	HJ	 processing	 required	 for	 the	majority	 of	 COs	 have	 come	 from	 genetic	 or	cytological	 studies.	 Especially	 for	 human	 MutLγ,	 no	 information	 on	 its	biochemical	behavior	is	available	in	the	literature.	Therefore,	in	my	second	PhD	project,	 I	 set	 out	 to	 biochemically	 characterize	 human	MutLγ	 and	 its	 interplay	with	human	MutSγ.				Initially,	 we	 showed	 that	 human	 MutLγ	 prefers	 binding	 to	 HJs	 and	 similar	structures	over	dsDNA,	ssDNA	and	Y-structures	(Ranjha	et	al.,	2014).	We	could	also	 show	 that	 hMutLγ	 binding	 to	 HJs	 is	 reduced	 in	 the	 presence	 of	 Mg2+	presumably	 due	 to	 the	 stacked	 configuration	 of	 HJ,	 which	 likely	 prevents	 the	hMutLγ	access	to	the	core	of	HJ.	MutLα,	another	member	of	MutL	family	of	MMR	pathway,	 is	 capable	 of	 incising	 the	 super-coiled	 dsDNA	 (sc-dsDNA)	 in	 the	presence	 of	 Mn2+,	 hence	 bypassing	 the	 requirement	 of	 otherwise	 requisite	factors	 (Kadyrov	 et	 al.,	 2006).	 Therefore,	 I	 also	 tested	 the	 nicking	 activity	 of	hMutLγ	 under	 the	 similar	 conditions	 and	 found	 that	 hMutLγ	 does	 incise	 sc-
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dsDNA	 in	 the	 presence	 of	Mn2+.	 	 No	 nicking	 activity	 by	 the	 nuclease	 deficient	mutant	 of	 hMutLγ	 (hMLH1-hMLH3D1223N)	 further	 confirmed	 our	 findings.	Hence,	I	could	show	that	hMutLγ	is	indeed	an	endonuclease,	which	shows	Mn2+	dependent	non-specific	dsDNA	nicking	activity.	This	result	added	a	piece	into	the	puzzle	 of	 formation	 of	 biased	 COs	 in	 meiosis	 by	 human	 MutLγ.	 However,	 the	nicking	activity	was	only	observed	in	Mn2+	and	was	missing	in	Mg2+,	which	does	not	 represent	 the	 physiological	 environment	 of	 the	 cells	 where	 Mg2+	 is	 much	more	 abundant	 than	 Mn2+.	 Furthermore,	 MutLγ	 did	 not	 show	 any	 cleavage	activity	 on	 oligonucleotide-based	 HJs.	 Double	 HJs	 are	 believed	 to	 be	 hMutLγ's	ideal	 substrate	 in	vivo.	No	 enhancement	of	 hMutLγ	nicking	 activity	by	hMutSγ,	was	 not	 surprising,	 as	 sc-dsDNA	 does	 not	 represent	 the	 structure	 upon	which	these	complexes	are	likely	to	function	in	vivo.	The	failure	of	yMutLγ	to	cleave	HJs	
in	 vitro	 further	 suggests	 that	 a	 specific	 structure	 or	 additional	 activators	 are	required	 for	 MutLγ	 specific	 nuclease	 activity.	 It	 is	 strongly	 believed	 that	 a	specific	configuration	of	the	DNA	substrate	will	be	one	of	the	key	requirements	to	understand	the	specific	MutLγ	mediated	cleavage.	These	findings	collectively	provide	hints	about	the	complexity	of	MutLγ	nuclease	action	and	its	regulation	in	
vivo.	MutLγ	exclusively	generates	COs	only,	which	indicates	the	controlled	biased	cleavage	mechanism	in	place	for	MutLγ	to	function.	Similar	to	MutLα,	MutLγ	may	also	possess	a	 latent	Mg2+-dependent	endonuclease	activity,	which	 is	promoted	by	other	known	or	yet	unknown	factors,	which	are	missing	in	our	reconstituted	reactions.	Therefore,	it	will	be	imperative	to	study	other	pro-CO	proteins	(which	may	 directly	 interact	with	MutLγ),	 post-translation	modifications	 and	 to	 use	 a	better	DNA	substrate	to	more	closely	mimic	the	in	vivo	substrate	to	understand	the	behavior	of	MutLγ	in	meiosis.		To	 further	 study	 the	 interplay	 between	 hMutLγ	 and	 hMutSγ,	 I	 expressed	 and	purified	recombinant	hMutSγ	in	Sf9	cells.	Previously,	hMutSγ	was	shown	to	bind	to	the	core	of	HJs	and	it	showed	sliding	on	HJ	arms	(Snowden	et	al.,	2004).	This	was	 dependent	 on	 ATP	 binding	 but	 independent	 of	 its	 hydrolysis.	 To	 test	whether	 our	 purified	 recombinant	 hMutSγ	 shows	 a	 similar	 behaviour,	 I	performed	 DNA	 binding	 analysis	 of	 hMutSγ.	 Expectedly,	 hMutSγ	 does	 exhibit	DNA	binding	preference	 for	HJs	over	dsDNA,	 confirming	 that	purified	MutSγ	 is	
	 163	
active	and	behaves	similarly	as	reported	previously.	Moreover,	I	could	show	that	hMutSγ	binding	to	HJ	decreases	when	ATP	is	present	in	the	reaction.	In	further	experiments,	 I	 could	also	confirm	that	MutSγ	does	 indeed	slide	on	 the	HJ	arms	rather	 than	 simply	 falls	 off	 upon	 DNA	 binding.	 Although	 hMutSγ	 behaved	similarly	as	characterized	earlier,	the	total	DNA	binding	affinity	of	hMutSγ	to	HJ	was	lower	than	previously	reported.	This	could	be	due	to	ATP	that	may	co-purify	with	our	recombinant	protein.	In	such	a	case,	it	would	also	explain	the	relatively	minor	decrease	of	hMutSγ	binding	to	HJs	upon	ATP	addition.	Therefore,	it	will	be	important	to	test	for	the	presence	of	ATP	in	our	purified	hMutSγ.	
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4.	Outlook			The	 focus	 of	my	 first	 PhD	project	was	 to	 elucidate	 the	mechanism	 involved	 in	DNA	end	resection	in	HR.	Specifically,	how	MRE11	plays	a	central	role	in	5'	to	3'	DNA	 end	 resection	 despite	 its	 opposite	 nuclease	 polarity.	 Here,	 I	 could	demonstrate	 that	 hyper-phosphorylated	 CtIP	 promotes	 MRN	 endonuclease	activity	 on	dsDNA.	This	main	 finding	provides	 the	 supporting	 evidence	 for	 the	proposed	bidirectional	resection	mechanism.			Although	 I	 could	 clearly	 establish	 the	 essential	 role	 of	 CtIP	phosphorylation	 in	MRN-pCtIP	 clipping	 activity,	 how	 exactly	 does	 CtIP	 phosphorylation	 activate	MRN	 on	 the	 mechanistic	 level	 remains	 unanswered.	 I	 believe	 that	 the	 key	 to	answering	 this	 question	 will	 require	 learning	 about	 the	 interactions	 between	MRN	 and	 both	 phospho-	 and	 non-phosphorylated	 CtIP	 variants.	 CtIP	 has	 been	known	 to	 interact	 with	 each	 of	 the	 individual	 subunits	 of	 the	 MRN	 complex	(Sartori	 et	 al.,	 2007;	 Yuan	 and	 Chen,	 2009).	 It	 will	 be	 useful	 to	 study	 these	interactions	 to	map	 the	 exact	position	of	 residues	 required	 for	 the	 interaction.	Upon	interaction	mapping,	various	non-interacting	mutants	of	MRN	and/or	CtIP	can	be	prepared,	which	are	likely	to	provide	further	hints	about	the	mechanism.	It	is	highly	conceivable	that	phosphorylation	of	CtIP	on	certain	sites	changes	its	confirmation.	 Therefore	 the	 structural	 analysis	 of	 wild	 type	 and	 various	 CtIP	mutants	is	greatly	desirable.	It	can	also	be	used	for	in-depth	analysis	of	MRN	and	CtIP	 interactions.	 However,	 the	 low	 yields	 of	 recombinant	 CtIP	 and	 MRN	obtained	during	purification	can	be	limiting.			The	 important	 role	 of	 NBS1	 in	 MRN-pCtIP	 clipping	 activity	 was	 surprising	 as	Xrs2	is	dispensable	in	the	yeast-reconstituted	system	(Oh	et	al.,	2016).	CtIP	has	been	shown	to	interact	with	NBS1	at	its	N-terminal	FHA	domain	as	well	as	the	C-terminus	 (Wang	 et	 al.,	 2013b).	 The	 FHA	 domain	 in	 various	 proteins	 has	 been	described	as	phospho-peptide	binding	domain,	and	the	phosphorylation	of	CtIP	allows	its	binding	to	the	FHA	domain	of	NBS1.	It	will	be	interesting	to	disrupt	the	pCtIP-(FHA)-NBS1	interaction	by	mutating	the	FHA	domain	and	to	determine	its	
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effects	on	the	MRN-pCtIP	activity.	Another	challenging	future	direction	will	be	to	identify	 the	 physiological	 protein	 blocks	 capable	 of	 stimulating	 the	MRN-pCtIP	activity.	It	is	possible	that	SPO11,	the	Ku	heterodimer	or	stalled	topoisomerase-DNA	 complexes	 can	 all	 serve	 as	 the	 protein	 blocks	 in	 different	 scenarios.	 To	investigate	 such	 possibilities,	 it	 will	 require	 the	 production	 of	 mentioned	recombinant	proteins,	which	by	 itself	will	be	a	challenging	 task.	 In	our	current	study,	 the	 usage	 of	 artificial	 block	 yields	 a	 specific	 pattern	 of	 MRN-pCtIP	cleavage.	 It	 will	 be	 intriguing	 to	 see	 the	 nature	 of	 MRN-pCtIP	 cleavage	 with	physiological	protein	blocks	(if	any)	and	whether	the	nicking	pattern	changes	or	it	remains	the	same.			According	to	the	bidirectional	resection	model,	the	MRN-pCtIP	nicks	the	dsDNA	near	to	DSB,	which	is	followed	by	the	degradation	of	ssDNA	in	3'	to	5'	direction	towards	breaks	by	MRE11exonucelolytic	activity.	Multiple	in	vivo	studies	carried	out	in	yeast	supports	this	proposed	model	(Symington,	2016).	However,	no	such	exonucleolytic	degradation	was	observed	in	our	reconstituted	assay	after	MRN-CtIP	 clipping	 of	 dsDNA	 substrate.	 This	 important	 piece	 of	 information	 is	therefore	still	missing	from	the	puzzle.	Moreover,	the	overall	nicking	activity	of	MRN-pCtIP	 is	 not	 very	 efficient.	 Recently,	 the	 roles	 of	 various	 proteins	 like	MCM8-MCM9,	EXD2,	the	SOSS	complex	and	RECLQ4	have	been	identified	in	DNA	end	resection	as	positive	regulators	(Broderick	et	al.,	2016;	Lee	et	al.,	2015;	Lu	et	al.,	 2016b;	 Yang	 et	 al.,	 2013).	 It	 is	 therefore	 possible	 that	 these	 proteins	 may	enhance	 MRN-pCtIP	 activity.	 It	 will	 be	 insightful	 to	 express	 and	 purify	 these	recombinant	proteins	to	see	their	effect	on	MRN-pCtIP	clipping	activity.			In	my	 second	PhD	project,	 I	 set	 out	 to	 study	 the	mechanism	of	 recombination	intermediates	resolution	in	humans	by	the	putative	endonuclease	hMutLγ.	Using	a	biochemical	approach,	I	could	establish	that	hMutLγ	is	indeed	an	endonuclease	that	binds	preferentially	to	HJ	like	structures	(Ranjha	et	al.,	2014).	Additionally,	I	could	I	also	demonstrate	that	human	MSH4-MSH5	positively	influences	hMutLγ	binding	to	HJ.	Despite	of	these	findings,	the	exact	mechanism	of	action	of	hMutLγ	to	process	HJ	remains	elusive.	The	failure	to	detect	any	specific	nuclease	activity	by	 hMLH1-hMLH3	 on	 HJ	 likely	 indicates	 the	 complexity	 of	 the	 underlying	
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mechanism.	 	 In	 the	 future,	multiple	approaches	can	be	 followed	to	better	 learn	about	 the	 anticipated	 HJ	 cleavage	 mechanism.	 It	 is	 strongly	 believed	 that	 the	"correct"	structure	of	recombination	intermediate	will	be	one	of	the	most	crucial	aspects	of	hMutLγ	mediated	biased	resolution.	Therefore	it	will	be	important	to	construct	 the	 dHJ	 structure,	 which	 can	 be	 either	 oligonucleotide-	 or	 plasmid	based,	 and	 test	 hMLH1-hMLH3	 nuclease	 activity	 on	 these	 structures.	 Another	possibility	 is	 the	 regulation	 of	 hMutLγ	 activity	 by	 yet-unidentified	 post-translation	modification(s)	(PTM).	To	test	this	possibility,	hMutLγ	can	be	treated	with	 various	 mediators/effectors	 of	 different	 PTMs	 in	 vitro	 and	 this	 modified	hMLH1-hMLH3	 (if	 any)	 can	 be	 used	 again	 in	 nuclease	 assay.	 Additionally,	 the	mass	spectrometry	analysis	of	hMutLγ	can	be	used	to	identify	the	potential	PTMs	sites	 during	meiotic	 recombination.	Although	hMSH4-hMSH5	did	not	 stimulate	hMutLγ	 nuclease	 activity	 on	 supercoiled	 dsDNA,	 it	 is	 possible	 that	 other	stimulatory	factors	are	missing	from	the	reaction.	For	instance,	the	activation	of	nuclease	activity	of	hMLH1-PMS2	requires	the	ensemble	of	various	proteins.	It	is	highly	 probable	 that	 the	 same	 is	 true	 for	 hMutLγ	 as	 well.	 	 The	 hMutLγ	 only	showed	Mn2+-dependent	nicking	activity	whereas	no	such	activity	was	observed	in	Mg2+.	As	Mg2+	is	more	abundant	than	Mn2+	in	physiological	condition,	it	will	be	useful	to	study	the	apparent	lack	of	activity	of	hMutLγ	in	Mg2+.	The	DNA	binding	analysis	 data	 showed	 that	while	ATP	 slightly	 stimulates	hMutLγ	binding	 to	HJ,	hMSH4-hMSH5	binding	to	HJ	decreases	with	ATP.	It	will	be	interesting	to	study	the	specific	effect	of	ATP	in	more	details	on	both	heterodimers	separately	as	well	as	 in	 combination.	 Similar	 to	 hMutLγ,	 it	 will	 be	 important	 to	 learn	 about	 the	posttranslational	 modifications	 of	 hMSH4-hMSH5	 and	 apply	 the	 knowledge	 to	further	 elucidate	 the	 mechanism.	 The	 understanding	 of	 the	 process	 of	 biased	resolution	by	hMLH1-hMLH3	may	require	any	of	the	processes	described	above	or	their	combination.		
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